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Abstract 
 
Bacteriophage are a diverse class of viruses that infect bacterial cells. As a result of over 60 
years of molecular biology advances, bacteriophage today feature as candidates for vaccination, 
gene therapy, biomaterial and antibacterial purposes. Consequently, scientific, commercial and 
public awareness of bacteriophage is growing rapidly. There is now an increasing need for the 
establishment of strong biochemical engineering foundations to serve as a guide for future 
bacteriophage bioprocessing. It has been the purpose of this study to contribute towards this 
knowledge base, by understanding the properties of the filamentous bacteriophage M13. 
Ultimately, this work has aimed to allow for the more efficient assembly of a large-scale 
production process. 
 
By the application of well-understood small-scale predictive techniques, it has been found that 
bacteriophage M13 should not be severely damaged by hydrodynamic shear forces of the 
duration and magnitude imparted by fermentation, pumping or continuous centrifugation 
operations. Thus, it may well be possible to manufacture on the large-scale using existing large-
scale equipment designs.  
 
Amongst bacteriophage, the reproduction strategy of M13 is unusual in that propagation occurs 
by the non-lethal extrusion of progeny through the cell wall of the E. coli host. Investigation of 
bacteriophage M13 propagation indicated that growth in a medium that increased host cell 
density concomitantly increased bacteriophage yield; a four-fold increase to 2 x 10
12 pfu ml
-1 
was achieved. At the end of culture, concentrations of supernatant DNA and protein 
contaminants were found to vary amongst three E. coli strains studied. 
 
Post-fermentation, bacteriophage M13 can be precipitated from the cell-free process fluid by as 
little as 2 % (w/v) PEG 6 000 plus 25 mM magnesium sulphate, or by isoelectric precipitation. 
Purification factors in excess of 100 were achieved by PEG-salt precipitations with regards to 
the reductions in DNA and protein concentrations. 
 
Methods used in this study have increased the processing knowledge of bacteriophage M13 and 
have a broader applicability to both derivatives of M13 and other bacteriophage.   5 
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1  Introduction 
1.1  Project Significance 
Bacteriophage-based products offer promise of a new generation of antimicrobial treatments, 
vaccines and gene therapy. There have been numerous discoveries  and proof-of-concept 
demonstrations in recent years (Hagens et al., 2006; Lankes et al., 2007; Lee et al., 2009; 
Solomon, 2008; Wright et al., 2009), and several companies exist in the UK and aboard to 
commercialize many of these findings (Housby and Mann, 2009). But the industry is very much 
in its infancy. On the road from discovery to market, a key challenge is the application of 
biochemical engineering principles to translate production of novel therapeutics from the 
laboratory to the large-scale process (Levy et al., 2000b). To be effective, a production process 
must manufacture bacteriophage in a rapid, robust and cost-effective manner whilst maintaining 
the quality of the product. Furthermore, an understanding of the process at a fundamental level 
is becoming ever more crucial, as regulatory bodies such as the USA Food and Drug 
Administration and the European Medicines Agency (EMEA) increase pressure on the industry 
to fully understand their processes, and for early stage material to be more representative in 
quality to that of final manufacture (Lionberger et al., 2008; Rathore and Winkle, 2009). 
 
The filamentous bacteriophage M13 features as a tool in several lines of investigation (Hagens 
and Blasi, 2003; Lee et al., 2009; Meola et al., 1995; Solomon, 2008), but if these concepts 
were to come to fruition, limited literature currently exists specifically contributing towards its 
large-scale manufacture (Grieco et al., 2009; Ling et al., 2004; Smith and Gingrich, 2005). 
There is therefore much to understand about the large-scale production of this bacteriophage 
and its processibility at a fundamental level. Work to contribute towards the biochemical 
engineering knowledge of these entities would be timely. 
 
Bacteriophage are relatively novel bioproduct entities and vary enormously in physical form 
and biological action. Understanding their form and manner of replication is fundamental to 
bioprocess design. This thesis concerns bacteriophage M13, which will be described in terms of 
its physical structure and replication strategy in the following pages. The relevance of 
bacteriophage as bioproducts will be discussed: today, bacteriophage-based therapeutics cover a 
broad spectrum of applications. Focusing on the manufacturing considerations of bacteriophage 
M13, an outline of potential strategies for its upstream production and downstream purification 
will be introduced. Drawing together the information presented thus far, the objectives of this 
thesis will be described. 
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1.2  Introduction to Bacteriophage 
Bacteriophage are a class of viruses whose hosts are bacterial cells. Like all viruses, 
bacteriophage exist in a metabolically inert extracellular state and reproduce only upon infection 
of a suitable host cell. Their discovery is credited to two researchers, Twort and d'Herelle, who 
independently identified these agents of bacterial lysis in the early twentieth century (d'Herelle, 
1917; Twort, 1915). Like bacteria, bacteriophage are ubiquitous in the environment, and, for 
every prokaryote group identified, almost invariably a corresponding bacteriophage has been 
isolated. Bacteriophage exhibit a variation and versatility as great as their hosts: therefore a 
level of caution is necessary when making generalisations about their behaviour.  
 
1.2.1  Bacteriophage structural diversity 
All bacteriophage carry a genome encased within a protein coat, although genomes may consist 
of single or double-stranded DNA or RNA, and may be circular or linear in form. Similarly, the 
protective protein coat (or capsid) displays a high level of morphological variety. As may be 
expected, bacteriophage classification is somewhat difficult and is chiefly defined by the 
physical morphology of the particle and the nature of the genome present (Ackermann, 2005). 
Broadly, bacteriophage are grouped into "tailed" or "tail-less" categories, referring to a common 
virion structure. The physical appearance of three bacteriophage which share Escherichia coli as 
a host is shown in Figure 1.1. The diversity of their physical forms is apparent: whereas 
bacteriophage R17 and ! both possess an icosahedral capsid, only ! displays a tail structure. In 
contrast, bacteriophage M13 appears as a semi-flexible tube several times longer than either 
R17 or !. 
   25 
 
 
Figure 1.1 Transmission electron micrographs of three bacteriophage of E. coli. (A) shows a 
cluster of bacteriophage R17 attached to an E. coli F pilus, reproduced from Schmidt (1966). 
(B) shows a single bacteriophage !, image available online (Inman, 2005). (C) shows the long 
thin filamental structure of several bacteriophage M13, image by this author. 
 
 
1.2.2  The filamentous structure of bacteriophage M13 
Bacteriophage M13 was first discovered in the sewers of Munich in 1963 (Hofschneider, 1963). 
It is one of several related filamentous bacteriophage, the other most commonly encountered 
being fd and f1. The genomic differences between M13, fd and f1 are slight and the particles are 
indistinguishable in appearance (Russel et al., 2004). Collectively, they are known as Ff 
bacteriophage. Each M13 particle contains a 6.6 kb single-stranded DNA genome containing 
nine genes which encode for eleven proteins. Five of these proteins (pIII, pVI, pVII, pVIII, pIX) 
form the bacteriophage coat, the other six being required for DNA replication and bacteriophage 
assembly (Table 1.1). As noted in Figure 1.1, the defining characteristic of M13 is its 
filamentous appearance: 900 nm in length and 6.5 nm in diameter (Berkowitz and Day, 1976; 
Model and Russel, 2006). Figure 1.2 shows a schematic diagram of an M13 particle, where each 
of the five coat proteins is labelled. The bulk of the coat is made from approximately 2 700 
copies of pVIII, a 5 kDa protein which has been shown to be arranged in an overlapping helical-
pitched cylinder about the single-stranded DNA core (Overman et al., 1996). The DNA genome 
runs almost the entire length of the particle (Makowski, 1992). Each end of the particle is 
"capped" by other coat proteins. Approximately five copies each of pVII (approximately 3.6 
kDa) and pIX (3.5 kDa) form the so-called "distal" tip of the virus, while five each of pIII 
(approximately 45 kDa) and pVI (13 kDa) form the "proximal" tip (Endemann and Model,   26 
1995; Russel et al., 2004). It is the proximal tip of bacteriophage M13 that interacts with the E. 
coli cell wall to initiate infection. 
 
 
Table 1.1 The nine genes of Ff filamentous bacteriophage encode for eleven proteins. Five 
proteins form the bacteriophage coat whilst six are required for DNA replication and 
bacteriophage assembly. The location of each protein in the E. coli host or on the bacteriophage 
particle are given. Adapted from Russel et al. (2004). 
 
Gene  Protein  Function  Location 
gI  pI  Assembly  Inner membrane 
  pXI  Assembly  Inner membrane 
gII  pII  Replication (nickase)  Cytoplasm 
  pX  Replication  Cytoplasm 
gIII  pIII  Coat component  Proximal tip 
gIV  pIV  Assembly (exit channel)  Outer membrane 
gV  pV  Replication (ssDNA bp)  Cytoplasm 
gVI  pVI  Coat component  Proximal tip 
gVII  pVII  Coat component  Distal tip 
gVIII  pVIII  Coat component  Virion filament 
gIX  pIX  Coat component  Distal tip 
 
 
 
 
 
Figure 1.2 A schematic diagram of a single M13 bacteriophage. The labels indicate the location 
of each of the five proteins that constitute the bacteriophage coat. Packaged within the coat is a 
circular single stranded (ss) DNA genome. 
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1.2.3  General principles of bacteriophage replication 
The replication cycles of bacteriophage are very different to their bacterial hosts and can 
typically be characterised by four distinct phases: adsorption, infection, multiplication and 
release (Guttman et al., 2005). The adsorption phase is dependent on the presence of specific 
receptors on the surface of the bacterial host cell, to which the bacteriophage can attach (Kutter 
et al., 2005). The bacteriophage is brought to the host receptor by random diffusion. Following 
adsorption, the infection phase occurs as the bacteriophage genome passes into the host cell by a 
mechanism likened to injection (Kutter et al., 2005). Post-infection, the onset of the 
multiplication phase is dependent on the bacteriophage species. In the so-called lytic replication 
cycle (that is, bacteriophage production will culminate in the lysis of the host cell), the 
multiplication phase begins immediately. Normal host metabolism ceases as replication of the 
bacteriophage genome and synthesis of virion proteins occupy the host cell’s synthetic 
machinery (Guttman et al., 2005). Progeny virion particles are systematically assembled in 
controlled stages inside the host cytoplasm (Shors, 2008). When this process is complete the 
final "release" phase occurs, where the host cell is lysed from within to release the newly 
constructed progeny bacteriophage in a single burst.  
 
The temperate cycle (also known as lysogeny) is an alternative replication strategy that also 
begins with adsorption and infection, but instead of entering the multiplication phase the bulk of 
bacteriophage-specific transcription slows to a halt whilst the bacteriophage DNA is maintained 
within the host cell as the cell divides and multiplies (Birge, 2000). The bacteriophage DNA can 
become integrated into the host genome and persist there indefinitely, replicating alongside the 
host cell genome as a heritable DNA segment (Campbell, 2006). An environmental trigger can 
induce the expression of the bacteriophage lytic genes from the bacteriophage DNA, through 
(for example) stimulation of the host cell SOS response (Little, 2006). The replication cycle 
therefore enters the multiplication phase, producing progeny as described in the lytic pathway. 
The well-studied bacteriophage ! has the ability to undergo the lytic and temperate cycles 
(Little, 2006). 
 
The replication strategy of M13 and other filamentous bacteriophage is an exception because 
the bacteriophage undergo neither a lytic nor a temperate cycle. As in the lytic cycle, 
bacteriophage multiplication begins immediately upon infection (Calendar and Inman, 2005). 
Crucially however, normal host cell processes are not shut down upon infection and progeny are 
not released in a single cell lysis event. Instead, progeny bacteriophage are continually 
assembled at, and extruded through, the cell wall into the milieu (Russel et al., 2004). The host 
cell is not killed and in fact continues to divide, albeit at a reduced rate (Salivar et al., 1964). 
Figure 1.3 shows a transmission electron micrograph of an E. coli cell infected with the   28 
filamentous bacteriophage ZJ/2, a relative of bacteriophage M13. Many progeny bacteriophage 
can be observed in the process of being extruded through the cell wall (Bradley and Dewar, 
1967). 
 
 
Figure 1.3 A transmission electron micrograph of an E. coli cell infected with filamentous 
bacteriophage ZJ/2, a close relative of bacteriophage M13. The largest filaments observed are 
flagella, the thinner ones F pili. The shorter, thin filaments clustered around the bacterium are 
the bacteriophage. Reproduced from Bradley and Dewar (1967). 
 
 
1.2.4  The replication of bacteriophage M13 
A schematic diagram summarising the essential steps of bacteriophage M13 replication is 
shown in Figure 1.4. The absorption phase of M13 replication begins upon the diffusion of an 
infective particle to the tip of an E. coli F pilus. Only E. coli cells holding the F-plasmid express 
the F pilus, therefore bacteriophage infection is limited to those cells. It is the pIII protein at the 
proximal end of the bacteriophage particle that adsorbs onto the tip of the F pilus, which is then 
retracted by a mechanism that is not yet fully understood (Model and Russel, 2006). Upon 
reaching the cell wall the pIII protein interacts with the bacterial Tol protein complex, allowing 
bacteriophage protein coat depolymerisation and injection of DNA into the cytoplasm 
(Pommier et al., 2005). Thus the infection phase occurs. 
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The multiplication phase begins with the conversion of the single-stranded M13 DNA (the 
"positive" or "+" strand) into a supercoiled double-stranded replicative form (RF) by host RNA 
and DNA polymerases and topoisomerase (Russel et al., 2004). The RF serves as the template 
for bacteriophage gene expression, which is necessary for further replication (particularly the 
synthesis of bacteriophage protein pII). M13 DNA replication proceeds by a modified rolling 
circle mechanism, beginning with a nick on the + strand origin by bacteriophage protein pII (a 
site-specific nicking-closing enzyme). Extension of the 3’ end of the nick is made by E. coli 
DNA polymerase III using the negative (–) strand as a template. The original + strand is 
displaced by E. coli Rep helicase as the new is synthesised, and when the process is complete 
the displaced positive strand is recircularised by pII and converted into more RF DNA. Thus, as 
this process is repeated for all newly synthesized RFs, the level of RF, and consequently 
synthesized bacteriophage protein, increases (Russel, 1995). 
 
The accumulation of RF DNA continues until critical concentrations of proteins pX and pV are 
reached. In particular, several copies of pV bind to newly generated + strands to form single-
stranded DNA-pV complexes, blocking their conversion to RF DNA. The sequestered + DNA 
strands are earmarked for bacteriophage assembly at the E. coli cell membrane (Birge, 2000). 
 
The release phase of bacteriophage M13 replication can be described as progressing in five 
stages: pre-initiation, initiation, elongation, pre-termination and termination. Pre-initiation 
encompasses the formation of an assembly site at the cell wall; a composition of three 
bacteriophage proteins pI, pXI and pIV at a point where the cytoplasmic and outer membranes 
are in close contact. The channel (through which the assembling bacteriophage passes) is 
formed by protein pIV (Russel et al., 2004). Initiation occurs when the assembly site, a single-
stranded DNA-pV complex and distal coat proteins pVII and pIX are present (Feng et al., 
1999). It is thought that an exposed region of DNA from the single-stranded DNA-pV complex 
(known as the "packing signal", or PS) interacts with the membrane-bound bacteriophage 
proteins pVII and pIX to initiate assembly and form the distal end of the bacteriophage particle 
(Russel and Model, 1989). During the elongation stage the single-stranded DNA genome 
translocates the cell wall. On the cytoplasmic side, pV is progressively shed from the DNA as it 
enters the pIV channel, whilst pVIII proteins are added in a helical array to form the bulk of the 
bacteriophage protein coat (Webster and Lopez, 1985). The pre-termination stage occurs once 
translocation of the DNA is almost complete. Five copies each of proteins pIII and pVI are 
incorporated to form the proximal end of the extruded bacteriophage particle. The complete 
M13 virus is then released from the cell wall. 
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Figure 1.4 A schematic drawing outlining the lifecycle of the M13 bacteriophage. Infection 
begins with the binding of the pIII coat protein to the tip of an F pilus, causing retraction, 
followed by interaction with the Tol protein complex. Accumulation of bacteriophage protein 
and RF DNA then occurs until sufficient pV is synthesized to sequester newly generated ssDNA 
from further RF DNA creation. The packing signal (PS) – a region of DNA protruding from 
ssDNA-pV complex – interacts with bacteriophage coat proteins pVII and pIX at the assembly 
site (pI/XI and pIV) to initiate bacteriophage assembly. Progeny bacteriophage are produced 
and continuously extruded in a non-lethal mechanism. 
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1.3  Techniques Underpinning Bacteriophage Use as Bioproducts 
The exploitation of bacteriophage as antimicrobial bioproducts first occurred soon after their 
discovery in the early 20th century. However, potential applications of bacteriophage today 
spread far beyond antimicrobial use, built upon over 60 years of advances made in the field of 
molecular biology. Therefore, the techniques underpinning modern bacteriophage-based 
bioproducts display diversity too. 
 
1.3.1  Bacteriophage use in infection control: bacteriophage therapy 
Since bacteriophage infection typically results in the death of the host bacterial cell, their use as 
antimicrobial agents has long been recognised. Indeed, the first known applications of 
bacteriophage to treat bacterial disease are reported to date back to within five years of their 
discovery (Sulakvelidze et al., 2001). 
 
The treatment of bacterial disease by bacteriophage is known as phage therapy. Early work 
focused on the treatment of humans (Asheshov et al., 1937; Burnett et al., 1930; Walker, 1929), 
although modern studies have demonstrated bacteriophage antimicrobial action in animals 
(Smith et al., 1987), aquaculture (Nakai and Park, 2002), food products (Carlton et al., 2005) as 
well as humans (Sulakvelidze and Kutter, 2005). Almost all trials utilize naturally occurring 
lytic bacteriophage for treatment, although success with genetically modified variants has been 
demonstrated (Fairhead et al., 2009; Westwater et al., 2003). 
 
The route of bacteriophage application is as varied as the uses themselves. Surface microbial 
decontamination of food and animals has been simply accomplished by bacteriophage solution 
wash or spray (Carlton et al., 2005; Smith et al., 1987) whilst intraperitoneal or intramuscular 
injection into animals has been conducted (Barrow et al., 1998; Nakai and Park, 2002). 
Meanwhile, phage therapy treatment of humans has included the topical, oral and intravenous 
routes (Sulakvelidze and Kutter, 2005).  
 
A defining characteristic of phage therapy is that the quantity of bacteriophage required for 
successful microbial control can be many times less than the number of target organisms: 
bacteriophage replication can occur in vivo, and is self-limiting (Smith and Huggins, 1982). 
That is, once the target bacteria are all infected and lysed, replication ceases and remaining 
bacteriophage are removed by the immune system. However, the host immune response to 
systemic bacteriophage (as opposed to oral or topical) has raised important questions 
concerning the repeated applicability of bacteriophage therapy intravenously: bacteriophage are 
immunogenic and therefore elicit an antibody response (van Houten et al., 2006). Consequently, 
debate exists as to whether in vivo bacteriophage therapy can be used repeatedly or for 
prolonged periods for each patient (Clark and March, 2006). Perhaps accordingly, many modern   32 
studies have focused on the topical or oral application of bacteriophage (Bruttin and Brussow, 
2005; Wright et al., 2009) or agriculture situations where repeated dosage is unlikely (Fiorentin 
et al., 2005; Wagenaar et al., 2005). 
 
A second important characteristic distinguishing phage therapy from antibiotics use is the 
specificity that bacteriophage exhibit for a target bacteria (Birge, 2000). This specificity is quite 
unlike the broad spectrum action of antibiotics. Therefore, phage therapy often uses so-called 
bacteriophage cocktails, where more than one bacteriophage type is applied concurrently (Smith 
and Huggins, 1983; Wright et al., 2009).  
 
1.3.2  Bacteriophage as molecular biology tools 
Scientific understanding of the structure and lifecycle of bacteriophage was pioneered in the 
middle of the 20th century (Doermann, 1952; Ellis and Delbruck, 1939; Luria, 1945), and laid 
the basis for the development of molecular biology. Bacteriophage have subsequently been 
exploited as model systems, aiding our primary understanding of DNA, the genetic code and the 
molecular mechanisms of gene regulation (Summers, 2005). Bacteriophage-derived enzymes 
including DNA polymerase (bacteriophage T4, T7) RNA polymerase (T3, T4, SP6) and DNA 
ligase (T4) are now widely and routinely exploited as molecular biology tools (Marks and 
Sharp, 2000). Further advances in molecular biology have resulted in the development of 
bacteriophage as expression vectors for the display of foreign gene products on the 
bacteriophage surface. This so-called phage display technique was first demonstrated in 1985 
(Smith) on bacteriophage M13, although the technique has been successfully applied to 
bacteriophage ! and others (Cicchini et al., 2002; Danner and Belasco, 2001; Heal et al., 1999). 
The expression of foreign gene products (such as antibody fragments) on the bacteriophage coat 
confers whole new functionalities to these molecules, and as a result this technology now 
underpins many of the modern applications of bacteriophage.  
 
1.3.3  Phage display technology 
A phage display construct is generated by the insertion of DNA encoding for a foreign 
(heterologous) protein into the bacteriophage genome. This DNA is added as a transcriptional 
fusion to one of the coat protein genes, meaning that progeny bacteriophage subsequently 
express the heterologous protein as a surface fusion to the corresponding coat protein.  
 
For bacteriophage M13, this technique has allowed the display of heterologous proteins on all 
five coat proteins, although by far the most commonly used are coat proteins pVIII and pIII 
(Russel et al., 2004). A fusion to these coat proteins is not consequence-free, however: peptides 
longer than six residues fused to every pVIII heavily decreases phage viability (Iannolo et al.,   33 
1995), while substantial fusions to pIII can reduce infectivity. Nevertheless the pIII coat protein 
can generally tolerate much larger phage display fusions, up to 100 residues (Baek et al., 2002). 
 
A common approach to solve both these issues is to supply an excess of wild-type coat proteins 
to the host cell, usually via the superinfection of the host cell by a helper bacteriophage. The 
foreign DNA-coat protein fusion is instead expressed from a phagemid vector within the 
infected host, which contains both plasmid and bacteriophage replication origins, but no other 
bacteriophage genes (Russel et al., 2004). The resulting progeny bacteriophage have only a few 
copies (and sometimes none) of the fused coat protein each. Due to their smaller genome 
packaged within, the progeny are also shorter in length than wild-type bacteriophage M13 
(Khalil et al., 2007). The mainly wild-type protein coat confers greater stability to the phage 
particle and allows the display of larger polypeptides: for pVIII the maximum fusion size 
increases from 7-8 residues to beyond 25 kDa (Corey et al., 1993; Intasai et al., 2003). 
 
The phage display technique is closely associated with the generation of random peptide 
"libraries", where DNA of interest is fragmented and randomly cloned into phagemid vectors, 
again as transcriptional fusions to a bacteriophage coat protein (Mullen et al., 2007). 
Subsequent screening of the library allows for the selection of bacteriophage with fusions that 
exhibit binding to specific antibodies, receptors or even inorganic materials of interest (Frenkel 
et al., 2003; Poul and Marks, 1999; Whaley et al., 2000). Further, DNA sequencing of the insert 
to the bacteriophage genome then allows for the rapid identification of the amino acid sequence 
of the fusion of interest. 
 
As mentioned previously, the phage display technique is not limited to filamentous 
bacteriophage such as M13. Other bacteriophage successfully displaying proteins on their 
surfaces include bacteriophage ! (Cicchini et al., 2002), T7 (Danner and Belasco, 2001) and 
MS2 (Heal et al., 1999). 
 
1.3.4  Gene delivery utilizing bacteriophage 
Developed using the technique of phage display, bacteriophage (both filamentous and lytic) 
now show applicability in the field of gene delivery (Hart et al., 1994; Larocca et al., 2001; 
Liang et al., 2006; Zanghi et al., 2005). Phage display enables the expression of specific surface 
molecules on bacteriophage that cause binding to mammalian receptors (Legendre and Fastrez, 
2002). The scientific advance lies in the additional insertion of mammalian promoter and 
reporter genes into the bacteriophage genome for transcription within the mammalian cell: 
successful internalisation and expression of reporter genes GFP (Poul and Marks, 1999) and 
luciferase (Lankes et al., 2007) have been demonstrated. In a related approach not necessarily 
requiring phage display, the use of bacteriophage as vehicles for DNA vaccine delivery has   34 
been reported (Clark and March, 2004a; March et al., 2004). Here, bacteriophage uptake is by 
antigen-presenting cells. Once engulfed and the protein coat broken down, the DNA is freed and 
the vaccine expression cassette is transcribed, resulting in vaccine protein expression. 
 
 
1.4  Examples of Bacteriophage-Based Bioproducts 
Clinical and food-related investigations of bacteriophage technology can be broadly categorised 
into the major areas of antibacterial action, vaccination and gene therapies. Further niche 
applications of bacteriophage include use as groundwater tracers (Harvey, 1997), as bio-defence 
agents and as bacterial diagnostic tools (Petrenko and Vodyanoy, 2003). Although many of the 
technologies described are in early stages of development, the breadth and depth of innovation 
in the field suggest that studies contributing the large-scale production of these entities are 
timely. 
 
1.4.1  Bacteriophage therapy 
Bacteriophage therapy became a major area of research interest the early 20th century 
(Asheshov et al., 1937; Burnett et al., 1930; Walker, 1929), some way before a thorough 
scientific understanding of bacteriophage structure and lifecycle was gained (Doermann, 1952; 
Ellis and Delbruck, 1939; Luria, 1945). Many early studies correspondingly reported failure 
(Davison, 1922; Morrison, 1932), and it is thought that a poor understanding of bacteriophage 
behaviour contributed to the mixed results achieved (Barrow, 2001; Chanishvili et al., 2001; 
Marks and Sharp, 2000). Chiefly, the concept of the lytic and temperate replication cycles was 
unheard of (thereby precluding the selection of effective, lytic bacteriophage), and the 
utilisation of broader host-range bacteriophage was not understood. Finally, poor experimental 
planning and quality control were also thought to have been responsible for several 
disappointing trials (Summers, 2005). As a result, research interest in bacteriophage therapy 
was already waning by the time antibiotics were introduced in the middle of the 20th century 
(Carlton, 1999). 
 
The situation has been quite different in the former Soviet countries of Eastern Europe, where 
research into bacteriophage therapy continued. Recently, effort has been expended to translate 
historical studies published in the region into English, although it has been found that with 
regards to control data, experimental methodology has been frequently flawed (Alisky et al., 
1998; Chanishvili et al., 2001). Therefore, such studies will not provide a shortcut to the 
rigorous proof of efficacy required of bacteriophage therapy today. 
 
In recent years interest in bacteriophage as antibacterial agents has been somewhat revived as 
the limitations of antibiotic therapy have become apparent. With a thorough understanding of   35 
bacteriophage biology, many of the issues described as afflicting early studies in the 20th 
century can now be avoided. Modern, controlled studies have successfully demonstrated 
microbial control by bacteriophage in a variety of settings. Advanced examples are the 
commercial control of Listeria monocytogenes on food by bacteriophage (Carlton et al., 2005) 
and their use as antibacterial "pesticides" on commercial tomato and pepper crops (Balogh et 
al., 2003). Clinical trials of bacteriophage-based therapies for human use include treatment of 
chronic Pseudomonas aeruginosa infections of the ear (Wright et al., 2009) and against 
Staphylococcus aureus infections (Fairhead, 2009; Housby and Mann, 2009). The former 
utilizes a cocktail of naturally-occurring lytic bacteriophage to kill bacteria, whilst the latter 
uses genetically modified bacteriophage as a vector to deliver lethal genes to the target cells: in 
effect a form of gene delivery. 
 
Other demonstrations of "gene delivery phage therapy" detail the use of the normally non-lethal 
bacteriophage M13 to deliver genes encoding for lethal agents to E. coli (Hagens and Blasi, 
2003; Westwater et al., 2003), and bacteriophage Pf3 to Pseudomonas aeruginosa (Hagens et 
al., 2004). These inventions are yet to be commercialised, however. An advantage of these gene 
delivery methods lies in the prevention of bacterial lysis: the cells are killed but not lysed by 
bacteriophage infection. The release of endotoxin from lysed Gram-negative cells has the 
potential to provoke a strong (negative) biological response in patients, so this could be usefully 
avoided (Gorbet and Sefton, 2005).  
 
A further alternative method to control microbial infection has been to apply bacteriophage-
derived lytic enzymes rather than whole bacteriophage. These have been shown effective in vivo 
against Streptococcus pneumoniae infections of mice (Entenza et al., 2005). 
 
With the increasingly widespread development of antibiotic-resistant pathogenic bacteria, the 
need for new antibiotics and new strategies to control microbial infection is of rapidly 
increasing importance; the cost of antibiotic resistant infections has been estimated at $7.7 
billion in the United States alone, a figure which does not include the wider costs to the 
community (Reed et al., 2002).  
 
With clinical trials in progress against P. aeruginosa and S. aureus, and successful animal-
model demonstrations of bacteriophage therapy treatments against S. aureus (Matsuzaki et al., 
2003), C. difficile (Ramesh et al., 1999) as well as E. coli and S. pneumoniae, bacteriophage 
therapy may yet have a renewed role to play in the treatment of infection. This may be as either 
as a single treatment or in conjunction with antibiotics – these therapies need not be mutually 
exclusive (Hagens et al., 2006). 
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1.4.2  Bacteriophage as vaccination tools 
Bacteriophage have been demonstrated to have a dual ability to act as tools for vaccine delivery. 
Firstly, using phage display, they can display vaccine antigens as fusions to their coat proteins, 
which elicit the desired immune response (Wang and Yu, 2004). Secondly, the bacteriophage 
particle can be used as a gene delivery vehicle to deliver a DNA vaccine expression cassette to 
eukaryotic cells (March et al., 2004).  
 
Reflecting their predominant use in phage display, filamentous bacteriophage such as M13 have 
been commonly used to display vaccine antigens. Examples include hepatitis B mimotopes 
(Meola et al., 1995; Wan et al., 2001), Plasmodium vivax (a protozoal parasite responsible for 
some types of malaria) surface protein mimotopes (Demangel et al., 1998) and segments of " 
amyloid peptides (Frenkel et al., 2003). The latter study investigated the use of filamentous 
bacteriophage to immunize against Alzheimer's Disease (AD). It is thought that progression of 
AD results from the increased production of " amyloid peptides (A"P) and their progressive 
accumulation as plaques in the brain of sufferers (Hawkes and McLaurin, 2007). Treatments 
have therefore focused on the promotion of plaque disaggregation. A randomly generated phage 
display library was screened with a specific anti-A"P antibody (which promotes plaque 
disaggregation), which preferentially selected clones displaying a sequence of four 
characteristic peptides (EFRH). This sequence corresponded to the N-terminal region of A"P 
(Frenkel et al., 1998). Subsequent intranasal immunisation of AD transgenic mice with the 
selected bacteriophage clones rapidly provoked an anti-A"P antibody response. The amyloid 
plaque burden reduced and cognitive ability improved, suggesting that a filamentous 
bacteriophage-based immunization procedure could potentially offer a treatment to AD 
sufferers (Frenkel et al., 2003; Solomon, 2008). This discovery is particularly significant when 
it is considered that the worldwide cost of Alzheimer's Disease and dementia combined has 
been estimated in excess of $300 billion (Wimo et al., 2007). 
 
Overall, the antigen-displaying bacteriophage vaccination therapy is thought to offer several 
potential advantages over recombinant protein, carbohydrate or peptide carrier protein fusions 
(Clark and March, 2004b). Chiefly, the ability to select displayed peptides from a phage display 
library against the specified antiserum means one need not have prior knowledge of the antigens 
themselves (Frenkel et al., 1998). Further, once isolated, it is straightforward to reproduce the 
bacteriophage for eventual manufacture. Finally, although the immunogenic nature of 
bacteriophage themselves is a cause for concern in the bacteriophage therapy arena (Section 
1.3.1) in terms of vaccination efficacy, the bacteriophage scaffold may have a useful immuno-
stimulatory "adjuvant" effect (van Houten et al., 2006). 
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Meanwhile, investigations into the use of bacteriophage as DNA vaccine candidates primarily 
utilize lytic bacteriophage (as opposed to non-lytic M13), and are a more recent innovation 
compared to antigen-displaying bacteriophage methods (Clark and March, 2004a; March et al., 
2004). Studies on bacteriophage ! expressing hepatitis B surface antigen have suggested that 
such vectors are more effective (that is, provoke a stronger antibody response) in mouse (Clark 
and March, 2004a) and rabbit (March et al., 2004) models than equivalent plasmid DNA 
constructs. 
 
1.4.3  Bacteriophage as vectors for gene delivery 
The wider field of bacteriophage-based gene delivery field is in its infancy. As noted earlier, 
successful demonstrations of gene delivery to mammalian cells have thus far been limited to the 
expression of reporter genes such as GFP (Larocca et al., 2002; Poul and Marks, 1999) by 
filamentous bacteriophage systems or luciferase by bacteriophage ! (Lankes et al., 2007). Work 
has instead focused on improving levels of gene expression (Burg et al., 2002; Liang et al., 
2006). 
 
In general terms there are several available technologies for gene delivery, the most advanced 
being naked (or plasmid) DNA-based vectors and eukaryotic-based viral vectors. Of the gene 
therapy clinical trials monitored worldwide in 2009 (Edelstein et al., 2009), the three most 
common vectors in use were adenovirus (n=377), retrovirus (n=329) and naked DNA-based 
vectors (n=281). No individual bacteriophage-based gene therapy trials are yet listed.  
 
More research is needed to determine the commercial viability of bacteriophage-based 
vaccination and gene therapy technologies. But with the total biopharmaceutical market 
expected to reach an overall value of $70 billion within four years (Walsh, 2006), the potential 
rewards are high. 
 
1.4.4  Bacteriophage M13 as a biomaterial 
Away from the pharmaceutical arena, considerable interest has been expressed in exploiting the 
physical properties of bacteriophage M13 and its close relations. Phage display has been 
extensively utilized to generate bacteriophage particles displaying surface peptides with 
functionality towards inorganic materials. For example, peptides promoting the nucleation of 
semiconducting and magnetic crystals have been demonstrated to create bacteriophage-based 
"nanowire" structures (Huang et al., 2005; Mao et al., 2004). Further work has harnessed the 
natural ability of bacteriophage M13 to form liquid crystal structures at high concentrations 
(Dogic and Fraden, 2006; Graf et al., 1993) together with the selection of bacteriophage 
displaying peptides with affinities for specified inorganic crystal surfaces. The result has been 
the creation of 2-D composite materials (Lee et al., 2002; Yoo et al., 2006). Most recently, the   38 
formation of multilayered structures has culminated in the demonstration of functional 
bacteriophage M13-based lithium-ion batteries. (Lee et al., 2009; Nam et al., 2006). A 
performance comparison with existing lithium-ion battery technology was broadly positive. If 
bacteriophage-based batteries proved economically feasible to produce, they would compete in 
a lithium-ion battery market worth in excess of $3 billion in the United States alone 
(Balakrishnan et al., 2006). 
 
 
1.5  Considerations Concerning Bacteriophage Bioproducts 
1.5.1  The regulatory perspective 
The regulatory hurdles a potential bacteriophage therapeutic must clear are dependent upon its 
intended use. Understandably, the controls on a bacteriophage-based therapeutic intended for 
clinical use (classified as a drug) are more stringent that those for food use (classified as a food 
additive). In turn, the application of bacteriophage to entirely non-pharmaceutical or food uses 
(such as a biomaterial) requires less regulation.  
 
For any product to be released onto the food or health markets it must receive approval from the 
relevant regulatory authorities in the country of release, such as the USA Food and Drug 
Administration (FDA) and the European Medicines Agency (EMEA). In order to achieve this, it 
must be shown to be efficacious and safe for use. A number of regulatory issues have arisen 
surrounding bacteriophage-based products intended for clinical use, in part due to the unique 
nature of these therapies. One (still current) example (Withington, 2001) is a guideline from the 
International Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use (ICH), concerning the test procedures and acceptance criteria 
for a biotechnological or biological product (ICH, 1999). The guideline specifically 
differentiates between certain products resulting from recombinant or non-recombinant cell 
culture: protein and peptide products (guideline applicable), and antibiotic, DNA and 
conventional vaccine products (guideline not applicable). The question arises: which guideline 
applies to bacteriophage? Are they a protein or a DNA product? Will the relevant guidelines 
applicable to a bacteriophage-based therapeutic depend on its final application? Close co-
ordination between regulators and bacteriophage-therapeutic companies will be required to 
clarify such situations over the next few years. 
 
The greatest advances in regulatory approval (and subsequent commercial use) of bacteriophage 
products have been in the agriculture and food industries. In 2005 the EPA registered the first 
pesticide product containing bacteriophage against Xanthomonas campestris pv. vesicatoria and 
Pseudomonas syringae pv. tomato, for use on tomato and pepper crops (EPA, 2005). As of 
2009 the proprietor of the product, Onnilytics, Inc., claims to have sold over 200 000 litres. In   39 
2006 the FDA approved a cocktail of bacteriophage for use as an antimicrobial agent against 
Listeria monocytogenes contamination in ready-to-eat meat and poultry products (FDA, 2006b). 
This was the first time that a bacteriophage preparation has been approved as a food additive, 
and since then a competing bacteriophage product against Listeria monocytogenes has received 
GRAS (Generally Regarded as Safe) status for all food products by the FDA (FDA, 2006a). 
Most recently, the USDA Food Safety and Inspection Service (FSIS) issued no objection letters 
for use the of bacteriophage against E. coli O157:H7 (USDA/FSIS, 2008a) and Salmonella 
(USDA/FSIS, 2008b; USDA/FSIS, 2008c) on live animals prior to slaughter. It is hoped that the 
repeated confirmation of the regulatory view that bacteriophage are safe for human use will 
assist the commercialisation of bacteriophage-based products for wider human applications 
(Housby and Mann, 2009). 
 
1.5.2  Commercialisation of bacteriophage 
Bacteriophage are being commercialised in several areas, typically by smaller enterprises (Table 
1.2). Intellectual Property (IP) has been filed for their use as antimicrobial agents in food and 
agricultural products, as gene and vaccine delivery vehicles as well as their use in antimicrobial 
human therapy. It is of note that much of the commercial development of bacteriophage for 
human use has been on oral or topical applications, where the regulatory hurdles are anticipated 
to be lower (and fewer), thereby reducing the time to market (Housby and Mann, 2009). 
 
However, as well as regulatory uncertainty it has been considered that the relatively slow 
development of bacteriophage therapy products for clinical use may be due to a perceived 
difficulty in obtaining intellectual property (IP) rights to protect product value (Clark and 
March, 2006; Parfitt, 2005). The absence of large pharmaceutical companies in human 
bacteriophage therapy development may reflect this. In traditional pharmaceutical product 
development terms, it is inexpensive to isolate any number of effective (and unrelated) 
bacteriophage against a bacterial strain, although rigorous clinical trials to gain approval for 
their use would still be required. The current model of an expensive drug development period 
(between $0.5 and $2bn) (Adams and Brantner, 2006) followed by many years of patent 
protection may not therefore be directly applicable to the development of bacteriophage therapy 
products.  
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Table 1.2 A selection of companies active in the commercialisation of bacteriophage-based 
products and therapies. 
 
Company  Location  Primary product 
Development 
stage 
BigDNA Ltd. 
Edinburgh, 
UK 
Oral/ intravenous bacteriophage DNA 
vaccination 
R&D 
       
Biocontrol Ltd. 
Nottingham,  
UK 
Pseudomonas aeruginosa 
infections of the ear 
Phase III 
       
Cambrios 
Technologies 
Corp. 
Sunnyvale,  
USA 
Filamentous bacteriophage-derived 
materials for the electronic industry. 
R&D 
       
EBI Food Safety 
Wageningen, The 
Netherlands 
Listex
TM P100 bacteriophage 
preparation against Listeria 
monocytogenes in food 
Market 
       
Intralytix, Inc. 
Baltimore, 
USA 
Bacteriophage cocktail against Listeria 
monocytogenes in food 
Market 
       
NeuroPhage, Inc. 
Boston, 
USA 
Filamentous bacteriophage-mediated 
A" plaque disaggregation 
R&D 
       
Onmilytics, Inc. 
Salt Lake City, 
USA 
AgriPhage
TM crop pesticide, 
bacteriophage preparations against E. 
coli, Salmonella on live animals 
Market 
       
Phico 
Therapeutics Ltd. 
Cambridge, 
UK 
Lethal bacteriophage-mediated DNA 
delivery to Staphylococcus aureus 
Phase I 
 
 
1.5.3  Considerations for the large-scale production of bacteriophage 
The requirements of a large-scale production process of a bacteriophage-based therapeutic will 
depend on the nature of the final application. Key issues are the scale of the manufacturing 
process and the necessary purity of the final product. Both strongly dictate the equipment 
required for, and the overall cost of, production.  
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Of the potential applications of bacteriophage described, it is probable that one of the most price 
sensitive would be in the biomaterial industry; that is, the manufacturing costs are critical to 
competitiveness. Whilst at a very early development stage, the quantities of bacteriophage 
required for lithium-ion cell production are potentially huge if one scales from the quantity of 
bacteriophage used in the pilot study. Here, the quantity of bacteriophage M13 loaded for a 
single 2- 4 volt lithium-ion battery cathode was approximately 2 mg cm
-2 of cathode (Lee et al., 
2009). The mass of an individual M13 virus is approximately 3 x 10
-17 g, which equates to about 
7 x 10
13 viruses cm
-2. Considering that the yield of bacteriophage M13 from shakeflask 
production in the laboratory is often of the order 5 x 10
11 viruses ml
-1 (Reddy and McKenney, 
1996), the potential need is for an efficient high-yield, large-scale process, scaleable to the order 
of thousands of litres.  
 
In the pharmaceutical arena, the quantity of bacteriophage required for each therapeutic 
application varies widely. Estimates range from 10
6 to 10
13 bacteriophage per patient per day of 
treatment; the overall requirement therefore being a function of treatment duration too 
(Bujanover, 2004). Bacteriophage propagation typically results in 10
9 to 10
12 viruses ml
-1 by the 
end of standard batch culture. However, it can be deduced that up to 10 litres of fermentation 
culture may still be required per treatment dose, suggesting that large-scale bacteriophage 
production in the pharmaceutical arena may also be essential for many therapies. 
 
The issue of product purification is of particular relevance for the large-scale manufacture of 
pharmaceutical-grade bacteriophage products. While it is relatively straightforward to produce 
high-titre, high-purity bacteriophage on the laboratory-scale, many of the standard purification 
processes are unfavourable on the large-scale. One example is caesium-chloride density 
centrifugation, which due to its batch nature and high equipment costs has substantial 
drawbacks for large-scale processing (Smith and Gingrich, 2005). A second is the common 
addition of chloroform to remove precipitants added in the course of concentrating the 
bacteriophage product. However, chloroform is a toxic chemical of known carcinogenic effect 
(Watts et al., 2004), and requires some handling care (McKetta, 1993). Therefore, the 
development of a bacteriophage production process will involve the translation of laboratory-
scale techniques to the large-scale, and the utilization of alternative scaleable processes. 
 
The task of scale-up is hindered by the relative lack of published data on large-scale 
bacteriophage production. Where available, studies detailing the large-scale deep-culture 
fermentation of lytic bacteriophage are typically over 20 years old (Husimi and Keweloh, 1987; 
Sargeant, 1970; Sargeant et al., 1968; Siquet-Descans et al., 1973) – although the principles still 
hold – and a recent study on the fermentation of filamentous bacteriophage-derived phagemids 
virtually stands alone in the field (Grieco et al., 2009). Similarly, studies primarily focusing on   42 
scaleable bacteriophage purification processes are sparse, but include purification by monolith 
chromatography (Smrekar et al., 2008), hydroxyapatite column chromatography (Smith and 
Gingrich, 2005) and expanded bed anion chromatography (Ling et al., 2004). Of assistance here 
is that in many processing respects, a bacteriophage may be expected to perform as a large 
protein complex, and principles applying to recombinant protein production will be applicable 
to bacteriophage processing. Hence a much greater pool of processing knowledge can be 
tapped. However, a difficulty common to the assembly of all biological production processes 
remains: although many generalities apply, often the exact conditions required will be 
dependent on the molecule (or bacteriophage) of interest (Sargeant, 1970). 
 
 
1.6  Production of Bacteriophage M13 as a Therapeutic 
As described in Sections 1.2.1 and 1.2.3, the physical structures and replication cycles can vary 
considerably between bacteriophage species. That said, almost all of the general principles of 
production outlined here will be at least partly applicable to the production of all bacteriophage, 
not just M13. The main exception, as described earlier, is the characteristic of filamentous 
bacteriophage (such as M13) not to lyse their bacterial hosts, but extrude into the fermentation 
medium. The result is a distinct post-fermentation process fluid. 
 
A number of large-scale fermentation and so-called "downstream processing" options are 
available for the production of bacteriophage M13. The sequence of large-scale production 
stages generally mirror those on the laboratory-scale: that is, a typical production process will 
begin with the generation of bacteriophage biomass by bacterial fermentation. Subsequently, 
downstream processing begins at the point of harvest. The first step would be the separation of 
cells from the fermentation medium, and, since bacteriophage M13 will be located in the 
extracellular environment, the cell-free fermentation medium would be taken forward for 
further processing. A volume reduction step is likely to follow to concentrate the bacteriophage, 
and ideally simultaneously achieve some purification. Given the stringent regulatory 
specifications required of a human therapeutic (Levy et al., 2000b), the bacteriophage product is 
still in an impure state and would require further, higher resolution purification for such uses. At 
the laboratory scale this may involve caesium-chloride density centrifugation or small scale 
chromatographic separation followed by various small scale "polishing" steps to remove 
residual contaminants (Smith and Gingrich, 2005). At the large-scale several chromatographic 
separation stages are likely, each stage ideally exploiting a different physicochemical attribute 
of the bacteriophage molecule to enact separation from contaminants (Atkinson et al., 1987). 
Finally, the pure bacteriophage product will be formulated in the manner in which it will be 
stably stored. The steps in this generalised production process are summarised in Figure 1.5. 
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Figure 1.5 A general outline of the essential production stages of bacteriophage M13 for high-
purity applications. 
 
 
1.6.1  The upstream process: the fermentation of M13 infected E. coli cells 
The primary function of the fermentation stage is to maximise bacteriophage M13 productivity 
in E. coli, where productivity is defined as the quantity of bacteriophage produced per unit 
volume per unit time. It would also be desirable to produce a post-fermentation process fluid 
allowing for the simplest downstream process possible. 
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Many factors can potentially affect the resulting yield of bacteriophage M13 from fermentation. 
These include the growth medium, the maintained dissolved oxygen tension (DOT), the 
infecting ratio of bacteriophage to E. coli, the infection time, the bacterial strain, the 
fermentation temperature, pH and the fermentation (feeding) strategy (Grieco et al., 2009; 
Reddy and McKenney, 1996). Frustratingly for the biochemical engineer, there is no overall 
scheme for the maximisation of production within E. coli, be the product plasmid, recombinant 
protein or indeed bacteriophage (Harrison and Keshavarz-Moore, 1996). For example, in the 
specific case of plasmid expression, productivity differences between E. coli strains have been 
found to depend on the plasmid in question (Yau et al., 2008). That is, one E. coli strain may 
show an excellent level of productivity for one plasmid, but a relatively poor level for another. 
Instead, optimisation of product yield will require at least some experimentation with E. coli 
expressing the product of interest, although that is not to say that several broad principles do not 
apply, such as the positive effects of maintenance of near-neutral pH and DOT above 30 % 
saturation (Garcia-Arrazola et al., 2005). 
 
The versatility of fermentation lies in the ability to monitor, control and amend the conditions 
within the fermenter to meet the nutritional needs of the cells during growth. As such, a 
fermentation can usually be expected to result in a more productive culture than that achieved 
by small-scale shakeflask experimentation (Grieco et al., 2009). Further, dedicated sampling 
ports reduce the likelihood of contamination, and off-gas analysis can be utilised as an 
immediate, online measure of the state of the culture. Finally, and perhaps most importantly, 
fermenters are scaleable unit operations (Doran, 1999). Therefore, even experimentation in 
small sub-litre fermentations is generally able to predict the performance within large-scale 
fermenters, using standard biochemical engineering scale-up criteria. 
 
1.6.2  Downstream process considerations 
The objective of an efficient downstream process is the purification of the product whilst 
maximising recovery (i.e. minimising losses at each stage) at minimum cost (Wenzig et al., 
1993). Assembly of the process is governed by the following core criteria (Petrides, 2003; 
Wheelwright, 1987): 
1.  Separate the most plentiful impurities first 
2.  Select conditions that exploit the greatest differences in the properties of the product 
and the impurities 
3.  Use as highly selective step as early as possible 
4.  Employ separation processes based on different properties 
5.  Conduct the most difficult or expensive separations last 
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It can be seen from these criteria that to design the downstream process, it will be necessary to 
know both the composition of the post-fermentation process fluid and the physicochemical 
properties of the product and contaminants. 
 
1.6.2.1  Separation of biomass 
The two leading large-scale methods of solids separation are centrifugation and microfiltration. 
Centrifugation separates solid/liquid or liquid/liquid systems on the basis of density and size 
differences. Separation is effected by the application of centrifugal forces by high speed 
rotation. Centrifuges are routinely used in the biotechnology industry to remove intact cells, cell 
debris and protein aggregates from the liquid phase. Therefore, in the downstream processing of 
bacteriophage M13 they may well be appropriate for both the removal of intact E. coli cells 
from the post-fermentation fluid as well as the capture of precipitated bacteriophage particles 
(i.e. the bacteriophage concentration step outlined in Figure 1.5).  
 
The centrifuges used in industry are usually of the continuous type as opposed to the standard 
batch centrifugation used in the laboratory. Here, the feed stream is continually fed into the 
rotating centrifuge chamber, where solids capture occurs. Clarified process fluid continually 
flows out. Depending on the type of centrifuge, the discharge of solids (sediment) can occur 
either intermittently (some designs requiring a temporary halt to centrifugation) or continuously. 
The most commonly used continuous centrifuges are the disk-stack, multichamber bowl and 
tubular bowl designs (Boychyn et al., 2004).  
 
Continuous centrifuges can process large volumes of process fluid. Large-scale disk-stack 
designs can separate whole cells at flow rates up to 3 000 to 5 000 litres hr
-1 (Asenjo and 
Patrick, 1990). However, they do have limitations. The capital cost is often high, and 100 % cell 
removal cannot be obtained. A filtration step is usually required to protect subsequent stages – 
such as chromatography – that are prone to fouling. Further limitations include heat, noise, 
aerosol generation and containment issues (Tinnes and Hoare, 1992). 
 
Microfiltration is often used for solids removal, most commonly after centrifugation to remove 
any remaining biomass. Less commonly, principally due to the issue of fouling, it is employed 
for total solids removal alone. In the biotechnology industry, cross-flow micro-filtration is often 
employed, where the process fluid flows tangentially to the filter membrane. The use of a 
sufficiently high flow rate reduces the issue of fouling by a self-scouring action (Mackay, 
1996). Such filters may exhibit cross-membrane volumetric fluxes of the order 15 to 50 litres m
-
2 hr
-1 with a pore size of 0.22 or 0.45 µm (Brocklebank, 1986), large enough to allow 
extracellular protein (or bacteriophage) to pass through. The capital cost of microfiltration 
equipment is less than continuous centrifuges, and they offer better process stream clarification.   46 
 
1.6.2.2  Primary purification and bacteriophage concentration 
The volume reduction stage (i.e. bacteriophage concentration) is consistent with the guiding 
principles of downstream processing outlined at the start of Section 1.6.2, particularly if one 
considers water as a particularly plentiful "impurity" which should therefore be removed early 
on. Various competitive concentration steps exist, the most common being ultrafiltration and 
precipitation.  
 
If the pore sizes are small enough, a membrane filter could be used to concentrate bacteriophage 
from the dilute cell-free medium. This is the principle behind ultrafiltration, where the 
membranes are rated in terms of their molecular weight (MW) cut offs (Busby and Ingham, 
1980). The industrial technique of ultrafiltration is similar to that of microfiltration. That is, 
flow is generally tangential to the membrane to reduce fouling. In theory, the achievable protein 
concentration on the large-scale is high, and the process usefully allows for buffer changes to be 
made ("diafiltration") (Eykamp, 1997). 
 
From a modern perspective, the traditional methods of protein precipitation may be considered 
unfavourable relative to ultrafiltration. In particular, salt fractionation via the additions of 
ammonium sulphate has been widely used due to its high solubility and low price, but at the 
cost of poor selectivity for the protein of interest. However, work exhibiting the fractional 
precipitation of proteins and plasmid DNA by CTAB (Lander et al., 2002; Tomanee et al., 
2004), polyethylene glycol (Tsoka et al., 2000) and spermine (Murphy et al., 1999) illustrate the 
selective ability of precipitation, as well as its capacity to concentrate. This dual ability is 
particularly useful prior to higher resolution purification stages (such as chromatography) again 
because these are prone to fouling by excess contaminants (Prazeres and Ferreira, 2004). 
 
1.6.2.3  High resolution purification 
Chromatographic separations can rightly be considered the longstanding workhorses of 
downstream processing (Przybycien et al., 2004). Differing chromatographic matrices can select 
on the basis of charge (ion exchange), size and shape (gel filtration), hydrophobicity 
(hydrophobic interaction) and affinity for a specific ligand (affinity chromatography) (Atkinson 
et al., 1987). The application of a combination of these techniques to the process stream allows 
for the high-resolution purification of the bacteriophage product for high-purity applications.  
 
Chromatographic separations are not without their drawbacks, however, the most oft-cited 
being high cost, batch operation and complex scale-up (Przybycien et al., 2004; Thommes and 
Etzel, 2007). Consequently, alternatives to chromatography are being explored, including 
selective precipitation (Lander et al., 2002), membrane chromatography (Teeters et al., 2003),   47 
and monolith separations (Smrekar et al., 2008). Monoliths in particular have been 
demonstrated as a viable high-resolution purification strategy for large particles such as 
bacteriophage (Etzel and Riordan, 2009; Jungbauer and Hahn, 2008).  
 
1.6.2.4  Polishing and formulation 
The final stages of downstream processing would focus on the formulation of the purified 
bacteriophage product into a form in which it can be stably stored, most likely in a buffered 
solution state. If necessary a diafiltration step may be employed to change the suspension buffer 
(Eykamp, 1997). 
 
1.6.3  Whole bioprocess considerations: GMPs, validation and containment 
If bacteriophage-based therapeutics are to be administered to humans or animals, then they must 
be manufactured in accordance with current Good Manufacturing Practices (GMP), as stated by 
FDA guidelines on the preparation of investigational new drug products (FDA, 1991). GMPs 
cover all aspects of drug product manufacture, from raw materials, utilities, packaging and 
transferral of the final product to the clinic (Kletch, 1997). In essence, the manufacturing 
process needs to be defined and controlled. Therefore, if any part of the procedure from 
manufacture to clinic is not in conformity with GMP, the product is "adulterated" and cannot 
legally be approved (Doblhoff-Dier and Bliem, 1999). 
 
The process of validation has been introduced to assure product consistency, and is therefore an 
essential provision of GMPs (Eckman, 1997). It requires the establishment of documented 
evidence that any product, process, procedure, system, equipment or software used in the 
process of manufacture consistently meets predetermined specifications. Thus, in a downstream 
process each unit operation must be validated to prove that it is capable of the consistent 
removal of the impurities to level required (Sofer, 1995). The validation process also extends to 
the cleaning of each piece of equipment. The process of validation is beneficial to the finalised 
downstream process: reduced process variability means fewer failed batches and reduced costs 
(Kozlowski and Swann, 2006). 
 
A basic demand of GMP is the avoidance of product impurity, be it by foreign matter or indeed 
cross-contamination (Sherwood, 1996). Therefore, the bioprocessing of a bacteriophage-based 
therapeutic raises important issues regarding containment, largely dependent on whether the 
bacteriophage product is biologically infective. The ability of an infective bacteriophage to 
propagate means carefully considered containment measures will need to be implemented to 
prevent the cross-contamination of fermentations in the manufacturing area, particularly if the 
facilities are of mixed use. Conversely, non-infectious bacteriophage particles can be considered 
simply as a DNA or RNA-protein product. When designing a bacteriophage-therapeutic facility,   48 
aspects of equipment and plant design from the dairy industry may be applicable, where 
bacteriophage control is a longstanding issue (McGrath et al., 2007; Moineau, 1999). As 
expected, practical approaches to contamination control include adapted plant design, 
ventilation and sanitation (Sherwood, 1996; Whyte, 1991). 
 
1.6.4  Techniques for the prediction of bioprocess performance 
At the early design stages of a bioprocess, the quantity of available material is often extremely 
limited, so the ability to experiment on small quantities of material is important. The 
conventional approach to scaled-down process development is experimentation with 
correspondingly scaled-down process equipment into the litre-sized range. Alternatively, the 
development of "ultra scale-down" (USD) techniques has allowed for the performance 
prediction of unit operations using only millilitres of material. The USD technique combines the 
use of standard laboratory equipment with custom-made devices to mimic the engineering 
environment within large-scale equipment. Upon verification of a particular USD method to 
mimic conditions, it can be used to great effect in process development and understanding at an 
earlier point in the discovery process. USD methods have been developed to mimic several 
process steps including depth filtration (Reynolds et al., 2003), filtering centrifugation 
(Boulding et al., 2002), continuous centrifugation (Boychyn et al., 2004) and chromatography 
(Wenger et al., 2007). 
 
The response of the target molecule (bacteriophage in this study) to the frequently intense fluid 
flow environment imposed by large-scale equipment has been of particular concern to 
biochemical engineers. Over the course of an entire bioprocess, the cumulative exposure to 
hydrodynamic shear forces can be significant. Continuous centrifuges are known to be 
particularly damaging to sensitive biological materials, which is why substantial attention has 
focused on the development of USD mimics of the feed-zone of this unit operation 
(Biddlecombe et al., 2007; Boychyn et al., 2001; Chan et al., 2006; Hutchinson et al., 2006; 
Levy et al., 1999a). Within a continuous centrifuge, the feed-zone is the point at which the 
process fluid first enters the rotating centrifuge chamber. Consequently, the shear forces within 
this region are high. At the laboratory-scale, where early experimentation and manufacture 
occurs, conditions are benign and little physical damage is caused. Therefore, standard 
laboratory-scale techniques are often a poor prediction of the quality of product that may be 
achieved on the large-scale.  
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1.7  Aims and Objectives 
It has been demonstrated that bacteriophage M13 (as well as its close relations and derivatives) 
features as a candidate in several promising biotechnological areas. However, it has also been 
explained that of all bacteriophage types, limited biochemical engineering literature currently 
exists to support large-scale filamentous bacteriophage manufacture. If this state of affairs 
persists, the assembly of production schemes for these future therapies will be hindered. 
 
With a focus on the fundamental properties of bacteriophage M13, the principal objective of 
this thesis is to contribute towards the processing knowledge of bacteriophage M13, its relations 
and derivatives. Ultimately, this work aims to pave the way for the assembly of a more efficient 
large-scale production process. Within this framework, five areas of research were undertaken, 
utilizing wild-type bacteriophage M13 as a model system. Each of the areas investigated 
corresponds to one of the results chapters presented of this thesis. The five goals of thesis are 
therefore: 
 
1.  Evaluate the effect of hydrodynamic shear on the filamentous bacteriophage 
particle (Chapter 3). 
Unit operations such as fermentation, continuous centrifugation and ancillary pumps 
will all impart flow conditions on the process fluid up to several orders of magnitude 
greater in energy than that imparted by standard laboratory processing.  It is therefore 
important to assess the response of bacteriophage M13 to high-energy hydrodynamic 
shear conditions. However, since so little is known about the response of bacteriophage 
M13 to any of these environments, a general approach will be undertaken using a USD 
rotating disk shear device. As described in Section 1.6.4, USD techniques allow for the 
rapid assessment of a range of shear conditions, using only millilitres of fluid. The 
fragility of bacteriophage M13 will be assessed upon exposure to fluid flows of varying 
intensity, and the effect of the fluid of suspension shall also be studied. Bacteriophage 
M13 will be compared to other complex molecules in terms of their relative resistances 
to hydrodynamic shear. Finally, experimentation to elucidate some of the mechanisms 
of damage will be studied. The potential implications for the large-scale bacteriophage 
M13 processing will then be assessed. 
 
2.  Investigate the fermentation and harvesting of bacteriophage M13 (Chapter 4). 
The efficient planning of a downstream process is dependent on knowing the 
concentration of the product and major contaminants in the process stream. The 
composition of the post-fermentation process fluid will therefore be examined. The E. 
coli host strain and growth medium will be investigated for improvements in   50 
bacteriophage M13 yield and the effects on the resulting post-fermentation process 
stream. Experimentation will be conducted at the shakeflask and bioreactor scales. 
 
3.  Evaluate the effect of hydrodynamic shear on E. coli cell integrity (Chapter 5). 
Using USD techniques, the response of the E. coli host to high-energy hydrodynamic 
shear conditions will be determined. The effects of M13 infection and culture age on the 
E. coli cells will be assessed in terms of the observed alterations in cell fragility. The 
implications for large-scale processing will be assessed: increased cell damage could 
result in increased process stream contamination by intracellular components. 
Downstream processing may therefore be hindered. 
 
4.  Investigate the primary purification of bacteriophage M13 (Chapter 6). 
Effective precipitants of bacteriophage M13 will be determined in pure as well as post-
fermentation fluid systems. Studies in pure systems will allow the fundamental 
characteristics of the precipitants to be evaluated. Precipitation of bacteriophage M13 
from post-fermentation fluid will allow for the comparison of selected precipitants in 
terms of the achieved bacteriophage yield and purification. 
 
5.  Consider the issues concerning the introduction of bacteriophage M13 to a mixed-
use production facility (Chapter 7). 
The resistance of bacteriophage M13 to several physical and chemical challenges will 
be examined, each relevant for the assessment of its safe introduction to a mixed-use 
facility. This will include exposure to common disinfection agents as well as extremes 
of temperature, pH and desiccated conditions. An effective disinfectant agent will also 
be determined against E. coli cells. The consequences of accidental bacteriophage M13 
release will be discussed. Standard operating procedures for the propagation of 
bacteriophage M13 at the 20 L scale in the UCL fermentation suite will be derived and 
discussed. 
 
While focus of this thesis is undoubtedly upon bacteriophage M13, many of the techniques used 
are general and will therefore be of use in the investigation of the properties of other 
bacteriophage types. 
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2  Materials and Methods 
2.1  Buffers, Solutions and Media 
All solutions and media were prepared using reverse osmosis (RO) water by Elga Option 4 
water purifier. Sterilisation was by autoclaving at 121 °C, 1 bar pressure for 15 minutes. 
 
2.1.1  Tris EDTA (TE) buffer pH 7.5 
TE buffer contained 10 mM Tris-HCl (pH 7.5 at 25 °C) and 1 mM EDTA suspended in RO 
water and autoclaved. 
 
2.1.2  3 x Loading buffer  
Loading buffer contained 40 % (w/v) sucrose, 100 mM EDTA and 150 µg ml
-1 bromophenol 
blue suspended in sterile RO water. 
 
2.1.3  Tris-Borate-EDTA electrophoresis buffer (TBE) 
Supplied as pre-mixed powder (Fisher) giving a 1 x concentration of 89 mM Tris, 89 mM boric 
acid, 2 mM EDTA suspended in RO water.  
 
2.1.4  2 x Laemmli loading buffer 
Laemmli loading buffer contained 4 % SDS, 130 mM Tris-HCl (pH 6.8 at 25 °C), 18 % (v/v) 
glycerol and 60 ug ml
-1 bromophenol blue suspended in sterile RO water. Immediately prior to 
use dithiothreitol was added to an aliquot of loading buffer to a concentration of 200 mM. 
 
2.1.5  Running buffer for SDS-PAGE 
SDS-PAGE running buffer contained 25 mM Tris, 29 mM glycine and 0.1 % (w/v) SDS 
suspended in RO water. 
 
2.1.6  Nutrient Broth Number 2 (NB2), agar (NB2A) and overlay agar (NB2OA) 
NB2 powder 25 g l
-1 (containing 10 g l
-1 meat-derived "Lab-Lemco" powder, 10 g l
-1 meat-
derived peptone, 5 g
-1 l sodium chloride, Oxoid) was suspended in RO water and autoclaved for 
NB2 broth, or supplemented with granulated agar (Difco) 1.4 % (w/v) prior to autoclaving for 
NB2A.  For NB2OA, NB2 powder 25 gl
-1 was supplemented with granulated agar (Difco) 0.7 
% (w/v). NB2 
 
2.1.7  Fermentation medium 
Fermentation medium contained 10 g l
-1 yeast extract (Difco), tryptone peptone (Difco), sodium 
chloride (BDH) and glycerol (BDH) suspended in RO water and autoclaved (Doig et al., 2001).   52 
 
2.1.8  Thiamine supplemented minimal agar 
Plain agar was prepared by autoclaving 130 ml of RO water with granulated agar (Difco) 1.4 % 
(w/v). Molten 55 °C plain agar was supplemented with M9 salts 1 x concentration, CaSO4 0.1 
mM and MgSO4 6 mM (BDH). Each individual stock was sterilised by autoclaving prior to 
addition. Further supplement was by glucose 0.8 % (w/v) (BDH) and thiamine 5 "g ml
-1, each 
stock filter sterilised (0.22 "m Millipore). The resulting minimal media was immediately poured 
to produce agar plates. 
 
2.1.9  DNAse Test Agar with Methyl Green 
DNAse Test Agar with Methyl Green powder 42 g l
-1 (Difco) was suspended in RO water, 
boiled by microwave for 1 minute to dissolve, then autoclaved.  
 
2.1.10  Antibiotic stocks 
2.1.10.1  Tetracycline 
Tetracycline (Sigma) was dissolved in ethanol to give 5 mg ml
-1 and stored at -20 °C as a stock 
solution. The typical working concentration was 5 "g ml
-1. 
 
2.1.10.2   Ampicillin 
Ampicillin (Sigma) was dissolved in sterile RO water to give 100 mg ml
-1, filtered (0.22 "m 
Millipore), and stored at -20 °C as a stock solution. The typical working concentration was 100 
"g ml
-1. 
 
2.1.10.3  Kanamycin 
Kanamycin (Sigma) was dissolved in sterile RO water to give 20 mg ml
-1, filtered (0.22 "m 
Millipore), and stored at -20 °C as a stock solution. The typical working concentration was 50 
"g ml
-1. 
 
2.1.11  5-bromo-4-chloro-3-indoyl-!D-galactopyranoside (X-gal) 
X-gal (Sigma) was dissolved in dimethyl sulphoxide (Sigma) to give a 40 mg ml
-1 stock 
solution. Where appropriate, the stock solution was added post-autoclaving to molten agar (55 
°C) to a final concentration of 40 "g ml
-1. 
2.1.12  Isopropyl !-D-1-thiogalactopyranoside (IPTG) 
IPTG (Sigma) was dissolved in sterile RO water to give a 20 mg ml
-1 stock solution. Where 
appropriate, the stock solution was added post-autoclaving to molten agar (55 °C) or growth 
media to a final concentration of 20 "g ml
-1. 
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2.2  Bacteria and Bacteriophage Strains 
All bacteria and bacteriophage strains used in this study are listed in Tables 2.1 and 2.2. 
 
 
Table 2.1 Names and genotype of bacterial strains used. 
Strain  Genotype  Source/ Reference 
Escherichia coli 
JM107 
 
F´[traD36 lacI
q $(lacZ)M15 proA+B+] e14– 
(McrA–) $(lac-proAB) thi gyrA96 (Nal
r) endA1 
hsdR17 (r 
k– mk
+) relA1 glnV44 
 
Yanisch-Perron et al. 
(1985) 
Escherichia coli 
TOP10F' 
 
F´[lacI
q, Tn10(Tet
R)] mcrA (mrr-hsdRMS-
mcrBC) #80lacZ$M15 $lacX74 recA1 ara$139 
$(ara-leu)7697 galU galK rpsL (Str
R) endA1 
nupG 
Invitrogen Ltd. 
Escherichia coli 
W1485 
F´ %- 
NCIMB
1 9481 
Lederberg 
 
 
Table 2.2 Names of bacteriophage used. 
Strain  Source/ Reference 
M13  ATCC
2 15669B1 
 
1NCIMB- National Collection of Industrial, Marine and Food Bacteria 
2ATCC- American Type Culture Collection 
 
 
2.3  Cultivation of E. coli and Propagation of Bacteriophage 
2.3.1  Preparation of working E. coli cultures 
Working liquid E. coli cultures were routinely prepared at the 5 ml scale as described below. 
Cultures were assumed to be in the stationary phase after overnight growth at 37 °C with 
shaking. Relative standard deviations in OD600 values between similarly prepared 5 ml cultures 
were <2 %. 
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2.3.1.1  JM107 
Cultures of JM107 were prepared by streaking a loopful of stock culture onto a minimal agar 
plate (Section 2.1.7) and incubated overnight at 37 °C. Working liquid cultures were then 
prepared by inoculating 5 ml NB2 with a loopful of cells taken from an isolated colony on the 
minimal agar plate and incubated overnight at 37 °C with shaking.  
 
2.3.1.2  Top10F' 
Cultures of Top10F' were prepared by streaking a loopful of stock culture onto an NB2A plate 
supplemented with 5 "g ml
-1 tetracycline and incubated overnight at 37 °C. Working liquid 
cultures were then prepared by inoculating 5 ml NB2 supplemented with 5 "g ml
-1 tetracycline 
with a loopful of cells taken from an isolated colony on the NB2A plate and incubated overnight 
at 37 °C with shaking. When larger culture volumes were required, 1 ml of working Top10F' 
culture was inoculated into 50 ml NB2 (in a baffled 250 ml shakeflask) supplemented with 5 "g 
ml
-1 tetracycline and incubated overnight at 37 °C.  
 
2.3.1.3  W1485 
Cultures of W1485 were prepared by streaking a loopful of stock culture onto an NB2A plate 
and incubated overnight at 37 °C. Working liquid cultures were then prepared by inoculating 5 
ml NB2 with a loopful of cells taken from an isolated colony on the NB2A plate and incubated 
overnight at 37 °C with shaking.  
 
2.3.2  E. coli cultivation 
Larger E. coli cultures were prepared by inoculating 400 ml NB2 or fermentation medium 
(Section 2.1.7) in a two-litre baffled shake flask (Nalgene) with 5 ml of overnight working 
culture (Section 2.3.1), equating to 1 x 10
10 colony forming units (cfu). Appropriate antibiotic 
selection was used if the culture was to be further propagated. Flasks were incubated at 37 °C 
with shaking (200 rpm).  
 
2.3.3  Propagation of bacteriophage M13 
Stocks of bacteriophage M13 were prepared by inoculating 400 ml NB2 in a two-litre baffled 
shake flask (Nalgene) with 1 x 10
10 colony forming units (cfu) of stationary phase Top10F' 
(Section 2.3.1.2) and 2 x 10
11 plaque forming units (pfu) of M13. Following overnight 
incubation at 37 °C with shaking (200 rpm), a bacteriophage concentration of mid-10
11 pfu ml
-1 
was routinely achieved. Each 400 ml culture was divided between two 250 ml Sorvall 
centrifuge bottles (Thermo Scientific Ltd). Centrifugation was by Sorvall GSA rotor at 14 000 & 
g (RCFmax) for 15 minutes at 4 °C, and the supernatants decanted. M13 concentration was 
achieved by polyethylene glycol (PEG) precipitation (Yamamoto et al., 1970). Briefly, M13 
was precipitated from the supernatants by the addition of 3.3 % (w/v) polyethylene glycol 6000   55 
and 330 mM NaCl and incubated at 4 °C overnight. Precipitated M13 particles were pelleted by 
centrifugation, again in 250 ml Sorvall centrifuge bottles. Centrifugation was by Sorvall GSA 
rotor at 14 000 & g (RCFmax) at 4 °C for 10 minutes, and resuspended in 4 ml 10 mM Tris (pH 
7.5 at 25 °C) per 250 ml bottle. Resuspended bacteriophage pellets were filtered through a 0.22 
"m filter and stored at 4 °C. 
 
 
2.4  Caesium Chloride Density Centrifugation 
Purification of bacteriophage was performed by caesium chloride density gradient 
centrifugation. Caesium chloride (0.4 g ml
-1) was added to each M13 bacteriophage preparation 
(10
12 pfu ml
-1 M13). M13 solutions were ultracentrifuged at 110,000 x g (RCFmax) for 23 h at 15 
°C in a Beckman ultracentrifuge using a Ti 70.1 rotor. The caesium chloride purified 
bacteriophage were visualized as a thin blue-tinted band within each tube. After removing each 
centrifuge tube cap, bacteriophage were recovered by piercing the tube wall with a hypodermic 
needle (1.0 mm x 16 mm) attached to a 2 ml syringe at the base of the band and drawing off the 
bacteriophage. The resulting concentrated bacteriophage suspensions were dialysed against 
three litres of 10 mM Tris (pH 7.5 at 25°C) using 10 000 MWCO dialysis tubing (Pierce, 
Rockford, IL, USA) for 24 hours. Dialysis solution was changed once. The resulting 
bacteriophage were then enumerated (Section 2.5.2) and stored at 4 °C. 
 
 
2.5  Enumeration of Bacterial and Bacteriophage Suspensions 
2.5.1  Enumeration of bacterial suspensions 
Unless otherwise stated, E. coli bacteria were enumerated using the spread plate technique. 
Here, the bacterial suspension was ten-fold serially diluted to 1 x 10
-8 in 10 mM Tris (pH 7.5). 
Typically, each dilution involved adding a 20 µl sample to 180 µl diluent. Triplicate volumes 
(100 "l) of each dilution were spread onto NB2A plates. The plates were then incubated at 37 
ºC for 12- 24 hours before examining for colony formation. Dilutions giving rise to 30 – 300 
colonies were used for enumeration. The number of cfu per 100 µl of suspension was calculated 
by multiplying the mean number of colonies by the reciprocal of the dilution factor. This figure 
was then multiplied by 10 to convert to cfu ml
-1. 
 
2.5.2  Enumeration of bacteriophage suspensions 
All bacteriophage were enumerated using the surface droplet technique, based on the protocol 
devised by Miles and Misra (Miles and Misra, 1938) for bacterial suspension enumeration. 
Briefly, the bacteriophage suspension was ten-fold serially diluted using an appropriate buffer, 
typically 10 mM Tris. Typically, each dilution involved adding a 20 µl sample to 180 µl diluent.   56 
Lawns of Top10F' were prepared by mixing 2 & 10
8 pfu cells (Section 2.3.1.2) with 5 ml molten 
(50 °C) NB2OA and pouring onto a solidified NB2A plate. The agar lawns were inoculated 
with triplicate 10 "l drops of each dilution and left to air dry for 20 min. The plates were then 
incubated at 37 ºC overnight before examining for plaque formation. Dilutions giving rise to 3 – 
30 plaques were used for enumeration. The number of pfu per 10 µl of undiluted solution was 
calculated by multiplying the mean number of plaques by the reciprocal of the dilution factor. 
This figure was then multiplied by 100 to convert to pfu ml
-1. 
 
 
2.6  Storage of Bacterial and Bacteriophage Stocks 
Stocks of each E. coli strain were propagated from the original sources as described in Section 
2.3.1. Each culture was supplemented with sterile glycerol 15 % (w/v) and stored at -20 ºC in 5 
ml polystyrene tubes. Agar plates streaked from the E. coli stocks were stored at 4 ºC for up to 
one week. Short and long term storage of bacteriophage was at 4 ºC in sterile polypropylene 
tubes. 
 
 
2.7  Analysis of Bacterial and Bacteriophage DNA and Protein 
2.7.1  Spectrophotometric DNA quantification 
Where appropriate, DNA quantification was determined by absorbance at 260 nm by NanoDrop 
ND-1000 spectrophotometer (Thermo Scienific). Extinction coefficients were taken as 50 and 
33 ng
 cm µl
-1 for double-stranded and single-stranded DNA respectively. 
 
2.7.2  Agarose gel electrophoresis 
Agarose (1.2 g, Bio-Rad) was added to 150 ml of 1 x TBE buffer (Fisher) in a Pyrex conical 
flask and dissolved completely by microwave heating for 2- 3 minutes at 800 W (Panasonic). 
Following cooling of the molten agarose to approximately 50 °C, ethidium bromide (10 mg ml
-1 
stock, Sigma) was added to a final concentration of 0.27 "l ml
-1 and gently mixed. The molten 
agarose was poured into a casting tray of suitable size and allowed to set. Typically, 30 well 
combs (5 mm diameter per well) were used. DNA samples were mixed with 0.33 volumes of 3 
x loading buffer (Section 2.1.2). %/HindIII (0.1 mg ml
-1 DNA, Fermentas) and 1 kb (0.15 mg ml
-
1 DNA, Bioline HyperLadder 1) markers were used where appropriate. Gels were 
electrophoresed in 1 & TBE buffer at approximately 80 V for 1 hour. All gels were scanned and 
analysed using a UV transilluminator gel doc system (Syngene Gene Genius) with GeneSnap 
acquisition software (Syngene).  
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2.7.3  Polyacrylamide gel electrophoresis (SDS-PAGE) 
Acrylamide gels (12 % (w/v)) were prepared for SDS polyacrylamide gel electrophoresis (SDS-
PAGE), based on the method of Sambrook et al. (2001). Gels of thickness 0.75 mm were cast 
and run using the Bio-Rad Mini-PROTEAN 3 system. For a single 5 ml gel, 1.3 ml 1.5 M Tris 
(pH 8.8 at 25 °C, Sigma), 50 µl 10 % (w/v) SDS solution (BDH), 2.0 ml 30 % (w/v) 
acrylamide/ 0.8 % (w/v) methylene bisacrylamide solution (National Diagnostics) was added to 
1.6 ml sterile RO water. Ammonium persulphate (50 µl, 10 % (w/v), BDH) and 2 µl 
tetramethylethylenediamine (TEMED, Amresco) were added simultaneously and the mixture 
gently swirled. This was immediately poured between the glass casting plates to a level 0.5 - 1 
cm below the furthest reach of the gel comb. Isopropanol was pippetted on top of the gel, which 
was subsequently allowed to polymerise for 20 minutes. The isopropanol was poured off and all 
remaining traces removed with blotting paper. A single 3 ml stacking gel was prepared by 
adding 0.38 ml 1.0 M Tris (pH 6.8 at 25 °C), 30 µl 10 % (w/v) SDS solution, 0.5 ml 30 % (w/v) 
acrylamide/ 0.8 % (w/v) methylene bisacrylamide solution to 2.1 ml sterile RO water. 
Ammonium persulphate (30 µl, 10 % (w/v)) and 3 µl TEMED were added simultaneously and 
the mixture gently swirled. This was immediately poured on top of the cast gel to the top of the 
glass plates and a 10 well comb inserted. The gel was allowed to polymerise for at least a 
further 30 minutes. Samples were mixed with one volume 2 x Laemmli loading buffer (Section 
2.1.4) and incubated at 95 °C for 5 minutes. A 2- 212 kDa broad range protein marker was used 
(P7702S, NEB) at 1, 5 or 10 x dilutions in 1 x Laemmli loading buffer and incubated 95 °C for 
5 minutes. All samples were centrifuged for 30 seconds, 13 000 x g, room temperature, before 
loading. Gels were electrophoresed in running buffer (Section 2.1.5), at 200 V for 45 minutes. 
Gels were either silver-stained by kit, according to the manufacturer's instructions (Owl 
Separation Systems), or by SYPRO Ruby gel stain (Invitrogen). Briefly, gels to be stained by 
SYPRO Ruby were first fixed by two 15 minute incubations in a 50 ml 50 % (v/v) methanol 7 
% (v/v) acetic acid solution. Gels were each stained overnight in 50 ml SYPRO Ruby stain and 
destained for 30 minutes in 100 ml 10 % (v/v) methanol 7 % (v/v) acetic acid solution. All 
SYPRO Ruby stained gels were scanned and analysed using a UV transilluminator gel doc 
system (Syngene Gene Genius) with GeneSnap acquisition software (Syngene). All silver-
stained gels were scanned and analysed using a backlit visible light gel doc system (Syngene 
Gene Genius) with GeneSnap acquisition software (Syngene). 
 
2.7.4  Analysis of agarose and acrylamide gels 
Quantitative analysis of DNA in agarose gels and protein in acrylamide gels were performed 
using GeneTools analysis software (Syngene). The absolute intensity of each band was 
measured and the local background intensity manually subtracted. Sample DNA quantification 
was achieved by comparison with the band intensities of the relevant DNA ladders. SYPRO   58 
Ruby stained protein gels were quantified in relative terms by comparing the intensity of each 
lane to a control lane. 
 
2.7.5  Bradford assay 
Quantitative analysis of protein concentration in solution was performed by the Bradford assay 
(Bradford 1976). Coomassie protein assay reagent (Sigma) was diluted five-fold in sterile RO 
water and filtered (0.22 "m Millipore). An aliquot (1 ml) of this working reagent was added to 
each 30 "l sample in a 1 ml semi-micro cuvette (Sarstedt), mixed, and incubated at room 
temperature for 5 minutes. The absorbance of all samples at 565 nm was read within 5 minutes 
on a Hitachi U-1800 spectrophotometer. A 1 mg ml
-1 bovine serum albumin (BSA) standard 
(Sigma) was 0.66 x serially diluted. Absorbance at 595 nm was linear in the range 13- 225 "g 
ml
-1 BSA. Samples were analysed in triplicate. 
 
 
2.8  Molecular Biology Techniques 
2.8.1  Preparation of bacteriophage M13 single-stranded DNA 
Naked single-stranded DNA was prepared from intact M13 bacteriophage by phenol- 
chloroform extraction. An equal volume of phenol- chloroform- isoamyl alcohol (of ratio 25: 
24: 1) was added to the M13 solution and vortexed for 20 seconds. Following centrifugation for 
three minutes at 17 000 x g, room temperature, the aqueous layer was removed and the process 
repeated. An equal volume of chloroform was added to the resulting aqueous layer and gently 
mixed. Following a further three minute centrifugation at 17 000 x g, room temperature, the 
aqueous layer was removed and the DNA precipitated on ice by two volumes -20 ºC 100 % 
ethanol/ 0.1 volumes room temperature 4 M sodium acetate for 15 minutes. DNA was pelleted 
by centrifugation for 20 minutes, 13 000 x g at 4 ºC. The supernatant was removed; the pellet 
washed by addition of 200 µl -20 ºC 70 % (v/v) ethanol, and then centrifuged for 10 minutes, 13 
000 x g at 4 ºC. The supernatant was removed and the pellet dried at 50 ºC for 5 minutes. The 
pellet was resuspended in TE, and DNA concentration quantified by absorbance at 260 nm 
(Section 2.7.1). 
 
2.8.2  Large-scale preparation of bacteriophage M13 double-stranded DNA 
Naked double-stranded DNA was prepared from infected E. coli cells by alkaline/SDS lysis 
(Birnboim and Doly, 1979), using a Qiagen Maxiprep kit (Qiagen). Cultures (400 ml) were 
prepared as described in Section 2.3.3 except that the bacterial pellets were kept. Cell paste (0.5 
g) was resuspended in 10 ml buffer P1 (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 100 µg ml
-1 
RNase A), before the addition of 10 ml buffer P2 (200 mM NaOH, 1 % (w/v) SDS). The cell 
suspension was vigorously inverted 4- 6 times, and incubated at room temperature for 5   59 
minutes. A total of 10 ml 4 ºC buffer P3 (3.0 M potassium acetate (pH 5.5) was then added and 
the mixture vigorously inverted 4- 6 times and immediately applied to a QIAfilter Maxi 
cartridge. The lysate was incubated for 10 minutes at room temperature, and cleared by 
filtration through the QIAfilter Maxi cartridge. The clarified supernatant was immediately 
applied to the anion-exchange resin of a Qiagen-tip 500 column, which had been pre-
equilibrated by the addition of 10 ml buffer QBT (750 mM NaCl, 50 mM MOPS (pH 7.0), 15 % 
(v/v) isopropanol, 0.15 % (v/v) Triton X-100), and allowed to empty under gravity flow. The 
column was then washed by the application of two 30 ml volumes of buffer QC (1.0 M NaCl, 
50 mM MOPS (pH 7.0), 15 % (v/v) isopropanol), before eluting the bacteriophage DNA by the 
addition of 15 ml buffer QF (1.25 M NaCl, 50 mM Tris-HCl (pH 8.5), 15 % (v/v) isopropanol). 
The nucleic acid was precipitated from the eluate by the addition of 0.7 volumes of room 
temperature isopropanol, and recovered by centrifugation for 30 minutes at 15,000 x g, 4 °C.  
The DNA pellet was then washed with 5 ml of room temperature 70 % (v/v) ethanol, 
centrifuged again (15,000 x g, 15 min, 4 °C) and the pellet air dried for 5 minutes at 50 °C. The 
pellet was resuspended in a suitable volume of TE buffer, and DNA concentration quantified by 
absorbance at 260 nm (Section 2.7.1). 
 
2.8.3  Small-scale preparation of plasmid DNA 
Plasmid DNA was isolated from 5 ml E. coli cultures (Section 2.3.1) by alkaline/SDS lysis 
(Birnboim and Doly, 1979), using Qiagen Miniprep kit (Qiagen). Cells were pelleted by 
centrifugation at 4 500 & g (RCFmax) for 15 minutes at 4 °C, and the supernatant discarded. The 
cells were resuspended in 250 µl buffer P1 (Section 2.8.2). 250 µl of buffer P2 (Section 2.8.2) 
was added and the cell suspension was gently inverted 4- 6 times. A total of 350 µl 4 ºC buffer 
P3 (Section 2.8.2) was then added and the mixture gently inverted 4- 6 times. The lysate was 
then centrifuged at 17 000 x g for 10 minutes, room temperature. The supernatant was 
immediately applied to the anion-exchange resin of a Qiagen QIAprep spin column, and 
centrifuged at 17 000 x g for 1 minute. The flow-through was discarded. The column washed by 
the successive application of 500 µl buffer PB (proprietary composition) and 750 µl buffer PE 
(proprietary composition), each followed by centrifugation at 17 000 x g for 1 minute and the 
flow-through discarded. All traces of buffer PE were removed by a further 1 minute 
centrifugation. The plasmid DNA was eluted into a sterile 1.5 ml polypropylene tube by 
addition of a suitable volume of buffer EB (10 mM Tris-HCl, pH 8.5) to the centre of the spin 
column, incubation for 1 minute at room temperature and centrifugation at 17 000 x g for 1 
minute. 
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2.9  Preparation and Transformation of Competent E. coli Cells 
2.9.1  Preparation of CaCl2 competent E. coli cells 
A 5 ml E. coli culture was first prepared as outlined in Section 2.3.1. A 20 ml NB2 solution, 
supplemented with 20 mM MgCl2 post-autoclaving, was prepared in a 50 ml polypropylene 
tube and warmed to 37 °C.  This was inoculated with the 5 ml overnight culture and incubation 
at 37 °C with shaking for 1 hour. The culture was cooled on ice for 10 minutes to arrest growth, 
and the cells pelleted by centrifugation at 4 500 & g (RCFmax) for 10 minutes at 4 °C. The 
supernatant was discarded, and the pellet held on ice. The pellet was resuspended in 2 ml ice-
cold sterile 15 % (v/v) glycerol, 75 mM CaCl2 solution by brief vortexing before being returned 
to ice. The cell suspension was divided into 100 "l aliquots in pre-cooled 1.5 ml polypropylene 
tubes on ice and stored at -80 °C. 
 
2.9.2  Transformation of CaCl2 competent E. coli cells 
Transformations were performed by adding approximately 50 ng ice cold DNA (prepared by 
Section 2.8.3) to 100 µl of thawed competent cells on ice, and incubating for 45 minutes.  The 
cells were subsequently heat shocked for 2 minutes at 42 °C and returned to ice for a further 2 
minutes. A 5 ml quantity of sterile NB2 was inoculated with all the cells, and grown for 90 
minutes at 37 °C with shaking. Transformants were typically selected by plating 100 µl of the 
incubated transformation culture onto appropriate antibiotic- supplemented NB2A plates. 
Where appropriate, further supplementation of NB2A with X-gal (Section 2.1.11) and IPTG 
(Section 2.1.12) facilitated blue/white colony screening. Where intact bacteriophage M13 or its 
derivatives were the target, incubated transformation culture cells were pelleted by 
centrifugation at 4 500 & g (RCFmax) for 10 minutes at 4 °C.  A 100 µl aliquot of supernatant 
was then mixed with 2 & 10
8 pfu of appropriate plating cells (Section 2.3.1.2) and 5 ml molten 
(50 °C) NB2OA and poured onto a solidified NB2A plate. Both base and overlay agars were 
supplemented with antibiotics (Section 2.1.10) and X-gal/ IPTG as required. All plates were 
incubated at 37 °C for a minimum of 18 hours (overnight). 
 
 
2.10  Electron Microscopy 
Caesium chloride purified bacteriophage M13 (Section 2.4) was visualised by transmission 
electron microscopy (TEM) at the Electron Microscopy Unit within the UCL Department of 
Anatomy and Developmental Biology. Each carbon grid (carbon film supported on 3 mm 400 
mesh copper grid, Agar Scientific) was placed mesh-side down onto a 50 "l droplet of 10
9 pfu 
ml
-1 bacteriophage sample for twenty seconds and removed. The excess was removed with 
absorbent paper. Each grid was then placed onto a 50 "l droplet of uranyl acetate (0.25 % w/v) 
for 10- 20 seconds, then immediately placed on a 50 droplet of sterile RO water for 1 minute.   61 
The excess was removed with absorbent paper and the grid allowed to air dry. Samples were 
imaged by JEOL 100CX electron microscope. 
 
 
2.11  Viscosity Measurement 
Sample fluid viscosity was determined by cone and plate viscometer (DV-II+, Brookfield) 
according to the manufacturer's instructions. Briefly, 0.5 ml samples were subject to increasing 
shear rates within the viscometer and the corresponding shear stresses recorded. At least four 
different shear rates were tested per sample. Sample viscosity was determined as the gradient of 
the linear relationship between shear stress and shear rate. Therefore samples were assumed to 
be Newtonian. Viscosity measurements were conducted in duplicate. 
 
 
2.12  Techniques Used to Study the Effects of Hydrodynamic Shear 
2.12.1  Sonication of bacteriophage M13 
Caesium chloride purified bacteriophage M13 (Section 2.4) were 100-fold diluted in sterile 10 
mM Tris (pH 7.5 at 25 °C) to give 25 ml of concentration of 10
11 pfu ml
-1. A 20 ml aliquot of 
this bacteriophage suspension was measured into a sterile 50 ml polypropylene tube. The tube 
was clamped over an ice-water slurry in a Soniprep 150 (Sanyo Gallenkamp) ultrasonic 
disintegrator, fitted with a 9.5 cm probe of transformation ratio 5.5:1. The probe was immersed 
1 cm below the bacteriophage suspension surface, and the tube was held to avoid touching the 
probe. The solution was sonicated for two minute periods. Samples (500 "l) were taken at 0, 2, 
4, 6, 8 and 10 minutes. The zero timepoint was sampled in triplicate. The entire experiment was 
repeated three times. Ultrasound amplitudes of 1, 5 and 10 "m were tested. The viability of 
bacteriophage M13 in each sample was determined by the surface droplet technique (Section 
2.5.2). 
 
2.12.2  Ultra scale-down (USD) shear device operation 
Turbulent hydrodynamic shearing was performed by a custom-built device consisting of a 
single rotating stainless steel disk of diameter 40 mm, thickness 0.14 mm, mounted centrally in 
a 20 ml capacity stainless steel cylindrical chamber (Figure 2.1). The temperature within the 
chamber was controlled by a surrounding cooling water jacket, through which 4 °C water was 
circulated. Initial experiments were conducted with an electrically-driven brushed DC motor 
attached to the shaft assembly, which could be operated at a maximum of 350 revolutions per 
second (rps). Shaft rotation speed was detected by optical sensor.  Similar equipment has been 
used by Levy et al. (1999b) to study the effects of shear on plasmids and Boychyn et al. (2001) 
to model the shear stresses within continuous centrifuges. Higher speed operation required the   62 
use of updated equipment, including the use of an electrically- driven brushless motor attached 
to the shaft assembly, which could be operated at a maximum of 533 rps. Shaft rotation speed 
was detected by phase sensor. Temperature was also monitored by a thermocouple bonded to 
the underside of the chamber by thermally conductive adhesive. Updated equipment also 
included a power analyser (Medusa Research), which allowed for the direct calculation of 
power input to the motor during operation (Figure 2.2). Each experimental run consisted of 
completely filling the chamber with the test solution and rotating the disk within the chamber at 
the required speed for the required time. Within each experimental run, direct samples of 500 "l 
were taken at the specified time-points. All experiments were performed at room temperature. 
The zero timepoint was sampled in triplicate. Between shearing runs, the chamber was 
completely filled with 1 % Virkon solution for 10 minutes, and rinsed with five changes of 
sterile RO water. The entire experiment was repeated three times. 
  
 
 
 
Figure 2.1 Photograph of the USD rotating disk shear device (A) together with a schematic 
diagram of the device chamber (B). A stainless steel disk of diameter 40 mm and thickness 0.14 
mm was mounted centrally within the chamber. The stainless steel chamber was cooled by ice 
water flowing through a water jacket.   63 
 
Figure 2.2 A schematic diagram of the USD rotating disk shear device with associated 
equipment. Ice water was supplied to the water jacket by flexible silicone tubing through a 
peristaltic pump. The power draw was calculated by voltage and current measurement from the 
DC power supply. Temperature was measured by thermocouple. DC motor rotation speed was 
measured by RPM (phase) sensor. 
 
 
2.12.3  Cavitation Detection 
The level of cavitation within test fluids subject to sonication (Section 2.12.1) and turbulent 
shear (2.12.2) was determined by Weissler's reaction (Weissler et al., 1950). That is, the 
generation of hydroxide and peroxyl radicals by cavitation in aqueous solution can be detected 
by the presence of potassium iodide. The free radicals oxidize the iodide anion (I
-) to liberated 
iodine of the form (I3
-) with a zero order rate law (Wayment and Casadonte, 2002). This change 
is measured by the change in absoption at 350 nm. Potassium iodide (Alfa Aesar) solution of 
concentration 3 M in RO water was subject to sonication exactly as described in Section 2.12.1, 
and turbulent shear in Section 2.12.2, where samples were taken at 0, 5, 10, 15, 20 and 25 
minutes, subject to 32 000 rpm disc rotation. Triplicate non-sonicated and non-sheared negative 
controls were present in each case. The change in absorbance at 350 nm was measured on a 
Hitachi U-1800 spectrophotometer with disposable UV-clear acryl-cuvettes (Sarsedt). The 
Beer- Lambert relationship was then used to calculate I3
- concentrations using an extinction 
coefficient of 2.6 x 10
4 
 M
-1 cm
-1 (Wayment and Casadonte, 2002). All experiments were 
repeated three times. 
 
   64 
2.13  Bacteriophage M13 Fermentation Techniques 
2.13.1  Shakeflask experimentation 
Three overnight 5 ml starter cultures of Top10F' were prepared in NB2 with antibiotic selection 
as described in Section 2.3.1, and the OD600 values measured following dilution in fresh NB2 
media (CO8000 Cell Density Meter, WPA-Biochrom). Three pre-warmed baffled shakeflasks 
(250 ml) containing 50 ml sterile NB2 were inoculated with 1 ml of starter culture each and 
incubated at 37 °C with shaking (200 rpm). When M13 infection was required 2.3 x 10
8 pfu of 
bacteriophage were added to each flask. Samples (1ml) were removed at 0 minutes, 30 minutes 
and 1 hour and then at hourly intervals afterwards. The OD600 value was recorded and 50 µl 
removed for cell and bacteriophage enumeration (Sections 2.5.1 and 2.5.2). Samples for 
enumeration were stored on ice until needed. The remainder of every sample was centrifuged at 
17 000 x g for 3 minutes to pellet the cells. Supernatants were carefully decanted and stored at -
20 °C until needed.  
 
2.13.2  Two-litre batch fermentation 
Laboratory scale fermentations were performed in a 2 litre (working volume 1.5 litre) LH 210 
series fermenter (Bioprocess Engineering Services) fitted with three equally spaced top driven 
six bladed turbines and four diametrically opposed baffles. pH was measured by a steam 
sterilisable Mettler Toledo pH probe (Mettler Toledo) and controlled at pH 7 (± 0.05) by the 
metered addition of 500 mM sodium hydroxide and 1 % (v/v) sulphuric acid. The dissolved 
oxygen tension (DOT) was measured by a polarographic oxygen electrode (Mettler Toledo). 
The inlet and exhaust gases were filtered through 0.2 µm PTFE filters (Millipore) and the 
oxygen and carbon dioxide levels in the exhaust gas were determined by Tandem gas analyser 
(Adaptive Biosystems). Data logging and exhaust gas measurements were recorded by Squirrel 
1600 data logger (Grant).  
 
The fermenter was sterilized by autoclaving (121 °C for 20 minutes) with 1.35 litres of all 
media components (excluding antibiotics, IPTG, or calcium chloride supplements, if required) 
and antifoam present (0.2 ml l
-1 polypropylene glycol 2000. BDH). Non-autoclaved 
supplements were added immediately prior to inoculation and sterilized by 0.2 µm filtration. 
After adjustment of vessel conditions to 37 °C and pH 7.0, the DOT was set to 100 %. The 
vessel was then inoculated with 150 ml of shake flask culture grown overnight (10 % (v/v) 
inoculum). Inoculum cultures were prepared as described in Section 2.3.2 with matching media 
for the fermentation. Where necessary, the culture was inoculated with caesium chloride 
purified bacteriophage M13 (Section 2.4). Bacteriophage M13 inoculation occurred at either the 
zero timepoint (1.3 x 10
11 pfu) or three hours into the fermentation (2 x 10
11 pfu), as appropriate 
for the experiment.   65 
 
The fermentation was carried out at a minimum DOT of 30 % of air saturation. Throughout 
fermentation, DOT was maintained above this level by increasing the rate of stirring, up to a 
maximum of 1 500 rpm. The agitation rate was initially set at 750 rpm, and increased when 
necessary. The vessel was aerated at a rate of 1 L min
-1 (0.67 vvm). Growth was monitored 
regularly by absorbance at 600 nm at hourly intervals, plus an extra sample at 30 minutes. 
Samples were suitably diluted with fresh media and absorbances measured in triplicate 
(CO8000 Cell Density Meter, WPA-Biochrom).  Viable cells were enumerated as described in 
Section 2.5.1. Bacteriophage were enumerated as described in Section 2.5.2. 
 
2.13.3  Dry cell weight determination 
Triplicate 0.5 ml aliquots of each sample were measured into 1.5 ml polypropylene tubes. All 
tubes had been pre-dried at 60 °C for 24 hours and weighed. Cells were pelleted by 
centrifugation at 17 000 x g, 3 minutes, room temperature, and the supernatants discarded. 
Pellets were dried at 60 °C for 48 hours and the tubes reweighed. The dry cell weight was then 
calculated in g l
-1. 
 
 
2.14  Primary Purification Techniques 
2.14.1  Precipitation of pure bacteriophage M13 in a 1 ml qualitative screen 
Stocks of 10 % (w/v) cetyl trimethylammonium bromide (CTAB), 5 M sodium chloride (BDH), 
100 mM spermidine (Sigma), 1M calcium chloride (BDH), 500 mM managanese sulphate 
(BDH), 50 % (w/v) ammonium suphate (BDH) were prepared in sterile RO water. Except for 
CTAB, every stock plus 500 ml of sterile RO water was adjusted to pH 7.0 prior to use with 1 
% (v/v) sulphuric acid/ 500 mM sodium hydroxide (Seven Easy pH meter, Mettler-Toledo). 
Each 1 ml precipitation reaction was performed in a 1.5 ml polypropylene tube. Appropriate 
amounts of each stock were added to each tube to give the desired final concentration in 1 ml, 
plus sterile RO water up to 0.99 ml. Finally, 10 "l caesium chloride purified bacteriophage M13 
(Section 2.4) of concentration 4 x 10
13 pfu ml
-1 was added and the tubes inverted 4- 6 times to 
mix. All tubes were incubated for 15 minutes at room temperature and then centrifuged at 8 000 
x g for 10 minutes at room temperature to pellet the bacteriophage. The exception was the 
ammonium sulphate reactions, which were left overnight at room temperature and centrifuged 
for 10 minutes at 17 000 x g (Rossomando and Zinder, 1968). Tubes were inspected for a white 
pellet of bacteriophage. The pH of reactions at the extremes of precipitant concentration was 
checked with indicator strips to confirm neutrality (BDH). The experiment was repeated twice. 
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2.14.2  Precipitation of pure bacteriophage M13 by polyethylene glycol (PEG) in a 10 ml 
quantitative screen 
Stocks of 15 % (v/w) polyethylene glycol (PEG) of average molecular weights 600 (Fluka), 2 
000 (Fluka), 6 000 (BDH), 8 000 (Fluka), 12 000 (Fluka) and 20 000 (Fluka) were prepared in 
RO water and autoclaved. Stocks of 5 M sodium chloride, 1 M magnesium chloride and 1 M 
sodium sulphate were prepared in RO water and autoclaved. Every stock plus 500 ml of sterile 
RO water was adjusted to pH 7.0 prior to use with 1 % (v/v) sulphuric acid/ 500 mM sodium 
hydroxide (Seven Easy pH meter, Mettler-Toledo). Each 10 ml precipitation reaction was 
performed in a 15 ml polypropylene tube. Appropriate amounts of each stock were added to 
each tube to give the desired final concentration in 10 ml, plus sterile RO water up to 9.9 ml. 
Finally, 100 "l caesium chloride purified bacteriophage M13 (Section 2.4) of concentration 4 x 
10
13 pfu ml
-1 was added and the tubes inverted 4- 6 times to mix. Typically, tubes were 
incubated on ice for 1 hour. All tubes were centrifuged for 10 minutes, 8 000 x g, 4 °C and the 
supernatants decanted into fresh 15 ml tubes (Yamamoto et al., 1970). Pellets were resuspended 
in 10 ml 20 mM Tris (pH 7.5 at 25 °C) by vortexing. Supernatants were also vortexed. The 
bacteriophage concentration in the pellets and supernatants was determined by the surface 
droplet technique (Section 2.5.2). Each precipitation experiment had a positive control of 3.3 % 
(w/v) PEG 6 000, 330 mM NaCl, and a negative control of sterile RO water. All experiments 
were repeated three times. 
 
2.14.3  Precipitation of pure bacteriophage M13 by isoelectric precipitation in a 10 ml 
quantitative screen 
The effect of pH was investigated first. Eight 30 ml aliquots of sterile RO water in 50 ml 
polypropylene tubes were each inoculated with 300 "l caesium chloride purified bacteriophage 
M13 (Section 2.4) of concentration 4 x 10
13 pfu ml
-1. The pH of each was adjusted with 1 % 
(v/v) sulphuric acid/ 500 mM sodium hydroxide to give pH readings of 3.7, 3.9, 4.1, 4.3, 4.5, 
4.7, 4.9 and 7.0 at room temperature (Seven Easy pH meter with three point calibration, 
Mettler-Toledo). A 15 ml quantity of each 30 ml aliquot was transferred to a fresh 50 ml tube 
on ice. All samples were incubated for 2 hours and the pH of each checked and adjusted back to 
target. A 10 ml quantity of each sample was then transferred to a fresh 15 ml polypropylene 
tube and incubated for a further 22 hours to allow the bacteriophage to precipitate (Bachrach 
and Friedmann, 1971). The pH of each sample was then checked and all samples centrifuged at 
15 000 x g for 8 minutes. Samples incubated on ice were centrifuged at 4 °C, samples incubated 
at room temperature were centrifuged at 25 °C. Supernatants were decanted into fresh 15 ml 
tubes, to which 100 "l Tris (pH 8.07 at 25 °C) was added to arrest precipitation. Pellets were 
resuspended in 10 ml 20 mM Tris (pH 7.5 at 25 °C) by vortexing. Supernatants were also 
vortexed. The bacteriophage concentration in the pellets and supernatants was determined by 
the surface droplet technique (Section 2.5.2). The experiment was repeated three times.   67 
 
The precipitation time was also investigated. Two 45 ml aliquots of sterile RO water in 50 ml 
polypropylene tubes were each inoculated with 450 "l caesium chloride purified bacteriophage 
M13 (Section 2.4) of concentration 4 x 10
13 pfu ml
-1, and cooled on ice. The pH of each was 
adjusted with 1 % (v/v) sulphuric acid/ 500 mM sodium hydroxide to give pH readings of 4.3 
and 7.0 at approximately 2- 4 °C (Seven Easy pH meter, Mettler-Toledo). A 10 ml sample of 
each 45 ml aliquot was transferred to a fresh 15 ml tube and centrifuged at 15 000 x g, 8 
minutes, 4 °C, and the supernatant decanted into a fresh 15 ml tube. After 1 hour's incubation, 
the pH of each remaining sample was checked and adjusted back to target. A second 10 ml 
sample of each remaining 35 ml aliquot was transferred to a fresh 15 ml tube and centrifuged at 
15 000 x g, 8 minutes, 4 °C, and the supernatant decanted into a fresh 15 ml tube. The same 
process was repeated after 2 and 24 hour's incubation on ice. After decanting, 100 "l Tris (pH 
8.07 at 25 °C) was added to every supernatant to arrest precipitation. Pellets were resuspended 
in 10 ml 20 mM Tris (pH 7.5 at 25 °C) by vortexing. Supernatants were also vortexed. The 
bacteriophage concentration in the pellets and supernatants was determined by the surface 
droplet technique (Section 2.5.2). The experiment was repeated three times. 
 
2.14.4  Precipitation of pure bacteriophage M13 by divalent and polyvalent cation 
precipitation in a 10 ml quantitative screen 
Stocks of 1 M calcium chloride and 5 M sodium chloride were prepared in RO water and 
autoclaved. A 100 mM stock of spermidine was prepared with sterile RO water. Precipitation 
reactions at the 10 ml scale were conducted as described in Section 2.14.2, except incubation 
was at room temperature for 15 minutes only, and post-centrifugation, 100 "l 5 M sodium 
chloride was added to each supernatant to arrest precipitation. Each precipitation experiment 
was repeated three times. 
 
2.14.5  Precipitation of bacteriophage M13 from broth in a 10 ml qualitative screen 
A 400 ml culture of E. coli Top10F' in NB2 was prepared as described in Section 2.3.2, and was 
infected with 2 x 10
9 pfu ml
-1 caesium chloride purified bacteriophage M13 prior to overnight 
incubation. The culture was centrifuged at 14 000 & g (RCFmax) for 10 minutes at 4 °C, and the 
bacterial pellet discarded. The supernatant was filtered by 0.2 µm Steritop GP Express Plus 
(Millipore) to remove remaining biomass. 
 
Stocks of 1 M calcium chloride, 5 M sodium chloride, 1 M magnesium sulphate, 15 % (v/w) 
PEG 6000 and 100 mM spermidine were prepared in sterile NB2. Every stock plus filtered 
culture was adjusted to pH 7.0 prior to use with 1 % (v/v) sulphuric acid/ 500 mM sodium 
hydroxide (Seven Easy pH meter, Mettler-Toledo). Precipitation reactions (10 ml each) were 
conducted as described in Sections 2.14.2, 2.14.3 and 2.14.4, except that the addition of caesium   68 
chloride purified bacteriophage M13 was unnecessary, and tubes were inspected for 
bacteriophage pellets post-centrifugation. In the isoelectric precipitation reaction, 15 ml of 
culture was adjusted to pH 4.3 and incubated for 1 hour on ice. Reactions giving successful 
precipitation at the lowest precipitant quantities were further investigated by bacteriophage 
enumeration using the surface droplet technique (Section 2.5.2). These experiments were 
repeated twice. 
 
2.14.6  Precipitant comparison in terms of bacteriophage M13 purification 
Filtered chilled culture (Section 2.3.2) was adjusted to pH 7.0 prior to use with 1 % (v/v) 
sulphuric acid/ 500 mM sodium hydroxide. Dry precipitants were added directly to culture 
supernatant of final volume 40 ml in sterile 50 ml polypropylene tubes. Precipitants were 
dissolved by incubation at room temperature with gentle shaking for 5 minutes, and the pH 
checked with indicator strips to confirm neutrality (BDH). The pH of 40 ml culture subject to 
isoelectric precipitation was adjusted by concentrated sulphuric acid to pH 4.3. All reactions 
were incubated on ice for 1 hour to precipitate the bacteriophage, and the pH of the isoelectric 
precipitation culture re-checked. Tubes were centrifuged for either 10 minutes, 8 000 x g, 4 °C 
or 8 minutes, 15 000 x g, 4 °C (isoelectric precipitation only) and the supernatants decanted into 
fresh 50 ml tubes. Pellets were resuspended in 800 µl 20 mM Tris (pH 7.5 at 25 °C) by gentle 
rocking and brief vortexing. Supernatants were also vortexed. Pellets, supernatants and 
untreated culture were analysed by SDS-PAGE (Section 2.7.3), agarose gel electrophoresis 
(Section 2.7.2), Bradford assay (Section 2.7.5) and surface droplet bacteriophage enumeration 
(Section 2.5.2) to determine the purification of bacteriophage M13 achieved by each 
precipitation method. The experiment was repeated three times. 
 
 
2.15  Bacteriophage and E. coli Characterisation Studies 
2.15.1  Determination of an effective decontamination agent 
2.15.1.1  Effect of Tego on bacteriophage M13 viability 
The liquid amphoteric surfactant Tego 2001 (proprietary composition based on 1-alkyl-1,5-
diazapetane in aqueous solution. Johnson Diversey) was tested for efficacy against caesium 
chloride purified bacteriophage M13 at concentrations of 0, 1, 2 and 10 % (v/v). The typical 
working concentration was 2 % (v/v) at room temperature. Solutions (9 ml) of Tego in sterile 
RO water were made in sterile 50 ml polypropylene tubes, to which 1 ml of bacteriophage were 
added, making the appropriate Tego concentration in 10 ml. Tubes were briefly mixed, and 
duplicate 20 "l samples were taken for bacteriophage enumeration (Section 2.5.2) after 10 
second, 1, 5, 10 and 20 minute incubations at room temperature. Samples were immediately ten-
fold serially diluted to 10
-2 of their original concentration. A control of 10 % Tego solution   69 
alone was also serially diluted and plated onto Top10F' overlay agar plates. The experiment was 
repeated three times. 
 
2.15.1.2  Effect of Solquest on bacteriophage M13 viability 
The liquid surfactant Solquest (proprietary composition based on 10- 30 % (w/v) tetrasodium 
EDTA, 5- 10 % (v/v) amino-tri(methylene phosphonic acid), 5- 10 % (w/v) sodium hydroxide, 
Arrowmight Biosciences) was tested for efficacy against caesium chloride purified 
bacteriophage M13 at concentrations of 0, 0.5, 1 and 5 % (v/v) at 50 °C and 70 °C. The typical 
working concentration was 1 % (v/v) in "hot" water. Solutions (900 "l) of Solquest in sterile 
RO water were made in sterile 1.5 ml polypropylene tubes and incubated at the appropriate 
temperature for 20 minutes in a pre-warmed heat block (Thermomixer Comfort, Eppendorf). 
Caesium chloride purified bacteriophage (100 "l) were added to each, making the appropriate 
Solquest concentration in 1 ml. Tubes were briefly mixed, and duplicate 20 "l samples were 
taken for bacteriophage enumeration (Section 2.5.2) after 10 second, 1, 5, 10 and 20 minute 
incubations. Samples were immediately ten-fold serially diluted to 10
-2 of their original 
concentration. A control of 5 % Solquest solution alone was also serially diluted and plated onto 
Top10F' overlay agar plates. All experiments were repeated three times. 
 
2.15.1.3  Effect of Virkon on bacteriophage M13 viability 
The oxidising disinfectant powder Virkon (proprietary composition based on < 50 % (w/w) 
pentasodium bis(peroxymonosulphate) bis(sulphate), 5- 10 % (w/w) sulphamidic acid, 5- 15 % 
(w/w) sodium dodecylbenzenesulfonate, <2 % (w/w) dipotassium peroxdisulphate, DuPont) 
was tested for efficacy against caesium chloride purified bacteriophage M13 as 0, 0.01, 0.1 and 
1 % (w/v) solutions. The typical working concentration was 1 % (w/v) at room temperature. A 2 
% (w/v) stock was prepared. Solutions (9 ml) of Virkon in sterile RO water were made in sterile 
50 ml polypropylene tubes, to which 1 ml of bacteriophage were added, making the appropriate 
Virkon concentration in 10 ml. Tubes were briefly mixed, and duplicate 20 "l samples were 
taken for bacteriophage enumeration (Section 2.5.2) after 10 second, 1, 5, 10 and 20 minute 
incubations at room temperature. Samples were immediately ten-fold serially diluted to 10
-2 of 
their original concentration. A control of 1 % Virkon solution alone was also serially diluted 
and plated onto Top10F' overlay agar plates. The experiment was repeated three times. 
 
2.15.1.4  Effect of Virkon on E. coli viability 
A 150 ml baffled shake flask containing 50 ml NB2 was inoculated with 1 ml of E. coli W1485 
working culture (Section 2.3.1.3), and incubated at 37 ºC with shaking, overnight. The oxidizing 
disinfectant powder Virkon (DuPont) was tested for efficacy against E. coli W1485 as 0, 0.1, 
0.5 and 1 % (w/v) solutions. The typical working concentration was 1 % (w/v) at room 
temperature. A 2 % (w/v) stock was prepared. Solutions (10 ml) of Virkon in sterile RO water   70 
were made in sterile 50 ml polypropylene tubes of concentration 0, 0.2, 1 and 2 % (w/v), to 
which 10 ml of culture was added, making the appropriate Virkon concentration in 20 ml. 
Tubes were briefly mixed, and duplicate 20 "l samples were taken for E. coli enumeration by 
the surface droplet technique (Section 2.5.2). Samples were taken after 10 second, 1, 5, 10 and 
20 minute incubations at room temperature. Samples were immediately ten-fold serially diluted 
to 10
-2 of their original concentration. The experiment was repeated three times. 
 
2.15.2  The effect of desiccation on bacteriophage M13 and E. coli 
2.15.2.1  Preparation of E. coli cultures 
Two 150 ml baffled shake flasks containing 50 ml NB2 were inoculated with 1 ml E. coli 
Top10F' working culture (Section 2.3.1.2). One flask was also inoculated with 2 x 10
9 pfu ml
-1 
caesium chloride purified bacteriophage M13 (Section 2.4), and both flasks incubated at 37 ºC 
with shaking, overnight. This procedure was repeated three times. 
 
2.15.2.2  Preparation of bacteriophage M13 
Caesium chloride purified bacteriophage M13 (4 ml) (Section 2.4) was combined with 1 ml 5x 
NB2 to give 1 x 10
13 pfu ml
-1 in 1x NB2. An aliquot of this solution (500 "l) was subsequently 
10-fold serially diluted in 4.9 ml amounts of NB2 to an M13 concentration of 1 x 10
4 pfu ml
-1. 
The serial dilution process was repeated three times. 
 
2.15.2.3  Preparation for desiccation 
Desiccation was conducted in polystyrene round-bottomed 96-well plates (Sterilin). Two 
hundred microlitre quantities of each E. coli culture (infected and non-infected with M13) and 
M13 dilutions of 10
13, 10
10, 10
7 and 10
4 pfu ml
-1 were loaded. Each 96-well plate held all three 
experimental repeats. Twenty-four 96-well plates were loaded. The wells of eight plates were 
sealed with self-adhesive impermeable tape (Fisher) as non-desiccated controls. All uncovered 
plates were placed under a fume hood until dry. The relative humidity of the fume hood was 
recorded (H-2 humidity meter, Testo). 
 
2.15.2.4  Desiccation 
Once dry, eight 96-well plates were immediately placed, uncovered, in a laboratory desiccator 
filled with anhydrous silica gel crystals (BDH). The desiccator was placed in a cupboard to 
protect the samples from light and draughts. Eight 96-well plates were placed alongside the 
desiccator, also uncovered, together with the eight sealed control plates. One plate was removed 
from each condition on days 0, 1, 3, 6, 12, 20, 30 and 47 post commencement of desiccation. 
The relative humidity within the desiccator and in the laboratory was recorded twice-weekly. 
   71 
2.15.2.5  Enumeration of viable bacteriophage M13 and E. coli 
At each time-point the cells and bacteriophage in the removed 96-well plates were rehydrated 
with 200 "l 20 mM Tris (pH 7.5 at 25 °C) per well. Plates were incubated for 20 minutes at 
room temperature, and the cells and bacteriophage gently pipetted to resuspend. After a further 
10 minute incubation and pipetting, cells and bacteriophage were enumerated by the surface 
droplet technique (Section 2.5.2). 
 
2.15.3  The effect of extremes of pH on bacteriophage M13 
Caesium chloride purified bacteriophage M13 suspension (640 "l) (Section 2.4) was combined 
with 160 "l 5 x NB2 to give 1 x 10
13 pfu ml
-1 in 1 x NB2. Aliquots (15 ml) of sterile RO water 
were adjusted with 10 % (v/v) sulphuric acid/ 4 M sodium hydroxide to give pH readings of 1.0, 
3.0, 7.0, 11.0 and 13.0 at room temperature (Seven Easy pH meter, Mettler-Toledo). The 
volumes were then each adjusted to 9.9 ml, and 100 "l of bacteriophage M13 solution added. 
Each tube was briefly inverted to mix and the pH checked with indicator strips (BDH). Samples 
of 400 "l were taken after 1, 5, 10 and 20 minute incubations. A total of 400 "l 1 M Tris (pH 
7.5 at 25 °C) was immediately added to every sample to neutralize the solution. pH was checked 
with indicator strips to confirm neutrality (BDH). Similarly, 100 "l of bacteriophage M13 
solution was added to 9.9 ml each of 10 % sulphuric acid, 4 M sodium hydroxide, and another 
pH 7.0 control. Each tube was briefly inverted to mix, and 400 "l samples were again taken 
after 1, 5, 10 and 20 minute incubations. Acidic samples were neutralised with 370 "l 4 M 
sodium hydroxide, 150 "l 1 M Tris (pH 7.5 at 25 °C) and 80 "l sterile RO water. Alkaline 
samples were neutralised with 450 "l 10 % sulphuric acid, 150 "l 1 M Tris (pH 7.5 at 25 °C). 
450 "l  sterile RO water and 150 "l 1 M Tris (pH 7.5 at 25 °C) was added to the pH 7.0 control. 
pH was again checked with indicator strips to confirm neutrality (BDH). Bacteriophage in all 
samples were then enumerated by the surface droplet technique (2.5.2). The entire experiment 
was repeated three times. 
 
2.15.4  The effect of temperature on bacteriophage M13 
One millilitre of caesium chloride purified bacteriophage M13 (Section 2.4) was combined with 
2 ml 5 x NB2 and 7 ml sterile RO water to give a stock of 1 x 10
12 pfu ml
-1 in 1 x NB2. Each 
experimental run consisted of eight 50 "l aliquots of M13 stock in 500 "l polypropylene PCR 
tubes, evenly spaced along the centre row of Techne TC- 512 PCR block (VWR- Jencons). The 
lid temperature was always set at 105 °C to prevent condensation. Timing began once the PCR 
block reached within 0.5 °C of the specified temperature, a process typically taking less than 10 
seconds. A sample tube was then removed after a 1, 5, 10, 20, 30, 40, 50 and 60 minute 
incubation time. The removed sample was immediately cooled in 10 °C water. Incubation 
temperatures of 99, 95, 90, 80, 70, 60, 50, 40, and 25 °C were tested, together with a room 
temperature control not incubated within the device. A 20 "l quantity of each sample was   72 
enumerated for bacteriophage by the surface droplet technique (2.5.2). A further 20 "l of each 
sample was directly plated onto Top10F' overlay agar plates to serve as a 10
0 dilution. The 
entire experiment was repeated three times. 
 
 
2.16  Data Transformation and Statistical Analysis 
All statistical analyses were performed using GraphPad InStat software (version 3.0) and 
Microsoft Excel for Mac (version 11.5.5). Unless otherwise stated all bacterial and 
bacteriophage titres were transformed to log10 values prior to the application of the statistical 
tests. In all data sets containing three or more data groups, a single factor analysis of variance 
(ANOVA) test was applied. Where the determination of significant differences between 
samples was required, a derivative of the ANOVA test was used (Wardlaw, 1999). The Dunnett 
statistical analysis test was used to compare values in a data set against a standard control value, 
and determined which values in the data set were significantly different from the control value 
only. The Tukey test allowed the comparison of each value in a data set to each of the other 
values where there was no control value. The confidence interval was set at 95 %. In all data 
sets containing two data groups, or groups of non-equal size, a Student's t test ("t-test") was 
applied of two-tailed, two-sample equal variance type. It was assumed that data sets possessed a 
normal distribution. Standard error analysis was performed alongside all statistical tests and was 
displayed graphically with every experiment or shown as a "±" figure in tables. 
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3  The Effect of Hydrodynamic Shear on the Filamentous 
Bacteriophage Particle 
3.1  Introduction 
It was noted in Section 1.2.2 that bacteriophage M13 and its close relations are filamentous in 
structure. They appear as extremely long protein-coated tubes, 900 nm in length but only 6.5 nm 
in diameter, and are semi-flexible in nature. In effect the filamentous bacteriophage are 
macromolecular complexes of molecular weight 16.4 MDa (Schmidt et al., 2000), which is 200- 
400 times that of the average globular protein and equivalent in mass to a 30 kb plasmid. In 
terms of size, the bacteriophage contour length is also significantly greater than the average 8-
12 nm antibody protein (Biddlecombe et al., 2007) and is comparable to the 1.2 µm 
characteristic dimensions of a 20 kb plasmid (Arulmuthu et al., 2007). This is important since it 
has been shown that both antibody proteins and 20 kb plasmids are sensitive to high-energy 
turbulent shear conditions (Biddlecombe et al., 2007; Levy et al., 1999b). Thus, would the large 
bacteriophage molecule combine shear-sensitive aspects of each? The investigation of shear 
sensitivity is relevant for bacteriophage large-scale processing, since unit operations such as 
fermentation, continuous centrifugation and ancillary pumps all impart flow conditions on the 
process fluid up to several orders of magnitude greater in energy than that imparted by standard 
laboratory processing (Yim and Shamlou, 2000). Since little is known about the response of 
bacteriophage M13 to any of these environments, it was considered that a general approach 
should be undertaken to examine its fragility. Thus, the primary aim of this chapter was to 
examine the effect of turbulent fluid flows of varying energy intensity on bacteriophage M13 by 
use of a rotating-disk ultra scale-down (USD) device (described in the Materials and Methods, 
Section 2.12.2).  
 
A shear resistance comparison between bacteriophage M13 and double-stranded DNA is 
particularly important since both entities have been studied for their effectiveness as vectors for 
gene therapy and vaccination (Kutzler and Weiner, 2008; Larocca et al., 2002; Wan et al., 
2001). As "competing" technologies, it would be of significant interest if one construct proved 
substantially more resilient to hydrodynamic shear forces than another. Therefore, the relative 
resistances of M13 bacteriophage, single-stranded and supercoiled double-stranded DNA to 
turbulent shear conditions were investigated. All three molecules were of the same genome size 
to allow for an equal basis of comparison.  
 
Over the course of a purification scheme the composition of the process fluid would alter 
considerably as contaminants are progressively removed, buffers changed and chemicals added. 
Since the shear resistance of both protein and DNA complexes have been shown to depend on 
the nature of the process fluid (Harrison et al., 1998; Levy et al., 1999a; Levy et al., 1999b), the   74 
shear resistance of bacteriophage M13 in several process fluid environments was consequently 
examined. 
 
This chapter begins with the revisiting of an early method determining the fragility of 
filamentous bacteriophage to ultrasonication. The rotating disk USD shear device is then 
introduced, and the theory of describing the imposed conditions discussed. The resistance of 
bacteriophage M13 to a range of shear conditions is first examined, followed by the comparison 
with single and double-stranded DNA molecules. The effect of solution conditions is then 
shown. Two experiments are presented which aimed to clarify some of the mechanisms of 
damage within the device. Finally, a comparison is made between bacteriophage M13 and 
existing data for various other complex macromolecules tested within the USD shear device. 
The implications of these results for the large-scale bioprocessing of bacteriophage M13 are 
then discussed. 
 
 
3.2  The Effect of Ultrasonication on Bacteriophage M13 
An early reference to filamentous bacteriophage fragility was made in 1963, where the severe 
sensitivity of bacteriophage fd to the shear imparted by sonication was described. This newly 
discovered bacteriophage was found be much more sensitive to these conditions relative to 
smaller, more spherical bacteriophage molecules (Marvin and Hoffman-Berling, 1963). Since 
bacteriophage M13 is closely related to fd, it was expected that a severe sensitivity would also 
be noted. 
 
3.2.1  The effect on bacteriophage viability 
The effect of sonication on the viability of caesium chloride purified bacteriophage M13 in 10 
mM Tris (pH 7.5 at 25 °C) was investigated as described in the Materials and Methods (Section 
2.12.1). The concentration of bacteriophage was 3 x 10
11 pfu ml
-1, similar to that achieved by 
the end of fermentation (Section 2.3.3). The decay in bacteriophage viability upon exposure to 
1, 5 and 10 µm amplitudes was recorded. The experiments were repeated three times. 
 
The resulting decay profiles were each plotted as fractional concentrations of viable 
bacteriophage relative to non-sonicated controls. A severe loss of bacteriophage viability was 
recorded upon exposure to sonication of 5 and 10 µm amplitudes (Figure 3.1). This is illustrated 
by the viability losses in the first two minutes: at the 10 µm amplitude 98 % of bacteriophage 
M13 had already been inactivated, and at the 5 µm amplitude 81 % of bacteriophage M13 had 
lost viability. However, there was no significant loss of viability at 1 µm amplitude over the 
course of the ten minute experiment (P>0.05, Dunnett). The decay profiles at the 5 and 10 µm   75 
amplitudes showed a linear decrease on the semi-log plot of Figure 3.1. This was indicative of a 
first order decay process represented by the general form shown in Equation (1), below: 
! 
ln
Ct
C0
= Kt            (1) 
where Ct is the concentration of viable bacteriophage at time t, C0 the initial viability prior to 
shearing and K the decay rate constant (representing a proportional loss in bacteriophage 
viability per minute). The decay constant was -0.87 at 5 µm amplitude (R
2=0.99) and -1.71 at 10 
µm amplitude (R
2=0.96). 
 
 
 
 
Figure 3.1 Fraction of viable bacteriophage M13 at sonication amplitudes 1 µm (!), 5 µm (!) 
and 10 µm (") as a function of time. The initial bacteriophage concentration (C0) was 4 x 10
11 
pfu ml
-1. Viability was determined by the surface-droplet technique (Section 2.5.2). Error bars 
represent the standard error of the mean fractions, N=3. 
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3.2.2  Visualisation of sonication damage by electron microscopy 
The extent of the physical damage caused by sonication was further investigated by 
transmission electron microscopy. Bacteriophage samples were prepared and visualised as 
described in the Materials and Methods (Section 2.10). The non-sonicated control was 
compared with the effect of sonication at the 10 µm amplitude for 10 minutes. 
 
It was found that the severe decline in bacteriophage viability noted in Section 3.2.1 correlated 
with severe damage to the particle structure (Figure 3.2). Very few intact bacteriophage 
particles were visible post-sonication. It was assumed that the abundant particulate matter 
observed after sonication was bacteriophage fragments. 
 
 
 
 
Figure 3.2 Transmission electron microscope (TEM) image of several non-sonicated intact 
M13 bacteriophage (A), and bacteriophage of the same concentration subject to 10 µm 
amplitude sonication for 10 minutes (B). Samples were negatively stained with 0.25 % (w/v) 
uranyl acetate. 
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3.3  The Effect of Hydrodynamic Shear on Bacteriophage M13 
3.3.1  Theoretical aspects: the calculation of energy dissipation within the rotating disk 
boundary layer 
A detailed description of the USD rotating disk shear device equipment can be found in the 
Materials and Methods, Section 2.12.2. In this thesis, the conditions within the shear device 
chamber were described in terms of the imposed maximum energy dissipation rate, a key 
parameter used extensively in the literature (Boychyn et al., 2001; Boychyn et al., 2004; 
Hutchinson et al., 2006). The maximum energy dissipation rate serves as a basis of comparison 
between the small-scale experimentation and large-scale unit operations. Substantial literature 
exists on the estimation of the maximum energy dissipation rates within large-scale unit 
operations (Mollet et al., 2004; Yim and Shamlou, 2000). 
 
Analytical predictions of the maximum energy dissipation rate within the USD shear device 
were previously described by Boychyn et al. (2001) by the application of flat-plate boundary 
layer theory to the rotating disk and the assumption that breakage of particles occurs by fluid 
stresses prevailing in this region. Alternatively, in this chapter rotating-disk boundary layer 
theory was applied, where the Reynolds number (used to determine the prevailing flow regime) 
in the rotating disk system was calculated at a radius r (m) by Re= r
2!/", where ! is the 
rotational speed (rad s
-1) and " the kinematic viscosity (m
2 s
-1). In the laminar flow regime the 
boundary layer thickness can be estimated for a rotating disk by (Schlichting, 2000): 
! 
"lam = 5.5
#
$
            (2) 
where #lam is the laminar boundary layer thickness (m). The laminar boundary layer thickness is 
independent of r. Lingwood (1995) observed that the transition from laminar to turbulent flow 
over rotating disks occurs as an abrupt axisymmetric phenomenon at a defined radius. 
Assuming a rapid transition from laminar to turbulent flow, the turbulent boundary layer 
thickness was estimated by (Schlichting, 2000): 
! 
"turb = 0.52r
3
5 #
$
% 
& 
' 
( 
) 
* 
+1
5
          (3) 
where #turb is the turbulent boundary layer thickness (m), which is dependent on r. The volume 
of the boundary layer was thus calculated from the integration of boundary layer expressions (2) 
and (3) over the areas of the disk within which each regime prevailed: 
! 
Vb = 2"rt
2#lam + 2 dr rd$
0
# max (r) % 0
2" % rt
R % d#    (4) 
where rt is the disk radius at which the laminar- turbulent transition occurs, and Vb is the volume 
of the boundary layer (m
3). Finally, the energy dissipation rate was calculated: 
!= P/"Vb            (5)   78 
where $ is the liquid density (kg m
3) and P the power input into the ungassed system (W).  
 
The power input P was calculated by more than one method. In initial experiments (Section 
3.3.2, below), it was estimated as described by Boychyn et al. (2001), from P=2%!T, where T is 
the applied torque to the disk (kg m
2 s
-2): 
! 
T = 0.664"µ#$
%#$
µ ( )
1
2 16R
5
2
15
& 
' 
(  ) 
* 
+         (6) 
where µ is the solution viscosity (Pa s), &' the tangential tip velocity (m s
-1) and R the disk 
radius (m). However, in further experimentation (Section 3.3.3, below), it was possible to 
calculate the power input directly from the electrical power draw of the attached motor, P=VI, 
where V is the voltage (V) and I the current (A). A maximum efficiency of 88 % for the motor 
was assumed according to the manufacturer's specifications. Thus, the maximum energy 
dissipation rate in the region of the boundary layer was estimated as a function of the rotational 
speed and compared with established data for various unit operations. 
 
3.3.2  Initial USD shear device experimentation 
Initial experiments were conducted with rotating disk shear device powered by an electrically-
driven brushed DC motor (see Materials and Methods, Section 2.12.2). The maximum disk 
rotation speed was 350 revolutions per second (rps); similar equipment has been used by Levy 
et al. (1999b) to study the effects of shear on plasmids and Boychyn et al. (2001) to model the 
performance of pilot-scale continuous centrifuges. Here, the power input to the device could not 
be measured directly so was estimated using Equation (6). 
 
A suspension of caesium-chloride purified bacteriophage M13 of concentration 3 x 10
11 pfu ml
-1 
in 10 mM Tris (pH 7.5 at 25 °C) was prepared and processed within the device at 350 rps for a 
total of 60 seconds, the maximum possible for the equipment. In addition to triplicate time zero 
samples, a timed non-sheared control was conducted within the device. This ensured that any 
observable declines in viability over time were due to shear effects alone. The experiment was 
repeated three times. 
 
The measured concentration of viable bacteriophage post-shearing was expressed as a fraction 
of the viable concentration in the non-sheared controls (Table 3.1). It was found that over the 
course of 60 seconds there was no significant fractional decrease in viability in either the 
sheared or non-sheared samples in the device. 
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Table 3.1 The viability of  bacteriophage M13 expressed as a fraction of the initial non-sheared 
viability (Ct/C0) after 60 seconds within the USD shear device at 350 rps and 0 rps. The 
equivalent maximum energy dissipation rate (!max) was estimated as described in Section 3.3.1. 
Uncertainties represent the standard error, N=3. 
 
Condition 
Equivalent 
!max x10
5 (W kg
-1) 
Ct/C0 after 60 seconds  P value (t-test) 
350 rps   1.6  0.95 ± 0.12  0.53 
0 rps   0  0.97 ± 0.06  0.66 
 
 
3.3.3  High-speed USD shear device experimentation 
Since no significant bacteriophage damage was observed in Section 3.3.2, the USD shear device 
was developed to operate reliably at significantly higher rotation speeds. An electrically-driven 
brushless DC motor system was developed as described in Section 2.12.2. The updated 
equipment was capable of a maximum speed of rotation of 533 rps, and direct measurement of 
the power draw of the motor improved the accuracy of the maximum energy dissipation 
calculation. Otherwise, experimentation was consistent with that described previously (Section 
3.3.2). 
 
Solutions of caesium-chloride purified bacteriophage M13 of concentration 3 x 10
11 pfu ml
-1 in 
10 mM Tris (pH 7.5 at 25 °C) were prepared and processed within the device at rotation speeds 
of 300, 400, 467, 500 and 533 rps for 25 minutes (Section 2.12.2). Triplicate non-sheared 
controls were present. All treatments were repeated three times. 
 
The maximum energy dissipation rate at each rotation speed was calculated as described in 
Section 3.3.1. The power input to the system was estimated from the torque applied to the disk 
(Equation (6)) and calculated from the power draw of the motor (Table 3.2), and the two 
methods compared. The power input as estimated from the torque applied to the disk was found 
to be up to 4-fold higher than the actual electrical energy input. Therefore the energy dissipation 
rates calculated using Equation (6) were significant overestimates relative to those employing 
the measured power draw of the motor, which were used for all further calculations. These 
maximum energy dissipation rates ranged from 8.9 x 10
4 to 3.1 x 10
5 W kg
-1, and were found to 
vary with the disk rotation speed as a power law relationship (Figure 3.3). The "tip speed" of the 
rotating disk, shown in Table 3.2, is an alternative expression of the rotation speed of the device 
used in the literature (Biddlecombe et al., 2007; Boychyn et al., 2004). It is a general parameter 
that allows for the comparison of conditions between shear devices of differing disk diameters. 
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Table 3.2 Relationship between disk rotation speed and maximum energy dissipation rate 
(!max), calculated by DC motor power draw and applied torque methods. 
     
     
Power input measured by 
DC motor power draw 
 
Power input estimated 
from applied torque, 
Equation (6) 
Rotation 
speed (rps) 
Tip speed 
(m s
-1) 
 
Power 
input (W) 
!max x10
5 
(W kg
-1) 
 
Power 
input (W) 
!max x10
5 
(W kg
-1) 
300  37.7    120  0.9    345  2.9 
400  50.3    209  1.8    708  6.0 
467  58.6    277  2.4    1041  8.9 
500  62.8    323  2.8    1237  10.6 
533  67.0    353  3.1    1454  12.6 
 
 
 
 
Figure 3.3 Maximum energy dissipation rate (W kg
-1) calculated as a function of USD shear 
device disk rotation speed (rps). The R
2 value for the power law trend was >0.99. The maximum 
energy dissipation rate was calculated using the power draw of the DC motor.   81 
 
There was no detectable effect on bacteriophage M13 viability following a 25 minute subjection 
to shear at 300 and 400 rps within the device at 25 °C (Figure 3.4). At 467 rps, the drop in 
viability was small and diverged significantly from a non-sheared control only after the full 25 
minutes exposure (P= 0.001, t-test). However, exposure to 500 and 533 rps resulted in much 
greater rates of viability decay (Figure 3.5). Indeed, at 533 rps the M13 viability had decreased 
by 62 % over the 25 minute period of study.  
 
 
Figure 3.4 Concentration fraction of bacteriophage M13 viability remaining at disk rotation 
speeds 300 (#), 400 (!) and 467 rps (!) as a function of time. The initial bacteriophage 
concentration (C0) was 3 x 10
11 pfu ml
-1. Error bars represent the standard error of the mean 
fractions, N=3. 
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Figure 3.5 Concentration fraction of bacteriophage M13 viability remaining at disk speeds 467 
rps (!), 500 rps (!) and 533 rps (") as a function of time. The initial bacteriophage 
concentration (C0) was 3 x 10
11 pfu ml
-1. Error bars represent the standard error of the mean 
fractions, N=3. 
 
 
Each set of data in Figure 3.5 was fitted to a first order decay process represented by the general 
form shown in Equation 1. Each decay rate constant (K, representing the proportional loss in 
bacteriophage viability per minute) was plotted against the corresponding maximum energy 
dissipation rate for the conditions tested (Figure 3.6). As expected, K was found to increase with 
maximum energy dissipation. This was found to be an exponential relationship: 
! 
K = (1 "10
#6)e
(3"10
#5)$         ( 7 )  
where ! is the energy dissipation rate, in W kg
-1. 
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Figure 3.6 The effect of the maximum energy dissipation rate (W kg
-1) on the bacteriophage 
rate of decay, K (min
-1). The R
2 value for the exponential trend was 0.98. 
 
 
3.3.4  The relative shear resistance of bacteriophage M13 and naked DNA 
Packaged bacteriophage M13, naked supercoiled double-stranded (ds)DNA (6.6 kb) and naked 
open circular single-stranded (ss)DNA (6.6 kb) in TE buffer were subject to turbulent shear at 
533 rps with the intention of comparing the relative resistances of these macromolecules.  
 
As described in Chapter 1 (Section 1.2.4), once infected by bacteriophage M13 an E. coli cell 
contains many copies of the M13 genome in a "non-packaged" supercoiled double-stranded 
form (Replicative Form 1, or RF1). Effectively, the RF1 form has the structure of a plasmid, 
and so was used for the relative robustness comparison between intact "packaged" M13 
bacteriophage and supercoiled dsDNA. M13 infected Top10F' cultures were cultivated as 
described in Section 2.3.3. The RF1 DNA was extracted from the cells by Qiagen MaxiPrep kit 
(Section 2.8.2). The DNA concentration was determined according to absorbance at 260 nm. 
The DNA was subsequently diluted in TE buffer to an equivalent concentration of 3 x 10
11 
molecules ml
-1 prior to shearing. 
 
Single-stranded DNA was prepared directly from caesium-chloride density gradient purified 
M13 bacteriophage, as described in Section 2.8.1. Again, the DNA concentration was   84 
determined according to absorbance at 260 nm. The DNA was subsequently diluted in TE 
buffer to an equivalent concentration of 3 x 10
11 molecules ml
-1 prior to shearing. 
 
Post-shearing, all DNA samples were subsequently concentrated ten-fold by ethanol 
precipitation (Section 2.8.1). Analysis was by 0.8 % (w/v) agarose gel electrophoresis (Section 
2.7.2) and densitometric scanning (Section 2.7.4). All experiments were performed three times 
at room temperature. Shear damage to supercoiled dsDNA was determined in terms of the 
decrease in supercoiled form, while shear damage to ssDNA was determined in terms of the 
decrease in open circular form.  
 
The proportion of supercoiled (SC) dsDNA was observed to decrease as shearing progressed 
over 25 minutes (Figure 3.7). Over the same period, the decrease in intact ssDNA was much 
more marked (Figure 3.7). Densitometric scanning of these gels allowed for the plotting of the 
relative decline in integrities, where they were compared with the viability data for packaged 
bacteriophage M13 particles (Figure 3.8). The degradation rate of supercoiled dsDNA was 
substantially less than that of both ssDNA and packaged bacteriophage particles. After 25 
minutes the proportion of remaining supercoiled DNA was 0.67, the proportion of intact ssDNA 
was 0.45 and the proportion of viable M13 bacteriophage 0.38. 
 
SC
0        5       10     15     20     25    (mins) 0         5        10      15       20      25    (mins)
OC
linear
fragments
A B
OC
fragments
6.6 kb SC dsDNA 6.6 kb OC ssDNA
 
 
Figure 3.7 Agarose gel electrophoresis of ethanol precipitated double-stranded M13 RF1 DNA 
(6.6 kb) is shown in (A), and single-stranded M13 DNA (6.6 kb) in (B). Samples were taken at 
0, 5, 10, 15, 20 and 25 minute timepoints at 533 rps. Densitometric scanning of the gels was 
performed as outlined in Materials and Methods. Abbreviations: OC, open circular, SC, 
supercoiled.   85 
 
 
 
Figure 3.8 Declines in the proportions of intact SC double-stranded DNA (!), intact OC 
single-stranded DNA (") and viable M13 bacteriophage (!) as a function of time at 533 rps. 
Declines are calculated relative to the quantities measured in non-sheared controls. Error bars 
represent the standard error of the mean fractions, N=3. 
   86 
 
3.3.5  The effect of process fluid conditions on bacteriophage M13 decay profiles 
Bacteriophage M13 was suspended in four process fluids representative of probable key 
processing stages, and each was subject to turbulent shear at 533 rps within the USD device. 
The conditions were: 
1.  In post-shakeflask fermentation culture with E. coli Top10F' cells, prepared as 
described in Section 2.3.3. Cultures were supplemented with 0.2 g l
-1 of PPG 2 000 
antifoam (BDH). The average OD600 value was 2.9. 
2.  In post-shakeflask fermentation culture supernatant. Cells had been removed by 
centrifugation at 14 000 ! g for 15 minutes at 4 °C (Section 2.3.3).  
3.  In post-shakeflask fermentation culture supernatant with 3.3 % (w/v) PEG 6 000 and 
330 mM NaCl to precipitate the bacteriophage. Samples were incubated on ice for 1 
hour prior to shearing to complete precipitation (Section 2.3.3). 
4.  Caesium-chloride purified bacteriophage M13 suspended in 10 mM Tris (pH 7.5 at 25 
°C), of concentration 3 x 10
11 pfu ml
-1. 
 
In particular, in a large-scale scheme the process fluid under conditions (1.) and (3.) (above) 
may be subject to the high-energy turbulent shear feed-zone of a continuous centrifuge to 
remove the E. coli cells and capture the bacteriophage, respectively.  
 
All fluids were prepared and processed within the USD device at a rotation speeds 533 rps for 
25 minutes (Section 2.12.2). Triplicate non-sheared controls were present. All experiments were 
repeated three times. 
 
The decline in bacteriophage viability over time under each condition (1.- 4.) is shown in Figure 
3.9. After 25 minutes exposure, the viable fraction of bacteriophage ranged from 0.12 in culture 
supernatant to 0.39 in culture. However, there were apparent differences in the patterns of 
decline. The viability of M13 in culture decreased in a trend consistent with first order decay 
kinetics. Under culture supernatant, precipitated and 10 mM Tris conditions, M13 displayed 
degradation patterns consistent with resistance to shear for up to 10 minutes before entering 
phases of increased susceptibility to shear. This trend was particularly marked in culture 
supernatant after 15 minutes shearing time.  
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Figure 3.9 The fractional concentration decline in M13 viability in four process fluid conditions 
as a function of time. The conditions were: fermentation culture (!); culture supernatant ("); 
culture supernatant with PEG and NaCl added (#); purified M13 in 10 mM Tris buffer (!). All 
samples were subjected to disk speed of 533 rps. Error bars represent the standard error of the 
mean fractions, N=3. 
 
 
3.3.6  Calculation of maximum energy dissipation rate for each process fluid condition 
The maximum energy dissipation rate was calculated for each process fluid subjected to 533 rps 
within the USD shear device to determine if variances in the M13 decay rate could be attributed 
to differences in the maximum energy dissipation rate, the calculation of which depends on the 
fluid viscosity (Section 3.3.1). The viscosity of each fluid described in Section 3.3.5 was 
measured in duplicate as described in the Materials and Methods (Section 2.11) using a cone 
and plate viscometer at 25 °C. A linear relationship existed between shear stress and shear rate 
(Figure 3.10); therefore every fluid was Newtonian and the viscosity (µ, Pa s) could be 
measured as the gradient of the line. The measured viscosity of the water control (µ= 1.04 mPa 
s) was in line with that expected at 25 °C (Perry et al., 1998). 
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Figure 3.10 The viscosity measurement of four process fluid solutions. Viscosity (") was 
calculated from the gradient of each line. The conditions were: fermentation culture (!); 
culture supernatant ("); culture supernatant with PEG and NaCl added (#); purified M13 in 10 
mM Tris buffer (!). A control of RO water was also tested (+). N=2. 
 
 
The energy dissipation rates were subsequently calculated using the measured viscosities and 
average power draw of the DC motor. The fluid density was assumed to remain at 1 000 kg m
-3. 
Despite variations in viscosity and power input between fluids, the calculated energy dissipation 
rates were similar (Table 3.3). That is, the differences in viscosity and power input between 
fluids resulted in a less than 10 % difference in maximum energy dissipation rate. It was 
therefore concluded that the differences in M13 decay profiles between process fluids was not 
chiefly due to differences in energy dissipation rate. 
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Table 3.3 The effect of solution viscosity on the power input and maximum energy dissipation 
rates calculated within the USD shear device at 533 rps. 
 
Process fluid  Viscosity (mPa s)  Power input (W)  !max x10
5 (W kg
-1) 
Culture  1.22  363  3.1 
Culture supernatant  1.23  348  3.0 
Culture supernatant, 
3.3 % PEG 6 000, 
330 mM NaCl 
1.87  392  3.3 
10 mM Tris  1.13  353  3.1 
 
 
3.3.7  The effect of air-liquid interfaces on bacteriophage M13 
It was considered that the variation in decay profiles of bacteriophage M13 in Section 3.3.5 may 
have been the result of the action of more than one mechanism of damage, dependent on the 
process fluid. Since some bacteriophage and proteins are known to display a vulnerability to air-
liquid interfaces (Thompson and Yates, 1999), it was surmised that air-liquid interfaces could 
be playing a part in the viability loss of M13. The main evidence for this lay in the apparent 
acceleration in decay rate as time increased in the culture supernatant, precipitated and 10 mM 
Tris environments (Figure 3.9), albeit to greater or lesser degrees in each. As time increased, 
500 µl samples had been removed from the 20 ml device chamber at five minute intervals 
(Section 2.12.2), leading to an increasing amount of air in the chamber. 
 
Four experiments were therefore conducted to determine if the sampling technique over time 
(each 500 µl sample represented 2.5 % of the total volume) was responsible for the accelerated 
decay rates by increasing the quantity of air-liquid interfaces within the device. Caesium-
chloride purified bacteriophage M13 of concentration 3 x 10
11 pfu ml
-1 in 10 mM Tris buffer 
were subject to shear at 533 rps for 5 minutes without sampling in the first treatment, and 25 
minutes without sampling in the second. In the third and fourth treatments the chamber was 
filled but then 2 ml of fluid removed, equivalent to a 10 % (v/v) air volume within the chamber 
and representative of the conditions between the standard 20 and 25 minute shearing times. The 
fluid was sheared for 5 minutes in the third treatment, and 25 minutes in the fourth. The 
experiment was repeated three times. 
 
The decay profile of bacteriophage M13 with standard interval sampling at 533 rps in 10 mM 
Tris (from Figure 3.5) is re-shown in Figure 3.11, together with the new limits of shearing for   90 
25 minutes with no sampling (i.e. the chamber was full), and 25 minutes with 10 % (v/v) air 
present. Shearing without sampling halved the rate of decay in M13 viability; the fraction of 
remaining viability was 0.78 after 25 minutes, rather than 0.38. Conversely, the fraction of 
remaining viability after 25 minutes shearing with 10 % (v/v) air was reduced to 0.29, but this 
was not significantly different from the drop experienced by the standard interval sampling 
(P=0.49, t-test). 
 
 
 
Figure 3.11 Concentration fraction of bacteriophage M13 viability remaining at disk speed 533 
rps with standard interval sampling (!), with no sampling (") and 10 % (v/v) air with no 
sampling (!) as a function of time. The initial bacteriophage concentration (C0) was 3 x 10
11 
pfu ml
-1. The no-sampling limits are fitted with first order decay trends, R
2 > 0.99 for each. 
Error bars represent the standard error of the mean fractions, N=3. 
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3.4  Detection of Cavitation within the Ultrasonicator and USD Shear Device 
To further elucidate the mechanisms of bacteriophage M13 decay within the USD shear device, 
an assay for the detection of cavitation was applied to determine if significant levels of 
cavitation were occurring within the chamber at the highest rotation speed (533 rps). Exposure 
to cavitation causes a measurable change in absorbance (at 350 nm) of 3 M potassium iodide 
solution. The mechanism is described in the Materials and Methods (Section 2.12.3) and 
essentially involves the liberation of iodine (which reacts to form the triiodide ion, I3
-) from the 
iodide (I
-) solution (Morrison et al., 1971). The assay has been used to detect cavitation within 
large-scale homogenisation equipment (Lander et al., 2000) and USD capillary shear equipment 
(Meacle et al., 2004). 
 
Firstly, 3 M potassium iodide alone was subject to identical ultrasonication conditions as 
solutions of bacteriophage M13 were (Section 3.2.1) to determine a correlation between 
bacteriophage decay (as shown in Figure 3.1) and iodine release. Sonication of a fluid is known 
to result in acoustic cavitation; essentially the formation and violent collapse of bubbles within 
the fluid gives rise to highly localised areas of intense temperature and pressure gradients 
(Didenko et al., 1999). The experiment was conducted as described in Section 2.12.3. The 
amount of cavitation was expressed in terms of the µM concentration of I3
- (Wayment and 
Casadonte, 2002). 
 
A linear rise in I3
- concentration over time was observed at the 5 µm amplitude (R
2=0.99), and a 
greater linear increase at 10 µm (R
2=0.97) (Figure 3.12). At 5 µm amplitude the I3
- 
concentration increased at a rate of 0.14 µM min
-1 and at 10 µm amplitude the rate was 0.20 µM 
min
-1. At the 1 µm amplitude, there was no detection of a significant rise in I3
- concentration 
over ten minutes (P>0.05, Dunnett). Comparing the concentration increase of I3
- (Figure 3.12) 
with the decrease in bacteriophage viability (observed earlier in Figure 3.1) showed that, as 
expected, the increased rate of I3
- liberation was associated with an increased rate of M13 decay. 
At 1 µm amplitude, the undetectable level of cavitation by this assay correlated with an 
undetectable decay in M13 viability under the same conditions.  
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Figure 3.12 Concentration of liberated I3
- at sonication amplitudes 1 µm (!), 5 µm (!), 10 µm 
(") and non-sonicated (") as a function of time. I3
- concentration was determined by 
absorbance at 350 nm. The R
2 values for the linear trends were 0.97 (10 µm), 0.99 (5 µm) and 
0.22 (1 µm). Error bars represent the standard error, N=3. 
 
 
Potassium iodide solution (3 M) was subsequently subjected to 533 rps within the USD rotating 
disk shear device. The device was operated as described in the Materials and Methods Section 
2.12.2 and the cavitation assay conduced as described in Section 2.12.3. Upon subjection to 533 
rps the detected concentration of I3
- was found not to be significantly different from the non-
sheared controls over the entire 25 minute experiment (P>0.05. Dunnett). The concentration of 
I3
- remained close to zero (Figure 3.13). 
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Figure 3.13 Concentration of liberated I3
- at 533 rps within the rotating disk shear device (") 
and non-sheared (") as a function of time. I3
- concentration was determined by absorbance at 
350 nm. Error bars represent the standard error, N=3. 
 
 
3.5  Comparison of the Hydrodynamic Shear Resistances of Several 
Macromolecules 
Over several years many biological macromolecules have been subject to turbulent shear 
conditions within the USD rotating-disk shear device (Biddlecombe et al., 2007; Boychyn et al., 
2000; Levy et al., 1999a; Zhang et al., 2007). A summary of some of these findings is found in 
Table 3.4 to provide context for the data gained for bacteriophage M13. The maximum energy 
dissipation rate associated with the shear device conditions in each study were calculated using 
expressions (4), (5) and (6). In Levy et al. (1999b) and Boychyn et al. (2001), a 30 mm disk was 
rotated at a maximum of 460 rps. In Biddlecombe et al. (2007), a 27 mm disk was rotated at a 
maximum of 250 rps. In this study, a 40 mm disk was rotated at a maximum of 533 rps. 
Solution viscosities were assumed to be of that of water. The complex macromolecules shown 
in Table 3.4 are diverse and varying in morphology, so the term "length scale" is difficult to 
define and therefore only approximate. For amorphous particles, this represents an average 
diameter. For the defined rod-shaped bacteriophage M13, this represents the contour length. 
Although direct comparisons between experiments is difficult (particularly due to differing 
exposure times to shear), it is noteworthy that particles of similar length scale to bacteriophage 
M13 $ such as supercoiled plasmid DNA (20 kb) and protein precipitates $ were found to be   94 
severely damaged in only seconds upon exposure to conditions (1.4 x 10
5 W kg
-1) which had no 
significant affect on the viability of bacteriophage M13 over 25 minutes (Table 3.4 and Figure 
3.4). 
 
 
Table 3.4 A comparison of the turbulent shear resistance of biological macromolecules treated 
within versions of the USD rotating-disk shear device. Except for the yeast protein precipitate, 
all particles were suspended in low ionic strength buffer solution. The shear device conditions 
described in each study (disk speed and rotation) were expressed as maximum energy 
dissipation rates, calculated using expressions (4), (5) and (6). 
 
Particle 
Approximate 
Length Scale 
Equivalent !max 
x10
5 (W kg
-1) 
Effect  Reference 
IgG4 antibody  8- 12 nm  0.26 
60 % monomer loss  
over 2 hours 
Biddlecombe 
et al. (2007) 
6.6 kb SC DNA 
(M13 RF1) 
350 nm  3.1 
33 % SC loss over  
25 minutes 
Present study 
Bacteriophage M13 
(6.6kb ssDNA) 
900 nm  3.1 
62 % viability loss over  
25 minutes 
Present study 
20 kb SC plasmid 
DNA (pQR150) 
1200 nm  1.4 
95 % SC loss over  
25 seconds 
Levy 
et al. (1999b) 
Homogenized yeast 
protein precipitate 
1300 nm 
average 
1.4 
45 % reduction in average 
particle size over 20 seconds 
Boychyn 
et al. (2001) 
 
 
3.6  Discussion 
The purpose of this chapter was to determine the fragility of the filamentous bacteriophage M13 
upon exposure to high-energy hydrodynamic shear forces, using a USD shear device. The 
resistance of bacteriophage M13 was compared with single and double-stranded DNA 
molecules, and the effect of solution conditions demonstrated. Two experiments were 
conducted which aimed to clarify the mechanisms of damage within the USD shear device. 
Finally, a comparison was made between bacteriophage M13 and existing data for various other 
complex macromolecules tested within the USD shear device. Here, the implications of these 
results for large-scale bacteriophage M13 processing will also be discussed. 
 
3.6.1  Description of the conditions within the USD shear device 
In this thesis the conditions within the USD shear device are determined analytically and 
characterised in terms of the associated maximum energy dissipation rate. The analysis of flow   95 
and energy dissipation patterns within both the USD shear device and indeed large-scale unit 
operations has been previously conducted by both computational fluid dynamics (CFD) and 
analytical calculations (Boychyn et al., 2001; Levy et al., 1999a; Zhang et al., 2007). Both 
approaches have successfully predicted the response of fluids in large-scale unit operations by 
small-scale experimentation, by matching the conditions within the USD shear device disk and 
the identified critical region within the process equipment. The basis of comparison by other 
authors has also been described in terms of the maximum energy dissipation rate (Boychyn et 
al., 2001; Boychyn et al., 2004; Hutchinson et al., 2006), but average energy dissipation rate 
(Levy et al., 1999b), shear rate (Biddlecombe et al., 2007; Harrison et al., 1998) and most 
simply disk tip speed (Boychyn, 2000) have also been employed. More generally, substantial 
literature exists on the estimation of the maximum energy dissipation rates within large-scale 
unit operations (Mollet et al., 2004). While precise estimation can still be difficult (Yim and 
Shamlou, 2000), many useful small-scale predictions of the response of novel biological 
macromolecules to high dissipation energy environments have been made.  
 
Difficulties in the precise estimation of the conditions within the USD shear device itself were 
highlighted in Table 3.2, where alternative methods for the calculation of energy input resulted 
in four-fold differences in maximum energy dissipation rate. Nevertheless, the calculated 
maximum energy dissipation rates in this study (of the order 10
5 W kg
-1) were in the range of 
those predicted for the feed-zones of continuous centrifuges, cited as the most potentially 
damaging unit operations in downstream processing (Boychyn et al., 2004; Yim and Shamlou, 
2000). Although verification of USD predictions at scale is essential, this is an important 
consideration because the unusual non-lethal lifecycle of M13 (where progeny bacteriophage 
are translocated through the E. coli cell wall) means that virus particles will be free in the 
fermentation fluid for a considerable period and will not be protected from high energy shear 
conditions imposed on the process fluid. 
 
3.6.2  Initial USD shear device experimentation 
The work of Levy et al. (1999b) served as a reference point for the parameters of operation of 
the USD shear device on pure bacteriophage M13 in 10 mM Tris buffer (Section 3.3.2). Levy et 
al. (1999b) outlined the effect of subjecting pure plasmid DNA preparations of 20 kb size to 
turbulent shear for 25 seconds at an equivalent rotation speed of 350 rps and a maximum energy 
dissipation rate of 1.4 x 10
5 W kg
-1. Under these conditions, there was a 95 % drop in 
supercoiled plasmid DNA content (Table 3.4). Although the 20 kb plasmid and bacteriophage 
M13 were of similar characteristic length scales (1200 nm and 900 nm respectively) their shear 
resistances in buffer were very different: no significant damage to bacteriophage M13 was 
observed when subject to the same treatment over 60 seconds (Table 3.1). However, it was 
considered that only by finding the point at which M13 viability declined would it be possible to   96 
assess the limits of its processability. To achieve this aim the USD shear device was hence 
upgraded to operate at the higher rotation speeds required (Section 3.3.3). 
 
3.6.3  High-speed USD shear device experimentation 
High-speed USD shear device experimentation found that there was no significant effect on the 
viability of bacteriophage M13 for up to 25 minutes at 400 rps (1.8 x 10
5 W kg
-1) (Figure 3.4). 
Moreover, even at 467 rps (2.4 x 10
5 W kg
-1) the drop in viability only diverged significantly 
from a non-sheared control after the full 25 minute exposure. However, the much greater rates 
of viability decay observed upon exposure to 500 and 533 rps (2.8 x 10
5 W kg
-1 and 3.1 x 10
5 W 
kg
-1) suggested that a threshold resistance had been exceeded (Figure 3.5). Indeed, the 
degradation rate then increased in an exponential fashion (Figure 3.6). This result showed that 
the total loss of bacteriophage M13 from shear was a function of maximum energy dissipation 
rate as well as the time of exposure.  
 
There are two implications for large-scale bacteriophage processing. Firstly, in the most 
damaging process equipment (such as continuous centrifuges) the exposure time to the critical 
high-energy dissipation areas is only of the order of a fraction of a second (Byrne et al., 2002), 
hence total damage will probably be small. Secondly, although the overall cumulative exposure 
time in large-scale processing can be considerably longer than this (Zhang et al., 2007), the 
highest maximum energy dissipation rates within mechanically agitated fermenters are typically 
only up to 10
3 W kg
-1 and within pumps up to 10
5 W kg
-1 (Yim and Shamlou, 2000). Since a 
maximum energy dissipation rate of 1.8 x 10
5 W kg
-1 was found to result in no significant 
bacteriophage viability loss over 25 minutes, bacteriophage damage may be unlikely. These 
predictions would need to be verified by experimentation at scale. 
 
3.6.4  The effect of process fluid conditions on bacteriophage M13 decay profiles 
Of course, bacteriophage M13 will not be in buffer over the entire course of a production 
scheme. Instead, from raw fermentation culture the composition of the process fluid will alter 
considerably as contaminants are progressively removed, buffers changed and chemicals added. 
This was of concern since the shear resistance of both protein and DNA complexes have been 
shown to depend on the nature of the process fluid (Harrison et al., 1998; Levy et al., 1999a; 
Levy et al., 1999b). The shear resistance of bacteriophage M13 in several process fluid 
environments was consequently examined, and it was found that the bacteriophage decay profile 
did depend on the fluid composition (Section 3.3.5). After 25 minutes exposure to turbulent 
shear at 533 rps, the fraction of viable bacteriophage increased in the order: culture supernatant 
(0.12) < culture supernatant plus PEG and NaCl (0.25) < 10 mM Tris (0.38)< culture medium 
with cells (0.39) (Figure 3.9). Furthermore, the decay profiles varied. While the viability of 
M13 in culture decreased in a trend consistent with first order decay kinetics, in the culture   97 
supernatant, PEG precipitated and 10 mM Tris conditions, M13 displayed degradation patterns 
consistent with resistance to shear for up to 10 minutes before entering a phase of increasing 
rates of damage. This trend was particularly marked in culture supernatant conditions after 15 
minutes shearing time. Similar decay profiles have been reported by other authors for both 
plasmids and proteins (Levy et al., 1999a; Thomas et al., 1979), but contrasts with a reported 
case of broth components providing protection for proteins relative to buffer (Harrison et al., 
1998). It was considered likely therefore, that the decay of bacteriophage viability was due to 
more than one mechanism of damage.  
 
Firstly, calculation of the maximum energy dissipation rates (Section 3.3.6) showed that there 
was little variation between process fluids, so this effect was discounted. Secondly, the effect of 
air-liquid interfaces was examined (Section 3.3.7), since a possible explanation for this 
behaviour was that M13, in common with other bacteriophage and proteins, displayed a 
vulnerability to air-liquid interfaces (Thompson and Yates, 1999). It was found that shear 
damage to bacteriophage M13 was indeed enhanced by the presence of air-liquid interfaces, 
although the distribution of these interfaces within the device remained unknown (Figure 3.11). 
Of particular note was that the drop in viability when deliberately sheared for 25 minutes with 
10 % air was not dramatically less than the standard sampling technique, which progressively 
increased the proportion of air within the chamber to 10 % (v/v) by the end of 25 minutes. This 
suggested that, in 10 mM Tris buffer at least, the effect of air-liquid interfaces began after the 
first sample point but did not substantially multiply after further sampling. This pattern could 
explain the noted decay trend of "resistance for a time followed by decay" in the buffer, culture 
supernatant and PEG precipitated environments (Figure 3.9). It is however an effect which 
depended on the process fluid, since protection was afforded when in culture but lost once the 
cells were removed.  
 
3.6.5  Detection of cavitation within the ultrasonicator and USD shear device 
The first part of this chapter (Section 3.2) revisited an early reference to the severe sensitivity of 
bacteriophage fd to the shear imparted by sonication (Marvin and Hoffman-Berling, 1963). 
Since bacteriophage M13 is closely related to fd, it was expected that a severe sensitivity would 
also be noted, and this was confirmed by experimentation (Figure 3.1). First order decay 
profiles were observed, which matched those reported for fd. Sonication damage to the 
bacteriophage particles in solution arose directly from the effects of cavitation. Cavitation in a 
fluid results in highly localised areas of intense temperature and pressure gradients (caused by 
the formation and violent collapse of bubbles within the fluid) (Didenko et al., 1999), shear 
forces associated with these gradients (Kondo et al., 1989) and also free radicals (McLean and 
Mortimer, 1988). This data was subsequently used to determine if bacteriophage viability loss 
within the USD shear device was due to cavitation effects (Section 3.4). The cavitation   98 
detection assay showed that increased rates of cavitation by sonication were associated with an 
increased rate of bacteriophage M13 decay (Figure 3.1 and Figure 3.12). In the USD shear 
device, no I3
- liberation was detected, which suggested that either cavitation was not present or 
was at very low levels undetectable by this assay. It was therefore considered likely that the 
decays in bacteriophage viability observed in the USD shear device were largely a result of 
turbulent shear (Section 3.3.3) and air-liquid interface effects (Section 3.3.7). 
 
3.6.6  The relative shear resistance of bacteriophage M13 and naked DNA 
A direct comparison of the shear resistances of M13 bacteriophage, ssDNA and SC dsDNA was 
made in the USD shear device at 533 rps. All three molecules were of the same genome size to 
allow for an equal basis of comparison. It was found that after 25 minutes exposure, the 
remaining proportion of intact molecules decreased in the order SC dsDNA (0.67) > ssDNA 
(0.45) > bacteriophage M13 (0.38) (Figure 3.7 and Figure 3.8). The difference in shear 
resistance between dsDNA and ssDNA molecules can be directly attributed to the differences in 
inherent molecular strength (Odell and Taylor, 1994), dsDNA being the stronger. But a study on 
the inherent strength of the M13 particle demonstrated its resistance to stretching forces that 
damage dsDNA (Khalil et al., 2007). This measure is of relevance when understanding a 
particle's resistances to the turbulent conditions within the shear device; the fluid flow within 
the chamber can be described in terms of the shear and elongational strain rates imposed 
(Zhang et al., 2007). Therefore, if the difference in behaviour between dsDNA and packaged 
M13 bacteriophage was not due to an inherently greater strength of dsDNA, then the greater 
resistance of dsDNA to these conditions could have been due to the very different morphologies 
of the two molecules. Naked DNA molecules are free to compact in solution while DNA 
packaged within a bacteriophage M13 particle is not due to the relative rigidity of the 
encapsulating protein coat. Consequently, the characteristic hydrodynamic diameter of the 6.6 
kb SC dsDNA molecule in this study was approximately a third of the contour length of the 
packaged M13 particle (Arulmuthu et al., 2007). USD shear device studies on SC plasmid 
dsDNA molecules of increasing genome size have demonstrated the critical effect the physical 
size of the DNA molecule has on its resistance to shear conditions (Levy et al., 1999b; Meacle 
et al., 2004). That is, the smaller molecules were more resistant. It is therefore possible that the 
significantly greater length scale of bacteriophage M13 resulted in the greater fragility than 
dsDNA of equivalent genome size, assuming damage was a result of mechanical effects. While 
it has been shown that this is not entirely the case$ air-liquid interfaces enhanced the 
degradation rate of bacteriophage M13 (Figure 3.11)$ similar effects have been demonstrated 
for SC plasmid dsDNA under similarly pure conditions (Levy et al., 1999b).  
 
Overall, there are likely to be several factors governing the difference in the rate of decay of 
dsDNA and packaged M13 particles. Particle size and inherent molecular strength are no doubt   99 
important, but properties such as density, stiffness and relative reactivity may also have had a 
significant effect on the shear-resistance outcome. This is particularly true of bacteriophage, 
where viability can be abolished by damage solely to the protein coat, leaving the encapsulated 
DNA intact. In practical terms, however, it was important that each particle was assessed in 
terms of its own recognised standard. The quality of a (plasmid) dsDNA therapeutic is typically 
assessed as the proportion supercoiled (Eastman and Durland, 1998; Lander et al., 2002; Levy 
et al., 1999b), and this convention was adhered to in this study. It may be reasonable to expect 
that viability emerges as the standard measure of the quality of a bacteriophage-based 
therapeutic, since the particle must be intact to be infectious. 
 
The comparison with plasmid DNA is particularly important since both have been studied for 
their effectiveness as vectors for gene therapy and vaccination, although plasmid-based 
technology is significantly more advanced (Kutzler and Weiner, 2008; Larocca et al., 2002; 
Wan et al., 2001). Whereas most early clinical trials have involved plasmids of 10 kb or less, it 
is predicted that in the future the production of larger plasmids of size 20 kb or more will be 
necessary (Levy et al., 2000b), sizes which, as Table 3.4 indicated, are very susceptible to shear 
damage. The length of the bacteriophage M13 particle depends solely on the nucleotide count of 
the tightly packaged DNA within; there is a linear scaling of bacteriophage length to genome 
size. Future work could investigate the important relationship between bacteriophage M13 
length and the impact on its susceptibility to shear damage. 
 
3.6.7  Concluding remarks 
This chapter described how a USD shear device was upgraded and used to evaluate the effect of 
hydrodynamic shear forces on bacteriophage M13. Within the device, conditions imposing a 
maximum energy dissipation rate up to 1.8 x 10
5 W kg
-1 upon the therapeutic candidate 
bacteriophage M13 were shown not to cause a significant drop in bacteriophage viability. This 
implies that the shear imposed by bioprocessing steps such as fermentation and pumping may 
not have an adverse effect, although large-scale experimentation would need to verify these 
predictions. At higher energy dissipation rates, the relationship between viability decay and 
maximum energy dissipation rate was found to be non-linear. Over the course of the 25 minute 
shear experiment, the pattern of viability decay was found to be affected by the condition of the 
process fluid. The rate of bacteriophage decay in buffer was shown to be enhanced by the 
presence of air-liquid interfaces, and an assay for the detection of cavitation showed 
undetectable levels of cavitation within the device at the highest energy conditions imposed (3.1 
x 10
5 W kg
-1). Under these same maximal conditions, the rate of decay of M13 was shown to be 
greater than SC plasmid DNA of the same genome size. However in practical terms, despite 
being noted in the literature as a fragile molecule, bacteriophage M13 appears to be largely 
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4  A Study of Bacteriophage M13 Fermentation and Harvesting 
4.1  Introduction 
In common with all other viruses, bacteriophage are parasitic and therefore dependent upon a 
host organism to propagate. For bacteriophage M13, this host is E. coli, a bacterium that is 
commonly used for the industrial production of recombinant proteins in industry (Baneyx, 
1999; Schmidt, 2004; Swartz, 2001). Therefore, the manufacture of products based upon 
bacteriophage M13 has the distinct advantage of using a well characterised host organism. As 
with recombinant protein production, the yield of progeny bacteriophage is inextricably linked 
to the state of the E. coli (in terms of both their concentration and health), particularly since 
bacteriophage M13 infection does not result in the death of the cells (Chapter 1, Section 1.2.3). 
Cells continue to divide, albeit at a reduced rate (Salivar et al., 1964), continually producing 
progeny M13 by an extrusion mechanism through the cell wall (Russel and Model, 1989). 
Amongst bacteriophage this reproduction strategy is unusual and limited to the filamentous 
bacteriophage group (Inoviridae), yet it is potentially advantageous. Propagation, in other 
classes of bacteriophage, is a lytic process where host cell division is halted upon infection and 
bacteriophage induced cell lysis is required to release the progeny bacteriophage. In avoiding 
cell lysis, the downstream processing of bacteriophage M13 could be assisted because 
contamination of the process stream with E. coli intracellular proteins, RNA and DNA would be 
greatly reduced. A key aim of this chapter, therefore, was to explore the composition of the 
post-fermentation process fluid (the culture supernatant fraction), since efficient planning of 
downstream recovery steps is dependent on knowing the concentration of the product and major 
contaminants in the process stream (Asenjo and Patrick, 1990).  
 
Whilst downstream processing primarily focuses upon minimizing product losses by application 
of fewer (or more efficient) steps (Wenzig et al., 1993), a defining characteristic of the 
fermentation step is the ability to increase the overall yield of a process. Limited studies 
currently exist on the optimisation of bacteriophage M13 yield from fermentation, although it is 
likely that productivity is a function of the physiological state of the host E. coli cells. What 
parameters allow the cells to be in the best state for bacteriophage replication and multiplication 
is uncertain, although it has been suggested that restriction of cell growth rate may increase 
bacteriophage yield (Salivar et al., 1964), as may medium supplementation with magnesium 
ions (Reddy and McKenney, 1996). That said, it has been demonstrated that the overall yield of 
bacteriophage M13 is relatively insensitive to the multiplicity of infection (MOI) (Reddy and 
McKenney, 1996). The MOI is the initial ratio of bacteriophage to E. coli cells at the start of 
fermentation.  
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The role of medium richness in improving cell growth and therefore bacteriophage yield is 
unclear. For example, SOB medium (2 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 10 mM 
NaCl, 2.5 mM KCl) has been shown to result in up a 60 % increase in bacteriophage M13 titre 
compared to LB medium (1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 80 mM NaCl) (Reddy 
and McKenney, 1996), whereas NYZ broth (1 % (w/v) NZ-Amine, 0.5 % (w/v) yeast extract, 
85 mM NaCl) was unequivocally shown to result in a 3-fold higher bacteriophage titre over SB 
medium (50 mM MOPS, 3 % (w/v) tryptone, 2 % (w/v) yeast extract) (Grieco et al., 2009). It is 
therefore likely that the bacteriophage productivity of E. coli is a complicated function, of 
which medium ion concentration and carbon source are just two factors.  
 
It was nevertheless hypothesized that since bacteriophage production occurs concomitantly with 
E. coli growth (Brown and Dowell, 1968), conditions which support increased E. coli cell 
density could conceivably lead to an improved yield of bacteriophage M13. 
 
It was also hypothesized that the choice of host E. coli cell would also impact upon the yield of 
bacteriophage as well as the quality of the process fluid. The E. coli strain used thus far in this 
thesis, Top10F', has been demonstrated in the literature to produce bacteriophage M13 
adequately (Karlsson et al., 2005). Further, in this thesis the typical yields of bacteriophage 
M13 resulting from the standard two-litre shakeflask fermentation (Section 2.3.3) are similar to 
that reported elsewhere (Reddy and McKenney, 1996; Sambrook and Russell, 2001). However, 
Top10F' is a cloning strain which is recombination deficient (recA
-). As a result, and in common 
with other recA
- strains, a Top10F' culture will consist of three sub-populations of actively 
dividing, residually dividing and non-dividing cells (Capaldo et al., 1974). Actively dividing 
cells typically represent only a 49 % fraction of the total population after 5 hours growth in a 
RecA
- host (Capaldo and Barbour, 1973). With regards to bacteriophage M13 manufacture, this 
implies that productivity could be hampered if such a large proportion of the cell population is 
non-viable. Hence, bacteriophage M13 propagation in recA
+ strains was investigated in terms of 
product yield and process fluid contamination, and compared to Top10F'. 
 
This chapter is structured in three parts. After selection of analyses to track contamination levels 
in 50 ml Top10F' culture (250 ml baffled shakeflasks), several E. coli strains were then 
compared at the same scale (in NB2) for bacteriophage yield and contaminant accrual. Thirdly, 
fermentation on the two-litre benchtop bioreactor scale was investigated with a medium shown 
to increase E. coli titre relative to NB2. Fermentations were also analysed in terms of 
bacteriophage yield and accumulated contamination. 
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4.2  Top10F' Culture and Selection of Analyses 
4.2.1  Identification of available analyses 
The post-fermentation process fluid will primarily consist of the M13 bacteriophage product, 
intact cells, some cell debris and medium components (chiefly ions, short chain soluble 
polypeptides and nucleotides). Some low level accumulation of cell debris is expected as a 
result of usual E. coli culture (Salivar et al., 1964), which will include host chromosomal DNA, 
RNA, proteins, lipids, endotoxins and chemical residuals (Eastman and Durland, 1998; Prazeres 
and Ferreira, 2004). Several techniques are available for the detection of these contaminant 
components, each with varying specificity, sensitivity and cost (Bristow, 1990). For example, 
detection of free chromosomal DNA in the culture could be detected by agarose gel, A260 and 
qPCR assays; protein by colorimetric assay, or SDS-PAGE followed by immunoassay or 
sensitive staining techniques; and endotoxin by the Limulus amoebocyte lysate (LAL) assay. In 
this chapter the quantities of released DNA and protein were measured to represent the level of 
culture contamination. DNA was measured by agarose gel and A260; protein by Bradford assay 
and SDS-PAGE with silver staining. These techniques were applied to 50 ml M13 infected and 
non-infected Top10F' cultures and their effectiveness compared.  
 
4.2.2  M13 infected and non-infected Top10F' culture 
All 50 ml NB2 cultures in 250 ml baffled shakeflasks were prepared and grown as described in 
the Materials and Methods (Section 2.13.1). Briefly, a loopful of frozen Top10F' stock culture 
was streaked on to an NB2A plate supplemented with 5 !g ml
-1 tetracycline and incubated 
overnight at 37 °C. Working liquid E. coli cultures were then prepared by inoculation of five 5 
ml aliquots of NB2 (supplemented with 5 !g ml
-1 tetracycline) with a single loopful of cells 
each, individually taken from isolated colonies on the NB2A plate and incubated overnight at 
37 °C with shaking. Three pre-warmed 50 ml NB2 cultures were subsequently inoculated with 1 
ml of individual working E. coli culture at the zero time-point. When M13 infection was 
required 2.3 x 10
8 pfu (from a single caesium chloride purified stock) was also added at the zero 
time-point. No static infection period was conducted. Culture OD600, cell and bacteriophage 
counts were recorded as described (Section 2.13.1). Cells were removed by centrifugation (17 
000 x g for 3 minutes) and supernatants were analysed for DNA and protein. To expose all 
DNA (including bacteriophage M13 DNA), 400 µl of each supernatant sample was subject to 
phenol-chloroform extraction, of which 250 µl was subsequently ethanol precipitated and 10-
fold concentrated (Section 2.8.1).  
 
Agarose gel analysis (Section 2.7.2) of untreated supernatant, phenol-chloroformed and 10-fold 
concentrated samples was performed to observe free DNA (10 µl of sample per well). 
Quantification of DNA bands was as described in Section 2.7.4. Spectrophotometric DNA   103 
quantification (A260) was performed on 10-fold concentrated samples only (Section 2.7.1): prior 
phenol-chloroform treatment was necessary to remove protein absorption contaminants and 
ethanol precipitation to concentrate the DNA but also remove residual phenol, which is a strong 
absorber at 260 nm (Santella, 2006). Readings required 1.5 µl of sample (measured in 
triplicate). The Bradford assay was performed on untreated supernatant as directed (Section 
2.7.5). SDS-PAGE was also performed as described in the Materials and Methods (Section 
2.7.3) with 10 µl of sample (plus 10 µl loading buffer) loaded per well, followed by silver 
staining. 
 
Growth as measured by OD600 ceased after four hours in M13 infected Top10F' cultures, 
attaining an OD600 value of 1.08 (Figure 4.1). This was less than that of non-infected cells 
(2.43), which ceased growing by six hours. Similarly, the viable cell count of non-infected 
Top10F' culture over time was consistently higher than M13 infected Top10F' culture (Figure 
4.2). Viable cell counts were divided by OD600 value at every timepoint to ascertain whether the 
viability of Top10F' culture was decreased by bacteriophage M13 infection (Table 4.1). On this 
normalised OD600 basis the viable cell count of M13 infected Top10F' was lower than non-
infected after two hours incubation. 
 
 
Figure 4.1 OD600 value of non-infected (!) and M13 infected (!) Top10F' culture as a 
function of incubation time. E. coli was infected with bacteriophage M13 at the zero hour 
timepoint. Error bars represent the standard error, N=3. 
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Figure 4.2 Viable cell count of non-infected (!) and M13 infected (!) Top10F' culture as a 
function of incubation time. Error bars represent the standard error, N=3. 
 
 
 
Table 4.1 The viable Top10F' count per OD600 unit as a function of time for non-infected and 
M13 infected cells. Values were similar until two hours incubation, after which the counts of 
non-infected cells per OD600 unit were increasingly greater than infected cell values. Statistical 
analysis (t-test) was performed on log10-transformed cell count data. 
 
Viable cell count (cfu ml
-1) per OD600 unit   
Incubation time  Non-infected 
Top10F' 
M13 infected Top10F'  P value 
0 hours  9.40 x 10
8  1.01 x 10
9  0.67 
30 minutes  5.85 x 10
8  7.37 x 10
8  0.03 
1 hour  2.40 x 10
8  3.58 x 10
8  0.04 
2 hours  2.30 x 10
8  3.39 x 10
8  0.34 
3 hours  3.67 x 10
8  1.39 x 10
8  0.02 
4 hours  9.58 x 10
8  9.04 x 10
7  0.0007 
5 hours  1.00 x 10
9  1.37 x 10
8  3.6 x 10
-6 
6 hours  9.54 x 10
8  8.48 x 10
7  4.7 x 10
-5 
7 hours  1.11 x 10
9  -  - 
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The titre of bacteriophage in infected Top10F' cultures ceased to increase significantly (P>0.05, 
Tukey) after four hours (Figure 4.3). The maximum titre achieved was 4.1 x 10
11 pfu ml
-1, 
attained by 5 hours growth. The production of bacteriophage was noted to closely correlate with 
the increase in culture OD600 (Figure 4.1). 
 
Figure 4.3 Bacteriophage concentration in M13 infected (!) Top10F' culture as a function of 
incubation time. Error bars represent the standard error, N=3. 
 
 
4.2.3  Quantification of DNA 
The quantity of DNA in the culture supernatant increased over time, as culture density increased 
(Figure 4.4). A DNA band greater than 10 kb was observed in both infected and non-infected 
cultures, later measured to be at least 20 kb in size (Section 4.2.4). It was assumed this 
represented released E. coli chromosomal DNA. In M13-infected culture, a secondary band was 
observed post phenol-chloroform treatment, which was subsequently proven to be 
bacteriophage DNA (see Section 4.2.4). This finding was consistent with published data stating 
that bacteriophage DNA is not visible by ethidium bromide staining when encapsulated within 
the bacteriophage protein coat (Moses et al., 1980). The amount of E. coli DNA in both infected 
and non-infected cultures was subsequently quantified at the 5 hour timepoint by densitometry, 
where bacteriophage M13 production has ceased and the culture would be harvested. This was 
achieved by running the untreated 5 hour timepoint culture supernatant samples in triplicate on 
a further agarose gel for the purposes of densitometry only. 
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Figure 4.4 Agarose gels indicating the quantity of DNA in the culture supernatant. Gel (A) 
represents non-infected Top10F' culture. Lanes 1, 4, 7, 10, 13, 16, 19, 22 and 25 are untreated 
culture supernatant samples. Lanes 2, 5, 8, 11, 14, 17, 20, 23 and 26 are phenol-chloroform 
treated culture supernatant samples. Lanes 3, 6, 9, 12, 15, 18, 21, 24 and 27 are phenol-
chloroform treated culture supernatant samples which have been 10-fold concentrated by 
ethanol precipitation. Lane 28 is Bioline HyperLadder 1. Gel (B) represents M13 infected 
Top10F' culture. Lanes 1, 4, 7, 10, 13, 16, 19 and 22 are untreated culture supernatant samples. 
Lanes 2, 5, 8, 11, 14, 17, 20, and 23 are phenol-chloroform treated culture supernatant samples. 
Lanes 3, 6, 9, 12, 15, 18, 21 and 24 are phenol-chloroform treated culture supernatant samples 
which have been 10-fold concentrated by ethanol precipitation. Lane 25 is Bioline HyperLadder 
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Quantification of band intensities in the agarose gels was determined relative to the Bioline 
HyperLadder 1 (Section 2.7.4). The concentration of chromosomal DNA in the supernatant of 
non-infected culture was measured to be 0.24 µg ml
-1. In infected culture the concentration was 
0.63 µg ml
-1, which was significantly higher (P=0.004, t-test). 
 
While the concentration of chromosomal DNA in the supernatant was observed to increase 
concomitantly with E. coli growth by agarose gel electrophoresis, a contrary trend was observed 
by A260 readings of the (phenol-chloroform treated, ethanol precipitated) 10-fold concentrated 
supernatant samples (Figure 4.5). Of particular note was that fresh NB2 medium subject to the 
same treatment gave the greatest A260 readings of all samples. Assuming all phenol has been 
removed, it was surmised that the dominant contributor to absorbance readings was not 
therefore chromosomal (and bacteriophage M13) DNA but a consumable component of the 
NB2 medium, which is meat-extract derived. It was decided to not continue this analytical 
technique, principally because DNA quantification by agarose gel provided an effective 
alternative.  
 
 
Figure 4.5 Concentration of DNA in non-infected (") and M13 infected (#) culture 
supernatants as a function of time. DNA concentration was measured by A260 reading. Error 
bars represent the standard error, N=3. 
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4.2.4  Identification of agarose gel DNA bands 
An experiment was conducted to confirm that the secondary band visible (post phenol-
chloroform treatment) from M13 infected culture was indeed bacteriophage DNA. Two 30 µl 
aliquots were taken from the supernatants of infected and non-infected Top10F' cultures 
incubated for 24 hours at 37 °C. To each aliquot 1 µl of 100 mM MgCl2 was added and the pH 
was confirmed to be above 6. To degrade all free DNA, 1 µl of Benzonase (Merck, Purity Grade 
II, approx. 20 000 U ml
-1) was added to one each of infected and non-infected aliquots. Every 
aliquot was subsequently incubated at 37 °C for 30 minutes, followed by 65 °C for 30 minutes 
to inactivate the Benzonase. To liberate bacteriophage DNA, 15 µl of each aliquot was then 
phenol-chloroform treated (Section 2.8.1). Loading buffer (3x concentrated, 5 µl) was added to 
10 µl of every sample, each of which was then subject to agarose gel electrophoresis. 
 
It was found that Benzonase treatment removed the DNA band suspected to be chromosomal 
DNA (Figure 4.6, Lanes 2 and 3 non-infected Top10F', Lanes 6 and 7 M13 infected Top10F'). 
However, in M13 infected cultures the secondary band still appeared post Benzonase and 
phenol-chloroform treatment (Lane 7). This suggested that the secondary band at 5-6 kb was 
indeed bacteriophage DNA which had been protected from Benzonase treatment by the 
bacteriophage protein coat. No secondary band was visible in non-infected cultures post phenol-
chloroform treatment (Lane 5). 
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Figure 4.6 Agarose gel determining the nature of the visible DNA bands in Top10F' culture 
supernatant. Lane 1 is Fermentas !/HindIII ladder. Lane 2 is Benzonase-treated non-infected 
Top10F' culture supernatant (no DNA visible cf. Lane 4). Lane 3 is Benzonase-treated non-
infected Top10F' culture supernatant, then phenol-chloroform treated (no DNA visible cf. Lane 
5). Lane 4 is non-infected Top10F' culture supernatant. Lane 5 is non-infected Top10F' culture 
supernatant, then phenol-chloroform treated. Lane 6 is Benzonase-treated M13 infected Top10F' 
culture supernatant (no DNA visible cf. Lane 8). Lane 7 is Benzonase-treated M13 infected 
Top10F' culture supernatant, then phenol-chloroform treated (no 20 kb DNA visible cf. Lane 9, 
secondary band visible). Lane 8 is M13 infected Top10F' culture supernatant. Lane 9 is M13 
infected Top10F' culture supernatant, then phenol-chloroform treated (two bands visible). Lane 
10 is Bioline HyperLadder 1. 
 
 
4.2.5  Quantification of protein 
The amount of protein in the culture supernatant increased as growth progressed, as observed 
qualitatively by silver staining of SDS-PAGE gels (Figure 4.7). A control lane was included, 
which contained caesium-chloride purified bacteriophage M13 of concentration 4 x 10
11 pfu ml
-
1, similar to that in the culture supernatant at the end of bacteriophage production.  A single 
band was visible at approximately 60 kDa, which corresponded to bacteriophage coat protein 
pIII. The other four coat proteins were of molecular masses below the 20.0 kDa size limit of the 
12 % acrylamide gels prepared, and so were not observed. Although the actual molecular 
weight of pIII is 42.6 kDa, it is known to run to the 60 kDa level (Gailus and Rasched, 1994;   110 
Steiner et al., 2006). Therefore it was concluded that the bands observed in culture supernatant 
samples were chiefly due to E. coli rather than bacteriophage proteins.  
 
 
Figure 4.7 SDS-PAGE gels showing the visible supernatant proteins in culture supernatant of 
molecular weight 20-212 kDa. A total of 10 !l of sample (plus 10 !l loading buffer) was loaded 
in each well. Gel (A) shows the increase in supernatant protein as a function of time for non-
infected Top10F' culture. Gel (B) shows the increase in supernatant protein as a function of time 
for M13 infected Top10F' culture. Gel (C) shows the control lane of 4 x 10
11 pfu ml
-1 of 
caesium-chloride purified bacteriophage M13. The bacteriophage coat protein pIII can be seen 
at approximately 60 kDa. 
 
 
The amount of protein in the supernatant as measured by Bradford assay did not correlate with 
the trends observed by SDS-PAGE. Whilst the quantity of protein was observed to qualitatively 
increase over time by acrylamide gel analysis (Figure 4.7), the Bradford assay indicated that it 
did not (Figure 4.8). Similarly to the data determining DNA concentration by sample A260 
reading, fresh NB2 medium gave one of the highest protein concentration readings. It was 
therefore assumed that the same pattern was occurring, i.e. the dominant contributor to the assay   111 
readings was not released E. coli protein but a consumable component of the NB2 medium. The 
Bradford assay was consequently not used to track protein over time.  
 
Henceforth, the Bradford assay was limited to being a measure of total protein at the point of 
culture harvest. From a downstream processing perspective, at the point of harvest both medium 
and free E. coli proteins may be considered as contaminants. Therefore, the assay has value as a 
general measure of protein concentration at this point. Comparing the quantity of total protein at 
the 5 hour timepoint when bacteriophage M13 production has ceased (Figure 4.8), it can be seen 
that the measured quantity of protein in the infected culture (30.5 !g ml
-1) was significantly 
higher (P=0.02, t-test) than that in the non-infected culture (20.6 !g ml
-1). A control of caesium-
chloride purified bacteriophage M13 (in 10 mM Tris, pH 7.5 at 25 °C) of concentration 4 x 10
11 
pfu ml
-1 showed that there was no contribution by bacteriophage coat proteins to the total 
measured quantity by Bradford assay (Figure 4.8). 
 
 
 
Figure 4.8 Concentration of protein in non-infected (") and M13 infected (#) culture 
supernatants as a function of time. "NB2" was unused Nutrient Broth Number 2. "M13" was 4 x 
10
11 pfu ml
-1 caesium chloride purified bacteriophage M13. Protein concentration was measured 
by Bradford assay. Error bars represent the standard error, N=3. 
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4.3  Comparison Between E. coli Top10F', JM107 and W1485 Culture 
M13 infected cultures of Top10F', JM107 and W1485 were compared for bacteriophage yield 
and contaminant accrual. Generally speaking, it has proven difficult to correlate host cell 
genotype with recombinant protein or plasmid DNA productivity (Harrison and Keshavarz-
Moore, 1996; Yau et al., 2008), although the recA mutation may be an exception due to its far 
reaching effects (Capaldo and Barbour, 1973).  
 
In this study, JM107 was selected as a representative recA
+ cloning strain, originally developed 
as a high transformation efficiency host for M13 derivatives (Yanisch-Perron et al., 1985). 
Top10F' was selected as a representative recA
- strain. In contrast, E. coli strain W1485 is close 
to wild-type, having only being cured of a ! lysogen by UV treatment (Jensen, 1993) and 
therefore possesses functioning restriction and modification systems. For all strain genotypes, 
see Section 2.2. 
 
4.3.1  M13 infected E. coli culture 
All strains were cultured as exactly described in Section 4.2.2 for Top10F' with the following 
exceptions: loopfuls of frozen JM107 stock culture were streaked on to a thiamine 
supplemented minimal agar plate (Section 2.1.8), whilst frozen W1485 stock culture was 
streaked onto NB2A plates (Section 2.1.6) without antibiotic selection. All were incubated 
overnight at 37 °C. Isolated colonies from these plates were then used to inoculate individual 5 
ml aliquots of NB2 and incubated overnight at 37 °C with shaking. Subsequent shakeflask 
experimentation at the 50 ml scale was identical to that described for Top10F' (Section 4.2.2). 
Bacteriophage infection occurred at the zero timepoint by the addition of 2.3 x 10
8 pfu 
bacteriophage M13. The average MOI (multiplicity of infection) for each strain was calculated 
to be 6.0 x 10
-2 for W1485, 7.1 x 10
-2 for JM107 and 1.0 x 10
-1 for Top10F' cultures. 
 
Similarly to Top10F' culture, the OD600 value of M13 infected JM107 cells plateaued after four 
hours growth (Figure 4.9), albeit at a value of 0.88 rather than 1.08. In contrast, the OD600 of 
W1485 cells did not plateau until seven hours growth, at which point the cell density was 
substantially greater at 1.54. Enumeration of the viability of cells showed a different pattern 
(Figure 4.10): the viability count of Top10F' cells was consistently lower than that of JM107, 
although the OD600 was higher. Strikingly, the concentration of viable W1485 cells was 
measured to decrease in the first two hours of growth, from 7.8 x 10
7 cfu ml
-1 at 0 hours, to only 
2.6 x 10
7 cfu ml
-1 at 2 hours. However, this was followed by a sustained period of viability 
increase.  
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Figure 4.9 OD600 value of Top10F' (!), JM107 (!) and W1485 (") cultures as a function of 
incubation time. Error bars represent the standard error, N=3. 
 
 
Figure 4.10 Viable cell counts of Top10F' (!), JM107 (!) and W1485 (") cultures as a 
function of incubation time. Error bars represent the standard error, N=3. 
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The maximum titre of bacteriophage was achieved by 5 hours growth in JM107 culture (3.9 x 
10
11 pfu ml
-1) which was similar to Top10F' (4.1 x 10
11 pfu ml
-1) (Figure 4.11). The 
bacteriophage concentration in W1485 culture also plateaued after 5 hours growth (at 4.6 x 10
11 
pfu ml
-1) and did not significantly rise for a further three hours (P>0.05, Tukey). However, the 
titre of bacteriophage reached a maximum after 9 hours growth" 7.8 x 10
11 pfu ml
-1 " which was 
significantly higher than that after 5 hours (P<0.05, Tukey). Regardless of the OD600 and cell 
viability profiles, all three strains produced yields of bacteriophage M13 that were not 
significantly different from one another after five hours growth (P>0.05, Tukey). 
 
 
Figure 4.11 Bacteriophage concentration in Top10F' (!), JM107 (!) and W1485 (") cultures 
as a function of incubation time. Error bars represent the standard error, N=3. 
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After 24 hours incubation, the OD600 values, viable cell and bacteriophage concentrations were 
again measured for each E. coli strain. These were compared with the last recorded values of 
each growth curve to detect any secondary growth phase. It was observed that JM107 and 
W1485 cultures exhibited significant increases in OD600 value, and all three strains showed 
significant increases in viable cell counts, suggesting that a biphasic growth phenomenon 
occurred (Table 4.2). However, no culture experienced a significant rise in bacteriophage 
concentration. 
 
 
Table 4.2 Comparing the OD600 values, viable cell and bacteriophage concentrations between 
the last recorded values of each growth curve and a 24 hour timepoint. Statistical analysis (t-
test) was performed on log10-transformed cell and bacteriophage count data. 
 
Strain    OD600 value 
Viable cell count 
(cfu ml
-1) 
Bacteriophage 
count (pfu ml
-1) 
6 hours  1.06  9.0 x 10
7  4.1 x 10
11 
24 hours  1.18  6.6 x 10
8  4.9 x 10
11  Top10F' 
P value  0.12  0.0003  0.40 
         
6 hours  0.91  2.5 x 10
8  3.0 x 10
11 
24 hours  1.95  1.5 x 10
9  3.6 x 10
11  JM107 
P value  0.000006  0.01  0.30 
         
9 hours  1.58  4.7 x 10
8  7.8 x 10
11 
24 hours  2.46  1.5 x 10
9  6.7 x 10
11  W1485 
P value  0.00006  0.001  0.14 
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4.3.2  Comparison of supernatant DNA concentration between strains 
The accumulation of free DNA in JM107 and W1485 cultures was analysed by agarose gel 
electrophoresis (Figure 4.12 and Figure 4.13) as conducted for Top10F' (Figure 4.4). All 
cultures showed an increase in chromosomal DNA over time. The pattern observed in JM107 
culture was identical to that for Top10F': chromosomal DNA appeared as a band of at least 20 
kb in size. However, in W1485 culture this DNA appeared as a smear of increasingly small 
fragments as time progressed. All three strains showed that post phenol-chloroform treatment a 
secondary band of bacteriophage DNA was observed. The amount of chromosomal DNA in 
JM107 and W1485 cultures was subsequently quantified by densitometry (on a further agarose 
gel) of triplicate 5 hour timepoint samples and compared to Top10F' (Table 4.3). The average 
concentration of DNA in the supernatant of JM107 culture was 0.38 µg ml
-1, which was 
significantly lower than the 0.63 µg ml
-1 in Top10F' culture (P=0.006, t-test). However, the 
amount of DNA in W1485 culture was quantified to be 5.7 µg ml
-1, which was considerably 
higher than both JM107 and Top10F'. 
 
 
Figure 4.12 Agarose gel indicating the quantity of DNA in the JM107 culture supernatant. 
Lanes 1, 4, 7, 10, 13, 16, 19 and 22 are untreated culture supernatant samples. Lanes 2, 5, 8, 11, 
14, 17, 20, and 23 are phenol-chloroform treated culture supernatant samples. Lanes 3, 6, 9, 12, 
15, 18, 21 and 24 are phenol-chloroform treated culture supernatant samples which have been 
10-fold concentrated by ethanol precipitation. Lane 25 is Bioline HyperLadder 1. 
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Figure 4.13 Agarose gel indicating the quantity of DNA in the W1485 culture supernatant. 
Lanes 1, 4, 7, 10, 13, 16, 19 and 22 are untreated culture supernatant samples. Lanes 2, 5, 8, 11, 
14, 17, 20, and 23 are phenol-chloroform treated culture supernatant samples. Lanes 3, 6, 9, 12, 
15, 18, 21 and 24 are phenol-chloroform treated culture supernatant samples which have been 
10-fold concentrated by ethanol precipitation. Lane 25 is Bioline HyperLadder 1. 
 
 
 
Table 4.3. Average DNA quantity in M13 infected Top10F', JM107 and W1485 culture 
supernatants, measured from agarose gels. Samples were quantified at the 5 hour timepoint. 
Uncertainties represent the standard error, N=3. 
 
Quantity of DNA after 5 hours incubation (µg ml
-1) 
Top10F'  JM107  W1485 
0.63 ± 0.03  0.38 ± 0.04  5.7 ± 1.2 
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4.3.3  Determination of endogenous nuclease activity 
It was surmised that the degradation of free DNA in W1485 culture (Figure 4.13) was due to 
low levels of endogenous nucleases released into the culture medium. Non-nuclease-deficient E. 
coli strains have been demonstrated to partially degrade host nucleic acid under alkaline lysis 
conditions (Monteiro et al., 1999). To test this hypothesis, M13 infected and non-infected 
cultures of Top10F', JM107 and W1485 were streaked on methyl green DNAse agar (Section 
2.1.9) where the presence of DNAse activity was indicated by the formation of colourless zones 
in the previously green agar plate. Cultures (5 ml) were prepared as described in the Materials 
and Methods (Section 2.3.1). M13 infected cultures were inoculated with 2 x 10
6 pfu caesium 
chloride purified bacteriophage M13. All cultures were incubated for five hours at 37 °C with 
shaking. After streaking onto the DNAse agar, all plates were incubated at 37 °C overnight. 
 
It was found that small zones of clearing were observed around colonies of all three strains, and 
were more pronounced when M13 infected (Figure 4.14). The strength of clearing around 
colonies were indistinguishable between Top10F' and JM107, but were visibly stronger on 
W1485. However, all zones of clearing were faint. 
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Figure 4.14 Methyl green DNAse agar plates streaked with non-infected and M13 infected 
Top10F', JM107 and W1485 cultures incubated overnight at 37 °C. Plate (A), Top10F'. Plate 
(B), M13 infected Top10F'. Plate (C), JM107. Plate (D), M13 infected JM107. Plate (E), 
W1485. Plate (F), M13 infected W1485. DNAse activity is indicated by a loss of green 
pigmentation. To highlight clearance zones, images were converted to greyscale and the 
contrast enhanced.   120 
4.3.4  Comparison of supernatant protein concentration between strains 
The concentration of protein in the JM107 and W1485 culture supernatants was observed to 
increase over time by SDS-PAGE and silver staining (Figure 4.15 and Figure 4.16) in a manner 
consistent with Top10F' (Figure 4.7). A further acrylamide gel was prepared to compare the 
three strains at the 5 hour timepoint (Figure 4.17). On a qualitative basis, the concentration of 
protein in the supernatant appeared to increase in the order JM107 < Top10F' < W1485, 
although this observation was of a single replicate. However, this pattern was matched by 
triplicate Bradford assay measurements of total protein at the harvest timepoint (Table 4.4), 
which increased in the order JM107 (22.1 !g ml-1) < Top10F' (36.8 !g ml-1)< W1485 (38.0 !g 
ml-1). The concentration of total protein in the supernatant of JM107 culture was significantly 
lower than that in Top10F' and W1485 cultures (P<0.001, Tukey). However, the concentration 
of protein in Top10F' and W1485 cultures was similar (P>0.05, Tukey). 
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Figure 4.15 SDS-PAGE gel showing the visible supernatant proteins in JM107 culture 
supernatant of molecular weight 20-212 kDa. A total of 10 !l of sample (plus 10 !l loading 
buffer) was loaded in each well. The gel shows the increase in supernatant protein as a function 
of time.  
 
   121 
27.0 kDa
42.7 kDa
34.6 kDa
20.0 kDa
66.4 kDa
97.2 kDa
158 kDa
0 hr    1 hr   3 hrs  5 hrs  7 hrs  8 hrs  9 hrs 24 hrs  Ladder
212 kDa
55.6 kDa
116.0 kDa
 
Figure 4.16 SDS-PAGE gel showing the visible supernatant proteins in W1485 culture 
supernatant of molecular weight 20-212 kDa. A total of 10 !l of sample (plus 10 !l loading 
buffer) was loaded in each well. Gel shows the increase in supernatant protein as a function of 
time. 
 
 
 
Figure 4.17 SDS-PAGE gels showing the visible supernatant proteins in culture supernatant of 
molecular weight 20-212 kDa. A total of 10 !l of sample (plus 10 !l loading buffer) was loaded 
in each well. The left hand portion of the gel shows the relative quantities of supernatant protein 
in M13 infected Top10F', JM107 and W1485 cultures after 5 hours growth. The right hand 
portion of the gel shows the control lane of 4 x 10
11 pfu ml
-1 of caesium-chloride purified 
bacteriophage M13. The bacteriophage coat protein pIII can be seen at approximately 60 kDa.   122 
Table 4.4 Protein quantity in M13 infected Top10F', JM107 and W1485 culture supernatants, 
measured by Bradford assay. Samples were quantified at the 5 hour timepoint. Uncertainties 
represent the standard error, N=3. 
 
Quantity of protein after 5 hours incubation (µg ml
-1) 
Top10F'  JM107  W1485 
36.8 ± 2.1  22.1 ± 1.9  38.0 ± 2.7 
 
 
Since the yield of bacteriophage M13 at the 5 hour harvest point was not significantly different 
between strains (Figure 4.11), it was concluded that E. coli JM107 was marginally preferable in 
terms of the quantity of protein and DNA released. Although partial degradation of DNA by 
W1485 was observed, it was incomplete, and total DNA and protein levels were higher.  
 
 
4.4  Culture of an M13 Infected Top10F' Strain Producing a Recombinant 
Nuclease 
4.4.1  Approach 
The free E. coli chromosomal DNA detected in the culture supernatant is a contaminant of the 
bacteriophage M13 product. One strategy for its removal is to exploit physicochemical 
differences between DNA and bacteriophage to separate them in a downstream processing step. 
An alternative approach would be to selectively degrade the free DNA by enzymatic action, 
leaving the bacteriophage intact. The addition of exogenous nucleases, such as Benzonase (a 
commercially available form of the extracellular nuclease of Serratia marcescens), would 
achieve this aim (as successfully demonstrated in Section 4.2.4) but at a cost not viable at large 
scale (Cooke et al., 2003). Instead, utilising a "biological" solution from the host strain may 
prove cost-effective. As noted in Section 4.3.3, the wholesale lysis of non-nuclease deficient E. 
coli results in partial nucleic acid degradation by endogenous nucleases (Monteiro et al., 1999). 
However, since the extent of cell lysis in bacteriophage M13 production is comparatively small, 
such effects may be minor. Instead of relying upon endogenous nuclease activity, a more 
effective solution would be to modify the E. coli host strain to express a heterologous nuclease 
targeted to the periplasmic space. This would circumvent both the issues of cost and quality, 
and regulatory issues concerning the source of non-recombinant enzymes would also be avoided 
(Cooke et al., 2003).  
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4.4.2  Transformation of a Staphylococcal nuclease-producing vector in Top10F' 
A plasmid vector conferring nuclease activity to an E. coli cell has been previously constructed 
in our laboratory (Cooke, 2003). A Staphylococcus aureus (NCTC 8323) nuclease B (nucB) 
expression cassette was cloned into a pMMB67EH expression vector to give pMMBompnucB. 
nucB is expressed as a fusion to the ompA signal peptide, which targets the protein to the 
periplasmic space during growth (Suciu and Inouye, 1996). A 5 ml culture of JM107 E. coli 
holding the pMMBompnucB plasmid was prepared as described in Section 2.3.1, and the 
plasmid extracted by Qiagen Miniprep (Section 2.8.3). Chemically competent Top10F' cells 
were prepared as described in Section 2.9.1, and transformed with the pMMBompnucB vector 
as described in Section 2.9.2. Transformants were isolated from overnight incubation (37 °C) on 
methyl green DNAse agar plates (Section 2.1.9) supplemented with 100 !g ml
-1 ampicillin. 
 
4.4.3  Culture of M13 infected Top10F' cells holding pMMBompnucB plasmid 
Top10F' cells holding the pMMBompnucB plasmid were cultured as described in Section 4.2.2. 
Starter cultures (5 ml) were supplemented with 5 !g ml
-1 tetracycline and 100 !g ml
-1 
ampicillin. Two sets of growth curves (50 ml) were conducted in triplicate. In the first set 
nuclease production was not induced whereas in the second, nuclease production was induced 
by supplementation with 20 !g ml
-1 IPTG.  
 
The OD600 value of M13 infected non-induced Top10F'-pMMBompnucB cells plateaued after 
four hours growth at a value of 1.11 (Figure 4.18), after which there was no significant increase 
(P>0.05, Tukey). This was very similar to the OD600 value of 1.08 measured at the same 
timepoint in Top10F' cultures. In contrast, the OD600 of induced Top10F'-pMMBompnucB cells 
plateaued an hour later, at a value of 0.82, which was significantly lower than the non-induced 
culture (P=0.002, t-test). Enumeration of viable cells showed that from one hour of growth 
onwards the viability of induced Top10F'-pMMBompnucB cells was consistently lower than 
that of non-induced Top10F'-pMMBompnucB and Top10F' cells (Figure 4.19). 
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Figure 4.18 OD600 value of Top10F' (!), non-induced Top10F'-pMMBompnucB ($) and 
induced Top10F'-pMMBompnucB (#) cultures as a function of incubation time. All cultures 
were M13 infected at time zero. Error bars represent the standard error, N=3. 
 
 
 
Figure 4.19 Viable cell counts of Top10F' (!), non-induced Top10F'-pMMBompnucB ($) 
and induced Top10F'-pMMBompnucB (#) cultures as a function of incubation time. All 
cultures were M13 infected at time zero. Error bars represent the standard error, N=3. 
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The maximum titre of bacteriophage was achieved by 5 hours growth in non-induced Top10F'-
pMMBompnucB culture (4.4 x 10
11 pfu ml-1), which was similar to Top10F' (4.1 x 10
11 pfu ml
-
1) (Figure 4.20). The bacteriophage concentration in induced Top10F'-pMMBompnucB culture 
reached a maximum an hour later, at a bacteriophage concentration of 3.0 x 10
11 pfu ml
-1. These 
maximum bacteriophage titres were not significantly different from one another (P>0.05, 
Tukey). 
 
 
Figure 4.20 Bacteriophage concentration in Top10F' (!), non-induced Top10F'-
pMMBompnucB ($) and induced Top10F'-pMMBompnucB (#) cultures as a function of 
incubation time. All cultures were M13 infected at time zero. Error bars represent the standard 
error, N=3. 
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The accumulation of released DNA in (M13 infected) non-induced and induced Top10F'-
pMMBompnucB cultures was analysed by agarose gel electrophoresis (Figure 4.21 and Figure 
4.22) as conducted for Top10F' (Figure 4.4). Compared to M13 infected Top10F' supernatant 
samples (Figure 4.4), sufficient nuclease was produced and released in both induced and non-
induced cultures to degrade all visible chromosomal DNA in untreated supernatant. A faint 
characteristic band of chromosomal DNA at >20 kb was only observed after 10-fold 
concentration by ethanol precipitation. Post-phenol chloroform treatment, the expected band of 
M13 DNA at 3-5 kb was visible. 
 
 
Figure 4.21 Agarose gel indicating the quantity of DNA in the (M13 infected) non-induced 
Top10F'-pMMBompnucB culture supernatant. Lanes 1, 4, 7, 10, 13, 16, 19 and 22 are untreated 
culture supernatant samples. Lanes 2, 5, 8, 11, 14, 17, 20, and 23 are phenol-chloroform treated 
culture supernatant samples. Lanes 3, 6, 9, 12, 15, 18, 21 and 24 are phenol-chloroform treated 
culture supernatant samples which have been 10-fold concentrated by ethanol precipitation. 
Lane 25 is Bioline HyperLadder 1. 
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Figure 4.22 Agarose gel indicating the quantity of DNA in the (M13 infected) induced 
Top10F'-pMMBompnucB culture supernatant. Lanes 1, 4, 7, 10, 13, 16, 19 and 22 are untreated 
culture supernatant samples. Lanes 2, 5, 8, 11, 14, 17, 20, and 23 are phenol-chloroform treated 
culture supernatant samples. Lanes 3, 6, 9, 12, 15, 18, 21 and 24 are phenol-chloroform treated 
culture supernatant samples which have been 10-fold concentrated by ethanol precipitation. 
Lane 25 is Bioline HyperLadder 1. 
 
 
 
To confirm nuclease activity, M13 infected and non-infected cultures of induced and non-
induced Top10F'-pMMBompnucB were prepared and streaked on methyl green DNAse agar as 
described in Section 4.3.3. The DNAse agar was supplemented with 20 !g ml
-1 IPTG for 
induced Top10F'-pMMBompnucB cells. After overnight incubation at 37 °C, large colourless 
zones were observed around induced and non-induced culture colonies (Figure 4.23) in 
comparison to very small zones of clearing around Top10F' colonies without pMMBompnucB 
plasmid (Figure 4.14). No visible difference was observed for M13 infected or non-infected 
cultures. 
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Figure 4.23 Methyl green DNAse agar plates. Plate (A), Non-induced Top10F'-
pMMBompnucB. Plate (B), M13 infected non-induced Top10F'-pMMBompnucB. Plate (C), 
induced Top10F'-pMMBompnucB. Plate (D), M13 infected induced Top10F'-pMMBompnucB. 
DNAse activity is indicated by a loss of green pigmentation. No image manipulation to increase 
contrast was conducted. 
 
 
At the point of maximum bacteriophage yield (and therefore the harvest point), the total amount 
of protein in the induced and non-induced Top10F'-pMMBompnucB cultures was measured in 
triplicate (i.e. three different cultures) by Bradford assay and compared to Top10F' (Table 4.5). 
The concentration of protein in the supernatant of induced Top10F'-pMMBompnucB cultures 
was significantly higher than that in Top10F' and non-induced Top10F'-pMMBompnucB 
cultures (P<0.001 and P<0.001 respectively, Tukey). However, the concentration of protein in 
Top10F' and non-induced Top10F'-pMMBompnucB cultures was similar (P>0.05, Tukey). 
 
A 
C 
B 
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Table 4.5 Protein quantity in M13 infected Top10F', induced and non-induced Top10F'-
pMMBompnucB culture supernatants, measured by Bradford assay. Samples were quantified at 
the timepoint where bacteriophage M13 production has ceased. Top10F' and non-induced 
Top10F'-pMMBompnucB cultures were therefore sampled at 5 hours, induced Top10F'-
pMMBompnucB cultures were sampled after 6 hours incubation. Uncertainties represent the 
standard error, N=3. 
 
Quantity of protein (µg ml
-1) 
Top10F' 
Non-induced Top10F' 
-pMMBompnucB 
Induced Top10F 
-pMMBompnucB 
36.8 ± 2.1  39.1 ± 1.4  45.5 ± 1.9 
 
 
4.5  2 L Fermentation Study 
Fermentations were preformed in a two litre (working volume 1.5 litres) LH 210 series 
bioreactor with pH control and exhaust gas data logging. Equipment details and method of 
operation are described in the Materials and Methods (Section 2.13.2). The E. coli inoculum 
formed 10 % (v/v) of the final working volume. Unless otherwise stated, M13 infection 
occurred at the zero timepoint in the bioreactor. 
 
4.5.1  Fermentation of non-infected Top10F': medium comparison 
The growth of non-infected Top10F' cells in NB2 and a richer fermentation medium (Section 
2.1.7) was investigated at the 1.5 litre scale. Top10 cells previously grown in the fermentation 
medium in the same two litre capacity bioreactor (10 g l
-1 each of yeast extract, tryptone 
peptone, sodium chloride and glycerol) have been reported to achieve OD600 values of at least 
12 (Doig et al., 2003). 
 
At the 1.5 litre fermentation scale the yield of Top10F' cells in NB2 was low compared to the 
richer fermentation medium (Figure 4.24). In NB2 the maximum OD600 of 2.72 was achieved by 
five hours growth, which was consistent with OD600 values achieved by Top10F' culture at the 
50 ml shakeflask (OD600=2.49 after 7 hours, Figure 4.1) and 400 ml shakeflask (OD600=2.80 
after 5 hours, Table 5.2) scales. However, this was six-fold lower than the maximum OD600 
value attained in the fermentation medium (18.45), which was achieved after six hours growth 
as was consistent with OD600 values reported in the literature for Top10F' (Doig et al., 2003). 
Similarly, at the cessation of growth the titre of viable cells in NB2 culture was ten-fold lower 
than that in fermentation medium (Figure 4.25).   130 
 
Figure 4.24 OD600 value of non-infected Top10F' culture in NB2 (!) and fermentation medium 
(!) as a function of incubation time. Cultures were inoculated with E. coli Top10F' at the zero 
timepoint. 
 
 
 
Figure 4.25 Viability count of non-infected Top10F' culture in NB2 (!) and fermentation 
medium (!) as a function of incubation time. Cultures were inoculated with E. coli Top10F' at 
the zero timepoint. 
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4.5.2  Fermentation of M13 infected Top10F' 
The richer fermentation medium was investigated in detail to determine if improved Top10F' 
growth translated to an increase in bacteriophage yield. The fermentation and analyses (exhaust 
gas data, OD600 readings, bacteriophage counts, cell counts and dry cell weight) were conducted 
as described in Section 2.13.2 and Section 2.13.3. A limited study of M13 infected Top10F' 
culture in NB2 was then conducted for comparison, where culture OD600 and bacteriophage titre 
was measured once after five hours growth. 
 
In Top10F' culture in fermentation medium, the increase in bacteriophage concentration over 
time was compared to the viable cell concentration, OD600, dry cell weight and fermentation 
exhaust gas data (Figure 4.26). The aim was to determine which measurements correlated best 
with bacteriophage production. Since bacteriophage enumeration is an off-line process requiring 
the overnight incubation of agar plates (Section 2.5.2), an at-line (such as OD600) or on-line 
measurement (such as dissolved oxygen tension (DOT), oxygen uptake rate (OUR) and carbon 
dioxide evolution rate (CER)) which could be used as a proxy for the cessation of bacteriophage 
production would be useful. In the fermentation medium a maximum bacteriophage 
concentration of 1.8 x 10
12 pfu ml
-1 was achieved after four hours growth (Figure 4.26). This 
was nearly 4-fold greater than the concentration achieved after 5 hours growth in NB2 (4.8 x 
10
11 pfu ml
-1, OD600=2.21). Comparison of the bacteriophage concentration trend with the 
available on-line, at-line and off-line data shows that maximum bacteriophage titre correlated 
with the end of growth, similarly to that observed at the 50 ml scale (Sections 4.2, 4.3 and 4.4). 
Maximum bacteriophage concentration therefore coincided with a plateau in OD600 value (4.40) 
and dry cell weight (2.4 g l
-1). After reaching a maximum at 2 hours, the OUR decreased as 
growth slowed and stabilised at 9.24 mmol l
-1 h
-1 by 5 hours, as did the CER at 8.79 mmol l
-1 h
-
1. Conversely, the reduction in oxygen demand after 2 hours resulted in a rise in DOT to 82.7 % 
by 5 hours.  
 
After the plateau in growth, further increases in OD600, OUR and CER were observed between 5 
and 8 hours growth. The viable cell concentration and dry cell weight also continued to rise, and 
the DOT dropped in response to the increased oxygen demand. This biphasic growth 
phenomenon did not result in an increase in bacteriophage M13 concentration (Figure 4.26).   132 
 
 
 
 
 
 
Figure 4.26 Recorded data from the 1.5 litre scale fermentation of M13 infected Top10F'. 
Bacteriophage and cell titres were off-line analyses, as well as dry cell weight. In this study, 
OD600
 measurement was at-line. The DOT, OUR and CER values were on-line measurements. 
The dashed vertical line marks the time at which maximum bacteriophage titre was achieved (4 
hours). 
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4.5.3  The effect of delayed infection on bacteriophage M13 yield 
Thus far, Top10F' cells have always been infected with bacteriophage M13 at the start of 
fermentation. At end of growth, the resulting culture density was typically lower than for non-
infected cells (Sections 4.2, 4.5.1 and 4.5.2). It was postulated that delaying the addition of the 
bacteriophage would result in a higher density of Top10F', which on infection with 
bacteriophage M13 would produce a greater bacteriophage concentration. Such a scheme 
resembled product manufacture by plasmid-based expression systems in E. coli, where cells are 
typically cultured to high density before induction to produce the desired product (Doig et al., 
2001; Tustian et al., 2007; Zhao et al., 2005). 
 
Prior to bacteriophage infection, the increase in culture OD600 value closely matched that of the 
non-infected Top10F' culture (Figure 4.27). After 3 hours incubation (at an OD600 of 11.47) the 
bacteriophage inoculum (2 x 10
11 pfu) was added, after which the optical densities diverged. 
One hour later the OD600 value of the infected culture was 2.82 units less than the non-infected. 
The culture reached a maximum OD600 value of 17.17 after 5 hours incubation, then decreased 
to 15.89 by 8 hours incubation. A maximum concentration of 4.58 x 10
11 pfu ml
-1 bacteriophage 
was achieved by 8 hours incubation, which was less than half the concentration achieved when 
bacteriophage infection occurred at the start of fermentation (Figure 4.28).  
 
 
Figure 4.27 OD600 value of non-infected Top10F' (!), M13 infected Top10F' at t= 0 hours (!) 
and M13 infected Top10F' at t= 3 hours (#) cultures as a function of incubation time.    134 
 
Figure 4.28 Bacteriophage concentration in M13 infected Top10F' at t= 0 hours (!) and M13 
infected Top10F' at t= 3 hours (#) cultures as a function of incubation time.  
 
 
4.5.4  Fermentation of M13 infected Top10F-pMMBompnuncB 
Top10F' cells holding the pMMBompnucB plasmid were also fermented in the richer medium 
at the 1.5 litre scale. The fermentation medium in both the starter culture and bioreactor was 
supplemented with 20 !g ml
-1 IPTG to induce nuclease production, 100 !g ml
-1 ampicillin to 
select for the pMMBompnucB plasmid and 10 mM Ca
2+ ions to promote nuclease activity. The 
fermentation was otherwise conducted as described in Section 2.13.2, with bacteriophage M13 
infection at the same time as culture inoculation. 
 
Both bacteriophage concentration and culture optical density began to plateau after 3 hours 
growth. A maximum bacteriophage concentration of 1.6 x 10
12 pfu ml
-1 was achieved after 8 
hours growth (Figure 4.29), and a maximum OD600 value of 4.88 was achieved after 8 hours 
growth also (Figure 4.30). The maximum bacteriophage concentration was similar to that 
achieved by Top10F' cells (1.8 x 10
12 pfu ml
-1, Section 4.5.2), albeit four hours later. While the 
Top10F'-pMMBompnucB culture OD600 profile was generally similar to that of Top10F', the 
viable cell count was substantially different (Figure 4.31). Upon infection with bacteriophage 
M13 the viable cell count dropped over the first three hours of fermentation (from 5.8 x 10
8 cfu 
ml
-1 to 7.2 x 10
5 cfu ml
-1) before stabilising. However, over the same three hour period the 
culture OD600 increased from 1.08 to 4.48. The viable cell count of Top10F' cells showed no 
such decline (Figure 4.31). 
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Figure 4.29 Bacteriophage concentration in M13 infected Top10F' (!) and M13 infected 
Top10F'-pMMBompnucB (#) cultures as a function of incubation time.  
 
 
 
Figure 4.30 OD600 value of M13 infected Top10F' (!) and M13 infected Top10F'-
pMMBompnucB (#) cultures as a function of incubation time.    136 
 
Figure 4.31 Viability counts of M13 infected Top10F' (!) and M13 infected Top10F'-
pMMBompnucB (#) cultures as a function of incubation time. 
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4.5.5  Quantification of supernatant DNA and protein concentrations 
The accumulation of DNA in M13 infected Top10F' and induced Top10F'-pMMBompnucB 
cultures at the 1.5 litre scale was analysed by agarose gel electrophoresis (Figure 4.32 and 
Figure 4.33) in a similar fashion to that conducted at the 50 ml scale (Section 4.2.3), although 
no phenol/chloroform treatment or DNA concentration was performed. The concentration of 
chromosomal DNA in Top10F' culture increased as growth progressed (Figure 4.32), whereas 
sufficient nuclease was produced and released in Top10F'-pMMBompnucB culture to degrade 
all visible chromosomal DNA in untreated supernatant (Figure 4.33). 
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Figure 4.32 Agarose gel indicating the increasing quantity of DNA over time in the Top10F' 
1.5 litre fermentation supernatant. Lane 1 is the Fermentas !/HindIII ladder, Lane 11 is Bioline 
HyperLadder 1. 
   138 
Figure 4.33 Agarose gel indicating the increasing quantity of DNA over time in the induced 
Top10F'-pMMBompnucB 1.5 litre fermentation supernatant. Lane 1 is the Fermentas !/HindIII 
ladder, Lane 11 is Bioline HyperLadder 1. 
 
 
The concentration of chromosomal DNA in M13 infected Top10F' culture was subsequently 
quantified at the point of maximum bacteriophage concentration (4 hours). Quantification of 
triplicate 10 !l samples on agarose gel (Section 4.2.3) gave an average concentration of 7.1 !g 
ml
-1. 
 
At the point of maximum bacteriophage concentration (which was similar between cultures), the 
total amount of protein in the M13 infected Top10F' and Top10F'-pMMBompnucB cultures was 
measured by Bradford assay. The concentration of protein in Top10F' culture was 166.7 !g ml
-1
 
(4 hours); in Top10F'-pMMBompnucB culture it was 114.0 !g ml
-1
 (8 hours). This was counter 
to the trend observed on the 50 ml scale (Section 4.4.3). 
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4.6  Discussion 
The purpose of this chapter was to explore aspects of the growth of the non-lytic bacteriophage 
M13 in E. coli. It was hypothesized that bacteriophage yield may be increased by a richer 
growth medium or by utilising a different E. coli strain. The choice of E. coli strain was also 
assessed in terms of the impact upon culture contamination levels, since it was a key aim to 
examine the composition of the post-fermentation process fluid.  
 
4.6.1  Selection of analyses to track contamination levels 
The first part of this chapter was concerned with the identification of contamination levels in 50 
ml Top10F' culture and the selection of analyses to identify them. Accumulation of E. coli cell 
debris during normal culture meant that cell components such as DNA, RNA, proteins, lipids, 
endotoxins and chemical residuals would be present in the milieu (Eastman and Durland, 1998; 
Prazeres and Ferreira, 2004), albeit at low concentrations since rates of cell death during growth 
are virtually undetectable (Hewitt et al., 1998; Salivar et al., 1964). Of these components, 
quantities of released chromosomal DNA and protein were measured. DNA measurement was 
selected due to the availability of a standard sensitive, robust detection method in the form of 
agarose gel electrophoresis. Since the second largest proportion of the E. coli cell (after water) 
is protein (Atkinson and Mavituna, 1991), it was considered an important quantity to measure. 
It was identified by Bradford assay and SDS-PAGE with silver staining.  
 
It was shown (Section 4.2.2) that the analyses chosen were able to detect both protein and 
chromosomal DNA in 50 ml Top10F' culture supernatant. Quantitative data was obtained from 
agarose gels and the Bradford assay respectively. Quantification of silver-stained protein in 
acrylamide gels was not performed: silver staining performance is known to be particularly 
protein-specific and the linear dynamic range relatively limited (Gromova and Celis, 2006; Yan 
et al., 2000) 
 
4.6.2  Comparison of M13 infected and non-infected Top10F' cultures 
In both non-infected and M13 infected Top10F' cultures, chromosomal DNA and protein was 
observed to accumulate as culture growth progressed and cell density increased, as predicted. 
(Figure 4.4 and Figure 4.7). Assuming a 4.6 Mbp E. coli genome has a mass of 4.9 x 10
-15 g 
(Lawrence and Ochman, 1998), and an average of 4 genomes exist per cell (Akerlund et al., 
1995), then approximately 5 x 10
7 cells needed to be lysed to produce 1 µg of DNA. After 5 
hours growth, the concentration of chromosomal DNA in the supernatant of non-infected 
culture was measured to be 0.24 µg ml
-1. In infected culture the concentration was 0.63 µg ml
-1. 
Therefore, in non-infected Top10F' culture the measured quantity of DNA represented less than 
1 % of the final viable cell count, and in the equivalent M13 infected culture this represented 20   140 
% of the final viable cell count. The proportion is greater for infected Top10F' cells because the 
culture density (OD600) and viable cell counts were substantially lower than non-infected and 
the chromosomal DNA concentration was higher. The lower infected culture density was 
expected, since reduced E. coli growth rates upon infection by bacteriophage M13 has been 
reported (Bradley and Dewar, 1967; Salivar et al., 1964). However it was shown that when 
normalised for optical density, the viability of infected E. coli cells was lower than non-infected 
cells after incubation times greater than two hours. It is apparent that M13 infection, while not 
generally lethal to E. coli, reduced the proportion of viable Top10F' cells and increased the 
release of chromosomal DNA (implying greater cell lysis). It has been reported that the 
infection of E. coli cells with filamentous bacteriophage causes damage to the cell membrane 
(Chen et al., 2009). Defined increases in cell sensitivity to several chemical and physical 
stresses, such as exposure to SDS, osmotic shock and freeze-thawing have also been noted as a 
result of M13 infection (Roy and Mitra, 1970). Such cell membrane damage may explain the 
increased rate of cell lysis during normal culture growth. 
 
In a similar pattern to that observed for DNA, after 5 hours of growth the total concentration of 
protein measured by Bradford assay was significantly higher in infected Top10F' culture (30.5 
!g ml
-1) than non-infected Top10F' (20.6 !g ml
-1) (Figure 4.8). However, unlike the measured 
chromosomal DNA concentration, this pattern may not only be a result of M13 infection 
causing increased cell lysis: it must be taken into account that the Bradford assay also detected 
medium components. The lower OD600 value of the infected culture could have meant a higher 
concentration of medium components remained. The unused NB2 medium was measured to 
contain an average of 24 !g ml
-1. Since the change in concentration of medium components 
over time could not be determined alone (and thereby subtracted from the total protein reading) 
the Bradford assay was found to be suitable only for total protein comparison at the end of 
growth, not for tracking protein contaminant accumulation over time. 
 
4.6.3  Comparison between E. coli Top10F', JM107 and W1485 culture 
At the 50 ml scale, the optical density (OD600) of M13 infected JM107 cells was 19 % lower 
than that of infected Top10F' cells at the cessation of growth. Conversely, the viable cell count 
of JM107 was 63 % higher than Top10F' (Figure 4.9 and Figure 4.10). This discrepancy in 
OD600 and cell count between strains is likely due to Top10F' being recA
-: the proportion of 
viable cells in a recA
- culture is typically half that of a recA
+ one (Capaldo-Kimball and 
Barbour, 1971). In terms of cumulative contaminant release by the end of growth, the 
concentration of chromosomal DNA and protein in JM107 culture were found to be 
significantly less than the values in Top10F' culture. In Top10F' culture, the lower proportional 
viability of M13 infected cells relative to non-infected coincided with greater levels of DNA   141 
and protein. It therefore followed that the lower viability levels of M13 infected Top10F' cells 
relative to JM107 also translated to a greater concentration of contaminants. 
 
The growth of E. coli strain W1485 resulted in similar levels of protein contamination after 5 
hours growth as Top10F', but from a culture with a 20 % greater OD600 value and only a 13% 
higher viable cell count. This suggested that on a unit OD600 basis, the proportion of viable cells 
in W1485 culture was lower than Top10F', although as a near wild-type strain, it may have been 
expected to be the most resilient. The growth dynamics of strain W1485 were noteworthy for 
other reasons too. Firstly, upon infection with bacteriophage M13 at the start of culture, the 
viable cell count decreased over the following two hours (Figure 4.10) even though OD600 value 
increased rapidly (Figure 4.9). It is unlikely that considerable cell death occurred here, since the 
quantity of free chromosomal DNA and protein did not spike by two hours growth (Figure 4.13 
and Figure 4.16). Rather, they were consistent with Top10F' and JM107 accumulation profiles. 
OD600 increase due to greater average cell size can also be discounted: it has been reported that 
M13 infection does not change average cell size (Brown and Dowell, 1968). However, a similar 
pattern of viability decrease upon M13 infection coupled with a lack of measurable cell death 
has been previously noted (Salivar et al., 1964). Here, it was surmised that the effect was a 
reaction of cells to the transfer from liquid culture to agar plate. W1485 may have been more 
susceptible to this effect than JM107 and Top10F', perhaps due to a different cell stress 
response. Alternatively, some form of extra-cellular component may have particularly 
contributed to the OD600 increase in W1485 culture. 
 
A further W1485 growth characteristic of note was a possible second phase of growth between 
7 and 9 hours incubation. The concentration of bacteriophage plateaued after five hours growth, 
in a fashion similar to Top10F' and JM107 cultures (Figure 4.11). However, unlike these two 
strains the concentration of bacteriophage subsequently increased such that after nine hours the 
titre was significantly higher. Over this period the concentration of viable W1485 cells and the 
OD600 value also increased. In practice, Top10F' and JM107 strains may also have exhibited this 
"biphasic" growth on the 50 ml scale but with the second phase sufficiently delayed such that 
hourly monitoring was already halted. It can be seen in Table 4.2 that all three cultures 
exhibited an increase in OD600 and viable cell count between the last timepoint of the growth 
curve and the 24 hour sample. However, no culture experienced a statistically significant rise in 
bacteriophage concentration over this time. Therefore, from the perspective of maximising 
bacteriophage yield it would still be appropriate to cease fermentation of Top10F' and JM107 
culture at this scale after five hours. For W1485 culture, harvesting at 5 hours would return the 
same bacteriophage concentration as Top10F' and JM107 (4-4.5 x 10
11 pfu ml
-1) whereas four 
further hours of culture would return 7.8 x 10
11 pfu ml
-1 (Section 4.3.1). A more marked 
biphasic growth pattern was later observed in the 2 L fermentation of Top10F' cells, cultured in   142 
the richer fermentation medium (Figure 4.26), although this was not accompanied by an 
increase in bacteriophage titre and formed a single replicate. In theory, the growth of cells 
without the F-plasmid could explain this biphasic pattern, although it is unlikely since 
tetracycline selection was employed in the seed culture and the F-plasmid is known for its 
stability (Zielenkiewicz and Ceglowski, 2001). 
 
Each E. coli strain provided benefits and weaknesses. Despite being recA
- (and therefore 
actively dividing cells made up only 49 % of all cells (Capaldo et al., 1974)), M13 infected 
Top10F' culture gave the same bacteriophage yield as JM107 after 5 hours. However, JM107 
culture resulted in lower free chromosomal DNA and protein. W1485 culture resulted in the 
greatest bacteriophage yield after 9 hours incubation, but at the cost of the highest DNA and 
protein concentrations (Sections 4.3.2 and 4.3.4). The yield of bacteriophage must also be 
balanced with the quality of the product. Mutations to the recA (Top10F') gene are known to 
reduce recombination effects, which could offer an improvement in stability for M13 
derivatives holding longer sequences of insert DNA (Yanisch-Perron et al., 1985). Therefore, in 
product quality terms the strain Top10F' may be preferable, particularly since the effect of the 
recA mutation on the viability of the cultures appeared not to compromise the bacteriophage 
yield. 
 
The nature of the F-plasmid within each strain must also be considered. The use of a 
conjugation-proficient F episome of the kind within W1485 has long been discouraged by NIH 
guidelines (Yanisch-Perron et al., 1985). The F-plasmids within strains JM107 and Top10F' 
hold a mutation to the tra operon, thereby preventing conjugation whilst allowing for M13 
infection (Achtman et al., 1971; Yanisch-Perron et al., 1985). An alternative to W1485 could be 
to transform the closely-related (F-) daughter strain MG1655 with a conjugation-deficient 
version of the F-plasmid. 
 
4.6.4  Culture of an M13 infected Top10F' strain producing a recombinant nuclease 
The S. aureus nuclease-producing pMMBompnucB vector was previously developed in our 
laboratory in response to the need for a cost-effective, non-bovine derived nuclease for the 
degradation of contaminating E. coli DNA in recombinant protein production (Cooke, 2003). 
This solution was applied to the issue of contaminating chromosomal DNA in M13-infected 
Top10F' culture (Section 4.4). Since the nuclease was targeted to the periplasmic space, 
interference with M13 assembly was therefore of concern: extrusion of bacteriophage particles 
from the E. coli cell occurs through gated channels traversing the inner and outer cell 
membranes (Russel, 1995). Culture was therefore conducted with and without nuclease 
production induced by IPTG. When nuclease production was not induced it was found that the 
growth characteristics of M13 infected Top10F'-pMMBompnucB cells closely matched those of   143 
infected Top10F' cells without the plasmid (Figure 4.18). When induced, maximum 
bacteriophage titre was achieved an hour later, but was not significantly less than that achieved 
by non-induced culture. However, both culture OD600 and cell viability were consistently lower 
throughout growth (Figure 4.18 and Figure 4.19). The burden of nuclease production has been 
shown to reduce E. coli culture OD600 by up to 20 % in early-to-mid stage exponential growth 
(Cooke, 2003), although this discrepancy closed as growth progressed. Even so, it was thought 
that the burden of nuclease production coupled with M13 infection probably caused the relative 
decline in culture OD600 and cell viability. The one hour delay in achieving maximum 
bacteriophage concentration could be explained by either membrane-area interference or 
metabolic burden effects. Nevertheless, whether induced or not, sufficient nuclease was 
produced and released into the milieu to degrade free chromosomal DNA such that it was not 
visible by agarose gel electrophoresis. It has been reported that some basal level transcription 
from the tac operon, which controls nuclease production, occurs (Cooke et al., 2003). This 
explains why degradation of supernatant chromosomal DNA occurred in non-induced Top10F' 
cultures too. In terms of protein concentration, the cost of induced nuclease production was a 
near 25 % rise in supernatant protein relative to Top10F' culture without the nuclease plasmid 
(Table 4.5). 
 
4.6.5  Fermentation at the 2 L bioreactor scale 
Fermentation of M13 infected Top10F' in a richer fermentation medium gave a four-fold greater 
bacteriophage yield than that obtained in NB2 (Section 4.5.2). At the end of growth, the OD600 
of Top10F' culture in fermentation medium was double that in NB2. Therefore in this study the 
richer medium was not only associated with greater cell density but also bacteriophage 
concentration. These findings agree with those of Reddy and McKenney (1996), where 
shakeflask growth in a richer medium resulted in up to 60 % higher bacteriophage yields, but 
are counter to those of Grieco et al. (2009), where fermentation in a richer medium doubled cell 
mass but produced only one third of the filamentous bacteriophage. These seemingly conflicting 
results may be reconciled by the knowledge that production of bacteriophage from E. coli is a 
more complicated function than just quantity of carbon source. For example bacteriophage yield 
has been negatively correlated with cell growth rate during culture (Salivar et al., 1964). Since 
the fermentation medium used in this study was of different composition to NB2, it is possible 
that several factors were favourably altered.  
 
An attempt was made to increase overall fermentation bacteriophage yield by delaying 
bacteriophage infection to 3 hours post E. coli inoculation (Section 4.5.3). It was postulated that 
this action would allow the growth of Top10F' to a higher density, which upon infection would 
result in a greater bacteriophage yield. However, this was not the case in this study (Figure 
4.28). This could have been due to bacteriophage infection occurring too late in the culture   144 
growth cycle, where a proportion of the culture population may have reached stationary phase 
before being infected. Furthermore, identical quantities of M13 were added to infect cultures at 
0 and 3 hours post E. coli inoculation, resulting in a lower effective MOI when infection 
occurred at the latter time. As will be demonstrated, a lower MOI requires a longer culture time 
to achieve maximum bacteriophage yield (Section 5.3.1). Further work to repeat this 
experiment, and to investigate earlier infection times would be of great interest. 
 
In terms of contamination levels, the increased cell and bacteriophage growth in the 
fermentation medium resulted in elevated DNA and protein concentrations. The concentration 
of supernatant DNA measured at the point of harvest was 11-fold greater than that at the 50 ml 
scale, for a 4.4-fold increase in bacteriophage titre and 4.1-fold rise in OD600 (Sections 4.2 and 
4.5). Similarly, the concentration of supernatant protein at the point of harvest was 5.5-fold 
greater at the 1.5 litre scale than at the 50 ml scale. However, the 1.5 litre fermentation of 
Top10F' cells producing the nuclease enzyme resulted in a DNA-free culture (Figure 4.33) of 
maximum bacteriophage concentration (1.6 x 10
12 pfu ml
-1) virtually identical to that of 
nuclease-free cells (Section 4.5.4). Further, at this scale the concentration of supernatant protein 
was not increased and was indeed measured to be lower than Top10F' culture without the 
nuclease plasmid (Section 4.5.5). However, in this study it took twice as long to reach the 
maximum bacteriophage concentration, thereby requiring a total fermentation time of eight 
hours. It is noteworthy at this scale that whilst OD600 values were similar, the viability of M13 
infected Top10F' cells expressing the nuclease enzyme was substantially decreased (up to 100-
fold) relative to Top10F' cells which did not (Figures 4.30 and 4.31). The poor correlation 
between cell count and OD600 value has been noted repeatedly throughout this chapter (Figures 
4.1 and 4.2, Figures 4.9 and 4.10, Figures 4.18 and 4.19) and commented on earlier in this 
discussion. Further fermentations are necessary to confirm the findings at this scale, and to 
examine the effects of nuclease expression on bacteriophage yield in depth.  
 
Overall, the utilization of an E. coli strain producing a nuclease enzyme may provide a useful 
and potentially cost effective option to remove contaminating chromosomal DNA. More 
generally, purification would be achieved by the exploitation of physicochemical differences 
between the bacteriophage and contaminants. Methods such as the selective adsorption of 
chromosomal DNA to nitrocellulose membranes (Levy et al., 2000a), selective precipitation 
processes (Juckes, 1971; Lander et al., 2002; Wenzig et al., 1993) or chromatographic steps 
(Atkinson et al., 1987) each employ different bases of separation to achieve the desired 
purification. 
 
When E. coli cells were infected at the start of fermentation, the resulting analytical profiles 
showed distinct features coinciding with the cessation of bacteriophage production (Figure   145 
4.26). From a bioprocessing standpoint, these would provide useful indicators that harvesting 
could proceed since bacteriophage concentration cannot be measured in an on-line fashion. In 
particular, the end of bacteriophage production usefully correlated with a plateau in OD600 value 
and a levelling in the OUR and CER. All three of these measurements can be made on-line or 
at-line to the bioreactor. Since similar trends between cell growth and bacteriophage production 
were observed throughout this chapter and in the literature (Brown and Dowell, 1968; Grieco et 
al., 2009; Salivar et al., 1964), it seems certain that these methods provide a reproducible way 
to track filamentous bacteriophage production. In the literature a similar approach has been 
taken to explicitly track the completion of lytic bacteriophage production. Here, CER or OD600 
have been used as a guide to bacterial cell density which substantially decreases upon 
bacteriophage release (and therefore cell lysis) at the end of production (Sargeant, 1970; 
Sargeant et al., 1968). 
 
4.6.6  Concluding remarks 
In summary, this chapter investigated aspects of the fermentation production of bacteriophage 
M13. The composition of the post-fermentation process fluid was explored and it was found 
that significant levels of chromosomal DNA and protein were released into the fermentation 
medium during growth. Contaminant concentration was found to be a function of bacteriophage 
infection, E. coli strain and culture time. A novel method for the removal of supernatant DNA 
was successfully tested by the culture of E. coli harbouring a nuclease-producing expression 
cassette. Small-scale experimentation (50 ml) showed that the yield of bacteriophage M13 was 
not significantly compromised by growth in recA
- cells (Top10F') relative to a recA
+ strain 
(JM107). However, bacteriophage yield was 4-fold improved by host cell growth in a richer 
fermentation medium. Therefore in light of the results of this chapter, bacteriophage M13 
growth in strain Top10F' harbouring the nuclease-producing plasmid in fermentation medium 
offered the best combination of bacteriophage yield, quality and purity. 
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5  The Effect of Hydrodynamic Shear on E. coli Cell Integrity 
5.1  Introduction 
The multiplicity of infection (MOI) is defined as the inoculating ratio of infective bacteriophage 
particles to viable E. coli cells at the start of propagation. A previous small-scale bacteriophage 
propagation study suggested that the final yield of bacteriophage M13 was independent of 
MOIs in the range of 10
-6 to 10
-4 (Reddy and McKenney, 1996). However, no detail was given 
concerning the overall fermentation time required to achieve maximum bacteriophage yield. It 
was hypothesised that lower MOIs would require a longer fermentation time, since further 
bacteriophage replication would be required to achieve total E. coli infection. As will be 
demonstrated, this was shown to be the case (Section 5.2). 
 
It was shown in Chapter 4 that the level of cellular debris in the culture supernatant increased 
concomitantly with E. coli growth. It might therefore be expected that the longer growth times 
and greater cell counts associated with lower MOI cultures would result in higher levels of 
cellular debris in the supernatant. If this translated to the large-scale, this could have a 
detrimental effect on further downstream processing. One aim of this chapter, therefore, was to 
examine the level of supernatant contamination at the harvest point as a function of culture 
MOI. 
 
Since bacteriophage M13 is an extracellular product it would be useful to process the cells 
without disruption and thereby avoid unnecessary contamination of the supernatant with cellular 
debris. The handling of cells in the early stages of a purification sequence therefore requires 
consideration to prevent this. To meet this goal, understanding of the effect of shear stresses on 
E. coli cells is important. In bacteriophage M13 processing, the cells are likely to experience 
shear stresses of varying levels and times, principally in the fermentation, pumping and 
centrifugation stages. Existing literature in the area has demonstrated the disruption of E. coli 
cells by homogenisation (Keshavarz-Moore et al., 1990), capillary shear (Lange et al., 2001) 
and jets (Chan et al., 2006). However, it has been shown by Hewitt et al. (1998) that under 
typical fermentation conditions (where shear forces are less) the shear effects on E. coli strain 
W3110 were minimal.  
 
The primary aim of this study, therefore, was to determine the response of E. coli cultures to 
high energy turbulent shear conditions. A USD rotating disk shear device was again used, and it 
was hypothesised that an older, more dense culture resulting from a low MOI would respond 
differently to a high MOI culture (which would be harvested sooner). For example, if similar 
fractions of cells are damaged in both low and high MOI cultures, it may be expected that the 
culture with a higher cell density would therefore result in greater supernatant contamination   147 
with cellular debris. The implications for the large-scale processing of host E. coli cells were 
subsequently assessed. 
 
It was also shown in Chapter 4 that the level of supernatant DNA and protein contamination in 
an M13 infected culture was higher than that in a non-infected culture of equivalent age, even 
though the optical density (OD600) was lower. This suggested that M13 infection had a 
detrimental effect on E. coli viability. Moreover, it is known that the infection of E. coli cells 
with filamentous bacteriophage causes damage to the cell membrane (Chen et al., 2009) 
resulting in a defined increase in sensitivity to several chemical and physical stresses, such as 
exposure to SDS, osmotic shock and freeze-thawing (Roy and Mitra, 1970). A secondary aim of 
this chapter, therefore, was to investigate whether this translated into a greater cell susceptibility 
to turbulent shear, relative to non-infected cells. Of course, in a bacteriophage M13 bioprocess 
the E. coli cells will be infected with M13, but it was considered important to run a parallel 
series of non-infected E. coli cultures to assist in interpreting the infected cell data. 
Furthermore, if infected cells are proven to be less shear resistant than infected, it lends further 
proof to the findings of Chapter 4 and elsewhere. 
 
 
5.2  The Effect of MOI on Bacteriophage M13 Propagation in E. coli 
A detailed bacteriophage M13 growth study was conducted in our laboratory under the guidance 
of Dr. Emma Stanley (publication in preparation). As part of this work, MOIs of 1 x 10
-5, 1 x 
10
-2 and 1 x 10
1 were investigated for their effect on bacteriophage M13 growth characteristics 
at the two-litre shakeflask scale. 
 
Starter 400 ml NB2 cultures of E. coli Top10F' were prepared as described in the Materials and 
Methods (Section 2.3.2), and grown overnight in two-litre baffled shakeflasks at 37 °C with 5 
µg ml
-1 tetracycline antibiotic selection. E. coli cells were previously enumerated from 
identically prepared overnight culture as described in Section 2.5.1, to allow for the subsequent 
calculation of MOI. Triplicate 400 ml NB2 filled two-litre baffled shake flask were pre-warmed 
to 37 °C and inoculated with 40 ml of overnight starter culture (measured to contain 4 x 10
11 
cfu). Cultures were then inoculated with 2 ml of appropriately diluted (by 10 mM Tris, pH 7.5 
at 25 °C) caesium chloride purified bacteriophage M13 to give the desired MOI (Table 5.1). 
Cultures were then incubated at 37 °C (with shaking at 200 rpm). Growth was monitored by 
absorbance readings at 600 nm at hourly intervals (OD600), plus an extra sample at 30 minutes. 
Samples were suitably diluted with fresh media and absorbances measured in triplicate. 
Bacteriophage were enumerated as described in Section 2.5.2. The experiment was conducted 
for each of the MOIs listed in Table 5.1. 
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Table 5.1 The tested multiplicities of infections (MOIs) together with the corresponding 
concentrations of two millilitre M13 inocula. 
 
Multiplicity of infection 
(MOI) 
Concentration of M13 
inoculum required 
5 x 10
1  1 x 10
12 pfu ml
-1 
5 x 10
-2  1 x 10
9 pfu ml
-1 
5 x 10
-5  1 x 10
6 pfu ml
-1 
 
 
As was hypothesised, it was shown that the lower the MOI, the longer it took to reach the 
maximum bacteriophage titre (Figure 5.1). At an MOI of 1 x 10
1, the maximum bacteriophage 
yield was reached after two hours growth. At an MOI of 1 x 10
-2 it took three hours to reach the 
maximum bacteriophage yield, and at an MOI 1 x 10
-5 it took five hours. Correspondingly, it 
was found that lower MOIs resulted in cultures of a greater OD600 value at the point maximum 
bacteriophage yield (Figure 5.2). 
 
 
 
 
Figure 5.1 Increase of bacteriophage M13 titre in cultures with initial multiplicity of infections 
(MOIs) of 5 x 10
1 (!), 5 x 10
-2 (#) and 5 x 10
-5 (!) as a function of time. The maximum yields 
of bacteriophage M13 were achieved after 2 hours (5 x 10
1), 3 hours (5 x 10
-2) and 5 hours (5 x 
10
-5). Error bars represent the standard error, N=3.    149 
 
 
Figure 5.2 Increase of OD600 in cultures with initial multiplicity of infections (MOIs) of 5 x 10
1 
(!), 5 x 10
-2 (#) and 5 x 10
-5 (!) as a function of time. The maximum yields of bacteriophage 
M13 were achieved after 2 hours (5 x 10
1), 3 hours (5 x 10
-2) and 5 hours (5 x 10
-5). Error bars 
represent the standard error, N=3.  
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5.3  Studying The Effect of Hydrodynamic Shear on E. coli  
5.3.1  M13 infected and non-infected E. coli culture 
As described in the Introduction to this chapter, the primary aim of this study was to determine 
the response of E. coli cultures to high energy turbulent shear conditions. The reasoning for this 
experimentation was two-fold. Firstly, since M13 infection is known to cause damage to the cell 
membrane (Chen et al., 2009), it was of interest whether this would translate to a greater 
susceptibility to turbulent shear. Secondly, it was noted in Section 5.2 that a lower MOI resulted 
in an older and more dense culture at harvest. Would this result in an altered susceptibility to 
turbulent shear? If differences are observed, then consideration would need to be given as to 
whether contamination of the supernatant by cellular debris could be reduced. The potential 
implications for large-scale processing would then be discussed. 
 
The growth data gained in Section 5.2 was used to prepare E. coli cultures of three different 
ages for investigation with shear forces. Fresh triplicate two-litre shakeflasks were prepared and 
inoculated exactly as described in Section 5.2. Cultures inoculated with an MOI of 5 x 10
1 were 
therefore harvested for shear studies after 2 hours growth.  Cultures inoculated with an MOI of 
5 x 10
-2 were harvested after 3 hours growth, and cultures with an MOI of 5 x 10
-5 after 5 hours. 
The initial (0 hr) OD600 of every culture was measured to be in the range OD600 0.48- 0.62. 
 
Triplicate non-infected E. coli Top10F' cultures were also prepared identically to that described 
in Section 5.2, except that no bacteriophage were added. These comparison cultures were 
harvested at the same times as the M13 infected ones. Therefore cultures were grown for 2, 3 
and 5 hour durations. 
 
In Table 5.2 the average culture OD600 readings and bacteriophage titres at the harvest points in 
this study are tabulated. The OD600 values measured for non-infected cultures were higher at the 
harvest times as compared with M13 infected cultures. This is expected since E. coli cells 
infected with bacteriophage M13 display a reduced rate of growth (Salivar et al., 1964). 
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Table 5.2 The OD600 and M13 titres achieved in infected and non-infected cultures by the 
harvest points in this study. 
    M13 infected cultures    Non-infected cultures 
MOI 
Harvest  
time (hrs) 
OD600 
M13 titre 
x 10
11  (pfu ml
-1) 
  OD600 
5 x 10
1  2
  1.2  2.2       1.5 
5 x 10
-2  3
  1.7  2.7    1.9 
5 x 10
-5  5
  2.3  2.2    2.8 
 
 
5.3.2  USD rotating disk shear device operation 
At the appropriate harvest time, cultures were immediately removed from the 37 °C incubator 
and placed in an ice bath to arrest growth for at least 10 minutes. A 20 ml sample from each 
culture was taken for shearing within the rotating disk shear device. Shearing was conducted as 
described in the Material and Methods (Section 2.12.2) with a disk rotation speed of 533 rps. 
This was to mimic the feed-zone conditions of a production-scale multi-chamber bowl 
continuous centrifuge, identified as a production-scale step imposing one of the greatest energy 
dissipation rates on the process fluid (Boychyn et al., 2004). A 20 ml non-sheared control was 
incubated at room temperature (25 °C) and run concurrently. Samples (500 µl) were taken from 
both sheared and non-sheared runs at 0, 2, 5 and 10 minutes and incubated on ice until needed. 
Additional triplicate non-sheared controls were sampled at the zero timepoint. Cell and 
bacteriophage counts in each sample were determined by the surface droplet technique (Section 
2.5.2). The remainder of every sample was then centrifuged at 17 000 x g for 3 minutes to pellet 
the cells. Supernatants were carefully decanted and stored at -20 °C. Each MOI was tested three 
times. The level of supernatant contamination was assessed in terms of the quantity of 
chromosomal DNA present (Chapter 4); agarose gels were prepared and quantified as described 
in the Material and Methods (Sections 2.7.2 and 2.7.4). The shearing experimentation was then 
repeated for the non-infected cultures harvested at the same 2, 3 and 5 hour timepoints indicated 
in Table 5.2. 
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5.3.3  The effect of shear on E. coli cell viability 
The viability of cells in all non-sheared runs remained stable over time, whether infected with 
M13 or not (Figure 5.3). Indeed, there were no significant drops in viability over the course of 
the experiments (P>0.05, Dunnett). This gave confidence that observed drops in viability in 
sheared samples would be due to the effects of shear. 
 
 
 
Figure 5.3 Fraction of viable E. coli Top10F' remaining in non-sheared controls as a function of 
time. Graph (A): M13 infected cells, MOI 5 x 10
1  ("), 5 x 10
-2 (") and 5 x 10
-5 (#). Graph 
(B): non-infected cells, 2 hours  ("), 3 hours (") and 5 hours (#) growth. Viability was 
determined by the surface-droplet technique (see Materials and Methods). Error bars represent 
the standard error of the mean fractions, N=3.   153 
Prior to shearing, the average viable cell counts in M13-infected cultures were 9.2 x 10
7 pfu ml
-
1, 7.3 x 10
8 pfu ml
-1 and 1.1 x 10
9 pfu ml
-1 for the MOIs of 5 x 10
1, 5 x 10
-2 and 5 x 10
-5 
respectively. The resulting decay profiles are shown in Figure 5.4, where remaining viability 
was expressed as a fraction of the viability of the triplicate non-sheared controls. The subjection 
to shear at 533 rps within the shear device resulted in fractional viability drops in all three 
cultures, to 0.60 (MOI 5 x 10
1), 0.71 (MOI 5 x 10
-2) and 0.77 (MOI 5 x 10
-5) after 10 minutes. 
These drops were all significantly different from their respective non- sheared controls 
(P=0.001, 0.010 and 0.032 respectively, t-test), but as fractional drops were not significantly 
different from one another (P>0.05, Tukey). It could not therefore be concluded that MOI had 
an effect on the overall viability decline.  
 
Figure 5.4 Fraction of viable E. coli Top10F' remaining at disk speed 533 rps for culture 
infected with MOI 5 x 10
1  ("), 5 x 10
-2 (") and 5 x 10
-5 (#) as a function of time. Viability 
was determined by the surface-droplet technique (see Materials and Methods). Error bars 
represent the standard error of the mean fractions, N=3. 
 
 
The decay profiles of non-infected E. coli cultures are shown in Figure 5.5, also expressed as 
fractional viabilities relative to the triplicate non-sheared controls. Prior to shearing, the viable 
cell counts were 9.6 x 10
8 pfu ml
-1 (2 hours incubation), 1.9 x 10
9 pfu ml
-1 (3 hours incubation) 
and 2.7 x 10
9 pfu ml
-1 (5 hours incubation). The subjection to shear at 533 rps within the shear   154 
device resulted in smaller fractional viability drops in all three cultures relative to the infected 
cultures. After 10 minutes, the viability of the 2 hour culture (equivalent to MOI 5 x 10
1) had 
declined to 0.69, that of the 3 hour culture (equivalent to MOI 5 x 10
-2) to 0.93 but the viability 
of the 5 hour culture (equivalent to MOI 5 x 10
-5) remained at 1.02. The drop in viability in the 
2 hour culture alone was significantly different from its non- sheared controls over this time 
(P=0.004, t-test). This was also significantly different from the 3 hour and 5 hour culture cell 
viabilities at the same 10 minute timepoint (P<0.01 and P<0.001, Tukey), which were not 
significantly different from one another (P>0.05, Tukey). 
 
 
Figure 5.5 Fraction of viable E. coli Top10F' remaining at disk speed 533 rps for culture of age 
2 hours ("), 3 hours (") and 5 hours (#) as a function of time. Viability was determined by the 
surface-droplet technique (see Materials and Methods). Error bars represent the standard error 
of the mean fractions, N=3. 
 
 
Since the OD600 of infected and non-infected cultures of the same age differed, it was thought 
that a plot of fractional cell viability after 10 minutes shearing versus OD600 may help delineate 
the potential effects of M13 infection and culture density (Figure 5.6). For infected cell cultures, 
regression analysis indicated that the linear relationship between OD600 and cell viability was 
not significantly different from zero (R
2=0.94, P=0.15). Therefore OD600 did not affect shear 
resistance, which was expected since the cell viabilities had been shown to not be significantly   155 
different from one another after 10 minutes shearing (Figure 5.4). For non-infected cells the 
increase in fractional viability with OD600 was not well described by a linear relationship 
(R
2=0.81, P=0.28). Instead, the trend appeared more of a "step-change" increase in fractional 
viability, where the viability of the more optically dense 3 and 5 hour cultures appeared 
virtually unchanged by shearing, whereas the 2 hour culture showed a 30 % fractional loss of 
viability.  
 
Figure 5.6 Fraction of viable E. coli Top10F' remaining after 10 minutes at disk speed 533 rps 
when infected (!) and non-infected (#) as a function of culture OD600. Viability was 
determined by the surface-droplet technique (see Materials and Methods). R
2 values for linear 
trends are 0.94 (infected) and 0.81 (non-infected). Error bars represent the standard error of the 
mean fractions, N=3. 
 
Since OD600 did not have an effect on the fractional viability of infected cells, it was therefore 
considered appropriate to compare the fractional viabilities of infected and non-infected cultures 
at the same harvest time, even though their OD600 values differed slightly. After 10 minutes 
shearing time, the difference in fractional viability between infected (MOI 5 x 10
1) and non-
infected cultures harvested at 2 hours was not significant (P=0.32, t-test), nor at 3 hours/ MOI 5 
x 10
-2 (P=0.12, t-test). However, the differences were significant at 5 hours/ MOI 5 x 10
-5 
(P=0.025, t-test).    156 
 
5.3.4  Quantification of DNA release as a measure of cell breakage 
Sheared, non-sheared and control culture supernatants were loaded onto agarose gels to observe 
the levels of released chromosomal DNA. Figure 5.7, Figure 5.8 and Figure 5.9 show gels run 
for the experiments with MOIs 5 x 10
1, 5 x 10
-2
 and 5 x 10
-5 respectively. For non-infected 
cultures, Figure 5.10, Figure 5.11 and Figure 5.12 show the gels run for the experiments 
harvested at 2, 3 and 5 hours respectively. A gel was run for each experimental repeat, that is, 
three gels for each MOI/ harvest time. 
 
In all cases it was found that the subjection of culture to shear reduced the size of the 
chromosomal DNA in the supernatant from approximately 20 kb to a smear between 1 and 6 kb 
(Figure 5.7- Figure 5.12). The quantity of DNA in the supernatant increased as shearing 
progressed, suggesting that release of DNA from cells was occurring. As might be expected, the 
amount of smaller DNA fragments also increased as shearing progressed. Meanwhile, the 
quantity of DNA in the non-sheared samples remained stable over time. 
 
 
 
Figure 5.7 Agarose gel indicating the quantity of DNA in the culture supernatant. This culture 
was inoculated with bacteriophage M13 to an MOI of 5 x 10
1. The triplicate non-sheared 
controls are labelled C1, C2 and C3. Shearing at 533 rps caused an increase in the amount of 
DNA in the supernatant.   157 
 
Figure 5.8 Agarose gel indicating the quantity of DNA in the culture supernatant, similar to 
Figure 5.7. This culture was inoculated with bacteriophage M13 to an MOI of 5 x 10
-2. 
 
Figure 5.9 Agarose gel indicating the quantity of DNA in the culture supernatant, similar to 
Figure 5.7. This culture was inoculated with bacteriophage M13 to an MOI of 5 x 10
-5.   158 
 
Figure 5.10 Agarose gel indicating the quantity of DNA in the culture supernatant. This non-
infected culture was harvested after 2 hours. The triplicate non-sheared controls are labelled C1, 
C2 and C3. Shearing at 533 rps caused an increase in the amount of DNA in the supernatant. 
 
Figure 5.11 Agarose gel indicating the quantity of DNA in the culture supernatant, similar to 
Figure 5.10. This non-infected culture was harvested after 3 hours.   159 
 
Figure 5.12 Agarose gel indicating the quantity of DNA in the culture supernatant, similar to 
Figure 5.10. This non-infected culture was harvested after 5 hours. 
 
 
The absolute amount of DNA in the supernatants was determined by the densitometric 
quantification of band intensities in the agarose gels (Section 2.7.4) relative to the Bioline 
HyperLadder 1. The standard curves generated by the HyperLadders displayed strong linear 
relationships between intensities and DNA quantities (R
2 > 0.96 in all cases, data not shown).  
 
Prior to shearing, the quantity of DNA in the supernatants of infected and non-infected cultures 
was similar after 2 hours growth (MOI 5 x 10
1), but diverged as growth continued. At the 3 hour 
(MOI 5 x 10
-2) and 5 hour (MOI 5 x 10
-5) harvest times the quantity of DNA in non-infected 
cultures was significantly less (P<0.001, t-test). (Table 5.3 and Table 5.4). However, on a per 
OD600 unit basis, the amount of DNA in non-infected cultures was substantially less in all cases 
(Table 5.5). This trend was consistent with the findings of Chapter 4, where it was noted that 
relative to the culture OD600, M13-infected cultures result in more heavily contaminated 
supernatants at the same timepoints than those that are not.  
 
In M13 infected cultures, it was observed that the quantity of DNA in the supernatant appeared 
dependent on the MOI used (Table 5.3). That is, the smaller the MOI the greater the 
concentration of DNA. This pattern corresponded with the greater optical density readings for   160 
cultures grown with a lower MOI in Table 5.2. Moreover, the measured quantities of DNA were 
all found to be significantly different from one another (P<0.01, Tukey). 
 
 
Table 5.3 DNA quantity in M13 infected culture supernatants, measured from agarose gels. The 
Control sample represented an average of the triplicate non-sheared controls. Culture was 
sheared at 533 rps and samples taken at 0, 2, 5 and 10 minutes. Uncertainties represent the 
standard error, N=3. 
 
Quantity of DNA (µg ml
-1) 
Sample 
MOI 5 x 10
1  MOI 5 x 10
-2  MOI 5 x 10
-5 
Control  0.41 ± 0.02  0.65 ± 0.03  1.40 ± 0.16 
0 mins  0.42 ± 0.02  0.69 ± 0.02  1.48 ± 0.25 
2 mins  5.39 ± 0.70  3.95 ± 0.41  5.23± 0.95 
5 mins  7.25 ± 1.01  4.94 ± 0.49  6.15± 0.96 
10 mins  8.15 ± 1.19  6.23 ± 0.56  7.41± 1.69 
 
 
Table 5.4 DNA quantity in non-infected culture supernatants, measured from agarose gels. The 
Control sample represented an average of the triplicate non-sheared controls. Culture was 
sheared at 533 rps and samples taken at 0, 2, 5 and 10 minutes. Uncertainties represent the 
standard error, N=3. 
 
Quantity of DNA (µg ml
-1) 
Sample 
2 hours
  3 hours
  5 hours
 
Control  0.48 ± 0.08  0.34 ± 0.03  0.83 ± 0.09 
0 mins  0.54 ± 0.10  0.32 ± 0.05  0.65 ± 0.13 
2 mins  5.87 ± 1.47  3.24 ± 0.63  4.47 ± 0.65 
5 mins  8.48 ± 2.34  4.37 ± 1.10  5.49 ± 0.83 
10 mins  14.5 ± 3.37  5.74 ± 1.17  6.92 ± 1.21 
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Table 5.5 Supernatant DNA quantities per OD600 unit at the point of harvesting. Uncertainties 
represent the standard error, N=3. 
 
M13 infected E. coli supernatant 
µg ml
-1 DNA per OD600 unit 
 
Non-infected E. coli supernatant 
µg ml
-1 DNA per OD600 unit 
MOI 5 x 10
1  MOI 5 x 10
-2  MOI 5 x 10
-5    2 hours  3 hours  5 hours 
0.35 ± 0.02  0.38 ± 0.01  0.60 ± 0.07    0.32 ± 0.05  0.18 ± 0.02  0.30± 0.03 
 
 
The quantity of DNA in all supernatants from infected cultures was confirmed to increase 
strongly with shearing at 533 rps. After 10 minutes there was a 20-fold increase in DNA 
concentration in cultures infected with an MOI 5 x 10
1; a 10-fold increase in cultures infected 
with an MOI of 5 x 10
-2; and a 5-fold increase in cultures infected with a MOI of 5 x 10
-5 (Table 
5.3). Therefore, while the absolute DNA concentrations were not significantly different after 10 
minutes shearing between all three MOIs (P>0.05, Tukey), the relative increases in DNA were 
dependent on the MOI. The data also showed that the greatest factor increase in DNA 
concentration was within the first two minutes of shearing. Between two and six minutes 
exposure time, the factor increase in DNA concentration in all three MOIs was only in the range 
1.4- 1.6. 
 
Similarly, the quantity of DNA in all non-infected culture supernatants was confirmed to 
increase strongly with shearing at 533 rps. After 10 minutes there was a 30-fold increase in 
DNA concentration in cultures harvested at 2 hours; a 17-fold increase in cultures harvested at 3 
hours; and an 8-fold increase in cultures harvested at 5 hours (Table 5.4). Therefore, the relative 
increases in DNA were dependent on the harvest time. Again, the data also shows that the 
greatest factor increase in DNA concentration was within the first two minutes of shearing. 
 
 
5.3.5  Relationship between cell viability and supernatant contamination  
It may have been expected that upon exposure to 533 rps within the shear device, the absolute 
number of E. coli cells losing viability over 10 minutes would have correlated with the increase 
in DNA in the supernatant over the same time period (Figure 5.13). However this was not the 
case. Regression analysis confirmed that the linear relationship was not significantly different 
from zero (R
2=0.18, P=0.42). Where the enumerated quantity of viable cells after 10 minutes of 
shear was greater than the control value, the quantity of cells "losing viability" was therefore 
calculated as a negative value.   162 
 
Figure 5.13 Quantity of E. coli Top10F' cells losing viability after 10 minutes at disk speed 533 
rps (!) as a function of increased supernatant DNA concentration. The R
2 value for the linear 
trend was 0.18. Error bars represent the standard error, N=3. 
 
 
5.4  Discussion 
The primary aim of this chapter was to identify the response of E. coli culture to turbulent shear 
forces and to investigate the effect of bacteriophage M13 infection. Specifically, the initial 
multiplicity of infection (MOI) of infected cultures was explored to determine if there were 
consequences for remaining cell viability and supernatant DNA levels. If so, it needed to be 
assessed whether this would alter the choice of MOI. 
 
5.4.1  The effect of shear on E. coli cell viability 
Both infected and non-infected E. coli cultures were exposed to shear at 533 rps for 10 minutes. 
In Chapter 3 (Section 3.3.3) 533 rps was modelled to impart a maximum energy dissipation rate 
of 3.1 x 10
5 W kg
-1. Furthermore, this rotation speed has been predicted in the literature to 
mimic the high shear conditions within the feed-zone of a production scale multichamber bowl 
centrifuge, the most damaging from a selection of designs studied (Boychyn et al., 2004). It was 
therefore chosen as a "worst case" scenario. For M13 infected cells the viability drops were 
independent of the MOI, and therefore culture age and culture optical density (OD600) (Figure   163 
5.4). However, for non-infected cells, the viability drops in the older cultures (3 and 5 hours) 
were significantly less than for the 2 hour culture (Figure 5.5). These trends may be explained 
as an interaction of two effects. Firstly, cell damage occurs once a threshold shear stress is 
breached (Lange et al., 2001), and evidence suggests that the cell membrane damage caused by 
M13 infection will reduce this threshold (Chen et al., 2009). This would explain the generally 
greater susceptibility of infected cells to shear. Secondly, it is important to note that the non-
infected cultures were in different stages of growth when subject to shear, unlike M13 infected 
cultures. All M13 infected cultures were in early stationary phase at the time of shearing, which 
correlated with the end of M13 production (and therefore harvesting) (Figure 5.1). However, for 
non-infected cultures, after two and three hours growth cells were still undergoing active cell 
division, since the OD600 value continued to increase up to 5 hours growth (Table 5.2). 
Furthermore, in Chapter 4 (Section 4.5.1), Top10F' culture in NB2 at the 2 L bioreactor scale 
(with the same 10 % (v/v) inoculum size as used in this study) had reached stationary phase by 
5 hours. This is important, since the physiological state of E. coli cells changes as growth 
progresses, particularly once cells reach stationary phase (Diaz-Acosta et al., 2006). Here, cells 
exhibit a distinct rounded morphology of reduced volume (Lange and Hengge-Aronis, 1991; 
Loewen and Hengge-Aronis, 1994), and a generalised resistance to extremes of temperatures, 
sodium chloride and oxidizing agents such as hydrogen peroxide (Kolter et al., 1993). It is 
possible that these effects contributed towards the greater shear-resistance observed in the non-
infected E. coli cultures harvested at the later times in this study. Since all M13 infected cultures 
were in stationary phase upon exposure to shear, this could explain why such an effect would 
not cause a differentiation between them. 
 
5.4.2  The effects of MOI and shear on supernatant DNA concentration 
The level of contaminating DNA in the non-sheared culture supernatant was found to decrease 
with increased MOI (Table 5.3). This pattern was consistent with the trends outlined in Chapter 
4, where the levels of DNA and protein contamination in the culture supernatant were found to 
increase concomitantly with E. coli growth. There is a trade-off: increased MOI results in a 
shorter fermentation time (and a less contaminated supernatant), but at the cost of needing a 
larger bacteriophage inoculum for no overall gain in yield. When normalised on a per OD600 
unit basis, it was also confirmed that the level of supernatant DNA was lower in non-infected 
cultures of equivalent age to infected cultures (Table 5.5). 
 
However, it was subsequently demonstrated that the level of supernatant DNA in all cultures 
increased sharply upon exposure to shear (Table 5.3, Table 5.4). After a 10 minute exposure 
time, the quantities of DNA in infected culture supernatants were no longer significantly 
different from one another. Therefore, MOI did not affect the overall quantity of supernatant 
DNA. For non-infected cells, cultures harvested after 2 hours growth released double the   164 
quantity of DNA after 10 minutes of shear, relative to the 3 hour and 5 hour cultures. This result 
mirrored the viability data: the 2 hour culture experienced the greatest proportional decrease in 
viability. 
 
In downstream processing the exposure time to the highest-energy dissipation conditions (for 
example, within continuous centrifuge designs) is of the order of a fraction of a second, not 10 
minutes (Byrne et al., 2002). Nevertheless, if the threshold shear stress resistance is exceeded, 
E. coli breakage can occur within such timeframes (Chan et al., 2006; Lange et al., 2001). The 
potential for an increase in contaminating supernatant chromosomal DNA therefore remains. 
Verification studies would need to be conducted to confirm this prediction for large-scale 
processing. From a bioprocessing perspective, the extra release of chromosomal DNA is 
generally undesirable, since it is known to be particularly susceptible to scission by the action of 
shear. This trend was observed in Figure 5.7- Figure 5.12, where the supernatant chromosomal 
DNA was noted to be reduced from >20 kbp to a 1 to 6 kbp smear. Particularly for plasmid 
DNA processing, fragmentation makes the removal of the chemically identical chromosomal 
DNA significantly more difficult, depending on the choice of downstream unit operation 
(Meacle et al., 2004). In bacteriophage downstream processing, however, since bacteriophage 
product and DNA contaminant are chemically and physically different, several purification 
options are available, as discussed in the Introduction to this thesis (Section 1.6.2.).  
 
It was not possible to accurately model the release of DNA into the supernatant as a function of 
shearing time since the majority of the DNA was generally released by the first two minute 
sample point. Similar degradation profiles have been reported for other biological materials 
subject to high shear conditions, where an initial high rate of damage occurs to a point beyond 
which little further loss is observed (Oliva et al., 2003; Thomas et al., 1979). However, putting 
this into perspective, even after a full 10 minutes of shearing at 533 rps, the quantity of 
supernatant DNA was relatively low (at an average of approximately 7 µg ml
-1). Revisiting an 
estimation for the quantity of chromosomal DNA in a single E. coli cell (Chapter 4, Section 
4.6), lysis of a typical 2 x 10
9 cfu ml
-1 culture would release approximately 40 µg ml
-1 of 
chromosomal DNA. Such a scenario could be expected at the end of lytic bacteriophage culture. 
 
5.4.3  Relationship between cell viability and supernatant contamination 
The overall lack of correlation between the quantity of cells losing viability and the increase in 
supernatant DNA concentration (Figure 5.13) indicates that, in practical terms, measurement of 
the loss of viability was a poor indicator of contaminant release. Firstly, this may have been 
because viability loss did not necessarily result in lysis. Secondly, this pattern may be explained 
by the strain used in this study, Top10F, being recA
-. As noted in Chapter 4, in recA
- E. coli 
culture, cells which actively grow and divide (and are therefore countable on an agar plate)   165 
typically represent only a 49 % fraction of the total population (Capaldo et al., 1974). It was 
also noted in Chapter 4 that M13 infection further reduced the cell count per OD600 unit. 
Therefore, large subpopulations of residually and non-diving cells existed to contribute towards 
the quantity of supernatant DNA measured. It is likely that these subpopulations behaved 
differently upon high shear exposure than viable cells (for example, by having a lower breakage 
threshold), or were susceptible to smaller differences in culture conditions (e.g. culture cell 
density) that did not affect cell viability (Figure 5.6). Such effects could mask a viability 
loss/DNA release relationship. 
 
5.4.4  Concluding remarks 
This chapter goes some way towards understanding the effect of shear upon E. coli culture. 
M13 infection reduced the resistance of E. coli to shear forces after five hours of growth: it 
therefore appears that cell integrity is marginally compromised by bacteriophage infection. 
Exposure to high shear conditions increased the concentration of supernatant DNA in culture, 
although this correlated poorly with cell viability losses. This was thought to be due to 
contributions from large subpopulations of residually and non-dividing cells. Post-exposure to 
10 minutes of high shear conditions, it was found that there was no correlation between MOI 
and the concentration of supernatant DNA. Therefore, from a practical perspective, the data 
obtained does not alter the main trade-off identified. That is, increasing the MOI decreases the 
fermentation time, but at the cost of a larger bacteriophage inoculum. This work suggests that 
cell removal by centrifugation could result in a supernatant DNA concentration significantly 
higher than the quantity recorded by the end of fermentation, although further experimentation 
would be needed to confirm this at scale. However, several straightforward options exist to 
separate DNA contamination from bacteriophage, from treatment with DNAse to precipitation 
and chromatography steps. In particular, it will be shown in the next chapter that DNA and 
bacteriophage M13 can be separated by precipitation. 
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6  The Primary Purification of Bacteriophage M13 
6.1  Introduction 
In the Introduction to this thesis, an outline of the steps for bacteriophage M13 processing was 
given (Section 1.6). The subsequent chapters have addressed aspects of this process. Essentially, 
once fermentation is complete (studied in Chapter 4), the resulting process fluid will contain 
bacteriophage M13 of concentration 10
11 to 10
12 pfu ml
-1, intact E. coli cells, cell debris and 
medium components. A clarification step (often centrifugation) is then required to remove host 
cells and debris from the process stream. The effect of the hydrodynamic shear conditions 
imparted by large-scale equipment such as continuous centrifuges was addressed in Chapter 3 
(for bacteriophage M13) and Chapter 5 (for E. coli). The next stage is typically a concentration 
step, reducing the volume of the process stream and making further downstream process stages 
more manageable. This is the primary purification stage, and forms the focus of this study. 
More than one competitive option exists at the large-scale (Chapter 1, Section 1.6.2), but this 
chapter shall focus on precipitation as a method for the primary purification of bacteriophage 
M13. 
 
In processing terms, bacteriophage M13 can be considered as a large (16 MDa) protein in 
solution, since the surface of the bacteriophage is protein coat. The precipitation characteristics 
of proteins are dependent on several factors including temperature; pH; precipitant type and 
concentration; precipitation time; and protein charge, size, shape and concentration (Wenzig et 
al., 1993). Therefore it is important to not only carefully control the factors being examined, but 
also those needing to be held constant. 
 
At the laboratory-scale, the precipitation of bacteriophage from solution is typically achieved by 
2- 10 % (w/v) polyethylene glycol (PEG) and up to 500 mM sodium chloride (Vajda, 1978; 
Yamamoto et al., 1970). Indeed, PEG-salt precipitation was used in this thesis to prepare 
working stocks of bacteriophage M13 (Section 2.3.3), although it was unknown whether the 
concentrations used were optimal. Therefore, the first aim of this chapter was to investigate the 
PEG precipitation characteristics of bacteriophage M13 in detail. Initial studies were conducted 
in systems containing only purified bacteriophage M13, to allow for the effect of each 
individual precipitation component to be assessed. 
 
However, many other precipitation techniques are available for the precipitation of protein, 
which exploit several underlying principles. The second aim of this study was to therefore 
identify other effective precipitants of bacteriophage M13. Isoelectric precipitation was first 
investigated, based on the method of Bachrach and Friedmann (1971) for several T-odd and T-
even type bacteriophage. Five further precipitants (CTAB, manganese sulphate, calcium   167 
chloride, spermidine and ammonium sulphate) were also studied in a qualitative screening 
experiment, of which effective precipitants were taken forward for further analysis. 
 
In reality, bacteriophage M13 will be precipitated from clarified process fluid. The third aim of 
this study was to examine the ability of candidate precipitants to precipitate bacteriophage M13 
from a broth system. Effective precipitants from this screening experiment were subsequently 
analysed in detail. An early primary purification step that achieves substantial concentration and 
purification simultaneously can reduce the overall cost of the bioprocess (Tsoka et al., 2000) 
either by reducing the number of processing stages required (Wenzig et al., 1993) or lessening 
the burden on subsequent chromatography stages (Thommes and Etzel, 2007). Therefore, the 
final aim of this chapter was to identify the precipitants that offered the greatest improvement in 
bacteriophage M13 purity. 
 
 
6.2  PEG Precipitation of Bacteriophage M13 
6.2.1  Introduction to PEG Precipitation 
PEG is a well known protein precipitation agent (Atha and Ingham, 1981; Sharma and Kalonia, 
2004; Vajda, 1978; Yamamoto et al., 1970). From an industrial perspective, its advantages 
include effecting protein precipitation without denaturation and requiring relatively small 
quantities to do so (generally 5- 20 % (w/v)). Experimental evidence of the action of PEG 
points to a volume exclusion mechanism: that is, proteins are sterically excluded from the 
regions of solvent that are occupied by the PEG chains (Atha and Ingham, 1981). Proteins are 
consequently concentrated and finally precipitated when their solubility is exceeded. However, 
the mechanism of precipitation must also include an electrostatic component, since the quantity 
of PEG required to precipitate a protein is affected by the system pH and ionic strength 
(Mahadevan and Hall, 1990; 1992). Protein-protein repulsion can be reduced by more 
favourable pH or ionic strength conditions, thereby making PEG precipitation occur more 
readily. Overall, PEG precipitation is poorly understood on the fundamental level (Ingham, 
1990) thus hampering efforts to fully explain or predict precipitation behaviour. Partial 
explanations of the theory of PEG precipitation are numerous, however, and are generally based 
on the volume exclusion mechanism (Atha and Ingham, 1981; Mahadevan and Hall, 1990; 
Shulgin and Ruckenstein, 2006). 
 
As noted in Section 6.1, the precipitation of bacteriophage by PEG and salt is itself a 
longstanding and common technique. Since larger proteins tend to precipitate at lower PEG 
concentrations (Atha and Ingham, 1981), bacteriophage precipitation typically requires the 
addition of only up to 10 % (w/v) PEG, usually of average molecular weight 6 or 8 000. Several   168 
hundred millimolars of salt, usually sodium chloride (NaCl), is also added to the bacteriophage 
solution (Vajda, 1978; Yamamoto et al., 1970). 
 
In this thesis, working stocks of bacteriophage M13 were produced using PEG and NaCl for the 
primary purification of M13 from clarified NB2 (Section 2.3.3). Precipitation was performed 
using a final concentration of 3.33 % (w/v) PEG 6 000, 330 mM NaCl, and incubated on ice for 
1 hour without pH monitoring (Bahri, 1990). The precipitant concentrations and conditions 
were not optimised. Therefore, the starting point of this study was to assess the recovery of M13 
by this method and to scale-down to a system containing only purified bacteriophage for 
detailed investigation. 
 
6.2.2  Method development: calculation of bacteriophage M13 recoveries and scale-
down of precipitation 
Bacteriophage M13 was propagated at the two-litre shakeflask scale and precipitated from NB2 
as described in Section 2.3.3. Samples (50 µl) were taken from each processing stage: culture, 
supernatant (E. coli cells removed), resuspended bacteriophage precipitate and post-
precipitation supernatant (bacteriophage M13 removed). Each sample was titred for 
bacteriophage by the surface droplet method (Section 2.5.2). The experiment was repeated three 
times.  
 
The concentration of bacteriophage M13 in both culture and culture supernatant was 3.5 x 10
11 
pfu ml
-1: as expected, no bacteriophage losses arose from E. coli removal. It was then checked 
whether bacteriophage losses had occurred by precipitation. A bacteriophage concentration of 4 
x 10
11 pfu ml
-1 was recovered post-precipitation (and resuspended in the same volume), which 
was not significantly different to the concentration in culture supernatant (P=0.43, t-test). It was 
therefore assumed for future experimentation that PEG precipitation did not result in 
bacteriophage losses. Bacteriophage M13 separation into precipitate and supernatant was 
subsequently expressed as a percentage of the total recovered bacteriophage (Table 6.1), a 
standard method used in the literature (Yamamoto et al., 1970). It was found that the employed 
precipitation step was efficient: 98 % of recovered bacteriophage were in the precipitate. 
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Table 6.1 The PEG-salt precipitation of bacteriophage M13 from NB2, using 3.3 % (w/v) PEG 
6 000, 330 mM NaCl. Recoveries are expressed as a percentage of the total. Uncertainties 
represent the standard error, N=3. 
 
  Condition 
  Bacteriophage precipitate  Precipitation supernatant 
Recovered 
bacteriophage (%) 
98.2 ± 0.9   1.8 ± 0.9  
 
 
Precipitation was then scaled down. Since successful, reproducible partitioning of bacteriophage 
T7 at 2 ml and 10 ml scales had been demonstrated (Negrete et al., 2007), precipitation of M13 
was initially trialled at these scales (in 2 ml and 15 ml polypropylene tubes) in duplicate. 
Precipitations were conducted as described in the Materials and Methods (Section 2.14.2) for 10 
ml scale precipitations, and at one-fifth scale for 2 ml precipitations. The concentration of 
purified bacteriophage examined, at about 4 x 10
11 pfu ml
-1, was chosen to represent the typical 
concentration of bacteriophage found in the post-fermentation broth. This variable was then 
held constant throughout this chapter, since it is known that bacteriophage concentration can 
affect precipitation performance (Yamamoto et al., 1970). The adjustment of each stock to pH 7 
with dilute sodium hydroxide (and sulphuric acid) was estimated to only add a maximum of 5 
mM of sodium ions to each precipitation reaction. The precipitation conditions were based upon 
previously reported methods (Yamamoto et al., 1970). As was used in broth, precipitation was 
performed using a final concentration of 3.3 % (w/v) PEG 6 000, 330 mM NaCl.  
 
Early experimentation found that white bacteriophage precipitates were visible post-
centrifugation, observed along the outermost wall of the polypropylene tube. These precipitates 
were unstable at the 2 ml scale; some of the precipitate was noted to come away as supernatants 
were decanted. Better precipitate stability was observed at the 10 ml scale, which was used for 
all further experimentation. Upon enumeration, bacteriophage recovery in the precipitate 
averaged 94 %. All further experimentations proved that successful precipitation resulted in 
recoveries typically in the range 90- 96 % in the precipitate.  
 
Several factors affecting precipitation efficiency were subsequently assessed at the 10 ml scale. 
These were PEG molecular weight (chain length) and concentration; precipitation temperature 
and time; salt type and concentration. Whilst one factor was being varied, all others were kept 
constant. 
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6.2.3  The effect of PEG molecular weight on bacteriophage M13 precipitation 
The degree of polymerisation increases the average molecular weight of PEG. It has been 
shown that using PEG of increased average molecular weight reduces the amount required for 
bacteriophage ! precipitation from broth (Yamamoto et al., 1970). Similarly, all other factors 
being constant, the solubility of lysozyme is reduced as PEG molecular weight is increased 
(Boncina et al., 2008). It was therefore expected that PEG molecular weight would have an 
effect on M13 precipitation. Experiments were conducted as described in the Materials and 
Methods, Section 2.14.2, using purified bacteriophage. PEG of average molecular weight 600, 2 
000, 6 000, 8 000, 12 000 and 20 000 were tested. The concentration of NaCl remained at 330 
mM throughout. The concentration of PEG was altered in 1 % (w/v) increments, reduced to 0.5 
% (w/v) increments in the region of bacteriophage precipitation. Experiments were conducted 
three times in total. 
 
The effect of increasing PEG molecular weight was greatest at the lowest average molecular 
weights (Figure 6.1). That is, a 3.3-fold increase in molecular weight from PEG 600 to PEG 2 
000 reduced the concentration required for total (>90 %) bacteriophage recovery from 10 % 
(w/v) to only 4 % (w/v). In comparison, a 3.3-fold increase in molecular weight from PEG 6 
000 to PEG 20 000 reduced the concentration required for total bacteriophage recovery from 2 
% (w/v) to 1.5 % (w/v). 
 
It was also noted that the amount of PEG 6 000 required to recover >90 % of the bacteriophage 
particles (2 % (w/v)) was substantially less than the non-optimised amount used previously (3.3 
% (w/v)). 
 
 
 
 
   171 
 
 
Figure 6.1 The effect of PEG molecular weight on the concentration required to induce 
precipitation of bacteriophage M13 with 330 mM NaCl. The percentage of recovered 
bacteriophage was calculated from the quantity of bacteriophage recovered in the precipitate as 
a proportion of the total. Symbols: PEG 600 (!), PEG 2 000 (!), PEG 6 000 (#), PEG 8 000 
(#), PEG 12 000 ($) and PEG 20 000 (#). Graph (A) shows all PEG molecular weights. Graph 
(B) shows PEG 2 000 to 20 000 only. Errors bars represent the standard error, N=3. 
 
 
When precipitated by PEG 600, it was noted that the percentage recovery of bacteriophage M13 
in the precipitate appeared consistently lower (2- 5 %) than for higher molecular weights. To 
check that this was not a result of insufficient centrifugal force, eight identical 10 ml 
precipitation reactions were prepared with 11 % (w/v) PEG 600. Following incubation on ice 
for 1 hour, four were centrifuged at 8 000 x g for 10 minutes, and four at 15 000 x g for the   172 
same period. It was found there was no significant difference between the M13 recoveries 
achieved (P=0.15, t-test). The reduced recovery was therefore considered to be either due to an 
inherent inability of PEG 600 to precipitate M13 as completely, or as a result of the precipitate 
being less stable under these conditions when subject to supernatant removal. 
 
6.2.4  Relationship between PEG molecular weight and solution viscosity 
On a quantity basis, it was shown that the effect of PEG molecular weight above 6 000 was 
small (Figure 6.1). However, the viscosity of the solution will rise as molecular weight, and 
therefore chain length, increases (Gonzalez-Tello et al., 1994). To investigate the effect of PEG 
molecular weight in this system, the viscosity of 10 ml precipitation reactions was measured. 
All reactions contained 3.3 % (w/v) PEG and 330 mM NaCl, as well as the purified 
bacteriophage, and were incubated on ice for one hour. The viscosity of each was measured as 
described in the Materials and Methods (Section 2.11) using a cone and plate viscometer. 
Chilled (4 °C) water was circulated around the viscometer chamber to keep the sample cool.  
 
A linear relationship existed between shear stress and shear rate (Figure 6.2). Thus every 
solution was Newtonian and the viscosity (µ, Pa s) could be measured as the gradient of the 
line. The measured viscosity of the water control (µ= 1.0 mPa s) was lower than expected: the 
viscosity of pure water at 4 °C is approximately 1.5 mPa s (Perry et al., 1998). This most likely 
suggested that the temperature of the sample was higher than 4 °C (and therefore less viscous). 
Nevertheless, as the average molecular weight of the PEG increased, the viscosity of the 
solution significantly rose (Figure 6.2). For example, the measured viscosity of the PEG 20 000 
solution was 2.9 mPa s, which was 70 % greater than the viscosity of PEG 6 000 solution of the 
same concentration (1.7 mPa s).  
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Figure 6.2 Viscosity measurement of several solutions of 3.3 % (w/v) PEG, 330 mM NaCl, 4 x 
10
11 pfu ml
-1 bacteriophage M13. A linear relationship existed between shear stress and shear 
rate: every solution was Newtonian in behaviour. Viscosity (!) was therefore calculated from 
the gradient of each line. Symbols: PEG 600 (!), PEG 2 000 (!), PEG 6 000 (#), PEG 8 000 
(#), PEG 12 000 ($) and PEG 20 000 (#). N=2. 
 
 
6.2.5  The effect of PEG and NaCl concentration on bacteriophage M13 precipitation 
In Section 6.2.3, the concentration of NaCl was held at 330 mM while the concentration and 
molecular weight of PEG was altered. However, it was also of interest to determine the 
minimum concentration of NaCl required to induce precipitation at a particular concentration of 
PEG 6 000. The salt concentration (or ionic strength) of solution is known to affect protein 
solubility (Atha and Ingham, 1981; Boncina et al., 2008; Mahadevan and Hall, 1992). 
Therefore, from a processing perspective, investigation of ionic strength gives the option of 
precipitating under high salt/ low % (w/v) PEG or low salt/ high % (w/v) PEG conditions. 
Experiments were again conducted as described in the Materials and Methods, Section 2.14.2. 
The concentration of NaCl was altered in 100 mM increments, reduced to 35 mM increments in 
the region of bacteriophage precipitation. Experiments were conducted three times in total. 
Figure 6.3 shows the relationship between bacteriophage M13 recovery and the concentration of 
NaCl at a range of PEG 6 000 concentrations. It was found that a 1 % (w/v) PEG 6 000 solution 
was not sufficient to precipitate M13 at NaCl concentrations up to 1 M. When precipitation did 
occur, it was observed that a higher percentage PEG solution reduced the minimum required salt 
concentration for bacteriophage precipitation. In the range examined, a 2-fold increase in PEG   174 
concentration (2 % (w/v) to 4 % (w/v)) was found to approximately reduce the concentration of 
NaCl required 2-fold (265 mM to 135 mM). 
 
In this system the addition of 3.3 % (w/v) PEG 6 000 and 330 mM NaCl to precipitate M13 was 
sub-optimal. It can be seen in Figure 6.3 that a PEG 6 000 concentration of 3.3 % (w/v) required 
only 165 mM NaCl for 93 % of precipitated bacteriophage particles to be recovered in the 
precipitate. Alternatively, 330 mM NaCl resulted in the successful precipitation of 
bacteriophage M13 with only 2 % (w/v) PEG 6 000 (Figure 6.1). 
 
Figure 6.3 The recovery of bacteriophage M13 in the precipitate as a function of NaCl 
concentration for five concentrations of PEG 6 000. The percentage of recovered bacteriophage 
was calculated from the quantity of bacteriophage recovered in the precipitate as a proportion of 
the total. Symbols: 1 % (w/v) PEG 6 000 (!), 1.5 % (w/v) PEG 6 000 (!), 2 % (w/v) PEG 6 
000 (#), 3.3 % (w/v) PEG 6 000 (#), 4 % (w/v) PEG 6 000 ($). Errors bars represent the 
standard error, N=3. 
 
 
Similarly to the trend observed in Figure 6.1, it was expected that at a fixed concentration of 
PEG in solution, increasing the average molecular weight would reduce the minimum quantity 
of NaCl required for successful bacteriophage precipitation. This was found to be the case when 
4 % (w/v) concentrations of PEG 2 000, 6 000 and 20 000 were compared (Figure 6.4). Again, 
the relative advantage of a PEG molecular weight significantly greater than 6 000 was small: 
PEG 20 000 reduced the minimum quantity of NaCl over PEG 6 000 by only 35- 70 mM. In   175 
comparison, increasing the PEG molecular weight from 2 000 to 6 000 reduced the required 
concentration of NaCl by at least 130 mM. 
 
 
Figure 6.4 The recovery of bacteriophage M13 in the precipitate as a function of NaCl 
concentration with 4 % (w/v) PEG of molecular weights 2 000 (!), 6 000 (#), and 20 000 (#). 
The percentage of recovered bacteriophage was calculated from the quantity of bacteriophage 
recovered in the precipitate as a proportion of the total. Errors bars represent the standard error, 
N=3. 
 
 
6.2.6  The effect of incubation time and temperature 
After the addition of precipitants to a solution, it is important that sufficient time is allowed for 
the complete precipitation of the bacteriophage particles. The incubation temperature (on ice) 
and time (1 hour) used in this study were derived from existing laboratory protocols for M13 
processing, based upon the methods of Bahri (1990) and Yamamoto et al. (1970). Sambrook et 
al. (2001) proposed similar conditions, albeit employing higher PEG 6 000 (4 % (w/v)) and 
NaCl (500 mM) concentrations, whereas Messing and Vieira (1982) incubated for only 30 
minutes at room temperature (3.6 % (w/v) PEG 6 000, 440 mM NaCl). It is obvious that some 
flexibility of incubation conditions exists. While the exact precipitation time for any protein (or 
bacteriophage) is a function of the many input factors affecting the precipitation reaction, it was 
considered useful to assess the temperature dependence and timescale of the reaction for a set of 
precipitant concentrations.    176 
 
Six 10 ml precipitation reactions were prepared as described in the Materials and Methods 
(Section 2.14.2), except that tubes were pre-cooled on ice for 20 minutes prior to bacteriophage 
addition. Following bacteriophage addition, tubes were re-incubated on ice (3.3 % (w/v) PEG 6 
000 and 330 mM NaCl in each) and one tube was removed and centrifuged for 10 minutes, 8 
000 x g at 4 °C at each of the following times: 0, 12, 24, 36, 48 and 60 minutes. Post 
centrifugation treatment was identical to that described in Section 2.14.2. The experiment was 
repeated for incubation at room temperature (25 °C), where centrifugation was also at 25 °C. 
All experiments were repeated three times. 
 
Data was plotted as the proportional difference in bacteriophage recovery in the precipitate from 
the standard incubation conditions of 1 hour, on ice (Figure 6.5). Only the 0 minute incubation 
on ice was significantly lower than the standard conditions (P=0.009, t-test). No recoveries from 
incubation at room temperature were significantly lower than the 1 hour, on ice standard. 
Indeed, recoveries after 12 and 36 minute incubations were significantly higher (P=0.043 and 
P=0.044 respectively, t-test). 
 
Figure 6.5 The effect of reducing the incubation time from 1 hour for incubations at room 
temperature (!) and on ice ($). Bacteriophage recoveries in the precipitate were plotted as the 
proportional difference from the standard incubation conditions of 1 hour, on ice. Only a 0 
minute incubation on ice gave a bacteriophage recovery that was significantly lower than the 
standard (P=0.009, t-test). Error bars represent the standard error, N=3. 
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6.2.7  The effect of salt type on bacteriophage M13 precipitation  
It was noted in Section 6.2.5 that PEG precipitation was assisted by an increase in solution ionic 
strength. This was achieved experimentally by increasing the concentration of NaCl. However, 
ionic strength is also a function of the charge of the ions in solution. Further, even ions of the 
same charge and concentration can perform differently (Boncina et al., 2008; Collins, 1997).  
 
Therefore, PEG precipitation of bacteriophage M13 was conducted with two additional salts. 
Magnesium sulphate (MgSO4) and sodium sulphate (Na2SO4) were compared with NaCl for 
effectiveness at concentrations of 0, 2, 3.3 and 4 % (w/v) PEG 6 000. Experiments were 
conducted as described in Section 2.14.2. The concentration of each salt was altered in 100 mM 
increments, reduced to 35 mM increments in the region of bacteriophage precipitation. Where 
precipitation was successful at less than 35 mM, 5, 15 and 25 mM intervals were tested. 
Experiments were conducted three times in total. 
 
Significant differences in the solubility of bacteriophage M13 were observed as a result of 
changing salt. At concentrations of 2, 3.3 and 4 % (w/v) PEG 6 000, MgSO4 was found to 
consistently induce precipitation at the lowest salt concentrations (Figure 6.6). At a 
concentration of 4 % (w/v) PEG 6 000, precipitation was induced with 15 mM MgSO4, less than 
one sixth the quantity of the next most efficient salt. Na2SO4 was a more effective precipitant 
than NaCl at higher concentrations of PEG (3.3 and 4 % (w/v), but was marginally less efficient 
at 2 % (w/v) PEG. The precipitation curves at 0 % PEG 6 000 confirmed that precipitation was 
a result of the presence of PEG and salt, not the salt alone. Overall, the reduced solubility of 
bacteriophage M13 in MgSO4, particularly compared to Na2SO4  (both having the same anion), 
clearly indicated the effectiveness of the Mg
2+ ion relative to Na
+. 
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Figure 6.6 The minimum concentrations of magnesium chloride (!), sodium sulphate (!) and 
sodium chloride (#) required to induce precipitation of bacteriophage M13 at (A) 0 % (w/v) 
PEG 6 000, (B) 2 % (w/v) PEG 6 000, (C) 3.3 % (w/v) PEG 6 000 and (D) 4 % (w/v) PEG 6 
000. Error bars represent the standard error, N=3.   179 
6.3  The Isoelectric Precipitation of Bacteriophage M13 
6.3.1  Introduction to isoelectric precipitation 
Proteins usually posses a net positive or negative charge which alters according to the pH of the 
solution. For most proteins there is a pH at which the net charge is neutralised: this is known as 
having reached the isoelectric point. It is here that protein-protein mutual repulsion is reduced to 
a minimum, and therefore precipitation may occur (Atkinson et al., 1987).  Compared to other 
precipitation methods, such as PEG, the chief advantage of isoelectric precipitation is that no 
precipitant is added which will subsequently require removal (Wenzig et al., 1993).  
 
The precipitation of several bacteriophage by isoelectric precipitation has been demonstrated by 
the addition of hydrochloric acid to clarified lysate (Bachrach and Friedmann, 1971), although 
none were filamentous bacteriophage. The recoveries achieved were variable, ranging from nil 
to 53 %. The authors surmised that some bacteriophage were more susceptible to inactivation 
by low pH values: indeed, protein denaturation is the main drawback of this method (Wenzig et 
al., 1993). However, the chosen pH (3.9 for all bacteriophage studied) did not appear to have 
been optimised either. Since limited literature exists on isoelectric bacteriophage precipitation, 
the feasibility of the isoelectric precipitation of bacteriophage M13 was investigated. The 
theoretical isoelectric point of the particle was first calculated to determine the pH region to 
focus on for experimentation (Section 6.3.2, below). 
 
6.3.2  Calculation of the isoelectric point of bacteriophage M13 
Generally, a theoretical estimation of the net charge of a protein must be calculated with 
caution. Despite being a fundamental parameter, the net charge of a protein not only depends on 
the number of ionisable residues, but also the amino acid sequence and the solution ionic 
strength (Winzor, 2003). However, agreement between theory and experimentation has been 
achieved for bacteriophage fd (which is closely related to M13) in low ionic strength conditions 
(Zimmermann et al., 1986). The isoelectric point of bacteriophage M13 was therefore calculated 
by a similar method. Essentially, the charge of the particle was modelled as a function of pH, 
where the number of negatively charged amino acid residues was subtracted from the positive. 
The Henderson-Hasselbalch equation was used to calculate the degree of ionisation of each 
ionisable amino acid (Stryer, 1995). Only the charge of the major coat protein (pVIII) was 
considered, since at 2700 copies per bacteriophage, it is the dominating molecule. Importantly, 
agreement with experimentation was found only when the charges on the exposed, hydrophilic 
outer portion of the pVIII molecule were considered (Zimmermann et al., 1986). Therefore, for 
bacteriophage fd the ionisable residues were (with position from the N-terminal end) the NH2 
terminus, Glu (2), Asp (4), Asp (5), Lys (8), Asp (12) and Glu (20) (Zimmermann et al., 1986). 
Due to a point mutation, the aspartic acid (Asp) residue of bacteriophage fd at position 12 is   180 
asparagine (Asn) for M13 (Model and Russel, 1988). M13 consequently carries approximately 
30 % less charge per particle than fd (Tang et al., 2002). 
 
For clarity, a derivation of the total charge of a protein is included in Appendix A. The total 
charge, Z, of a protein is given by: 
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where j is each of n positively charged residues and i is each of m negatively charged residues. 
At the isoelectric point the total charge is equal to zero. For comparison purposes, the taken pKa 
values of the amino acid residues were those used for the calculation of the charge of 
bacteriophage fd at 25 °C (Zimmermann et al., 1986). For bacteriophage fd the isoelectric point 
was calculated to occur at pH 4.32, for bacteriophage M13, pH 4.50. The estimated value for fd 
was close to an experimental value of 4.2 measured by titration by Zimmerman et al. (1986), 
but greater than the value of 3.9 measured by isoelectric focusing (Berkowitz and Day, 1976). It 
was therefore assumed that the estimated isoelectric point of bacteriophage M13 was broadly 
correct. 
 
6.3.3  Experimental isoelectric precipitation of bacteriophage M13 
The precipitation of purified bacteriophage M13 was conducted at a range of pH values (3.7, 
3.9, 4.1, 4.3, 4.5, 4.7, 4.9 and 7.0) about the theoretical isoelectric point of pH 4.5. Experiments 
were conducted at the 10 ml scale as described in the Materials and Methods (Section 2.14.3), 
using purified bacteriophage M13. Precipitation was conducted at two temperatures: on ice and 
at room temperature. The incubation time (24 hours) and centrifugation speed (equivalent to 30 
minutes at 4 000 x g) were based on the method of Bachrach and Friedmann (1971). 
Bacteriophage precipitates were resuspended in 10 mM Tris (pH 7.5 at 25 °C). Post-
precipitation, in addition to the usual percentage calculation of bacteriophage recovery in the 
precipitate, the recovered bacteriophage were investigated for viability decline from the acidic 
conditions (Section 6.3.4). Any temperature-induced alteration of optimal pH was also of 
interest, since amino acid pKa values (and therefore bacteriophage isoelectric point) show a 
weak dependence on temperature (Stryer, 1995). All experimentation was conducted three 
times. 
 
The recovery of bacteriophage M13 in the precipitate as a function of pH is shown in Figure 
6.7. At the end of incubation, pH values were re-measured immediately prior to centrifugation. 
In this unbuffered system, it was found that pH values had often varied from the initial target.   181 
Therefore, every data point was plotted in Figure 6.7 instead of average recoveries at each target 
pH.  
 
Recoveries of bacteriophage M13 >90 % in the precipitate occurred in range pH 3.9- 4.5 
(Figure 6.7). The incubation temperature made little observable difference to this range. 
Therefore it may be assumed that the isoelectric point of the bacteriophage did not vary with 
temperature (Zimmermann et al., 1986). Bacteriophage recovery in the precipitate decreased to 
below 50 % at pH values below 3.9 and decreased to less than 10 % by pH 5.0 and above. 
Experimental reproducibility diminished at the limits of successful precipitation, particularly at 
pH 4.5 and above. This was most likely due to the critical dependence on pH at these borderline 
conditions. 
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Figure 6.7 The recovery of bacteriophage M13 in the precipitate as a function of pH. (A) 
Incubation on ice for 24 hours (%). (B) Incubation at room temperature for 24 hours 
(&)."Recovered Bacteriophage (%)" refers to the quantity of bacteriophage in the precipitate as 
a proportion of the total recovered from the precipitate and supernatant fractions. Each data 
point represents an individual recovery, not an average of three recoveries. The experiment was 
conducted three times.    183 
 
6.3.4  Assessment of bacteriophage degradation from acidic conditions 
The total quantity of bacteriophage recovered (i.e. a summation of precipitate and supernatant 
counts) was calculated for each data point to allow for an assessment of bacteriophage 
degradation from the acidic conditions. The recoveries in the target pH ranges 3.7- 4.1, 4.1- 4.5 
and 4.5- 4.9 were compared with the pooled recoveries at pH 7 for the experiments conducted 
on ice and at room temperature. 
 
Table 6.2 shows that when incubated on ice for 24 hours the average bacteriophage titres at pH 
7 and at pHs in the ranges 3.7- 4.1, 4.1- 4.5 and 4.5- 4.9 were not significantly different. When 
incubation was conducted at room temperature for 24 hours, the average bacteriophage titres at 
pH 7 and at pHs in the range 4.5- 4.9 were not significantly different, but were between titres at 
pH 7 and at pHs in the ranges 3.7- 4.1 and 4.1- 4.5. The data therefore suggest that conducting 
the experiment at a lower temperature may reduce the drop in titre. The "loss" of bacteriophage 
may be due to degradation by the acidic conditions, or perhaps aggregation, but since 
precipitation occurred on ice and viability losses were not significant it suggests that viability 
losses at room temperature were due to bacteriophage degradation.  
 
 
Table 6.2 Total bacteriophage M13 recoveries (precipitate plus supernatant) expressed as pfu, 
post-isoelectric precipitation. Recoveries were averaged within the pH ranges of 3.7- 4.1, 4.1- 
4.5 and 4.5- 4.9, and compared with the average recovery at pH 7. Statistical tests (t-test) were 
conducted on log10-transformed data. Uncertainties represent the standard error. 
  pH condition 
  pH 3.7- 4.1  pH 4.1- 4.5  pH 4.5- 4.9    pH 7 
Average titre after 
incubation on ice (pfu) 
3.23 x 10
12 ± 
7.8 x 10
11 
3.88 x 10
12 ± 
8.4 x 10
11 
4.29 x 10
12 ± 
7.1 x 10
11 
  4.34 x 10
12 ± 
6.2 x 10
11 
P value (t-test)  0.10  0.44  0.88    - 
           
Average titre after 
incubation at room 
temperature (pfu) 
2.5 x 10
12  
± 3.6 x 10
11 
3.16 x 10
12 ± 
5.5 x 10
11 
3.42 x 10
12 ± 
6.8 x 10
11 
 
4.34 x 10
12 ± 
6.2 x 10
11 
P value (t-test)  0.002  0.04  0.12    - 
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6.3.5  Reduction of the isoelectric precipitation incubation time 
Since isoelectric precipitation of bacteriophage M13 was found to be possible, it was considered 
that the next appropriate step was to deviate from the conditions outlined by Bachrach and 
Friedmann (1971). In particular, the 24 hour incubation time was considered impractical. It was 
therefore investigated whether the incubation time could be reduced to zero, one or two hours 
without a reduction in bacteriophage recovery. The experiment was conducted as described in 
the Materials and Methods (Section 2.14.3). As a result of the data collected in Section 6.3.3, all 
precipitations were conducted at pH 4.3 and incubated on ice. 
 
It was found that a 24 hour incubation time was unnecessary: an average 96.7 % of 
bacteriophage M13 were recovered in the precipitate even after no incubation on ice (Figure 
6.8), increasing to 99.0 % after 1 hour. It was decided that one hour's incubation on ice would 
be prudent since the exact starting point of precipitation was subject to variation of several 
seconds depending on the speed of titration to pH 4.3. This variation may be reflected in the 
larger standard error of the zero hour incubation time relative to the 1 hour, 2 hour and 24 hour 
incubations (Figure 6.8). 
 
 
Figure 6.8 The percentage recovery of bacteriophage M13 in the precipitate as a function of 
incubation time on ice at pH 4.3 and pH 7. The percentage of recovered bacteriophage was 
calculated from the quantity of bacteriophage recovered in the precipitate as a proportion of the 
total. Errors bars represent the standard error, N=3.   185 
6.4  Screening Experimentation of Several Precipitants 
6.4.1  Introduction 
Five further precipitants were investigated for the ability to precipitate bacteriophage M13 in a 
qualitative screening experiment. It was recognised in the previous work (Sections 6.2 and 6.3) 
that successful precipitation resulted in obvious white precipitates of bacteriophage at the tube 
wall after centrifugation. Using this knowledge to aid the speed of screening in this experiment, 
precipitation was solely judged on the appearance of the white bacteriophage precipitate. 
Precipitants CTAB, manganese sulphate, calcium chloride, spermidine and ammonium sulphate 
were selected for their diversity of action.  
 
6.4.2  Reasoning for precipitant selection 
The cationic precipitant CTAB has been demonstrated to selectively precipitate plasmid DNA 
from RNA, protein and LPS in clarified lysate (Lander et al., 2001; Lander et al., 2002; 
Tomanee et al., 2004) at a concentration of less than 1 % (w/v). The dependence of protein 
solubility on CTAB concentration in clarified alkaline lysate has also been demonstrated 
(Tomanee et al., 2004). The logic in investigating CTAB was that like DNA, bacteriophage 
M13 is a large biological polyanion which may therefore be readily precipitated.  
 
The divalent cations Mn
2+ (as manganese sulphate) and Ca
2+ (as calcium chloride) have been 
shown to precipitate bacteriophage fd and M13 in a low ionic strength system (Tang et al., 
2002). In particular, bacteriophage M13 was shown to aggregate at concentrations as low as 15 
mM (Mn
2+) and 60 mM (Ca
2+) and displayed resolubilisation as the concentration of calcium 
ions increased. Since these chemicals may afford effective low-cost bacteriophage precipitation, 
it was considered important to include them in this study.  
 
Similarly to CTAB, the polycation spermidine has been demonstrated to selectively precipitate 
DNA from smaller oligonucleotides (Murphy et al., 1999; Pelta et al., 1996) at very low 
concentrations, typically of the order 1 mM in a low ionic strength system. However, in 
common with divalent cations, the action of spermidine is very sensitive to the concentration of 
monovalent cations, such as Na
+. It is thought that the monovalent cations reduce the bundling 
efficiency by a competitive mechanism (Murphy et al., 1999; Tang et al., 2002). The extent of 
this sensitivity was explored since the process fluid will contain several tens of millimoles of 
monovalent salts (such as sodium chloride). 
 
Finally, the precipitation of bacteriophage M13 by 50 % (w/v) ammonium sulphate was 
assessed, based on the method of Rossomando and Zinder (1968). Although precipitation by 
inorganic salts lacks selectivity, ammonium sulphate precipitation was included for comparison 
because it has been employed on the large scale for many years (Atkinson et al., 1987).   186 
 
6.4.3  Experimentation 
Screening experiments were conducted at the 1 ml scale, as described in the Materials and 
Methods (Section 2.14.1). The precipitation reactions were incubated for 15 minutes at room 
temperature, the most conservative conditions found in the literature (Pelta et al., 1996). The 
exception was ammonium sulphate precipitation, which required a 24 hour incubation at room 
temperature (Rossomando and Zinder, 1968). Centrifugation speeds and times also varied 
between methods, so 10 minutes at 8 000 x g was chosen, which reflected the PEG precipitation 
conditions. The ranges of precipitant concentrations examined were based upon the existing 
literature (cited above). To investigate the effect of monovalent cations upon polyvalent cation 
precipitation, calcium chloride precipitation was conducted at 0, 50 and 100 mM NaCl, and 
spermidine precipitation was conducted at 0, 25 and 50 mM NaCl. All experiments were 
conducted twice. 
 
6.4.4  Results 
It was observed that, as expected, successful precipitation resulted in a white bacteriophage 
precipitate after centrifugation (first noted in Section 6.2.2). Again, the exception was 
ammonium sulphate precipitation where the bacteriophage formed a white float on the liquid 
surface. The measurement of pH of the reactions at the extremes of precipitant concentration 
showed that the pH remained between 6 and 7 in all cases, except for CTAB where the pH was 
5.5 at 10 % (w/v). Successful precipitation was not observed from the addition of CTAB in the 
range 0.2- 10 % (w/v) (Table 6.3).  
 
 
Table 6.3 Precipitation of bacteriophage M13 by CTAB of concentration 0- 10 % (w/v). 
Symbols: white bacteriophage precipitate observed (%), no precipitate observed (').  
 
  Concentration of CTAB, % (w/v) 
  0  0.2  0.4  0.6  0.8  1.0  2.0  4.0  6.0  8.0  10 
M13 precipitate?  '  '  '  '  '  '  '  '  '  '  ' 
 
 
Precipitation was observed from a concentration of 40 mM Mn
2+ (Table 6.4) and 50 mM Ca
2+ 
(Table 6.5). These values were similar to that reported by Tang et al. (2002) for Ca
2+ ions, but 
was somewhat higher than the 15 mM reported for Mn
2+.  
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In low ionic strength conditions, spermidine was an effective precipitant of bacteriophage M13: 
precipitation was induced by 1.5 mM (Table 6.6). However, precipitation by both spermidine 
and Ca
2+ ions was strongly dependent on the monovalent cation concentration (Table 6.5 and 
Table 6.6). The minimum concentration of Ca
2+ ions to induce precipitation increased to 80 mM 
with the addition of 50 mM NaCl, and was prevented by the addition of 100 mM NaCl. 
Spermidine proved even more susceptible to Na
+ ions since precipitation was prevented by only 
50 mM NaCl.  
 
 
Table 6.4 Precipitation of bacteriophage M13 by Mn
2+ ions of concentration 0- 50 mM. 
Symbols: white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of Mn
2+ (mM) 
  0  15  20  30  40  50 
M13 precipitate?  '  '  '  '  %  % 
 
 
Table 6.5 Precipitation of bacteriophage M13 by Ca
2+ions of concentration 0- 20 mM (0 or 50 
mM NaCl present) and 0- 800 mM (100 mM NaCl present). Symbols: white bacteriophage 
precipitate observed (%), no precipitate observed ('). 
 
  Concentration of Ca
2+ (mM) 
  0  20  40  50  60  80  100  120 
0 mM NaCl  
M13 precipitate? 
'   '  '  %  %  %  %  % 
50 mM NaCl  
M13 precipitate? 
'  '  '  '  %  %  %  % 
                 
  Concentration of Ca
2+ (mM) 
  0  50  100  200  300  400  600  800 
100 mM NaCl  
M13 precipitate? 
'  '  '  '  '  '  '  ' 
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Table 6.6 Precipitation of bacteriophage M13 by spermidine of concentration 0- 4 mM (0 mM 
NaCl present) and 0- 50 mM (25 or 50 mM NaCl present). Symbols: white bacteriophage 
precipitate observed (%), no precipitate observed ('). 
 
 
 
 
Precipitation of bacteriophage M13 by the traditional "salting out" method occurred at 
concentrations above 40 % (w/v) ammonium sulphate (Table 6.7). The resulting bacteriophage 
"float" on the liquid surface could be removed by filtration (Rossmando and Zinder 1968). 
 
 
Table 6.7 Precipitation of bacteriophage M13 by ammonium sulphate of concentration 0- 50 % 
(w/v). Symbols: white bacteriophage float observed (%), no precipitation observed ('). 
 
 
Concentration of 
ammonium sulphate (%, w/v) 
  0  15  20  30  40  50 
M13 precipitate?  '  '  '  '  %  % 
 
 
6.5  Divalent and Polyvalent Cation Precipitation of Bacteriophage M13 
Of the five methods tested in Section 6.4, spermidine and Ca
2+ ion precipitations were taken 
forward for investigation at the 10 ml scale and titred for bacteriophage recovery. It was 
considered that these offered the greatest potential benefits in terms of cost (little is needed for 
precipitation), biocompatibility (less likely to denature protein) and potential selectivity 
  Concentration of spermidine (mM)   
  0  1  1.5  2  3  4   
0 mM NaCl 
M13 precipitate? 
'  '  %  %  %  %   
               
  Concentration of spermidine (mM)   
Spermidine mM  0  4  10  20  30  40  50 
25 mM NaCl 
M13 precipitate? 
'  '  '  %  %  %  % 
50 mM NaCl 
M13 precipitate? 
'  '  '  '  '  '  '   189 
(demonstrated in the literature). Precipitation experiments were conducted as described in the 
Materials and Methods (Section 2.14.4), and were repeated three times. Spermidine and Ca
2+ 
ions were examined under low ionic strength conditions and at the NaCl concentrations found in 
Section 6.4 to prevent the formation of visible bacteriophage precipitates. The concentration 
ranges were increased beyond those examined in Section 6.4 to observe the resolubilisation 
phenomenon reported elsewhere for Ca
2+ ions (Tang et al., 2002) and spermidine (Pelta et al., 
1996). If carefully controlled, such a phenomenon could be exploited to assist bacteriophage 
purification. 
 
Post-centrifugation, it was confirmed that the visibility of a white precipitate in Ca
2+ and 
spermidine precipitations in Section 6.4 correlated with a  >70 % recovery of bacteriophage in 
the precipitate (Figure 6.9 and Figure 6.10). In Ca
2+ ion precipitations (Figure 6.9) with 0 mM 
NaCl present, bacteriophage recovery above 94 % in the precipitate was observed in the range 
60- 100 mM Ca
2+, but dropped in the range 100- 200 mM to 73 %. Precipitation was prevented 
once the concentration of Ca
2+ ions exceeded 300 mM. No precipitation of bacteriophage 
occurred in the presence of 100 mM NaCl up to a concentration of 400 mM Ca
2+ ions.  
 
 
Figure 6.9 The recovery of bacteriophage M13 in the precipitate as a function of Ca
2+ ion 
concentration at 0 mM (%) and 100 mM (!) NaCl. The percentage of recovered bacteriophage 
was calculated from the quantity of bacteriophage recovered in the precipitate as a proportion of 
the total. When no NaCl was present, it can be seen that >90 % recovery of bacteriophage M13 
in the precipitate was achieved between Ca
2+ ion concentrations of 60 mM and 100 mM. Errors 
bars represent the standard error, N=3.   190 
For spermidine precipitation in the absence of NaCl, bacteriophage recovery above 95 % in the 
precipitate was observed above a spermidine concentration of 1.5 mM (Figure 6.10). No failure 
to precipitate was observed at the higher spermidine concentrations tested in this experiment. 
However, a resolubilisation phenomenon may still be possible at concentrations of spermidine 
greater than those tested here. No precipitation of bacteriophage occurred in the presence of 50 
mM NaCl up to a concentration of 50 mM spermidine. 
 
 
Figure 6.10 The recovery of bacteriophage M13 in the precipitate as a function of spermidine 
concentration at 0 mM (") and 50 mM (#) NaCl. The percentage of recovered bacteriophage 
was calculated from the quantity of bacteriophage recovered in the precipitate as a proportion of 
the total. Error bars represent the standard error, N=3. 
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6.6  Precipitation of Bacteriophage M13 from Broth 
6.6.1  Determination of the major NB2 ion components 
In reality, bacteriophage M13 will be precipitated out of a culture medium. Since the 
components present will depend on the media used, precipitant performance needs to be 
examined prior to use in a new medium. Of particular importance will be the ion concentration. 
The medium used in this study was NB2 (see Section 2.1.6). Chemical analysis of NB2 shows it 
should contain approximately 92 mM of NaCl at 1x concentration (data supplied by the 
manufacturer), which suggests that it will alter precipitation behaviour. This value was 
confirmed experimentally by the testing of three 1 ml samples of sterile unused NB2 in a Nova 
BioProfile 400 chemical analysis device (Table 6.8). For comparison, three 1 ml samples of 
used NB2 were also tested (three 50 ml M13 infected E. coli Top10F' cultures grown for 5 
hours, cells pelleted at 13 000 x g for 3 minutes. See Chapter 4, Section 4.2.2). It can be seen 
that in addition to the 95 mM of Na
+ ions in fresh NB2, several millimolars of ammonium 
(NH4
+) and potassium (K
+) ions were present, both of which are monovalent cations and 
therefore may also affect precipitation behaviour. It can also be seen that ion levels were 
broadly unchanged by culture growth. 
 
 
Table 6.8 Chemical analysis of fresh and used NB2 by Nova BioProfile 400. Figures are an 
average of three readings. In addition to these components the BioProfile also outputs readings 
for glucose and lactose, neither of which were detected. 
 
 
Concentration in 
broth (mM) 
 
 
Component  Fresh sterile NB2  Post culture NB2  P value (t-test) 
Glutamine  0.61  0.22  5.5 x 10
-6 
Glutamic acid  2.05  1.5  7.7 x 10
-5 
NH4
+  1.42  5.45  1.3 x 10
-7 
Na
+  95  97  0.24 
K
+  4.9  5.0  0.25 
 
 
6.6.2  Screening experimentation of precipitants in broth 
Seven precipitants were tested for their ability to precipitate bacteriophage M13 from clarified 
culture medium in a qualitative screening experiment at the 10 ml scale (Materials and Methods, 
Section 2.14.5). These were: 2 % (w/v) PEG 6 000 with MgSO4 or NaCl; 4 % (w/v) PEG 6 000 
with MgSO4 or NaCl; isoelectric precipitation (pH 4.3); spermidine; Ca
2+ ions. The PEG   192 
concentrations were selected to represent the higher PEG/ low salt and lower PEG/ higher salt 
options (Section 6.2.5). As was conducted in Section 6.4, successful precipitation was primarily 
determined by the appearance of a bacteriophage precipitate post-centrifugation. However, 
reactions giving successful precipitation (at the lowest precipitant quantities) were investigated 
for bacteriophage recovery in the precipitate. All experiments were conducted twice.  
 
For PEG-salt precipitation reactions, successful precipitation occurred by the addition of 135 
mM NaCl to 2 % (w/v) PEG 6 000 (Table 6.9), which was over 100 mM less than the 
concentration of NaCl required to induce precipitation in the pure system (Section 6.2.5). In 
Table 6.10 it can be seen that precipitation occurred by the addition of 25 mM MgSO4 to 2 % 
(w/v) PEG 6 000, which was 40 mM less than the concentration required to induce precipitation 
in the pure system (Section 6.2.7).  
 
 
Table 6.9 Precipitation of bacteriophage M13 in NB2 by 2 % (w/v) PEG 6 000 and NaCl of 
concentration 0-  500 mM. The percentage of recovered bacteriophage was calculated from the 
quantity of bacteriophage recovered in the precipitate as a proportion of the total. Symbols: 
white bacteriophage precipitate observed (%), no precipitate observed (').  
 
  Concentration of NaCl (mM) 
  0  35  65  100  135  165  200  300  400  500 
M13 precipitate?  '  '  '  %  %  %  %  %  %  % 
Recovered 
Bacteriophage (%) 
      75.0  97.0  97.3         
 
 
Table 6.10 Precipitation of bacteriophage M13 in NB2 by 2 % (w/v) PEG 6 000 and MgSO4 of 
concentration 0-  200 mM. The percentage of recovered bacteriophage was calculated from the 
quantity of bacteriophage recovered in the precipitate as a proportion of the total. Symbols: 
white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of MgSO4 (mM) 
  0  15  25  35  65  100  200 
M13 precipitate?  '  '  %  %  %  %  % 
Recovered 
Bacteriophage (%) 
    97.4         
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Under pure conditions, the precipitation of bacteriophage M13 by 4 % (w/v) PEG 6 000 
required the addition of 135 mM NaCl or 15 mM MgSO4. In NB2, it was found that 
precipitation occurred due to the addition of 4 % (w/v) PEG 6 000 alone (Table 6.11 and Table 
6.12). The ionic strength of NB2 was therefore sufficiently high already. It was of subsequent 
interest to determine the minimum concentration of PEG 6 000 in NB2 that would induce 
precipitation of M13. It was found that 4 % (w/v) PEG 6 000 was the minimum required (Table 
6.13). 
 
Table 6.11 Precipitation of bacteriophage M13 in NB2 by 4 % (w/v) PEG 6 000 and NaCl of 
concentration 0-  300 mM. The percentage of recovered bacteriophage was calculated from the 
quantity of bacteriophage recovered in the precipitate as a proportion of the total. Symbols: 
white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of NaCl (mM) 
NaCl mM  0  15  25  35  65  100  200  300 
M13 precipitate?  %  %  %  %  %  %  %  % 
Recovered 
Bacteriophage (%) 
95.3               
 
 
Table 6.12 Precipitation of bacteriophage M13 in NB2 by 4 % (w/v) PEG 6 000 and MgSO4 of 
concentration 0-  200 mM. The percentage of recovered bacteriophage was calculated from the 
quantity of bacteriophage recovered in the precipitate as a proportion of the total. Symbols: 
white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of MgSO4 (mM) 
  0  15  25  35  65  100  200 
M13 precipitate?  %  %  %  %  %  %  % 
Recovered 
Bacteriophage (%) 
90.2             
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Table 6.13 Precipitation of bacteriophage M13 in NB2 by PEG 6 000 of concentration 2- 4 % 
(w/v). Symbols: white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of PEG 6 000, % (w/v) 
  2.0  2.5  3.0  3.3  3.5  4.0 
M13 precipitate?  '  '  '  '  '  % 
 
 
Isoelectric precipitation of bacteriophage M13 in NB2 was successful at pH 4.3 with an average 
of 99.7 % of recovered bacteriophage in the precipitate. 
 
As a result of experimentation with purified bacteriophage M13 (Section 6.5) it was 
hypothesized that since spermidine and Ca
2+ ions failed to precipitate M13 in the presence of up 
to 100 mM NaCl, precipitation would not be successful in NB2. This indeed proved to be so 
(Table 6.14 and Table 6.15). No white bacteriophage precipitates were observed at any 
concentration of spermidine. No white bacteriophage precipitates were observed at any 
concentration of Ca
2+ ions either, but a heavy brown sediment was observed in every tube to 
which Ca
2+ ions had been added. To check that this sediment did not include M13, precipitates 
and supernatants were titred for bacteriophage (Table 6.15). As a further check a control run 
was conducted, essentially repeating the experiment in fresh sterile NB2 (no bacteriophage 
present). Identical brown sedimentation was observed. The 1 M CaCl2 stock (made up in sterile 
NB2) was noted to be turbid from which brown sediment could also be pelleted. It was 
concluded that irreversible precipitation of NB2 components may have occurred in the 1 M 
CaCl2 stock. Enumeration of bacteriophage M13 showed that no bacteriophage precipitation 
had occurred. 
 
 
Table 6.14 Precipitation of bacteriophage M13 in NB2 by spermidine of concentration 0- 50 
mM. Symbols: white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of spermidine (mM) 
  0  4  10  20  30  40  50 
M13 precipitate?  '  '  '  '  '  '  ' 
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Table 6.15 Precipitation of bacteriophage M13 in NB2 by Ca
2+ ions of concentration 0- 400 
mM. The percentage of recovered bacteriophage is the proportion within the precipitate. 
Symbols: white bacteriophage precipitate observed (%), no precipitate observed ('). 
 
  Concentration of Ca
2+ (mM) 
  0  50  100  200  300  400 
M13 precipitate?  '  '  '  '  '  ' 
Recovered 
Bacteriophage (%) 
2.4  1.7  1.8  2.0  2.6  2.0 
 
 
6.7  Precipitant Comparison in Terms of Bacteriophage M13 Purification 
6.7.1  Introduction 
The aim of the final stage of this chapter was to take candidate precipitants of bacteriophage 
M13 and compare them in terms of the purification factor achieved. In this study, purification 
factor (P.F.) is defined as: 
! 
P.F.=
pfu/X
pfu0 /X0
    (2) 
 
where pfu is the concentration of bacteriophage, X the concentration of contaminant and 
subscript 0 denotes an initial concentration. Purification is important, since application of the 
most selective primary purification step possible could reduce the number of further 
downstream processing stages, thereby reducing production costs. Since every one of the 
successful precipitants identified in Section 6.6 achieved greater than 90 % bacteriophage 
recovery, differentiation instead must focus on their relative purification abilities, costs and 
removal. 
 
On the large-scale, precipitation ingredients are typically added as a dry powder, rather than as 
concentrated liquid stocks (Belter et al., 1988). To reflect this, precipitants were added as dry 
ingredients to clarified, filtered culture. Since at the 10 ml scale the quantities of precipitants 
added would be very small, precipitation reactions were scaled to 40 ml in 50 ml polypropylene 
tubes. As a result of the findings of Section 6.6, the precipitants examined were: 
•  2 % (w/v) PEG 6 000 with 135 mM NaCl 
•  2 % (w/v) PEG 6 000 with 25 mM MgSO4 
•  4 % (w/v) PEG 6 000 alone 
•  isoelectric precipitation at pH 4.3 
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Experiments were conducted as described in the Materials and Methods (Section 2.14.6). Each 
precipitate was resuspended in 800 µl 20 mM Tris to give a 50-fold increase in bacteriophage 
concentration: this represented a realistic concentration factor (Asenjo and Patrick, 1990). A 
portion of each resuspended precipitate (5 !l) was 50-fold diluted back to the same 
bacteriophage concentration found in untreated culture, which allowed for a like-for-like 
comparison of the purification achieved. All experiments were conducted three times. 
 
Following the methods described in Chapter 4, the quantities of chromosomal DNA (Section 
4.2.3) and protein (Section 4.2.5) were measured in each resuspended precipitate, 50-fold 
diluted precipitate, supernatant and untreated culture. Therefore, DNA was measured by agarose 
gel electrophoresis and protein by Bradford assay (for total protein) and SDS-PAGE (for larger 
polypeptides). 
 
6.7.2  Comparison of bacteriophage M13 recovery 
The recoveries of bacteriophage M13 by each precipitation method are shown in Table 6.16. As 
usual, the percentages of recovered bacteriophage from precipitation are presented, calculated 
from the quantity of bacteriophage enumerated in the precipitate (or supernatant) as a proportion 
of the total. In addition, absolute bacteriophage numbers are given (in pfu) in the untreated 
culture, precipitate and supernatant environments. Finally, the bacteriophage recoveries are 
expressed as fractional quantities relative to the average amount of bacteriophage in all 
untreated cultures.  
 
It can be seen that recoveries of bacteriophage M13 were in excess of 90 % in the precipitate 
from precipitation methods 2 % (w/v) PEG 6 000 with 135 mM NaCl (93 %), 4 % (w/v) PEG 6 
000 alone (92 %) and isoelectric precipitation (96 %). The exception was 2 % (w/v) PEG 6 000 
with 25 mM MgSO4, which yielded a recovery of 89 %. Here, it was noted that some precipitate 
loss occurred on supernatant decantation.  
 
When compared on a fractional basis – that is, bacteriophage recovery expressed as a fraction of 
the average quantity enumerated in untreated cultures – all precipitants performed similarly 
(Table 6.16). A >0.9 fraction of the input bacteriophage were recovered in the precipitate in 
every case. 
 
In terms of the percentage bacteriophage recovery in the precipitate, the recoveries achieved by 
isoelectric precipitation in this chapter were consistently higher than those achieved by PEG 
precipitation methods. Since PEG precipitation methods generally produced maximum 
recoveries in the range 90- 96 % by this assay (Section 6.2.2), it was assumed that isoelectric   197 
precipitation either led to more firmly attached precipitates or that the lower solution viscosity 
resulted in less precipitate disturbance on supernatant decantation. 
 
Table 6.16 Precipitation of bacteriophage M13 in NB2 by four precipitation methods. The 
percentage of recovered bacteriophage was calculated as a proportion of the total recovered. 
Bacteriophage quantities (in pfu) represent the total population in each environment. Each 
fractional quantity was calculated relative to the average quantity of bacteriophage in untreated 
cultures.  
  Recovered Bacteriophage (%) 
Precipitants  Untreated culture  Precipitate  Supernatant 
2 % (w/v) PEG 6 000, 135 mM NaCl  -  93.0 ± 0.8  6.9 ± 0.8 
2 % (w/v) PEG 6 000, 25 mM MgSO4  -  89.1 ± 1.3  10.9 ± 1.3 
4 % (w/v) PEG 6 000  -  92.2 ± 0.1  7.8 ± 0.1 
Isoelectric precipitation, pH 4.3  -  95.5 ± 0.2  4.5 ± 0.2 
       
  Bacteriophage quantity (pfu) 
Precipitants  Untreated culture  Precipitate  Supernatant 
2 % (w/v) PEG 6 000, 135 mM NaCl 
2.2 x 10
13  
± 1.2 x 10
12 
2.2 x 10
13  
± 1.9 x 10
12 
1.6 x 10
12  
± 2.9 x 10
11 
2 % (w/v) PEG 6 000, 25 mM MgSO4 
2.2 x 10
13  
± 1.6 x 10
12 
2.0 x 10
13  
± 8.6 x 10
11 
2.5 x 10
12  
± 3.6 x 10
11 
4 % (w/v) PEG 6 000 
2.1 x 10
13  
± 2.2 x 10
12 
2.0 x 10
13  
± 2.6 x 10
12 
1.7 x 10
12  
± 1.9 x 10
11 
Isoelectric precipitation, pH 4.3 
1.9 x 10
13  
± 5.5 x 10
11 
1.9 x 10
13  
± 1.4 x 10
12 
9.2 x 10
11  
± 3.1 x 10
10 
   
  Fractional value 
Precipitants  Untreated culture  Precipitate  Supernatant 
2 % (w/v) PEG 6 000. 135 mM NaCl  1.04 ± 0.06  0.98 ± 0.06  0.12 ± 0.01 
2 % (w/v) PEG 6 000, 25 mM MgSO4  1.00 ± 0.07  0.98 ± 0.08  0.08 ± 0.01 
4 % (w/v) PEG 6 000  1.06 ± 0.03  1.07 ± 0.06  0.08 ± 0.01 
Isoelectric precipitation, pH 4.3  0.92 ± 0.06  0.93 ± 0.06  0.04 ± 0.00 
       
   198 
6.7.3  Quantification of DNA 
All three PEG-based precipitation methods resulted in a marked separation of bacteriophage 
M13 from contaminating DNA (Figure 6.11). DNA remained in the supernatant as 
bacteriophage M13 was pelleted. Quantification of the chromosomal DNA bands by 
densitometry showed that there was no significant difference in the precipitate DNA 
concentration between the three PEG-based methods (P>0.05 in all comparisons, Tukey). 
 
In the three PEG-based methods the average reduction in DNA was from 4.7 µg ml
-1 in 
untreated culture to only 0.7 µg ml
-1 in the resuspended precipitates, even though the 
bacteriophage concentration was fifty-fold greater (Figure 6.12). On an equal bacteriophage 
concentration basis, this represented an average purification factor in excess of 300.   
 
The purification performance of isoelectric precipitation was different. The quantity of DNA in 
the precipitate was high such that it could not be enumerated by densitometry (Figure 6.12). 
However, the amount of DNA quantified in the fifty-fold diluted precipitate, at 4.1 µg ml
-1, 
nearly matched that of the untreated culture (5.0 µg ml
-1). This represented an average 
purification factor of only 1.2.  
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Figure 6.11 Agarose gel showing the fate of chromosomal DNA in each of the four tested 
precipitations. Bacteriophage M13 DNA is not visible due to the encapsulating protein coat 
(Section 4.2.3). An equivalent of 10 !l of sample was loaded in each well. The three PEG-based 
precipitation methods performed similarly, in that DNA remained in the supernatant fractions. 
Of particular note was the large quantity of DNA that was sedimented by isoelectric 
precipitation, and was therefore identified in the precipitate. An agarose gel was prepared for 
each of the three experimental repeats. Band intensities were subsequently quantified by 
densitometry as described in the Materials and Methods (Section 2.7.4).   200 
 
Figure 6.12 Quantification of the DNA band intensities shown in Figure 6.11. The quantity of 
DNA in the undiluted isoelectric precipitation precipitate was not measured due to its high 
concentration ("N.D."). Symbols: 4 % (w/v) PEG 6 000 alone ($), 2 % (w/v) PEG 6 000 with 
135 mM NaCl ($), 2 % (w/v) PEG 6 000 with 25 mM MgSO4 ($), isoelectric precipitation 
(!). Error bars represent the standard error, N=3. 
 
 
6.7.4  Controls for the quantification of protein by Bradford assay 
The Bradford assay was performed as described in the Materials and Methods (Section 2.7.5) 
with a 0.66-fold serially diluted 1 mg ml
-1 BSA standard. Absorbance at 595 nm was linear in 
the range 13- 225 !g ml
-1 BSA. To ensure that readings were not due to chemical interference 
from the precipitants used, control samples were first analysed. These consisted of each of the 
candidate precipitants made up in sterile RO water with 4 x 10
11 pfu ml
-1 caesium chloride 
purified bacteriophage M13, as well as unused NB2 and sterile RO water alone. The theoretical 
concentration of BSA corresponding to each of the absorbances of these precipitants is shown in 
Table 6.17. It can be seen that the measured effect of each of the precipitants was minimal, 
giving confidence that absorbances observed were indeed due to protein. As shown previously 
in Chapter 4 (Section 4.2.5), the peptide content of NB2 is detected by the Bradford assay. 
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Table 6.17 Bradford assay control samples. Precipitants were made up in sterile RO water 
(rather than NB2) and the absorbance at 595 nm measured. The equivalent concentration of 
BSA giving the same absorbance is shown. 
 
Control Sample  Equivalent BSA Concentration µg ml
-1 
Sterile RO water  0.0 ± 2.7 
NB2  24.3 ± 3.5 
2 % (w/v) PEG 6 000, 135 mM NaCl  3.3 ± 2.3 
2 % (w/v) PEG 6 000, 25 mM MgSO4  1.7 ± 1.6 
4 % (w/v) PEG 6 000  1.8 ± 1.9 
Isoelectric precipitation, pH 4.3  0.4 ± 2.2 
 
 
It was also necessary to control for the measurement of protein as a consequence of the 
bacteriophage present, particularly important after concentration into the precipitate. A 500 µl 
aliquot of caesium chloride purified bacteriophage M13 of concentration 6.3 x 10
13 pfu ml
-1 was 
three-fold serially diluted down to a concentration of 2.9 x 10
10 pfu ml
-1. Samples were then 
subject to the Bradford assay and the (measured) concentration of protein determined as a 
function of pfu ml
-1 (Figure 6.13).  
 
For comparison, the concentration of protein theoretically present (also as a function of pfu ml
-
1) was calculated by summation of the total quantity of coat protein per bacteriophage (see 
Chapter 1, Section 1.2.2, for a description of the bacteriophage coat proteins and their 
corresponding molecular weights). This value was expected to be greater than the measured 
quantity, since a significant proportion of the amino acids of the bacteriophage coat are not 
exposed to the surroundings.  
 
The detected concentration of protein was very low up to a bacteriophage count of mid- 10
12 pfu 
ml
-1, and increased rapidly above this point (Figure 6.13). The concentration of protein 
correlating to the bacteriophage count in every precipitate was therefore subtracted, since 
bacteriophage concentrations of the order 10
13 pfu ml
-1 were present in these samples.   202 
 
 
 
Figure 6.13 The concentration of protein measured by Bradford assay as a function of (A) 
bacteriophage concentration (!). (B) Comparison between the theoretical quantity of protein as 
a function of bacteriophage concentration (!) and the measured quantity by Bradford assay 
(!).   203 
 
6.7.5  Quantification of protein by Bradford assay 
On the basis of measured protein concentration, all three PEG-based precipitation methods 
again resulted in separation of bacteriophage M13 from contaminants (Figure 6.14). All 
performed similarly, that is, there was no significant difference in the precipitate protein 
concentrations (P>0.05 in all comparisons, Tukey). On average, a reduction of protein from 
approximately 92 µg ml
-1 in untreated culture to 9 µg ml
-1 in the resuspended precipitates was 
observed, even though the bacteriophage concentration was fifty-fold greater. On an equal 
bacteriophage concentration basis, this represented a minimum purification factor in excess of 
250, similar to that observed for DNA. The purification performance of isoelectric precipitation 
was again different to the PEG-based methods: precipitation of soluble culture protein occurred. 
The quantity of protein in the fifty-fold diluted precipitate, at 24.2 µg ml
-1, was high compared 
to the virtually undetectable levels of protein in the fifty-fold diluted precipitates of the PEG-
based precipitation methods (Figure 6.14). Isoelectric precipitation achieved an average 
purification factor of 3.8. 
 
 
 
Figure 6.14 The quantity of total protein measured in each sample by the Bradford assay. The 
protein contribution from bacteriophage M13 was subtracted from all reading (Section 6.7.4). 
Symbols: 4 % (w/v) PEG 6 000 alone ($), 2 % (w/v) PEG 6 000 with 135 mM NaCl ($), 2 % 
(w/v) PEG 6 000 with 25 mM MgSO4 ($), isoelectric precipitation (!). Error bars represent 
the standard error, N=3. 
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6.7.6  Quantification of protein by SDS-PAGE densitometry 
The purification ability of each precipitation method was also visualised by SDS-PAGE (see 
Materials and Methods, Section 2.7.3, SYPRO Ruby stain). The quantity of protein in the range 
20- 212 kDa in each lane was measured relative to the untreated culture sample (Section 2.7.4.). 
Therefore, protein quantity in each sample was calculated as a fraction of that in untreated 
culture.  
 
The three PEG-based precipitation methods resulted in lower levels of protein in the precipitate 
than isoelectric precipitation (Figure 6.15). Compared with the protein concentration in 
untreated culture, the relative concentrations of protein in each precipitate were 1.4 (4 % (w/v) 
PEG 6 000 alone), 1.0 (2 % (w/v) PEG 6 000 with 135 mM NaCl), 1.3 (2 % (w/v) PEG 6 000 
with 25 mM MgSO4) and 13.4 (isoelectric precipitation). Furthermore, on an equal 
bacteriophage concentration basis (50-fold diluted precipitate) the PEG-based methods 
represented an average purification factor of approximately 50, which was substantially less 
than the purification factors in excess of 250 calculated on the basis of total protein by the 
Bradford assay. As before, isoelectric precipitation achieved a substantially lower average 
purification factor, which remained at 3.8. 
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Figure 6.15 SDS-PAGE gels showing the relative quantities of protein in each precipitation 
sample. An equivalent of 10 !l of sample was loaded in each well. An SDS gel was prepared for 
each of three experimental repeats. Relative intensities were determined by densitometry as 
described in the Materials and Methods (Section 2.7.4). 
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6.8  Discussion 
The aim of this chapter was to identify precipitants of bacteriophage M13 which would have 
potential in an effective primary purification step at the large-scale. Therefore, all precipitations 
were conducted at a bacteriophage concentration of approximately 10
11 pfu ml
-1, similar to that 
found in the post-fermentation broth (see Chapter 4). Precipitants were initially investigated 
with purified bacteriophage to determine fundamental characteristics, before experimentation 
was conducted in a broth system. Finally, four precipitation candidates were taken forward and 
compared on the basis of purification ability. 
 
6.8.1  PEG precipitation of M13: the effect of increasing PEG molecular weight 
Several precipitants were investigated in this chapter, beginning with the PEG-salt system. 
Increasing the degree of polymerisation of the PEG (and thereby increasing chain length and 
average molecular weight) improved its ability to precipitate protein. The effect was found to be 
most significant at lower average molecular weights, and became increasingly marginal at 
average molecular weights above 6 000. Such a pattern was consistent with reported 
experimentation for other proteins (Atha and Ingham, 1981; Boncina et al., 2007; Boncina et 
al., 2008; Mahadevan and Hall, 1992). This trend suggested that an optimum PEG molecular 
weight existed. Although increasing the molecular weight from 6 000 to 20 000 only reduced 
the required PEG concentration by 0.5 % (w/v), solution viscosity was shown to increase by 70 
% (Section 6.2.5). Therefore in processing terms there appeared to be little benefit in increasing 
the PEG molecular weight above 6 000. Similar conclusions have been drawn by reporters 
investigating the precipitation behaviour of other proteins (Mahadevan and Hall, 1992; 
Yamamoto et al., 1970). 
 
6.8.2  PEG precipitation of M13: the effect of incubation time and temperature 
The volume exclusion mechanism is primarily an entropic rather than enthalpic process (Atha 
and Ingham, 1981; Boncina et al., 2008), which explains why temperature had only a marginal 
effect on the precipitation of bacteriophage M13 (Section 6.2.6). The effective precipitation by 
PEG over a broad temperature range confers certain processing advantages: dispensing with 
process stream cooling saves on operating expenses, and its robustness means the precipitation 
temperature can also be less tightly controlled. However, its flexibility means that if lower 
temperatures were required – for example, to protect a particularly fragile display protein – 
precipitation would not be compromised. Nevertheless, it has also been extensively noted in the 
literature that PEG is generally a non-denaturing precipitation agent (Ingham, 1990; Sharma and 
Kalonia, 2004; Tsoka et al., 2000). That PEG precipitation was observed to occur rapidly 
(Section 6.2.6) means that such a stage need not be time-intensive. 
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6.8.3  PEG precipitation of M13: the effect of increasing solution ionic strength 
It was noted that PEG precipitation was assisted (that is, required less PEG) by an increase in 
the ionic strength of the solution. Solution ionic strength is a function of ion type, charge and 
concentration. Hence, increasing the concentration of NaCl reduced the quantity of PEG 
required to induce precipitation (Section 6.2.5), and at a fixed PEG concentration different salts 
could induce precipitation at very different concentrations (Section 6.2.7). Ions in solution 
augment the volume exclusion mechanism of PEG precipitation by reducing the net repulsive 
force between like-charged proteins. It is proposed this occurs by a form of electrostatic 
screening, which essentially means the ions allow proteins to aggregate more easily 
(Mahadevan and Hall, 1990; 1992). Since bacteriophage M13 is a net negatively charged 
molecule at neutral pH (Graf et al., 1993; Tang et al., 2002), the ions of most importance in 
electrostatic screening were positively charged (cations), although negatively charged ions 
(anions) would have had a small effect also.  
 
It is therefore straightforward to explain why solution ionic strength was important: increasing 
the concentration or charge of cations in solution increased electrostatic screening and thereby 
reduced protein-protein repulsion. However, the potency difference between cations which are 
otherwise of identical charge and concentration is less well understood. Many theories exist, but 
it is generally believed to be function of ion size and charge density, and a resulting altered 
interaction with water (Boncina et al., 2008; Collins, 1997). These competing effects explain 
the trends observed in Section 6.2.7 where MgSO4 was found to be far more effective than 
either Na2SO4 or NaCl. The higher valency (charge) and ion-specific abilities of Mg
2+ must 
have outweighed the effect of adding two moles of Na
+ ions per mole of Na2SO4. This also 
explains why Na2SO4 proved a more effective precipitant than NaCl. Although Cl
- anions 
reduce protein solubility more than SO4
2- (Zhang and Cremer, 2006), the effect of adding two 
moles of Na
+ ions per mole of salt in Na2SO4 more than compensated (Boncina et al., 2008). 
The difference in effectiveness between salts was shown to reduce as the concentration of PEG 
reduced. This was consistent with findings elsewhere (Boncina et al., 2008; Mahadevan and 
Hall, 1990), and is probably a function of the reduction in the dominance of the volume 
exclusion mechanism.  
 
From a practical perspective, the choice between high PEG/low salt or low PEG/high salt 
concentrations will be determined by the relative chemical costs and the tolerable limit of 
solution viscosity for the bioprocess. Choice between salts also depends on the supplier costs 
versus the quantity required. A further consideration is the corrosive nature of salt chlorides 
(such as NaCl) relative to non-halide salts (such as sulphates) with regard to the usually 
stainless steel downstream processing equipment (Korb, 1987; Shreir et al., 1994). While the   208 
process decision will necessarily be a function of the individual circumstances, it is clear that 
flexibility of PEG precipitation allows for some tailoring to suit the conditions. 
 
6.8.4  Isoelectric precipitation of M13 
Similarly to the effect of ions in solution, judicious alteration of pH reduces mutual protein-
protein repulsion, even to a point where precipitation occurs alone (Atkinson et al., 1987). It 
was shown that bacteriophage M13 could be precipitated by so-called isoelectric precipitation, 
and exhibited a >90 % recovery in the precipitate in the range pH 3.9- 4.5 (Section 6.3.3). Such 
a broad pH range may be advantageous since it can be difficult to control pH on the large scale 
due to imperfect mixing (Hofland et al., 2003). Bacteriophage M13 also exhibited reasonable 
resistance to the acidic conditions imposed, particularly when incubated on ice (eliminating 
significant drops in titre) but especially when compared to the T-odd and T-even bacteriophage 
types (T2, T3, T4, T5 and T7) investigated by Bachrach and Friedmann (1971). Severe 
bacteriophage denaturation by the acidic environment was described, which appeared to have 
been a factor in the poor recoveries (< 55 %) obtained.  
 
It was shown in this chapter that the isoelectric precipitation of bacteriophage M13 needed only 
one hour of incubation rather than 24, which could save time and resources if translation to the 
large-scale was similarly effective. However, the large scale isoelectric precipitation of other 
proteins, such as casein, is known to depend on dynamic factors such as acid mixing, particle 
aggregation/break-up and mass transport phenomena into and out of the precipitate particles 
(Hofland et al., 2003). 
 
6.8.5  Divalent and polyvalent cation precipitation of M13 
The cations spermidine and Ca
2+ were shown to be effective facilitators of bacteriophage M13 
precipitation, requiring only 1.5 and 50 mM respectively in the low ionic strength systems 
(Sections 6.4 and 6.5). However, as expected, their action was shown to be very dependent on 
the monovalent cation concentration (Murphy et al., 1999; Tang et al., 2002). Indeed, 
precipitation by spermidine was prevented by only 50 mM NaCl and Ca
2+ ions by 100 mM 
NaCl. As a result it was hypothesized, then proven, that due to the monovalent cation content of 
NB2 neither spermidine nor Ca
2+ would precipitate bacteriophage M13 from clarified 
shakeflask fermentation broth (Section 6.6).  
 
The effect of monovalent cation addition on the spermidine precipitation of bacteriophage M13 
appeared greater than that reported for plasmid DNA. It has been demonstrated that 5- 10 mM 
of spermidine would still precipitate a 6 kb plasmid in the presence of 100 mM NaCl (Murphy 
et al., 1999), in contrast to the present study where only 50 mM of NaCl prevented 
bacteriophage precipitation by up to 50 mM spermidine. This may be because bacteriophage   209 
M13 exhibited a higher solubility than DNA in the presence of spermidine, thereby making 
precipitation more susceptible to competitive interference. Existing literature studying the 
selective precipitation of DNA by CTAB supports this theory, since it was shown that DNA 
precipitated at lower CTAB concentrations than protein (Lander et al., 2002; Tomanee et al., 
2004). This may also explain why bacteriophage M13 was not precipitable by CTAB under the 
conditions studied. 
 
Work to model the net attractive forces between filamentous bacteriophage molecules as a result 
of divalent cation action has shown that these are reduced in a competitive manner by the 
presence of monovalent cations (Tang et al., 2002). Therefore, with regards to bacteriophage 
M13 processing, precipitation by spermidine and Ca
2+ may be useful further downstream under 
lower ionic strength conditions, particularly if the bacteriophage resolubilisation phenomenon 
observed by Ca
2+ ions could be carefully exploited. Alternatively, the filamentous bacteriophage 
could be modified to become a more highly-charged molecule. The naturally occurring variant 
of bacteriophage M13, fd, possesses a net 30 % greater negative charge at neutral pH and has 
been shown to be precipitable by Ca
2+ ions in the presence of 100 mM of monovalent salt (Tang 
et al., 2002). Therefore, the deliberate creation of even more highly charged filamentous 
bacteriophage molecules may augment divalent and polyvalent cation precipitation further. It 
would then be of interest if selective precipitation of bacteriophage from DNA and protein 
contaminants could be achieved. 
 
6.8.6  Evaluation of screening experimentation 
Overall, the screening experiments under pure conditions provided useful insight into the 
effectiveness of several precipitants. They rapidly highlighted the effective concentration of 
precipitant, and, by analysing the ion concentration of the growth mediums of interest, could 
allow for the revised prediction of precipitation behaviour. In particular, the failure of 
spermidine and Ca
2+ ions to precipitate bacteriophage M13 from NB2 would have meant two 
potentially useful precipitants would have been missed if the screening under pure conditions 
had not come first. In industry, where optimisation of conditions is important, the use of 
factorial design in conjunction with this screen could provide a rapid robust method to achieve 
this aim. 
 
6.8.7  PEG and isoelectric precipitation purification performance 
Bacteriophage M13 is in effect a very large, highly asymmetric 16 MDa protein. For PEG 
precipitation this resulted in very sharp precipitation curves, like those reported for the similarly 
rod-like tobacco mosaic virus (TMV) (Juckes, 1971). That is, bacteriophage recovery in the 
precipitate increased from near zero to >90 % within a narrow range of precipitant 
concentration. Furthermore (although the trend is less defined) large proteins such as M13 tend   210 
to display a lower solubility than smaller ones (Atha and Ingham, 1981; Honig and Kula, 1976; 
Mahadevan and Hall, 1992). Firstly, this explains why the minimum concentration of PEG 6 
000 shown in this study to precipitate bacteriophage M13 – at 1.5 % (w/v) – is five- to ten-fold 
lower than values published in the literature for smaller proteins, and indeed other 
bacteriophage (Atha and Ingham, 1981; Juckes, 1971; Sharma and Kalonia, 2004; Tsoka et al., 
2000; Yamamoto et al., 1970) (Section 6.2.5). Secondly, this explains why high purification 
factors (approximately 250) were achieved from total protein by the three PEG-based 
precipitation methods analysed in Section 6.7, and why purification factors were lower (at 
approximately 50) from larger proteins. Since the total protein measurement by the Bradford 
assay included the many small polypeptide media components, it is perhaps of no surprise that 
almost all of these smaller components were not precipitated. Meanwhile, isoelectric 
precipitation appeared to perform consistently by both protein measures (Bradford Assay and 
SDS-PAGE densitometry), which is consistent with bacteriophage precipitation being by a 
different mechanism. 
 
Although PEG-based precipitation of DNA is also possible, it typically requires 5- 15 % (w/v) 
of at least PEG 6 000 to induce precipitation of even the larger fragments (e.g. 10 kbp) (Field, 
1993; Paithankar and Prasad, 1991; Sambrook and Russell, 2001). Hence at the PEG 6 000 
concentrations used in this study, DNA remained in solution (Section 6.7). The fact that all 
three PEG-based precipitation methods performed similarly in terms of bacteriophage M13 
purification is probably due to the dominant volume exclusion mechanism of precipitation, 
which is common to all. Although careful control of pH should in theory have meant that only 
proteins of similar isoelectric point to bacteriophage M13 would co-precipitate, it was clear 
from Section 6.7 that many contaminating proteins (and DNA) were precipitable around pH 4.3. 
Hence the purification factors achieved by isoelectric precipitation were substantially lower than 
those by PEG-precipitation. That said, the average purification factor achieved by isoelectric 
precipitation for protein removal (at 3.8) was not necessarily poor in absolute terms, since 
similar purification factors have been reported for the PEG precipitation of VLPs from total 
protein (Tsoka et al., 2000). Furthermore, in Chapter 4 (Section 4.4) it was shown that 
alternative methods of DNA removal exist, such as nuclease addition. 
 
That isoelectric precipitation requires essentially no precipitant addition is a benefit relative to 
PEG precipitation (Wenzig et al., 1993). However, the low quantities of PEG required in this 
study somewhat assuages the drawbacks of precipitant cost and solution viscosity (Rodrigues et 
al., 2007). Reduced precipitant cost is especially important since PEG polymer recycling can be 
difficult (Mahadevan and Hall, 1990; Nagaraj et al., 2005). Although it has been shown that 
there is little co-precipitation of PEG with protein (Sharma and Kalonia, 2004; Yamamoto et 
al., 1970), options on the large-scale to remove PEG from the concentrated bacteriophage   211 
include ultrafiltration (Busby and Ingham, 1980; Papamichael and Kula, 1987) or standard 
chromatographic steps to which PEG has no tendency to absorb (Ingham, 1990). Therefore, the 
negative impact on subsequent high-resolution purification steps is likely to be minimal, 
although the performance of some size-exclusion columns may be altered due to osmotic effects 
of the polymer (Ingham, 1990). Overall, the processing benefits of a highly selective primary 
purification step, such as the PEG-precipitation options outlined in this chapter, are clear: 
subsequent high resolution purification steps will be less susceptible to fouling if the feed 
stream is less heavily contaminated (Thommes and Etzel, 2007) and fewer steps may be needed 
thereby improving the overall yield (Wenzig et al., 1993). 
 
6.8.8  Concluding remarks 
In summary, millilitre-scale screening methods were used to identity several potentially useful 
precipitants of bacteriophage M13 for large-scale processing. Understanding the effect of 
monovalent salt concentration on precipitation allowed for the prediction of precipitant 
behaviour in culture medium. PEG-based precipitation methods showed selective precipitation 
of bacteriophage M13 particles from protein and DNA contaminants. Isoelectric precipitation 
was shown to be an efficient method to precipitate bacteriophage M13, but gave a lower 
improvement in purity. It was noted that the novel precipitation agents spermidine and Ca
2+ ions 
could potentially offer an alternative precipitation option for more highly charged bacteriophage 
molecules. However, for bacteriophage M13, PEG-based precipitation appeared to offer the best 
combination of reproducibility, robustness and selectivity. The choice between the three PEG-
based precipitation techniques (4 % (w/v) PEG 6 000 or 2 % (w/v) PEG 6 000 with 135 mM 
NaCl or 25 mM MgSO4) remains a function of the relative costs of the precipitants and the ease 
of handling. 
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7  Consideration of the Issues Concerning the Introduction of 
Bacteriophage M13 to a Mixed-Use Production Facility 
7.1  Introduction 
Bacteriophage attack has always been a key issue in industrial fermentations, especially in the 
dairy industry (Brussow et al., 1994). Here, contamination of the fermenter or starter culture by 
virulent bacteriophage can result (at best) in reduced product yield but total culture and product 
loss can commonly be expected. The costs can be considerable and so consequently, extensive 
effort has been devoted to controlling bacteriophage contamination (Jones et al., 2000; 
Moineau, 1999) 
 
In contrast, the deliberate culture of bacteriophage has been a cornerstone of this thesis. 
However, the introduction of a bacteriophage to a production facility that also requires the 
routine (successful) culture of permissive bacteria raises several important issues concerning 
their co-experimentation. Indeed, successful bacteriophage production itself requires the ability 
to grow non-infected starter cultures. These issues are especially relevant for small bioscience 
firms and academic institutions operating areas of mixed-use. Prior to bacteriophage 
introduction it is essential to consider not only the implications of accidental release but also the 
risk of such an event occurring and how it could be minimised. Further, in the event of release 
occurring, remedial actions would need to be predefined. 
 
The precise level of precaution required depends on several factors. Ideally, the host range of 
the bacteriophage of interest would not encompass bacterial strains routinely (or intended to be) 
cultured in unrelated experimentation. However, if this were unavoidable, then extra measures 
would need to be exercised to prevent unplanned bacteriophage propagation. It would also be 
important to assess the potential environmental persistence of the bacteriophage of interest, 
since bacteriophage vary enormously in their resistance to the challenges of desiccation, 
temperature and pH (Jepson and March, 2004; Pollard and Solosko, 1971; Rahn, 1945) For 
example, a bacteriophage displaying a strong desiccation resistance would warrant more 
concern that one showing acute sensitivity. Such information would allow an informed 
judgement to be made on the long-term implications of accidental bacteriophage release.  
 
While the bacteriophage studied in this thesis (M13) infects the common microbiological tool E. 
coli, it can only infect cells harbouring the F-plasmid, an episome which is not essential for 
recombinant protein production. However, because bacteriophage M13 infection is not lethal to 
the host cell, which continues to grow whilst extruding progeny bacteriophage particles, the 
infected cells themselves must be treated with the same caution as free bacteriophage.  
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It was considered that the determination of an effective decontamination regime was essential; 
several commercial disinfectant agents were therefore tested for effectiveness against 
bacteriophage M13 and subsequently E. coli cells. The resistance of bacteriophage M13 to 
several challenges was then examined, relevant for the assessment of its safe fermentation in a 
mixed-use facility. This included exposure to extremes of temperature, pH and to desiccated 
conditions. Additionally, the effect of desiccation on E. coli cells was also investigated. In light 
of these data the consequences of accidental bacteriophage M13 release was discussed. This 
experimentation gave context to the derivation of a method for the contained propagation of 
bacteriophage M13 at the 20 litre scale in the UCL Department of Biochemical Engineering 
fermentation suite. Several Standard Operating Procedures (SOPs) were derived, and their more 
general application discussed. 
 
 
7.2  Determination of an Effective Decontamination Agent 
7.2.1  Effect of Tego on bacteriophage M13 viability 
Tego 2001 is liquid amphoteric surfactant typically used at a working concentration of 2 % 
(v/v) at room temperature. It is of proprietary composition, but is based on 1-alkyl-1,5-
diazapetane in aqueous solution. Experimentation was conducted as described in the Materials 
and Methods (Section 2.15.1). Briefly, caesium chloride purified bacteriophage M13 (Section 
2.4) were diluted to a final concentration of 1 x 10
12 pfu ml
-1 in 0, 1, 2 and 10 % (v/v) Tego 
solutions. Samples were taken for bacteriophage enumeration (Section 2.5.2) after 10 second, 1 
minute, 5 minute, 10 minute and 20 minute incubations with Tego at room temperature. Upon 
sampling, bacteriophage were immediately ten-fold serially diluted to 10
-2 of their original 
concentration to remove the detergent; further serial dilution to enumerate the bacteriophage 
was conducted once all sampling was complete. A control of 10 % Tego solution alone (no 
bacteriophage) was also serially diluted and plated onto Top10F' overlay agar plates to test for 
bacterial lawn inhibition. Each treatment was repeated three times. 
 
It was found that the concentration of viable bacteriophage decreased as the concentration of 
Tego increased (Figure 7.1). The greatest reduction in bacteriophage titre therefore occurred at a 
10 % (v/v) Tego after 20 minutes. The concentration of viable bacteriophage at this point was 
1.4 x 10
11 pfu ml
-1, which was a 0.14 fraction of the 0 % (v/v) Tego control value. Statistical 
analysis showed that the drop in viability at this timepoint was the only one which was 
significantly lower than the 0 % (v/v) Tego control (P<0.05, Dunnett).  
 
A serially diluted control of 10 % (v/v) Tego alone resulted in zones of clearing on the Top10F' 
overlay plates at the 10
-1 dilution, and poorer growth at the 10
-2 and 10
-3 dilutions. No alteration 
to bacterial lawn growth was observed at greater dilutions.   214 
 
 
Figure 7.1 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at room temperature in 0 % (v/v) Tego (!), 1 % (v/v) Tego (!), 2 % (v/v) 
Tego (#) and 10 % (v/v) Tego (#). Bacteriophage titre was expressed as the log10 value of the 
pfu ml
-1 concentration. A value of 2 was added to every bacteriophage concentration, since 
log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
7.2.2  Effect of Solquest on bacteriophage M13 viability 
Solquest is a liquid surfactant typically used at a working concentration of 1 % (v/v), described 
for use in hot water. Like Tego, it is also of proprietary composition, but is based on 10- 30 % 
(w/v) tetrasodium EDTA, 5- 10 % (v/v) amino-tri(methylene phosphonic acid) and 5- 10 % 
(w/v) sodium hydroxide. Experimentation was conducted as described in the Materials and 
Methods (Section 2.15.1) at two temperatures (50 and 70 °C) to determine the temperature 
dependence of the detergent effectiveness. Caesium chloride purified bacteriophage M13 
(Section 2.4) were diluted to a final concentration of 1 x 10
12 pfu ml
-1 in 0, 0.5, 1 and 5 % (v/v) 
Solquest solutions, pre-warmed to the required temperature. Samples were taken for 
bacteriophage enumeration as described for Tego experimentation (Section 7.2.1). A control of 
5 % Solquest solution alone (no bacteriophage) was also serially diluted and plated onto 
Top10F' overlay agar plates to test for bacterial lawn inhibition. The experiment was repeated 
three times. 
 
At 50 °C, the concentration of viable bacteriophage in the 0.5 and 1 % (v/v) Solquest samples 
only diverged significantly from the 0 % (v/v) control after the full 20 minute exposure time   215 
(P<0.01, Dunnett). However, at a concentration of 5 % (v/v) Solquest the concentration of 
viable bacteriophage was very low by the first 10 second timepoint (5.0 x 10
3 pfu ml
-1) and did 
not significantly decrease further over the following 20 minutes (Figure 7.2). 
 
 
Figure 7.2 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at 50 °C in 0 % (v/v) Solquest (!), 0.5 % (v/v) Solquest (!), 2 % (v/v) 
Solquest (#) and 5 % (v/v) Solquest (#). A value of 2 was added to every bacteriophage 
concentration, since log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
The effect on bacteriophage viability was stronger upon incubation with Solquest at 70 °C. A 
ten second contact time was sufficient for the concentration of viable bacteriophage in the 1 % 
(v/v) Solquest samples to significantly diverge from the 0 %  (v/v) control (P<0.01, Dunnett), 
whilst a five minute contact time was required for the 0.5 % (v/v) samples to diverge 
significantly (P<0.01, Dunnett) (Figure 7.3). At a concentration of 5 % (v/v) Solquest, no viable 
bacteriophage were detected in any sample taken after 10 minutes incubation.  
 
The serially diluted control of 5 % (v/v) Solquest alone did not result in any alteration to 
bacterial lawn growth at any dilution. 
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Figure 7.3 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at 70 °C in 0 % (v/v) Solquest (!), 0.5 % (v/v) Solquest (!), 1 % (v/v) 
Solquest (#) and 5 % (v/v) Solquest (#). A value of 2 was added to every bacteriophage 
concentration, since log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
7.2.3  The effect of Virkon on bacteriophage M13 viability 
Virkon is an oxidising disinfectant powder typically used at a working concentration of 1 % 
(w/v) in water. Like Tego and Solquest it is of proprietary composition, but is based on < 50 % 
(w/w) pentasodium bis(peroxymonosulphate) bis(sulphate), 5- 10 % (w/w) sulphamidic acid, 5- 
15 % (w/w) sodium dodecylbenzenesulfonate, <2 % (w/w) dipotassium peroxdisulphate. 
Experimentation was conducted as described in the Materials and Methods (Section 2.15.1). 
Caesium chloride purified bacteriophage M13 (Section 2.4) were diluted to a final concentration 
of 1 x 10
12 pfu ml
-1 into Virkon solutions of final concentrations 0, 0.01, 0.1 and 1 % (w/v) 
Virkon at room temperature. Samples were taken for bacteriophage enumeration as described 
for Tego experimentation (Section 7.2.1). A control of 1 % Virkon solution alone (no 
bacteriophage) was also serially diluted and plated onto Top10F' overlay agar plates to rest for 
bacterial lawn inhibition. The experiment was repeated three times. 
 
It was found that the concentration of viable bacteriophage substantially decreased upon 
incubation with 0.1 and 1 % (w/v) Virkon solutions. No viable bacteriophage were detected in 1 
% (w/v) Virkon after a contact time greater than 1 minute (Figure 7.4). Incubation with 0.01 % 
(w/v) Virkon solution did not result in a significant drop in the concentration of viable 
bacteriophage over 20 minutes.    217 
 
The serially diluted control of 1 % (w/v) Virkon alone did not result in any alteration to 
bacterial lawn growth at any dilution. 
 
 
Figure 7.4 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at room temperature in 0 % (w/v) Virkon (!), 0.01 % (w/v) Virkon (!), 0.1 % 
(w/v) Virkon (#) and 1 % (w/v) Virkon (#). A value of 2 was added to every bacteriophage 
concentration, since log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
7.2.4  The effect of Virkon on E. coli viability 
Experimentation to study the effect of Virkon on E. coli cells was conducted as described in the 
Materials and Methods (Section 2.15.1). Virkon was added to overnight W1485 culture to give 
final concentrations of 0, 0.1, 0.5 and 1 % (w/v). Experiments were conducted at room 
temperature. Samples were taken for bacterial enumeration as described in the Materials and 
Methods (Section 2.5.1). 
 
Over the course of the twenty minute experiment the concentration of viable E. coli cells was 
significantly reduced by incubation at all three Virkon concentrations (Figure 7.5). At the 
lowest Virkon concentration" 0.1 % (w/v)" the concentration of viable cells decreased 
significantly after 5 minutes incubation (P=<0.01, Dunnett). After 20 minutes, it had decreased 
to a 0.24 fraction of that of the 0 % (w/v) Virkon control. The effect of greater Virkon 
concentrations on cell viability was more pronounced. At Virkon concentration of 0.5 and 1 % 
(w/v), no viable cells were detected after 5 minutes or more incubation.   218 
 
 
Figure 7.5 The change in concentration of viable E. coli as a function of time, when incubated 
at room temperature in 0 % (w/v) Virkon (!), 0.1 % (w/v) Virkon (!), 0.5 % (w/v) Virkon (#) 
and 1 % (w/v) Virkon (#). A value of 2 was added to every E. coli concentration, since log10(0) 
is undefined. Error bars represent the standard error, N=3. 
 
 
7.3   The Effect of Desiccation on Bacteriophage M13 and E. coli 
The effect of desiccation on bacteriophage M13 and E. coli Top10F' was studied as described in 
the Materials and Methods (Section 2.15.2). In summary, caesium chloride purified 
bacteriophage M13 solutions of concentration 10
13, 10
10, 10
7 and 10
4 pfu ml
-1 in NB2 were 
desiccated, as were 50 ml overnight cultures of M13 infected and non-infected E. coli cells in 
NB2. Desiccation was conducted in polystyrene round-bottomed 96-well plates loaded with 200 
!l of each sample. All loaded plates to be desiccated were first dried in a fume hood, necessary 
to rapidly remove the 200 !l of fluid in each well. Non-desiccated control plates were also 
prepared, sealed with a self-adhesive impermeable membrane and stored alongside the drying 
plates in the fume hood.  
 
Immediately after drying in the fume hood, half the plates were subsequently desiccated under 
dry (silica gel desiccator) conditions and half under standard (laboratory) conditions. Non-
desiccated control plates were stored alongside the dried plates. Desiccated plates were stored 
with their corresponding plate lids supported above the wells, allowing for air circulation 
beneath. At the desired timepoints, dried samples were rehydrated and resuspended with 200 !l 
20 mM Tris (pH 7.5 at 25 °C) per well. Non-desiccated control samples were simply   219 
resuspended. Bacteriophage and E. coli were enumerated by the surface droplet technique 
(Section 2.5.2). Triplicate cultures and bacteriophage dilutions were prepared and desiccated 
concurrently. 
 
The effect of the initial desiccation on E. coli and bacteriophage in the fume hood was 
investigated. It was noted that there was a significant drop in E. coli titre on drying, though not 
of bacteriophage M13. The drop in M13 infected E. coli titre was insignificant (Table 7.1). 
 
 
Table 7.1 The effect of the initial desiccation on the viability of E. coli Top10F' and 
bacteriophage M13 in a fume hood. Statistical analysis was conducted on log10 transformed 
data. 
 
Sample 
Pre-desiccation 
titre 
pfu/ cfu ml
-1 
Post-desiccation 
titre 
pfu/ cfu ml
-1 
P value 
(t-test) 
  M13 10
13 pfu ml
-1  1.2 x 10
13  1.2 x 10
13  0.84 
  M13 10
10 pfu ml
-1  1.3 x 10
10  9.8 x 10
9  0.15 
  M13 10
7 pfu ml
-1  1.3 x 10
7  9.8 x 10
6  0.18 
Caesium  
chloride purified 
bacteriophage M13 
in NB2    M13 10
4 pfu ml
-1  1.3 x 10
4  1.1 x 10
4  0.34 
 
     
M13 in Top10F' culture   8.1 x 10
11  6.9 x 10
11  0.28 
       
E. coli Top10F'   1.0 x 10
9  4.9 x 10
8  0.0002 
M13 infected E. coli Top10F'  2.5 x 10
8  3.6 x 10
7  0.09 
 
 
Over the course of the subsequent 47 day experiment the mean average relative humidity in the 
laboratory was 43.5 %, the median 43.9 %. Relative humidity ranged from 35.4 to 49.2 %. The 
mean average relative humidity in the desiccator was 5.6 % and ranged from 5.4 to 5.7 %. The 
relative humidity in the desiccator was measured to drop below 10 % within four hours and 
reached 5.5 % within 48 hours. The mean temperature was 22 °C. 
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7.3.1  The effect of desiccation on bacteriophage M13  
Figure 7.6 shows the change in measured bacteriophage concentration over the course of the 
experiment for all four starting concentrations of 10
13, 10
10, 10
7 and 10
4 pfu ml
-1. Table 7.2 
summarises the average count data at days zero and 47. It was observed that after 47 days the 
measured concentration of bacteriophage had significantly decreased in all cases from the zero 
timepoints under each of the desiccated dry, laboratory and non-desiccated conditions (Table 
7.3). 
 
Compared to the non-desiccated control the drops in titre from a bacteriophage concentration of 
10
13 pfu ml
-1 after 47 days were significantly greater when desiccated under laboratory 
(P<0.001, Tukey) and dry conditions (P<0.001, Tukey). Between these, the decrease in titre 
from desiccation under laboratory conditions was significantly greater than that from dry 
conditions (P<0.001, Tukey). However, at bacteriophage concentrations of 10
10, 10
7 and 10
4 pfu 
ml
-1, the drops in titre were not significantly different between all three conditions after 47 days. 
 
 
Figure 7.6 The change in concentration of viable caesium chloride purified M13 bacteriophage 
in NB2 as a function of time, when stored at room temperature under non-desiccated conditions 
(!), desiccated dry conditions (!), and desiccated laboratory conditions (#). The four starting 
bacteriophage concentrations were 10
13, 10
10, 10
7 and 10
4 pfu ml
-1. A value of 2 was added to 
every bacteriophage concentration, since log10(0) is undefined. Error bars represent the standard 
error, N=3.   221 
 
Table 7.2 Average count data comparing the viable bacteriophage M13 concentrations at 
desiccation days zero and 47 under non-desiccated, desiccated dry and desiccated laboratory 
conditions.  N=3. 
 
Bacteriophage concentration (pfu ml
-1)  Initial 
bacteriophage 
concentration 
(pfu ml
-1) 
Non- 
desiccated 
Desiccated, 
dry conditions 
Desiccated, 
laboratory 
conditions 
1.2 x 10
13  3.8 x 10
12  5.2 x 10
12  4.5 x 10
11 
9.8 x 10
9  4.8 x 10
9  5.7 x 10
9  3.1 x 10
9 
9.8 x 10
6  3.3 x 10
6  2.9 x 10
6  3.2 x 10
6 
1.1 x 10
4  3.2 x 10
3  3.3 x 10
3  3.6 x 10
3 
 
 
Table 7.3 Significance data comparing the viable bacteriophage M13 concentrations at 
desiccation days zero and 47 under non-desiccated, desiccated dry and desiccated laboratory 
conditions. Statistical analysis was conducted on log10 transformed data, N=3. 
 
P value (t-test)  Initial 
bacteriophage 
concentration 
(pfu ml
-1) 
Non- 
desiccated 
Desiccated, 
dry conditions 
Desiccated, 
laboratory 
conditions 
1.2 x 10
13  0.0001  0.037  0.0001 
9.8 x 10
9  0.001  0.003  0.006 
9.8 x 10
6  0.001  0.001  0.022 
1.1 x 10
4  0.001  0.0003  0.003 
 
 
Assuming an exponential decay trend, the half-life of purified bacteriophage M13 at each 
concentration under each desiccation condition was calculated using Equation 1: 
! 
T0.5 =
ln(2)
m
      (1) 
where T0.5 is the half-life, and m the gradient of the fitted trend line (linear on the plot of Figure 
7.6). The resulting half-lives are shown in Table 7.4. The shortest calculated half-life was 22 
days, corresponding with bacteriophage of initial concentration 10
13 pfu, desiccated under   222 
laboratory conditions. The longest half-lives were in excess of 100 days, achieved by 
desiccation under dry conditions. 
 
 
Table 7.4 Summary of the half-life data of purified bacteriophage M13 in NB2 desiccated 
under laboratory and dry conditions, together with non-desiccated control. Half-lives were 
calculated using Equation (1), applied to the data in Figure 7.6. 
 
Half-life of bacteriophage M13  
under each condition (days) 
Initial 
bacteriophage 
concentration 
(pfu ml
-1) 
Non-
desiccated 
Desiccated, 
dry conditions 
Desiccated, 
laboratory 
conditions 
1.2 x 10
13  68  115  22 
9.8 x 10
9  79  120  50 
9.8 x 10
6  61  71  57 
1.1 x 10
4  75  70  62 
 
 
7.3.2  Effect of desiccation on bacteriophage M13 in culture 
The desiccation conditions affected the rate of decay of bacteriophage M13 titre in Top10F' 
culture (Figure 7.7). Here, the bacteriophage titre decreased most when desiccated under 
laboratory conditions and least when non-desiccated. After 47 days the bacteriophage titres had 
significantly decreased relative to the corresponding zero timepoints when desiccated under dry 
(P=0.005, t-test) and laboratory (P=0.00004, t-test) conditions. Conversely, there was no 
significant decrease in bacteriophage titre when stored under non-desiccated conditions. After 
47 days the bacteriophage titre was not significantly different between desiccated laboratory and 
dry conditions. However, the bacteriophage titre under each of these treatments was 
significantly lower than under non-desiccated conditions after 47 days (P<0.001 in each case, 
Tukey). 
 
Using Equation (1), the half-life of bacteriophage M13 was calculated for each of the trends in 
Figure 7.7. It was calculated that under non-desiccated conditions, the half-life was 182 days, 
under desiccated dry conditions it was 74 days, and under desiccated laboratory conditions 38 
days. 
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Figure 7.7 The change in concentration of viable M13 bacteriophage in E. coli Top10F' culture 
as a function of time, when stored at room temperature under non-desiccated conditions (!), 
desiccated dry conditions (!), and desiccated laboratory conditions (#). A value of 2 was 
added to every bacteriophage concentration, since log10(0) is undefined. Error bars represent the 
standard error, N=3. 
 
 
7.3.3  The effect of desiccation on E. coli  
It was observed that there was a marked effect of desiccation on the titre of E. coli strain 
Top10F'. The titre of non-infected cells dropped considerably over the 47 day experiment 
(Figure 7.8): the viable cell count dropped from 5.2 x 10
8 cfu ml
-1 at the zero timepoint to 4.8 x 
10
2 cfu ml
-1 after desiccation under laboratory conditions. Under dry conditions, it dropped from 
4.4 x 10
8 cfu ml
-1 at the zero timepoint to 1.2 x 10
5 cfu ml
-1. However, under non-desiccated 
conditions the drop in titre was only from 5.1 x 10
8 cfu ml
-1 at the zero timepoint to 9.4 x 10
7 
cfu ml
-1 after 47 days  
 
Over 47 days the decline in viability of M13 infected cells was similarly large (Figure 7.9). The 
greatest decline in titre was again observed for cells desiccated under laboratory humidity 
conditions, where the cell titre declined from 2.7 x 10
7 cfu ml
-1 at the zero timepoint to 6.2 x 10
2 
cfu ml
-1 over 47 days. Over the same time span the viability decline under dry conditions was 
from 9.5 x 10
6 cfu ml
-1 at the zero timepoint to 2.8 x 10
3 cfu ml
-1. When stored under non-
desiccated conditions, the drop in titre was only from 1.9 x 10
8 cfu ml
-1 at the zero timepoint to 
8.6 x 10
7 cfu ml
-1. 
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Figure 7.8 The change in concentration of viable E. coli Top10F' cells as a function of time, 
when stored at room temperature under non-desiccated conditions (!), desiccated dry 
conditions (!), and desiccated laboratory conditions (#). A value of 2 was added to every E. 
coli concentration, since log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
Figure 7.9 The change in concentration of viable M13 infected E. coli Top10F' cells as a 
function of time, when stored at room temperature under non-desiccated conditions (!), 
desiccated dry conditions (!), and desiccated laboratory conditions (#). A value of 2 was 
added to every E. coli concentration, since log10(0) is undefined. Error bars represent the 
standard error, N=3. 
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Again using Equation (1), the half-life of E. coli Top10F' was calculated for each of the trends 
in Figure 7.8 and Figure 7.9. It was calculated that under non-desiccated conditions, the half-life 
was E. coli Top10F' was above 100 days, i.e. the decline in viability over the 47 day treatment 
was small (Table 7.5). Upon desiccation, there was little observed difference between the half-
lives of infected and non-infected E. coli cells under each desiccation condition: 8 days and 6 
days respectively under laboratory conditions, 10 days each under dry conditions. 
 
 
Table 7.5 Summary of the half-life data of E. coli Top10F' desiccated under laboratory and dry 
conditions, together with non-desiccated control. Half-lives were calculated using Equation (1), 
applied to the data in Figure 7.8 and Figure 7.9. 
 
Half-life of E. coli under each condition (days) 
E. coli 
culture type  Non-desiccated 
Desiccated, dry 
conditions 
Desiccated, 
laboratory 
 condition 
Non-infected  100  10  6 
M13 infected  173  10  8 
 
 
7.4  The Effect of Extremes of pH on Bacteriophage M13 
Caesium chloride purified bacteriophage M13 was subject to a range of pH values as described 
in the Materials and Methods (Section 2.15.3). In summary, 100 !l of bacteriophage M13 of 
concentration 1 x 10
13 pfu ml
-1 in NB2 was added to 9.9 ml of acid or alkali solution at room 
temperature. Samples were taken after 1, 5, 10 and 20 minute incubations, neutralised (Section 
2.15.3) and enumerated by the surface droplet technique. Experiments were repeated three 
times. 
 
Two experiments were conducted. In the first experiment, bacteriophage M13 was subject to 
incubation at pH 1.0, 3.0, 7.0, 11.0 and 13.0. It was found that exposure to pH 3.0, 7.0 or 11.0 
did not result in a significant reduction in infective titre over the course of 20 minutes (Figure 
7.10). Upon incubation at pH 1.0, the titre had decreased significantly from the pH 7.0 control 
by 5 minutes incubation (P<0.01, Dunnett). After 20 minutes, the titre has decreased 300-fold to 
4.7 x 10
8 pfu ml
-1. At pH 13.0, however, the titre decreased by seven orders of magnitude by the 
first 1 minute timepoint, and continued to decrease as time progressed.   226 
 
Figure 7.10 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at room temperature at pH 1.0 (!), 3.0 (!), 7.0 (#), 11.0 (#) and 13.0 ($). A 
value of 2 was added to every bacteriophage concentration, since log10(0) is undefined. Error 
bars represent the standard error, N=3. 
 
 
In the second experiment, bacteriophage M13 was subject to incubation under acidic and 
alkaline conditions representative of those used for the pH control of pilot-scale fermentations. 
Here, concentrated acid and alkaline solutions are typically connected directly to the fermenter 
by flexible hoses and fed in as required under computer control. As such, during the course of a 
fermentation bacteriophage may be expected to be in contact with the acid and base lines. 
Bacteriophage M13 was therefore incubated with 10 % (v/v) sulphuric acid (pH 0.0) solution 
and 4 M sodium hydroxide (pH 14.0) solutions to investigate the ability of the bacteriophage to 
survive these conditions. It was found that by the 5 minute timepoint there were no detected 
bacteriophage in either the 10 % (v/v) sulphuric acid or 4 M sodium hydroxide solutions (Figure 
7.11). Indeed, no bacteriophage were detected in the 4 M sodium hydroxide solution by the first 
1 minute sample. 
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Figure 7.11 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at room temperature with 10 % (v/v) sulphuric acid (!), at pH 7.0 (#) and with 
4 M sodium hydroxide (!). A value of 2 was added to every bacteriophage concentration, since 
log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
7.5  The Effect of Temperature on Bacteriophage M13 
Caesium chloride purified bacteriophage M13 of concentration 1 x 10
12 pfu ml
-1 in NB2 was 
incubated at a range of temperatures in a PCR block as described in the Materials and Methods 
(Section 2.15.4). In summary, 50 !l aliquots of bacteriophage solution were incubated at 99, 95, 
90, 80, 70, 60, 50, 40, and 25 °C, together with a room temperature control not incubated within 
the device. Single aliquots were removed after 1, 5, 10, 20, 30, 40, 50 and 60 minute 
incubations, cooled and enumerated by the surface droplet technique. Experiments were 
repeated three times. 
 
It was found that decreases in bacteriophage M13 titre of several orders of magnitude occurred 
upon incubation at temperatures above 80 °C (Figure 7.12). There were no detected 
bacteriophage after 20 minutes incubation at 99 °C and 50 minutes at 95 °C. At 90 °C there was 
an eight order of magnitude drop in titre over 60 minutes. However, a 60 minute incubation at 
80 °C only decreased the titre from 6.0 x 10
11 pfu ml
-1 to 1.5 x 10
11 pfu ml
-1. Incubation at 
progressively lower temperatures resulted in correspondingly smaller decreases in titre relative 
to the room temperature control (Figure 7.13). Indeed, even after incubation at 70 °C the 
bacteriophage viability did not diverge significantly from the room temperature control over the 
entire 60 minute experiment.   228 
 
Figure 7.12 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at temperatures 99 °C (&), 95 °C ("), 90 °C ("), 80 °C (#), 70 °C ($) and 
room temperature (+). A value of 2 was added to every bacteriophage concentration, since 
log10(0) is undefined. Error bars represent the standard error, N=3. 
 
 
 
 
Figure 7.13 The change in concentration of viable bacteriophage M13 as a function of time, 
when incubated at temperatures 60 °C (#), 50 °C (#), 40 °C (!), 25 °C (!) and room 
temperature (+). A value of 2 was added to every bacteriophage concentration, since log10(0) is 
undefined. Error bars represent the standard error, N=3.   229 
7.6  Derivation of Modified Standard Operating Procedures to Minimise 
Bacteriophage Release at the 20 L Fermentation Scale. 
The UCL Department of Biochemical Engineering hosts extensive fermentation and 
downstream processing facilities, enabling study at scales close to those used in industry. These 
facilities are necessarily mixed-use; the bioprocessing of various strains of E. coli and S. 
cerevisiae are routine. The purpose of this section is to derive a practical method for the 
fermentation of bacteriophage M13 in such a facility whilst minimising the risk of release. 
 
7.6.1  Applikon 20 litre fermenter 
This study investigates the fermentation of bacteriophage using an existing piece of plant 
equipment: the Applikon 20 litre capacity stirred tank reactor. This particular fermenter is 
sterilisable in situ, and as such requires connection to a steam supply. Connection to a cooling 
water supply is also necessary for normal fermentation temperature regulation and off-gas 
condenser functionality. Sterilisation and operation of the fermenter is assisted by computer 
control, and is therefore semi-automatic. In the sterilisation cycle the fermenter will 
automatically heat to 121 °C, but user action is required to steam sterilise the associated 
pipework, such as the sample, harvest and addition lines. During normal operation, automatic 
control of pH and temperature is routine, whilst air flow-rate and stirrer speed are manually 
controlled as standard. Proprietary "BioXpert" software is loaded onto an attached PC, and 
allows for variable control and data logging during operation. A photograph and schematic 
drawing of the fermenter is shown in Figure 7.14. It can be seen that the air supply to the 
fermenter is filtered (typically 0.22 µm) to prevent contamination of the fermenter contents, and 
the air exit supply is similarly filtered to prevent escape of micro-organisms. The pH of the 
fermenter is controlled by automatic addition of acid and base through two lines at the top of the 
fermenter. Typically, 10 % (v/v) sulphuric acid and 4 M sodium hydroxide are used. A third 
connection allows for the manual addition of antifoam to the fermenter (polypropylene glycol of 
average molecular weight 2 000). The addition port lies above the fluid level in the fermenter 
and allows for the introduction of inocula or other additions (such as broth, carbon source or 
inducer) at any point during the fermentation via a steam-sterilisable connection. Small fluid 
samples can be taken from the sample port during the course of the fermentation, and the larger 
harvest port allows for the drainage of the vessel.   230 
 
Figure 7.14 The 20 litre Applikon fermenter. (A) shows a photograph of the equipment, (B) a 
schematic diagram. The working volume is 15 litres. 
 
 
7.6.2  Update of Standard Operating Procedures 
A Standard Operating Procedure (SOP) is a set of written instructions that documents a routine 
or repetitive activity followed within an organisation (Sherwood, 1996). As such, an SOP exists 
for the routine sterilisation and operation of the Applikon 20 litre fermenter, as does every 
fermenter within the facility. The development and use of SOPs is an essential part of the 
successful operation of plant equipment, since they provide users with the information needed 
to perform each task correctly and consistently. Therefore, within manufacturing organisations 
SOPs form an important component of achieving Good Manufacturing Practice (GMP) 
(Sherwood, 1996). 
 
The existing SOP for the Applikon 20 litre fermenter was studied with a view to adapting it for 
the particular needs of a bacteriophage fermentation (SOP 45, see Appendix B). Four key points 
were noted from data gained in Sections 7.2- 7.5 to highlight areas within the existing SOP 
which may require modification. These points were: 
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1.  Virkon (1 % (w/v) solution) is an effective bacteriophage M13 and E. coli 
decontamination agent (Section 7.2). TEGO and Solquest are inadequate for 
bacteriophage M13 inactivation. 
2.  Bacteriophage M13 and E. coli are relatively desiccation resistant, therefore release 
(particularly by means of aerosolisation) should be avoided (Section 7.3). 
3.  The acid and alkali lines to the fermenter should be self-sterilising, due to the 
demonstration that bacteriophage M13 can be inactivated by exposure to such 
conditions (Section 7.4). 
4.  Bacteriophage M13 is sensitive to elevated temperatures, particularly above 99 °C 
(Section 7.5). Therefore, steam-based sterilisation of the fermenter should be 
effective provided that it is verified (by temperature mapping) that all contaminated 
parts will reach in excess of 100 °C for at least 20 minutes. 
 
The assumption was made that the fermentation area would continue to be used for unrelated 
experimentation on permissive bacterial strains. Therefore, in conjunction with the plant 
manager, several modifications were made to the existing SOP for the operation of the 
Applikon 20 litre fermenter (Table 7.6). The chief alterations concerned the avoidance of 
actions that may result in the aerosolisation of fermentation fluid. Further, areas such as 
inoculation, sampling and harvesting were described in greater depth, such that separate SOPs 
were defined for each. Finally, an SOP was written to describe the remedial actions required if 
accidental spillage of bacteriophage-containing fermentation fluid occurred. The practicality of 
each of the new methods was verified by a "blank" fermentation run, filled with RO water. 
   232 
 
Table 7.6 Details of the major changes made to the standard operating procedure (SOP) for the 
sterilisation and operation of the 20 L Applikon fermenter. The SOP references given in the 
Document Reference column refer to the new SOP document. SOP documents can be found in 
Appendix C. 
 
Action  Standard method  Revised Method 
Document 
Reference 
Fermenter 
inoculation 
Inoculum transfer (shake-flask 
culture to fermenter addition 
flask) occurs in the 
fermentation suite. 
Inoculum transfer is conduced in 
a separate laboratory. Flask 
surfaces are 1 % (w/v) Virkon 
treated before introduction to 
facility. 
SOP 45/P2 
       
Fermentation 
sampling 
method 
Samples of fermentation fluid 
are collected from sample port 
into open 25 ml 
polypropylene tubes. 
Sterile silicone tubing is attached 
to sample port with Robertsite
TM 
needleless valve. Samples are 
drawn through the valve into a 
sterile polypropylene syringe. 
The junction is surrounded by 
paper towel dampened with  
1 % (w/v) Virkon. 
SOP 45/P3 
       
Fermentation 
harvesting 
method 
Fermentation fluid is 
harvested into a connected 20 
litre capacity Nalgene 
container without air exit 
filters. The harvest line end is 
exposed upon Nalgene 
disconnection. 
0.22 µm filter is attached to the 
Nalgene container. To 
disconnect, silicone harvest line 
is double clamped under 1 % 
(w/v) Virkon solution and cut 
between clamps. Incubated for 10 
minutes to sterilise. 
SOP 45/P4 
      (cont.) 
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Action  Standard method  Revised Method 
Document 
Reference 
Fermentation 
post-culture 
sterilisation 
procedure 
Acid, base and antifoam lines 
are disconnected, and steam is 
vented directly from 
fermenter chamber into the 
plant area. 
Acid, base and antifoam lines are 
closed but not disconnected due 
to contamination in fermenter 
chamber. No direct venting from 
fermenter chamber to 
surroundings occurs. 
SOP 45/P1 
       
Fermentation 
post-culture 
sterilisation 
procedure 
In the event of an emergency 
shutdown during sterilisation, 
pressure is released by venting 
from the fermentation 
chamber into the plant area 
via one of the 
acid/base/antifoam ports. 
A 1 litre Nalgene container with 
0.22 µm air exit filter is 
connected to fermenter addition 
port prior to the fermentation 
sterilisation procedure. If 
emergency venting is required, it 
will be into this container. 
SOP 45/P1 
       
Fermentation 
post-culture 
sterilisation 
procedure 
Steam is vented directly from 
sample port into plant area to 
sterilise. 
 
A 1 litre Nalgene container with 
0.22 µm air exit filter is 
connected to sample port during 
fermentation sterilisation 
procedure.  
SOP 45/P1 
       
Fermentation 
post-culture 
sterilisation 
procedure 
Steam is vented directly from 
harvest port into plant area to 
sterilise. 
 
A 20 litre Nalgene container with 
0.22 µm air exit filter is 
connected to harvest port during 
fermentation sterilisation 
procedure.  
SOP 45/P1 
 
 
The SOP document describing the remedial actions required if accidental spillage of 
bacteriophage-containing fermentation fluid occurred (SOP 45/P5, see Appendix C) was written 
for spillages of three scales. Spillages of the few millilitre scale should be treated with 1 % 
(w/v) Virkon solution and left for 10 minutes. Spillages of the tens of millilitre scale should be 
treated with Virkon power directly, following the manufacturer's instructions. Spillages of the 
litre scale should also be treated with Virkon power directly, but the area subsequently requires 
monitoring at regular intervals for confirmation of bacteriophage control. If persistent infection   234 
of subsequent cultures in the facility occurs in the following months, then hydrogen peroxide or 
formaldehyde fumigation of the facility may need to be considered. 
 
7.6.3  Evaluation of risk 
With the modified SOPs in place, an overall evaluation of the risk of bacteriophage release from 
the fermenter was conducted. This was considered to be a useful further step in the risk 
management process, and as such was conducted in the style of a Risk Assessment. Therefore, 
the potential hazards were identified and an assessment made of the likelihood of occurrence 
together with the potential severity of the outcome. Finally, the control measures taken were 
described to minimise the risk of bacteriophage release.  
 
Principally, it was identified that the remaining areas of potential culture release stemmed from 
silicone line leaks (inoculation, sample or harvest lines) or inoculum flask or harvest container 
failure (Appendix D). It was concluded that careful checking and renewal of silicone lines prior 
to inoculation would mitigate the risk of line leak. It was also concluded that release of 
bacteriophage from the inoculum flask remained one of the most likely release points. 
Mitigating actions included flask transport in a secure manner, and the use of plastic (rather than 
glass) flasks. The 20 litre capacity Nalgene harvest container was identified as presenting the 
greatest consequences in the event of bacteriophage release, due to the large post-fermentation 
volumes being handled, although the likelihood of this occurring was considered small. The 
mitigating action was identified as proper adherence to SOP 45/P4, which was updated to 
stipulate the checking of the plastic container and silicone line for damage before use. 
 
 
7.7  Discussion 
The purpose of this chapter was to investigate several physical and chemical challenges to 
bacteriophage M13 and E. coli to assist in their safe introduction to a mixed-use facility. This 
experimentation gave context to the derivation of a method for the contained propagation of 
bacteriophage at the 20 litre scale in the UCL Department of Biochemical Engineering 
fermentation suite. Several SOPs incorporating additional measures preventing bacteriophage 
release were then derived.  
 
7.7.1  Determination of an effective decontamination agent 
That bacteriophage are small, infectious particles makes the determination of efficient control 
methods important. Therefore, an investigation into effective decontamination agents against 
bacteriophage M13 (and E. coli) was conducted. The results showed the importance of 
experimentation (Section 7.2): the performance of the three agents tested was found to vary 
considerably. The least effective agent was Tego. After a twenty minute exposure time the   235 
maximum bacteriophage inactivation was only 85 %, at a Tego concentration five-fold more 
concentrated than that used as standard in the department. Solquest proved more effective, albeit 
also at concentrations five-fold greater than that used as standard. Total bacteriophage 
inactivation was only achieved for 5 % (v/v) Solquest at 70 °C. From a practical standpoint the 
performance was not sufficiently effective. Specifically, the concentration of Solquest was 
relatively high and performance was very dependent on temperature: it was found that 5 % (v/v) 
Solquest at 50 °C was not measured to inactivate all the bacteriophage over the twenty minute 
experiment. The use of a surface disinfectant agent that is only effective at 70 °C is not realistic. 
In contrast, Virkon proved effective at inactivating all bacteriophage within one minute at the 
standard working concentration" 1 % (w/v)" at room temperature. Furthermore, no viable E. 
coli cells were detected within five minutes incubation with Virkon of the same concentration. 
The effectiveness of Virkon was perhaps to be expected: Virkon is widely marketed as a "broad 
spectrum" bactericidal, fungicidal and virucidal agent with use in the veterinary, agriculture, 
hospital and laboratory arenas (Dunowska et al., 2005; Moreton and Delves, 1999). 
Specifically, Virkon effectiveness against several other bacteriophage has been demonstrated in 
the literature (Barrow et al., 1998; Halfhide et al., 2008). In conclusion, Virkon was considered 
to be the disinfectant of choice for all bacteriophage M13 experimentation, and was specifically 
included in the SOP written for clean-up of bacteriophage spillages. 
 
7.7.2  The effect of desiccation on bacteriophage M13 and E. coli 
Bacteriophage M13 was shown to be remarkably resistant to desiccation: the shortest half-life 
observed out of all treatments was 22 days, although half-lives in excess of 50 days were 
typical. The longevity of M13 was found to depend on the conditions of desiccation. In all 
treatments desiccation under laboratory conditions (45 % relative humidity) resulted in shorter 
half-lives than dry conditions (6 % relative humidity). These results are consistent with reports 
linking bacteriophage survival to desiccation to the relative humidity: generally, survival at 
moderate humidity (30- 50 %) is poorer than either high or low humidity environments (Abad et 
al., 1994; Songer, 1967). Whilst desiccation studies on bacteriophage vary considerably in the 
methods of drying and the conditions imposed, it has been found that several other 
bacteriophage similarly display a strong resistance to desiccation (Iriarte et al., 2007; Jepson 
and March, 2004; Prouty, 1953; Schade and Caroline, 1944). In the context of the long-term 
storage of a bacteriophage-based product, such stability is beneficial. However, from the 
standpoint of bacteriophage persistence in the laboratory space, such resistance indicates that it 
is indeed important to take steps to prevent their release, particularly on the large-scale. That 
said, the desiccation experimentation conducted in this study is likely to overestimate the 
survivability of bacteriophage M13; desiccation was conducted under dark stagnant conditions. 
Under less controlled conditions, other sources such as low-level UV irradiation (to which   236 
bacteriophage M13 is sensitive) are likely to contribute towards its degradation (Kurosaki et al., 
2003).  
 
In comparison to bacteriophage M13, the desiccation survival of E. coli Top10F' was relatively 
poor. The half-life under laboratory conditions was only six days. The rate of inactivation of 
dried cells is known to depend on many factors, including the cell growth phase, cell 
concentration, drying method and storage conditions (Lievense and van't Riet, 1993). Overall 
however, in terms of concern for bacteriophage M13 persistence in the laboratory, these results 
suggest that the bacteriophage is itself more of a contamination concern than the infected host.  
 
7.7.3  The effect of extremes of pH on bacteriophage M13 
In this study, bacteriophage M13 was found to be completely stable when incubated for twenty 
minutes in solutions of pH 3.0 to 11.0, a result in close agreement with existing literature 
(Marvin and Hohn, 1969). Stability over such a broad pH range is not confined to bacteriophage 
M13, however. Studies on the pH stability of bacteriophage ! suggest that it is a similarly 
robust particle (Jepson and March, 2004). Nevertheless, the key purpose of this study was to 
provide experimental support for the procedures necessary for the contained fermentation of 
bacteriophage M13. Since bacteriophage M13 was completely inactivated within five minutes 
exposure to 4 M sodium hydroxide or 10 % (v/v) sulphuric acid, it could be subsequently 
determined that the acid and base lines to a 20 litre fermentation of bacteriophage M13 should 
be "self sterilising" with regards to the bacteriophage. With regards to the E. coli host, existing 
literature states that the range of survival lies approximately between pH 2 and pH 10.5 (Lin et 
al., 1995; Small et al., 1994). Therefore, providing the lines were completely "primed" (that is, 
filled with acid or base from the reservoir to the fermenter) before disconnection, no special 
measures needed be taken for the decontamination of bacteriophage or E. coli. 
 
7.7.4  The effect of temperature on bacteriophage M13 
The assessment of the thermal resistance of bacteriophage M13 also aimed to support 
procedures for the prevention of bacteriophage release during fermentation in the 20 litre 
Applikon fermenter. In particular, the air exit filter from the fermenter has the potential to 
become blocked from excess moisture during normal operation, thereby preventing the 
subsequent passage of steam through the condenser and filter assembly. The result is that 
instead of the normal sterilising temperature of 121 °C, temperatures only of the order 100 to 
110 °C can be achieved (confirmed by temperature mapping) (Orsborn, 2007, UCL Department 
of Biochemical Engineering, pers. comm.). Since it was found that bacteriophage M13 was 
inactivated within 20 minutes of heating to 99 °C, and E. coli thermal death above 70 °C is of 
the order of seconds (Mazzotta, 2001), it is likely that such a scenario would still allow for 
component sterilisation.   237 
 
7.7.5  Evaluation of challenge experimentation 
The challenge experiments conducted in this study were of the "time kill" variety, where 
bacteriophage M13 or E. coli were exposed to challenges for a certain period before 
neutralisation. Following this, survivors within the test solutions were directly enumerated. For 
desiccation, pH and elevated temperature treatments, the neutralisation of the challenge was 
trivial: rehydration, pH neutralisation or cooling. But neutralisation of chemical antimicrobial 
agents presented more of a challenge. For bacterial studies, there is the option of cell capture by 
filtration, but no similarly straightforward capture of bacteriophage was possible. Instead, 
"neutralisation" of detergent was achieved by 100-fold dilution of the test solution, which was 
found to be appropriate since no detergent was effective when diluted by this amount. An 
alternative strategy could have been to employ a version of "fraction-negative" determination, 
where small samples of the bacteriophage test solution are diluted into growth media, inoculated 
with cells and allowed to propagate (McDonnell, 2007). The fraction of cultures that avoid 
bacteriophage infection thus allows the concentration of the original bacteriophage solution to 
be deduced. Versions of each of the tests outlined here are embodied in guidelines established 
by the (U.S. based) Association of Official Analytical Chemists (AOAC) (Sarli, 2007). 
 
7.7.6  Derivation of modified standard operating procedures 
Overall, the experiments challenging bacteriophage M13 to detergents, desiccation, pH and 
temperature provided useful evidence for the modifications required to the standard Applikon 
fermenter SOP. The five resulting SOPs covering inoculation, operation and sterilisation, 
sampling, harvesting and remedial action against spillages were aimed to minimise 
bacteriophage release from the fermenter and reduce the likelihood of affecting any unrelated 
work in the plant. Any new SOP will require rounds of modification and improvement, and the 
SOPs written for bacteriophage fermentation were no exception. Each was subject to two 
rounds of review. The first followed a blank fermentation, principally allowing for the 
practicality of the prescribed alterations to be tested. The second followed the Risk Assessment 
document, where each fermentation action was analysed for its effectiveness in controlling the 
potential for bacteriophage release. Further rounds of review and modification are to be 
expected. Nevertheless, the process of risk evaluation was an extremely useful tool. The process 
of assessing of the likelihood of a release occurring together with the potential severity of the 
outcome highlighted some hazards (such as harvest vessel failure) which may otherwise have 
been overlooked.  
 
The containment of a large-scale bacteriophage process would be assisted by the careful 
consideration of plant design (e.g. air flow, layout, non-shared facilities) and the equipment 
used (minimisation of aerosol generation, contained design). However, the ability to control all   238 
these design aspects is not always possible, particularly regarding budgetary, building or time 
constraints (Litman, 1997). Instead, sensible utilisation of selected existing equipment, 
modification of operating procedures, and adherence to high standards of facility hygiene, 
equipment sterilisation and good microbial practice may prevent unwanted bacteriophage 
release, cross-contamination and propagation.  
 
7.7.7  Concluding remarks 
The work presented in this chapter goes some way towards the contained propagation of 
bacteriophage M13 in the Department of Biochemical Engineering pilot-scale facility. The 
process of experimentation, SOP derivation and risk evaluation followed here was conducted 
with bacteriophage M13 in mind. However the process itself is general and is therefore 
applicable for the fermentation of most bacteriophage.  
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8  Overall Discussion 
Some of the most pressing health issues of our time demand the development of new and stable 
antibiotics and vaccines. Globally, malaria causes up to three million deaths per year (Breman, 
2001) and 30 million people are living with HIV-AIDS (Merson, 2006). Meanwhile, the cost of 
antibiotic resistance is estimated at $7.7 billion in the USA alone (Reed et al., 2002). Recent 
reports on the use of bacteriophage-based tools and therapies to tackle these important diseases 
are extremely encouraging, although many investigations are at an early stage (Demangel et al., 
1998; Sathaliyawala et al., 2006; Wright et al., 2009). It is clear, however, that there is a large 
potential demand for successful therapies. It is perhaps timely that public and commercial 
awareness of bacteriophage is gaining momentum in light of the latest scientific advances in the 
field and as the first bacteriophage products come to market. As such, there is now a clear and 
growing need for the establishment of strong biochemical engineering foundations to serve as a 
guide for future bioprocessing. It has been the purpose of this study to contribute towards this 
knowledge base. 
 
Five aspects of large-scale filamentous bacteriophage production were investigated in this 
study, each with a corresponding thesis objective. The knowledge gained in fulfilling these 
objectives will now be discussed. 
 
8.1  Objective 1: Evaluate the Effect of Hydrodynamic Shear on the 
Filamentous Bacteriophage Particle 
The intensity of fluid flow over critical structures within large-scale process equipment has 
often been characterised in terms of the associated maximum energy dissipation rate (W kg
-1) 
(Hutchinson et al., 2006; Mollet et al., 2004). This has allowed for the identification of the 
types of process equipment that are likely to be the most damaging to the processed biologics 
within. This is important because considerable variation in fluid stress can occur even between 
types of process equipment that otherwise serve the same function (Boychyn et al., 2004). For 
common pieces of process equipment the magnitude of the energy dissipation rate increases in 
order from stirred fermentation vessels (10
2 W kg
-1) to pumps (10
4 - 10
5 W kg
-1), continuous 
centrifuges (10
5 W kg
-1) and finally homogenisers (10
7- 10
8 W kg
-1) (Yim and Shamlou, 2000). 
It is perhaps of no surprise that homogenisers, frequently used to disintegrate micro-organisms, 
are associated with imparting the greatest energy dissipation rate on the process fluid. 
 
Extensive literature exists demonstrating the sensitivity of many biological products to the 
hydrodynamic shear forces within process equipment, USD devices, or both. For example, 
entities such as fungal hyphae and filamentous bacteria have been demonstrated to be directly 
damaged within stirred fermentation vessels (Heydarian et al., 2000; Li et al., 2000).   240 
Meanwhile, plasmid DNA of size 20 kb and above has been shown to be sensitive to the action 
of pumps and continuous centrifuges (Zhang et al., 2007), and by a rotating disk USD device 
imparting a similar energy dissipation rate (Levy et al., 1999b). Furthermore, hydrodynamic 
shear damage to mammalian cells (Hutchinson et al., 2006) and protein precipitates (Boychyn 
et al., 2001) have been demonstrated at the USD scale and verified by experimentation with 
pilot scale process equipment. Finally, whole antibodies have been shown to be shear sensitive 
from experimentation at the USD scale (Biddlecombe et al., 2007). 
 
However, until now no such data has existed for bacteriophage. It was therefore of concern that 
bacteriophage M13 may also prove extensively shear sensitive, since each virus is in effect a 
large protein rod 200- 400 times that of the average globular protein (Schmidt et al., 2000) and 
of contour length approaching the characteristic dimensions of a supercoiled 20 kb plasmid 
(Arulmuthu et al., 2007). If so, this would have important implications for the processability of 
filamentous bacteriophage-based products; severe susceptibility to hydrodynamic shear forces 
could in theory constrain the choice of unit operations, and hamper the purification of the 
product. 
 
This study has provided the first evidence of the response of bacteriophage M13 to 
hydrodynamic shear forces. Using the USD shear device, it was found that exposure to a 
maximum energy dissipation rate of 1.8 x 10
5 W kg
-1 did not reduce bacteriophage viability over 
25 minutes. This suggests that unit operations such as pumps and stirred fermentation vessels 
may not cause any damage to bacteriophage M13, since the maximum energy dissipation rates 
associated with these unit operations are lower than this threshold level. At higher energy 
dissipation rates (up to 3.1 x 10
5 W kg
-1) bacteriophage damage was found to occur. However, 
the loss of 60- 90 % of viability occurred over 25 minutes, which is a considerable period. In 
comparison, the exposure time to the similarly shear-intensive feed-zone of a continuous 
centrifuge is only of the order of a fraction of a second (Byrne et al., 2002). Therefore, even 
repeated exposure to continuous centrifugation (or even high-shear ancillary pumps) over the 
course of a bioprocess is probably unlikely to approach the 25 minute treatment time studied. 
Large-scale verification of these predications would be the next logical step to take. 
Furthermore, USD and large-scale experimentation could examine the effect of exiting a 
continuous centrifuge; impaction effects can occur on both the exiting clarified process fluid 
and (depending on the design) the dewatered sediment (Chan et al., 2006; Tustian, 2008). A 
study on E. coli, at least, showed impaction damage linearly increasing with discharge velocity 
up to a maximum of 85 ms
-1 with 6 % cell breakage (Chan et al., 2006). The actual discharge 
velocity will depend critically on the design of the centrifuge, making prediction of the likely 
response of M13 difficult. However, since bacteriophage M13 is of smaller size and mass than 
an E. coli cell, it may be feasible that impaction damage could be correspondingly less.   241 
 
Of further use to process design was the testing of bacteriophage M13 in several process fluid 
environments, including post-fermentation process fluid (with and without E. coli cells), post-
precipitation (with polyethylene glycol) and post-purification (in buffer). This work 
demonstrated a dependence of the hydrodynamic shear resistance of bacteriophage M13 on the 
state of the process fluid. After a 25 minute treatment to 3.1 x 10
5 W kg
-1 (the maximum 
studied), the remaining bacteriophage viability was found to increase in the order of culture 
supernatant (0.12) < post-precipitation (0.25) < post-purification (0.38)< culture medium with 
cells (0.39). It was also determined that shear-related damage to bacteriophage M13 could be 
halved by the prevention of air-liquid interfaces. That is, over 25 minutes, the viability loss of 
purified bacteriophage M13 was reduced from 60 % loss to only 20 %, providing useful 
bioprocessing knowledge for bacteriophage M13 that already existed for plasmid constructs. 
Here, it has been demonstrated that under conditions resulting in a maximum energy dissipation 
rate of 1.4 x 10
5 W kg
-1 (less than that in this study), air-liquid interfaces decreased 20 kb 
plasmid supercoiling by as much as a factor of 10 within 5 seconds exposure (Levy et al., 
1999b). 
 
The hydrodynamic shear data has two important implications for the large-scale bioprocessing 
of bacteriophage M13.  Firstly, it indicates that a decision to use fermentation, pumping or 
continuous centrifugation steps can be mainly made on the basis of cost and/or effectiveness, 
rather than particle fragility. In contrast, selection of continuous centrifugation conditions for 
fragile molecules (such as >20 kb supercoiled plasmids) can involve a trade-off between 
clarification achieved and product damage (Levy et al., 2000b). Secondly, it is important to note 
that the extent of damage caused to (otherwise similar) particles by hydrodynamic shear is often 
closely related to its size (Levy et al., 1999b). In this study, wild-type bacteriophage M13 of 
contour length 900 nm was examined for shear-resistance, but the results have implications for 
the processability of M13 derivatives, namely phagemids. Since the genetic material within a 
phagemid does not encode for the entire bacteriophage particle (the necessary genes are 
provided by helper phage superinfection, see Chapter 1, Section 1.3.3), phagemids are typically 
of half the contour length of wild-type viruses (Khalil et al., 2007). Therefore it is highly likely 
that phagemids will be equally resistant to, if not more than, hydrodynamic shear in the 
bioprocess. 
 
The benefits of the ultra scale-down approach to this study are apparent. This technique tested 
several process fluids at many energy dissipation rates, allowing for a fuller characterisation of 
the bacteriophage whilst using only small amounts of material. The rotating-disk shear device 
has potential as a decisional tool in bacteriophage bioprocess design, in a similar fashion to that 
found for other complex macromolecules (Boychyn et al., 2001; Zhang et al., 2007).   242 
 
8.2  Objective 2: Investigate the Fermentation and Harvesting of 
Bacteriophage M13 
The fermentation step is unique in the bioprocess since it presents the only opportunity for the 
biochemical engineer to increase product yield, rather than just minimise losses. As noted in the 
Introduction (Section 1.6.1), the primary purpose of the fermentation stage is to maximise 
productivity: that is, the quantity of product produced per litre of fermentation fluid per unit 
time. At the time of harvest, the fermentation medium will primarily consist of the 
bacteriophage M13 product, intact cells, cell debris and medium components (chiefly ions, short 
chain soluble polypeptides and nucleotides). Some low level accumulation of cell debris was 
expected as a result of usual E. coli culture (Salivar et al., 1964), which will include host 
chromosomal DNA, RNA, proteins, lipids, endotoxins and chemical residuals (Eastman and 
Durland, 1998; Prazeres and Ferreira, 2004). In this chapter the quantities of chromosomal 
DNA and protein were measured to represent the level of culture contamination. If 
contamination of the process stream with these components could be reduced, then subsequent 
downstream processing would be assisted. 
 
Generally, it is known that there is no substitute for experimentation when selecting an E. coli 
strain to maximise recombinant protein or plasmid DNA production. It is generally impossible 
to predict the outcome from cell genotype alone (Harrison and Keshavarz-Moore, 1996; Yau et 
al., 2008). An examination of three E. coli strains was made at the 50 ml shakeflask scale, and 
the results of this small study suggested it may be similarly difficult to predict bacteriophage 
quantity (and purity) on the basis of E. coli genotype. Strains Top10F', JM107 and W1485 were 
selected for comparison. JM107 and Top10F' are laboratory strains, and of these two Top10F' is 
recA
-. W1485, in contrast, is near wild-type in genotype. A recA
- strain was deliberately chosen 
because of the far-reaching effects of this genotype: a benefit is the potential protection of M13 
derivatives holding repeater sequences from recombination effects (Yanisch-Perron et al., 
1985), whilst it was hypothesized that the known detrimental effect on cell viability (Capaldo et 
al., 1974) may compromise bacteriophage yield. 
 
It was found that the concentrations of supernatant chromosomal DNA or protein varied 
considerably between the three strains. The highest levels of supernatant DNA and protein 
accumulated in E. coli W1485 culture (5.7 and 38 !g ml
-1 respectively), the lowest in JM107 
(0.38 and 22 !g ml
-1 respectively). Bacteriophage M13 production in Top10F' and JM107 
strains ceased by 5 hours growth (at an average M13 concentration of 4 x 10
11 pfu ml
-1) and was 
not significantly different between all three strains at this time. However, in W1485 culture, the 
concentration of M13 continued to increase such that by 9 hours growth the titre of M13 was 
significantly higher at 7.8 x 10
11 pfu ml
-1. Therefore, despite the detrimental effects on cell   243 
viability, the recA
- mutation did not result in Top10F' culture having the highest chromosomal 
and protein concentrations, and neither was the final bacteriophage yield compromised in 
comparison to a recA
+ strain (JM107). 
 
In a complementary approach to this study, a novel biological route was utilised to eliminate the 
chromosomal DNA from the process stream (Cooke, 2003). It was shown that propagation of 
bacteriophage M13 in E. coli Top10F' concurrently expressing a recombinant nuclease was a 
feasible method of early DNA removal. For an unaffected yield of bacteriophage M13, all DNA 
contamination was degraded to below measurable levels by 0.8 % (w/v) agarose gel 
electrophoresis. However, at the 2 L bioreactor scale, concurrent nuclease expression doubled 
the time to achieve maximum bacteriophage yield.  Nevertheless this was the first time that such 
an approach had been examined for bacteriophage M13 production. It offers a successful, low-
cost alternative to commercial exogenous nucleases such as Benzonase (Cooke et al., 2003). 
This technique is applicable to the production of other bacteriophage therapeutics, particularly 
those requiring lytic bacteriophage propagation in E. coli. Here, wholesale lysis of host cells can 
be expected to result in a process stream heavily contaminated with chromosomal DNA. 
 
Use of two different complex media at the 2 L bioreactor scale resulted in a 4-fold difference in 
bacteriophage yield, which highlighted the potential importance of this variable when designing 
a fermentation process. Using Top10F', the overall maximum titre of bacteriophage achieved in 
this study was 2 x 10
12 pfu ml
-1. As a result of its non-lytic replication strategy, the 
concentrations of contaminating E. coli Top10F' chromosomal DNA in the post-fermentation 
process fluid was quantified to be only 7 µg ml
-1. The concentration of protein was quantified to 
be 170 µg ml
-1, a figure which included both intracellular and medium components. 
 
Since bacteriophage concentration in fermentation culture cannot be measured in an on-line 
fashion, the use of indirect measurements will be necessary in the fermentation process to 
determine the cessation of bacteriophage production. The completion of lytic bacteriophage 
growth is characterised by a spike in dissolved oxygen tension (DOT) and a sharp reduction in 
carbon dioxide evolution rate (CER) as bacteria cease to respire prior to lysis (and therefore 
bacteriophage release) occurring (Sargeant et al., 1968). Hence the end of production can be 
easily noted. Although less stark, it was noted in this study that the end of bacteriophage M13 
production usefully correlated with a plateau in the culture OD600 value and a levelling in the 
oxygen uptake rate (OUR) and CER. That is, bacteriophage M13 production ended as E. coli 
growth ceased. From a bioprocessing standpoint, these measurements could provide indicators 
for when harvesting can proceed.  
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8.3  Objective 3: Evaluate the Effect of Hydrodynamic Shear on E. coli Cell 
Integrity 
It was shown in Chapter 5 that E. coli damage could result from exposure to high-energy 
turbulent shear conditions. The quantity of chromosomal DNA in the post-fermentation process 
fluid increased 5 to 10-fold within two minutes exposure to a maximum energy dissipation of 
3.1 x 10
5 W kg
-1. However, the increase in supernatant DNA did not correlate against the 
measured number of cells losing viability. This may have been due to further DNA release from 
existing subpopulations of non-viable Top10F' cells, a known effect of the recA
- genotype 
(Capaldo et al., 1974). Furthermore, the relationship between culture OD600 and supernatant 
DNA release on shearing was not linear. That is, an increase in culture OD600 did not translate 
into greater supernatant DNA upon shearing. In practical terms, this meant that the multiplicity 
of infection (MOI) of M13 infected culture could be selected without concern for chromosomal 
DNA release from shearing.  
 
A high MOI (5 x 10
1) culture was found to require only a two hour fermentation time to reach 
maximum bacteriophage yield, and resulted in a lower cell density at harvest than lower MOI 
cultures. In comparison, a culture with MOI of 5 x 10
-5 took nearly three times longer to 
produce the same bacteriophage yield. A trade-off exists in weighting the cost of a greater 
bacteriophage inoculum against the cost of an increased fermentation time. The final choice 
would depend on the overall costing of the bioprocess. 
 
Post-fermentation, a solids separation stage is needed remove the E. coli cells from the process 
stream. Future experimentation using pilot-scale centrifugation equipment could determine 
whether the clarified process fluid will indeed be significantly higher in chromosomal DNA 
than the post-fermentation fluid. Since the cumulative exposure time E. coli would experience 
in the feed-zone of a continuous centrifuge would be considerably shorter than two minutes 
(Byrne et al., 2002), it may well be that the increase in chromosomal DNA is lower than that 
observed in this USD study. Although from a bioprocessing perspective the extra release of 
chromosomal DNA is generally undesirable, the primary purification study of Chapter 6 
suggested that DNA and bacteriophage M13 can be separated by precipitation. 
 
Finally, although not studied as part of this thesis, microfiltration remains a less shear intensive 
step for E. coli removal from the process stream. The viability of this option should be 
considered in the assembly of a large-scale bacteriophage production process. 
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8.4  Objective 4: Investigate the Primary Purification of Bacteriophage M13 
Once biomass has been separated from the process stream, it is certain that a concentration stage 
is required since the bacteriophage product is relatively dilute. A reduction in process stream 
volume makes further downstream process stages more manageable. The feasibility of 
bacteriophage precipitation as a volume reduction step was investigated in Chapter 6, with 
encouraging results.  
 
An effective large-scale precipitant of bacteriophage is one which would inexpensively offer a 
high bacteriophage yield, display robust precipitation characteristics and ideally offer some 
selectivity early on in the downstream process. Several precipitation methods were tested in this 
thesis against these criteria, including PEG-salt (volume exclusion), sulphuric acid (isoelectric), 
ammonium sulphate (salting out), calcium chloride (divalent cation) and spermidine (polyvalent 
cation). 
 
In this chapter the fundamental actions of each precipitant on M13 was analysed in pure system 
work, and, depending on precipitant effectiveness, the effect of broth components on 
precipitation behaviour was subsequently studied.  
 
It was identified that the monovalent ion concentration in broth was an important factor 
affecting many of the precipitation characteristics observed: for example, bacteriophage M13 
precipitation by calcium ions and spermidine did not occur at the 100 mM monovalent salt 
concentration in NB2. In particular, the potential of spermidine as a precipitant of bacteriophage 
M13 would have been missed if experimentation was conducted purely in broth. Overall, 
isoelectric and PEG-salt precipitations were found to be effective precipitants of bacteriophage 
M13 in NB2. 
 
For PEG-salt precipitation, consideration of the existing ion concentration in broth meant that – 
depending on the PEG concentration – added salt would not always be necessary, thereby 
reducing processing costs. Furthermore, it was demonstrated in this study that when salt 
addition is required, there exists much flexibility in the choice of salt type. Sodium chloride is 
traditionally used with PEG to precipitate bacteriophage at the laboratory scale (Vajda, 1978; 
Yamamoto et al., 1970), but magnesium sulphate in particular was demonstrated to be much 
more effective, the concentration required to induce precipitation was up to 80 % lower. For the 
biochemical engineer, a further consideration is the corrosive nature of salt chlorides (such as 
sodium chloride) relative to non-halide salts (such as sulphates) with regards to the usually 
stainless steel downstream processing equipment (Korb, 1987; Shreir et al., 1994).  
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There are many variables in PEG-salt precipitation. In this study, PEG of average molecular 
weight 6 000 was selected as a balance between effectiveness and solution viscosity. 
Precipitation appeared equally effective at room temperature or on ice. In NB2 systems, PEG 6 
000 of concentration 4 % (w/v) was sufficient to induce bacteriophage precipitation alone. 
Reducing the amount of PEG to 2 % (w/v) therefore required salt addition, of which either 135 
mM sodium chloride or 25 mM magnesium sulphate was necessary. It is noteworthy that the 
minimum effective concentration of PEG in this study (at 1.5 % (w/v) PEG 6 000) was five- to 
ten-fold lower than values published in the literature for smaller proteins, and indeed other 
bacteriophage (Atha and Ingham, 1981; Juckes, 1971; Sharma and Kalonia, 2004; Tsoka et al., 
2000; Yamamoto et al., 1970). From a practical perspective, the choice of PEG and salt 
concentrations and types will be a function of the relative chemical costs, corrosion 
considerations and the tolerable limits of solution viscosity.  
 
Isoelectric precipitation of bacteriophage M13 from NB2 was also found to be feasible: 
reducing solution pH into the range 3.9- 4.5 resulted in near 100 % bacteriophage recovery. 
Bacteriophage losses to the acidic conditions were not significant if the precipitation 
temperature was kept at 4 °C, which was in contrast to the severe effects reported for several T-
odd and T-even type bacteriophage precipitated by the same method (Bachrach and Friedmann, 
1971). It also determined that the incubation time could be reduced by 95 % (to one hour) 
without affecting recovery. 
  
Cost-effectiveness and robustness are important hallmarks of an efficient precipitation step. 
Furthermore, if high purification of the bacteriophage molecule can simultaneously be achieved, 
the overall cost of the downstream process could be reduced (Tsoka et al., 2000; Wenzig et al., 
1993). It has been shown in this thesis that bacteriophage M13 can be selectively precipitated 
from the post-fermentation process fluid. Particularly effective were the PEG-salt systems 
tested, where the ratios of DNA and protein contaminants to bacteriophage M13 were reduced 
to less than 1 % of their previous values. The corresponding purification factors (>100) were far 
in excess of those achieved in the literature for smaller, more spherical particles such as VLPs 
(Tsoka et al., 2000). Such an improvement in bacteriophage purity from a relatively low-cost 
step is important. Firstly, it increases flexibility of the upstream process, meaning decisions can 
be made to increase bacteriophage yield or reduce processing costs without penalty in terms of 
increasing process stream contamination. Secondly, for high-purity applications requiring high 
resolution purification, the burden on subsequent chromatography or monolith stages is 
therefore reduced (Thommes and Etzel, 2007).  
 
The precipitation behaviour of systems such as PEG-salt depend on the protein (or 
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concentration will vary between bacteriophage species. The precipitation techniques used in this 
thesis are rapid and were conducted at the laboratory bench scale. Therefore, their application to 
derivatives of M13 or indeed other bacteriophage would allow for the straightforward 
identification of optimal conditions for any bacteriophage of interest. 
 
8.5  Objective 5: Consider the Issues Concerning the Introduction of 
Bacteriophage M13 to a Mixed-Use Production Facility 
The principles determined for the contained fermentation of bacteriophage M13 are also 
applicable to all bacteriophage (Chapter 7). If a bacteriophage product is biologically infective, 
then the bioprocessing of such a therapeutic raises important issues regarding containment; 
bacteriophage (including M13) can effectively propagate from very low infecting numbers 
(Reddy and McKenney, 1996). It was shown in this chapter that it is important to test for an 
effective decontamination agent against the bacteriophage of interest prior to commencing 
large-scale work: standard disinfection agents in use may not be effective. Experimentation to 
determine the fundamental resistance of the target bacteriophage to various physical and 
chemical challenges have been shown to assist in the modification of the fermentation Standard 
Operating Procedures (SOPs). In the case of bacteriophage M13, it was found that the particle 
was indeed remarkably desiccation resistant. However, it proved sensitive to temperatures 
above 99 °C and was completely inactivated by strongly acidic and alkaline conditions.  
 
The implications for bioprocessing were that firstly, the generation of bacteriophage M13 
aerosols should be avoided, and that decontamination procedures must be defined prior to 
experimentation. However, fermenter acid and base pH control lines should be self sterilising, 
and that steam-based sterilisation should be effective if all fermenter parts are verified to exceed 
100 °C. The fermentation SOPs were updated to reflect these findings. 
 
Modern published guidance on the specific containment needs of large-scale bacteriophage 
production is limited. Specific strategies cited in early literature have included continuous 
centrifugation within an enclosed cabinet with exhaust air filter (Sargeant and Yeo, 1966), 
preparation of seed cultures in remote laboratories (Sargeant, 1970) and the storage of host 
stock ampoules prior to bacteriophage work (Sargeant and Yeo, 1966). Most obviously, aspects 
of existing literature regarding the issues of bacteriophage infection of industrially important 
cultures – such as in the dairy industry (McGrath et al., 2007; Moineau, 1999) – may be 
applicable. This uncertainty may explain anecdotal evidence of difficulty in securing contract 
manufacture of bacteriophage-based therapies (Anonymous, 2009). Overall, the work presented 
in this chapter contributes practical knowledge towards the containment needs of bacteriophage 
M13, although the principles are applicable to all bacteriophage-based therapeutics.  
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9  Conclusions and Future Work 
9.1  Conclusions 
In summary, the insights gained are drawn together in Figure 9.1, where a prospective 
production scheme has been assembled for the large-scale manufacture of bacteriophage M13. 
In addition, the knowledge gained in relation to each unit operation has been tabulated. In 
essence it has been found that the resistance of bacteriophage M13 to high-energy shear forces 
may mean it can be manufactured on the large-scale using existing designs of fermentation, 
pumping or continuous centrifugation equipment. It was found that the E. coli strain used can 
affect the composition of the post-fermentation process fluid. The choice of strain will depend 
on the application: for genetically modified bacteriophage containing repeated sequences in 
their genome, growth in a recA
- E. coli strain such as Top10F' may be preferable. Bacteriophage 
growth in a recombinant nuclease-producing E. coli strain can provide a cost-effective 
improvement in purity if further downstream processing is to be limited. The growth medium 
was confirmed to play an important role in the bacteriophage yield. That is, a four-fold increase 
in bacteriophage titre was achieved by changing the growth medium for one which supported 
denser E. coli growth. Post-fermentation, hydrodynamic shear was found to reduce M13 
infected E. coli cell integrity, and the concentration of DNA in the clarified process fluid was 
found to increase. However, the subsequently identified selective precipitation options suggest 
that less shear-intensive biomass separations may not be necessary. PEG-salt precipitation was 
found to result in a >100-fold improvement in bacteriophage M13 purity, with regards to 
contaminating DNA and protein. Precipitation typically required relatively low PEG 
concentrations in the range 2- 4 % (v/w), depending on the salt concentration desired. It was 
found to be effective at both chilled and room temperatures, giving operative flexibility. In 
conclusion, this work has contributed towards the processing knowledge of bacteriophage M13 
by investigating the fundamental properties of this unusual entity. Moreover, the methods used 
have a broader applicability to M13-derivatives and beyond to other bacteriophage. 
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Stage  Summary of knowledge gained 
 
Fermentation 
Hydrodynamic shear damage unlikely. Fermentation medium 
influences bacteriophage yield. Greater bacteriophage 
inoculum reduces fermentation time. E. coli strain affects 
contamination accrual. M13 growth in nuclease-producing E. 
coli strain effective. 
 
Pump  Hydrodynamic shear damage unlikely. 
 
Centrifuge 
Hydrodynamic shear damage to M13 and E. coli may not be 
severe in feed-zone of continuous types. 
 
Precipitation 
Several effective precipitants identified. PEG-salt 
precipitation offers concurrent purification of M13. 
Isoelectric precipitation is a potential alternative. 
 
Figure 9.1. A scheme outlining the essential production stages in the large-scale manufacture of 
bacteriophage M13.   250 
9.2  Future Work 
Since the bioprocessing of bacteriophage is a relatively new area, there is much to understand 
about the response of these novel therapeutics to large-scale manufacture. This thesis goes some 
way to understanding the fundamentals of bacteriophage M13 bioprocessing, and as may be 
expected it has opened up several interesting future lines of enquiry.  
 
9.2.1  Extending Objective 1: Evaluate the Effect of Hydrodynamic Shear on the 
Filamentous Bacteriophage Particle 
This work has shown that bacteriophage M13 demonstrates considerable resistance to 
hydrodynamic shear conditions imposed by the USD rotating disk device. Moreover, 
contributions were made towards understanding the causes of damage, including assaying for 
cavitation, and demonstrating damage enhancement by air-liquid interfaces. That said, the 
physical mechanisms behind the loss of bacteriophage viability still remain largely unknown.  
 
From a practical perspective, work to further assess the effects of air-liquid interfaces could 
utilise a shear device with an optically clear top plate. This would allow for verification of the 
elimination of all air from the chamber. Alternatively, in air-liquid systems, such a "viewing 
window" could help determine the distribution of air within the chamber whilst the disk is 
spinning. In addition, a study of bacteriophage M13 exposure to shear in degassed fluids would 
allow for an extended assessment of the effects of air-liquid interfaces. 
 
A further area of interest concerns the extent to which shear-related damage has depended on 
the type of shear device disk. That is, how the nature of the solid-liquid interface affects shear 
stability. In this study, a 316 stainless steel disk was used for all shear experiments. However, 
recent work has shown that the severity of shear damage to antibodies is a function of not only 
disk surface roughness, but also the material of construction (Biddlecombe, 2009). It would 
therefore be of considerable interest to investigate solid-liquid interface effects on the shear 
resistance of bacteriophage M13. Further work could not only attempt to understand the 
fundamental nature of the bacteriophage-surface interaction, but to quantify the effect of 
solution properties (such as ionic strength and pH) on this system. Such work would relate back 
to the findings of this thesis, where various solutions of suspension were found to alter the 
pattern of bacteriophage decay. 
 
The physical changes to the bacteriophage particle that result in viability loss also remain to be 
examined. Further work to tackle this area could help elucidate the specific mechanisms of 
bacteriophage damage. For example, an EM study could highlight whether wholesale 
bacteriophage fragmentation has occurred in tandem with viability loss. 
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This thesis focused on wild-type M13 as a model filamentous bacteriophage, but the effects of 
hydrodynamic shear on M13 derivatives (namely phagemids) would be of considerable interest 
for two reasons. Firstly, phagemids are typically of shorter contour length than the wild-type, 
suggesting that a study to correlate shear damage against bacteriophage length would be 
extremely useful. Secondly, phagemids typically display a foreign protein on their surface. The 
shear resistance of these surface proteins remains unknown, as does whether attachment to the 
bacteriophage capsid alters their inherent resistance to hydrodynamic shear. There is much to 
understand about the potential processability of these entities. 
 
Extending shear work beyond the rotating disk device, further endeavour could explore the 
effect of other fluid physical challenges on the bacteriophage particle, such as extensional shear 
forces and impaction damage. Investigations of this type have been conducted at the USD scale 
for E. coli cells (Chan et al., 2006) and plasmid DNA (Meacle et al., 2004). 
 
An obvious next step is to verify the USD predictions of bacteriophage shear stability at the 
pilot scale. The subjection of bacteriophage M13 suspensions to hydrodynamic shear within 
pumps and continuous centrifuges would then provide comparable data to that for biological 
macromolecules such as plasmids (Zhang et al., 2007). 
 
9.2.2  Extending Objective 2: Investigate the Fermentation and Harvesting of 
Bacteriophage M13 
In this thesis the yield of bacteriophage M13 was increased by growth in a medium which 
supported increased cell density. A logical extension could be to translate this work from batch 
to fed batch fermentation, to further increase cell density and therefore bacteriophage titre. At 
the same time, a detailed investigation of delayed bacteriophage infection could be conducted to 
extend the experiment conducted here. The observed biphasic growth at the fermentation scale 
could also be revisited, primarily to determine the reproducibility of this phenomenon in 
Top10F', but also to determine whether it occurs for other E. coli strains cultured in the same 
medium. The results of producing bacteriophage by fermentation in defined or semi-defined 
media would certainly be of enduring use. 
 
Three E. coli strains were investigated for their ability to produce M13. Further work could 
involve the wide-ranging screening of many more E. coli strains to obtain a more detailed 
picture of which provide the highest bacteriophage yields. 
 
This chapter looked at the growth of M13 as a model filamentous bacteriophage. A new study 
to examine the fermentation of phagemids would be useful. This work could complement   252 
existing literature in the area (Grieco et al., 2009) by extending to fed-batch growth or by 
comparing the growth characteristics of several different phagemids in parallel. 
 
A plasmid was transformed into Top10F' to allow recombinant nuclease production (Cooke et 
al., 2003), and several experiments were conducted to study the success of degrading 
supernatant DNA whilst producing bacteriophage M13. This work could be usefully extended 
by further growth studies at the fermenter scale. For example, it could be confirmed that the 
achievement of maximum bacteriophage yield is markedly delayed by concomitant nuclease 
production.  
 
9.2.3  Extending Objective 3: Evaluate the Effect of Hydrodynamic Shear on E. coli 
Cell Integrity 
Several extensions to the bacteriophage M13 shear work in Objective 1 also apply to the study 
of E. coli. Of particular interest would be the determination of the physical effects of E. coli 
viability loss upon exposure to shear. One way to achieve this could be to study cells by 
transmission electron microscopy.  
 
Future experimentation could attempt to determine differences in the shear resistance of several 
E. coli strains. It would be of particular interest to compare the DNA release from a recA
+ E. 
coli culture to the recA
- Top10F' studied here. It was postulated in this thesis that the dominant 
source of supernatant DNA in Top10F' culture was the characteristic recA
- subpopulations of 
residually and non-dividing cells. 
 
Finally, the subjection of M13 infected E. coli cultures to pilot plant scale processing equipment 
would provide a valuable verification of the USD hydrodynamic shear work conducted thus far. 
 
9.2.4  Extending Objective 4: Investigate the Primary Purification of Bacteriophage 
M13 
The net surface charge of a protein molecule strongly affects its precipitation characteristics. 
For example, bacteriophage M13 and its close relation fd do not possess the same net charge 
and therefore exhibit differences in precipitation (Tang et al., 2002). A future investigation 
could involve the design, by mutagenesis, of bacteriophage M13 particles with a specified net 
charge to optimise precipitation. 
 
The precipitation behaviour of proteins can also depend on molecular size (Juckes, 1971), where 
larger molecules generally precipitate more easily. Because the length of a filamentous 
bacteriophage depends only on the size of its encapsulated genome, it is straightforward to 
manipulate this parameter. The value of this is twofold. Firstly, from an academic perspective,   253 
the generation of such molecules would allow for a controlled study of the effects of particle 
size on precipitation behaviour. Secondly, such data could be used to predict the optimal 
precipitation conditions for novel phagemids. 
 
Since phagemids also typically display a foreign protein on their capsid, a new study could also 
be performed to examine whether such modifications have a strong effect on precipitation 
behaviour. 
 
Here, the purification performance of several precipitations was measured on the basis of 
reductions in supernatant DNA and protein. Additional work could analyse reductions in other 
important process stream contaminants, such as LPS and lipids. 
 
 
9.2.5  Extending Objective 5: Consider the Issues Concerning the Introduction of 
Bacteriophage M13 to a Mixed-Use Production Facility 
Further studies into the contained bioprocessing of bacteriophage must be welcomed. A 
continuation of the containment work presented here would lead to trial fermentations of a non- 
E. coli bacteriophage to check for containment, whilst minimising the effect on unrelated 
experimentation in the facility.  
 
Studies on contained downstream processing would also be timely, since little data currently 
exists for bacteriophage in this area. A starting point could be to extend related experimentation 
on the bacterial biocontainment of downstream processing equipment (Tinnes and Hoare, 1992) 
to bacteriophage. In addition to investigating these physical containment methods, work could 
also be conducted to explore biological routes to prevent unwanted bacteriophage propagation. 
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Appendix A  
Derivation of an Equation to Estimate the Total Charge of a Protein 
 
Proteins have many different ionisable groups in their structures. Therefore, at a particular pH, 
some parts take on a negative charge while others take on a positive charge. The net charge of 
the protein will be the difference between the number of positive and negative charges arising 
from the deprotonation of acidic groups and the protonation of basic groups. The Henderson-
Hasselbalch equation allows for the estimation of the charge of each ionisable species in 
solution at a particular pH. Finding the pH at which all the charges on a protein sum to zero is 
the process of finding that protein's isoelectric point, or pI. The resulting equation can be found 
directly in the literature (Bergfors, 1999), although a derivation has been included here for 
reference. 
 
For acidic residues, the Henderson-Hasselbalch equation (Stryer, 1995) is: 
! 
pH = pKa + log
A
" [ ]
HA [ ]
 
 
where the pKa is the acid dissociation constant, [A
-] the concentration of conjugate base and 
[HA] the concentration of acid. For basic residues the equivalent equation is: 
! 
pOH = pKb + log
B
+ [ ]
BOH [ ]
 
 
where pKb is the base dissociation constant, [B
+] the concentration of conjugate acid and 
[BOH] the concentration of base. 
 
The concentration (C) of negatively charged elements on the ith acidic residue (a) as a fraction 
of the total is: 
! 
Ca,i =
A
" [ ]
AH [ ]+ A
" [ ]
 
 
Inserting the Henderson-Hasselbalch equation for acidic residues gives: 
! 
Ca,i =
1
1+10
pKa "pH  
 
The corresponding equation for the jth basic residue (b) is thus:   255 
! 
Cb, j =
1
1+10
pKb "pOH  
 
The following equation (Sutton et al., 2000): 
! 
pH + pOH = pKa + pKb 
 
is used to substitute for pKb and pOH, making the concentration of positively charged elements 
on a single basic residue as a fraction of the total: 
! 
Cb, j =
1
1+10
pH"Ka  
 
The total charge of a protein is a sum of the fractional positive and negative charges from the 
ionisable residues. Therefore the total charge, Z:  
! 
Z = Cb, j
j=1
n
" # Ca,i
i=1
m
"  
 
! 
Z =
1
1+10
pH"pKa
j=1
n
# "
1
1+10
pKa "pH
i=1
m
#  
 
where j is each of n positively charged residues and i is each of m negatively charged residues. 
At the isoelectric point, pI, the total charge, Z is equal to zero. Therefore, for given pKa values, 
one can determine the pI of a protein. 
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Appendix B 
Standard Operating Procedure 
 
SOP No. 45 
______________________________________________________________________ 
Title: 
Sterilisation and Operation of Applikon 20L Fermenter, located in ACBE 
______________________________________________________________________ 
WRITTEN BY DATE    OPERATING HEAD  DATE     DOC.REF. 
I.BUCHANAN 20/08/03  B.DOYLE     20/08/03  SOP.45 
Signature        Signature 
 
1.0  Introduction 
 
1.1  This document outlines the procedure to follow for sterilising and setting up the 
fermenter vessel prior to inoculation.  The Applikon 20L fermenter has an ADI 1030 
Bio Controller for process variables, an ADI 1065 Bio Bench console for insitu 
sterilisation and temperature control and an ADI 1035 Bio Console for gas addition and 
stirrer speed control.  BioXpert PC software is also connected for control and data 
logging. 
  
1.2  SAFETY NOTE:  In the event of having to leave the building in an emergency (ie 
fire alarm), whilst vessel is at pressure during sterilisation cycle, the 
EMERGENCY SHUTDOWN PROCEDURE outlined in steps 3.12 or 3.14 must 
be followed. 
There is no need to take any action before leaving the area if operation is not part 
of sterilisation cycle. 
 
2.0  Pre sterilisation Set-Up 
 
2.1  Refer to technician or previous fermenter checklist to ensure that no technical faults 
  encountered with this fermenter from the previous run, and if any faults noted, 
verify with a member of the technical staff that these have been rectified. 
 
2.2  Ensure the vessel is clean.  If vessel is not clean, carry out appropriate cleaning 
procedure as outlined in SOP No. 32D. 
 
2.3  Check condition of all 'O'-rings and replace any if damaged. 
 
2.4  If the foam probe is to be used, ensure that it is in place and at an appropriate height.  If 
at this stage there is any doubt regarding the appropriate height, ensure that the probe is 
fully down into the headplate so that any later repositioning after sterilisation involves 
moving the probe up to an appropriate height rather than pushing down which may 
possibly cause contamination. 
 
2.5  Check the main air supply PRV is set to 10psi. 
 
2.6  Check condition of Domnick Hunter tetpor air filter cartridges for inlet and exit air 
housings. 
 
2.7  Prepare fermenter ancillaries for separate sterilisation in autoclave. 
  e.g.  Acid addition reservoir, line and conical connector 
    Alkali addition reservoir, line and conical connector 
    Inoculum flask, line and connector 
    Antifoam reservoir, line and conical connector   257 
    Media addition flask, line and connector 
   
2.8  Calibrate pH probe - see SOP No. 6.  Place probe in fermenter 
 
2.9  Check DOT probe calibration (do not calibrate at this stage) - see SOP No. 7.  Place 
probe in fermenter. 
 
2.10  Ensure agitator is correctly attached to motor drive shaft. 
 
2.11  Ensure harvest port is closed. 
 
2.12  Ensure sample valve is closed. 
 
2.13  Disconnect quick release water to condenser line on Bio Bench. 
  Disconnect quick release water from condenser line on Bio Bench. 
 
2.14  Remove pressure gauge and fill vessel with medium to required level.  Replace pressure 
gauge ensuring seal and tri-clamp are firmly connected. 
 
2.15  Carry out checks on Fermenter Sterilisation Checklist. 
 
 
3.0  Heating Up – Sterilisation 
 
3.1  Ensure protective safety gowns and face visors are worn during sterilisation cycle. 
 
3.2  NOTE. Ensure to check previous fermenter checklists/calibration records for last 
recorded temperature map of vessel to determine temperature reading to use as 
sterilisation holding temperature. 
Due to non linearity of temperature amplifier over entire range, this holding temperature 
reading may not correspond to 121°C, likewise Pressure Gauge may not correspond to 
1.0 Bar at sterilsation temperature. 
 
3.3  Ensure all valves are closed at this time. 
 
3.4  Open air exit valve V11.01. 
 
3.5  Check agitator speed control is wound fully counter-clockwise.  Set tumbler switch to 
On and manually increase setpoint to 200rpm. 
 
3.6  Open main condensate return valve at wall. 
 
3.7  Open blue handled ball valve to condensate return. 
 
3.8  Open main steam supply valve at wall. 
 
3.9  On the ADI 1030 change the temperature process setpoint to 126°C 
 
3.10  Change the temperature process control to Start 
 
3.11  Set the ‘Ferm/Off/Ster’ tumbler switch on the ADI 1065 to ‘Ster’(-ilisation) 
 
3.12  Increase the steam PRV to 30psi 
 
3.13  Valve V-11.01 on exit air filter housing is open to evacuate air from the headspace 
while the vessel heats up.  At around 99°C steam will begin to enter the condenser.  
Carefully feel the top of the condenser until it gets hot, at which point close the valve.   258 
 
3.14  EMERGENCY SHUT DOWN: at this stage when vessel is not yet under pressure.  
Close main steam valve at services panel.  Close main condensate return at 
services panel. 
  Press Emergency Stop button on ADI 1065. 
 
3.15  When the temperature in the fermenter reaches 105°C the Biocontroller is programmed 
to open valve VY-10.05 to allow steam into the inlet air filter. Listen for an audible 
click at which point open condensate drain valve V-10.06 below the inlet air filter. 
 
3.16  EMERGENCY SHUT DOWN:  at this stage and from now on when vessel is under 
pressure.  Close main steam valve at services panel.  Close main condensate 
return valve at services panel.  Press Emergency Stop button on ADI 1065.  Using 
heat resistant gloves crack open one of the conical connections on the 3 way port, 
note: this may cause media to boil out. 
 
3.17  At 110°C open steam valve V-14.04 and condensate valve V-14.02. 
    
3.18  At 122°C slowly open valve V-11.01 to allow a small amount of steam to vent through 
the filter for the remainder of the sterilisation period. 
 
3.19  Close valve V-14.04.  Open side addition valve V-14.03.  
 
3.20  On the 3 way port turn each connector ring slightly counter clockwise and pull the 
blinded hose barb out in order to create a small bleed of steam. 
 
3.21  Close valve V-10.06.  Open valve V-10.08 to sparge line.  Open valve V-10.07 to 
headspace. 
 
3.22  To sterilise the sample assembly close sample valve V-17.01.  Open steam supply valve 
V-20.02.  Open condensate valve V-17.02. 
 
3.23  To sterilise the harvest port assembly close harvest valve V-12.01.  Open steam supply 
valve V-20.03.  Open condensate valve V-12.02. 
 
3.24  Maintain sterilisation temperature in the vessel for the desired time (usually 20 
minutes). 
                                        
 
4.0  Cooling Down After Sterilisation 
 
4.1  Close valves V-17.02 and V-20.02 on sample assembly.  
 
4.2  Close valves V-12.02 and V 20.03 on harvest port. 
 
4.3  Close connical connectors on the 3 way port. 
 
4.4  Close valves V-14.02 and V14.03.   
 
4.5  Close valve V-11.01 on exit air line.  
 
4.6  On BioXpert go to Control Laws and select Manual Setpoint ! sGas.  Check the box 
next to Manual and enter a value of 10 L/m. Check for positive air pressure and 
connect air line to inlet Air filter. 
 
4.7  Close valves V10.08 and V10.07.   
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4.8  Set Ferm/Off/Ster tumbler switch to Off. 
 
4.9  Close blue handled condensate valve at wall. This is to prevent the Kill Tanks filling 
up with cooling water returning from the condenser. 
 
4.10  Open Cooling Water Return valve at wall.  Open Cooling Water Supply valve at wall. 
 
4.11  Open valve V-10.09 to inlet air filter. 
 
4.12  On the ADI 1030 change the temperature setpoint to the desired process temperature. 
 
4.13  Set ‘ferm/off/ster’ tumbler switch to ‘ferm’(entation). 
Water will now begin to enter the jacket and the fermenter will begin to cool down. 
 
4.14  At 0.1Bar open valve V-10.07 allowing air into the headspace.  
The fermenter will now pressurise to 10psi. and cool safely to the new temperature 
setpoint. 
 
 
5.0  Set-Up for Fermentation Running 
 
5.1  The fermenter should now be sterile, pressurised to 10psi., agitator running and 
temperature at setpoint.  The fermenter ancillaries should be sterilised and ready for 
insertion. 
 
5.2  Connect condenser line labelled ‘water from condenser’ to Bio bench. 
  Connect condenser line labelled ‘water to condenser’ to Bio Bench. 
 
5.3  Open blue handled cooling water return ball valve at wall.  Check that the condenser 
gets cold otherwise adjust the condenser tuning valve inside Biobench. 
 
5.3  Slowly release the pressure in the fermenter by gradually opening valve V-11.01 on the 
exit air line. 
 
5.4  Open valve V-10.08 to sparge line.  Close valve V-10.07 to headspace. 
  Check thar air is sparging and there is no head pressure in the vessel 
 
5.5  Change setpoint of sGas to running value. 
 
5.6  Take a sample and use it to recheck pH.  Refer to SOP No. 6 for adjustment of the pH 
probe at this stage.  A sample can be taken to check sterility. 
 
5.7  With stirrer and air flow at desired settings, check DOT probe is reading 100.0%.  Refer 
to SOP No. 7 for adjustment of DOT probe at this stage.  Ensure mass spec. pump is 
connected and switched on.  Sparge nitrogen through air inlet filter to check DOT probe 
response and to check readings on mass spec.  Once the probe response has been 
checked, reconnect fermenter air supply to air inlet filter and ensure air flow is at the 
correct setting. 
 
5.8  For acid, alkali and PPG additions run the tubing through the appropriate pumphead on 
the ADI 1035.  Using aseptic technique remove the blinded conical connectors from the 
3 way inlet and replace with connectors from the addition bottles.  Check and adjust the 
pH setpoint if necessary.  Prime the lines up to the addition inlets.  Switch the acid and 
alkali control switches to the remote position to achieve pH control. 
 
5.9  Once any other remaining media additions have been added, the fermenter can now be 
inoculated.  Ensure logging has started on BioXpert computer before inoculating.  It   260 
may be necessary to stop or reduce the air flow, to allow the inoculum to run into the 
fermenter by gravity, or it can pumped in with a peristaltic pump. 
 
 
6.0  Closing Down The Fermenter 
 
6.1  Switch off automatic control of temperature, pH, etc.  Stop logging on BioXpert. 
 
6.2  Harvest cells if required through harvest port, leaving stirrer running during 
harvesting.  Turn off stirrer when vessel is almost drained.  Ensure good containment 
practices are adhered to. 
 
6.3  Turn off the stirrer by turning control fully counter-clockwise then set tumbler switch to 
Off 
 
6.4  Disconnect and drain acid, alkali and antifoam cylinders. 
 
6.5  If the cells are not to be harvested, then they should be killed off by sterilisation, 
following the same procedure as for sterilising the media, but exercising more care due 
to the increased danger of flash boiling.  Additional antifoam can be added to counteract 
any cell lysis which may cause foaming.  Do not attempt to vent steam out through air 
outlet filter if foaming occurs.  
In the event of having to carry out an emergency shut down when the vessel is at 
pressure carry out Step 3.16. 
If this does cause release of any live culture, ensure that the collection vessel used is 
dosed with 2% Tego solution for a contact time of at least 30 minutes on return to the 
area. 
 
6.6  If cells are harvested, then refill with RO water up to the working volume and carry out 
Sterilisation Kill Cycle using the same procedure as for sterilising the media. 
 
6.7  After killing the cells, clean the fermenter referring to SOP No.32D. Ensure that both 
the DOT and pH probes are removed and properly stored before carrying out the 
cleaning procedure. 
  Remove air inlet and exit filters. 
 
6.8  Ensure that all valves are closed, all control switches are in the off position and no 
steam or water is left on.   261 
Appendix C 
Standard Operating Procedure 
 
SOP No. 45/P1 
______________________________________________________________________ 
Title: 
Bacteriophage Fermentation: Sterilisation and Operation of Applikon 20L Fermenter 
______________________________________________________________________ 
 
WRITTEN BY DATE    OPERATING HEAD  DATE    DOC.REF. 
S. BRANSTON 16/08/07            SOP. 45/P1 
 
 
1.0  Introduction 
 
1.1  This document outlines the procedure to follow for sterilising and setting up the 
fermenter vessel prior to inoculation.  It is based upon SOP 45 (written by I. Buchanan) 
with a few modifications, principally regarding closing down the fermenter. The 
Applikon 20L fermenter has an ADI 1030 Bio Controller for process variables, an ADI 
1065 Bio Bench console for insitu sterilisation and temperature control and an ADI 1035 
Bio Console for gas addition and stirrer speed control.  BioXpert PC software is also 
connected for control and data logging. 
  
1.2  SAFETY NOTE:  In the event of having to leave the building in an emergency (i.e. 
fire alarm), whilst vessel is at pressure during sterilisation cycle, the EMERGENCY 
SHUTDOWN PROCEDURE outlined in steps 3.14 or 3.16 must be followed. 
  There is no need to take any action before leaving the area if operation is not part of 
sterilisation cycle. 
 
 
2.0  Pre sterilisation Set-Up 
 
2.1  Refer to technician or previous fermenter checklist to ensure that no technical faults 
encountered with this fermenter from the previous run, and if any faults noted, verify with 
a member of the technical staff that these have been rectified. 
 
2.2  Ensure the vessel is clean.  If vessel is not clean, carry out appropriate cleaning procedure 
as outlined in SOP No. 32D. 
 
2.3  Check condition of all 'O'-rings and replace any if damaged. 
 
2.4  If the foam probe is to be used, ensure that it is in place and at an appropriate height.  If 
at this stage there is any doubt regarding the appropriate height, ensure that the probe is 
fully down into the headplate so that any later repositioning after sterilisation involves 
moving the probe up to an appropriate height rather than pushing down which may 
possibly cause contamination. 
 
2.5  Check the main air supply PRV is set to 10psi. 
 
2.6  Check condition of Domnick Hunter tetpor air filter cartridges for inlet and exit air 
housings. 
 
2.7  Prepare fermenter ancillaries for separate sterilisation in autoclave. 
  e.g.  Acid addition reservoir with 0.2 µm filter, line and conical connector 
      Alkali addition reservoir with 0.2 µm filter, line and conical connector   262 
      Antifoam reservoir 0.2 µm filter, line and conical connector 
Two Inoculum flasks, lines with Tee’d connector and side-addition valve tree 
      1L Nalgene, line with Tee’d connector and side-addition valve tree 
       20L Nalgene container, line and connector (for harvesting) 
(optional: sterilisation of 1L and 20L Nalgenes for the post-harvesting 
sterilisation of sample and harvest lines) 
      All Nalgenes must have a 0.2 µm exit air filter. 
 
2.8  Calibrate pH probe - see SOP No. 6.  Place probe in fermenter 
 
2.9  Check DOT probe calibration (do not calibrate at this stage) - see SOP No. 7.  Place 
probe in fermenter. 
 
2.10  Ensure agitator is correctly attached to motor drive shaft. 
 
2.11  Ensure harvest port is closed. Attach woven metal mesh harvest line. 
 
2.12  Ensure sample valve is closed. Attach silicone sample line to the sample port. 
 
2.13  Disconnect quick release water to condenser line on Bio Bench. 
  Disconnect quick release water from condenser line on Bio Bench. 
 
2.14  Remove pressure gauge and fill vessel with medium to required level.  Replace pressure 
gauge ensuring seal and tri-clamp are firmly connected. 
 
2.15  Carry out checks on Fermenter Sterilisation Checklist. 
 
 
3.0  Heating Up – Sterilisation 
 
3.1  Ensure protective safety gowns and face visors are worn during sterilisation cycle. 
 
3.2  NOTE.  Ensure to check previous fermenter checklists/calibration records for last  
  recorded temperature map of vessel to determine temperature reading to use as 
sterilisation 
  holding temperature. 
  Due to non linearity of temperature amplifier over entire range , this holding temperature 
  reading may not correspond to 121°C, likewise Pressure Gauge may not correspond to 
1.0 Bar 
  at sterilisation temperature. 
 
3.3  Ensure all valves are closed at this time. 
 
3.4  Open air exit valve V11.01. 
 
3.5  Check agitator speed control is wound fully counter-clockwise.  Set tumbler switch to On 
and  
  manually increase setpoint to 200rpm. 
 
3.6  Open main condensate return valve at wall. 
 
3.7  Open blue handled ball valve to condensate return. 
 
3.8  Open main steam supply valve at wall. 
 
3.9  On the ADI 1030 change the temperature process setpoint to 126°C 
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3.10  Change the temperature process control to Start 
 
3.11  Set the ‘Ferm/Off/Ster’ tumbler switch on the ADI 1065 to ‘Ster’(-ilisation) 
 
3.12  Increase the steam PRV to 30psi 
 
3.13  Valve V-11.01 on exit air filter housing is open to evacuate air from the headspace while 
the vessel heats up.  At around 99°C steam will begin to enter the condenser.  Carefully 
feel the top of the condenser until it gets hot, at which point close the valve. 
 
3.14  EMERGENCY SHUT DOWN: at this stage when vessel is not yet under pressure.  
Close main steam valve at services panel.  Close main condensate return at services 
panel. 
  Press Emergency Stop button on ADI 1065. 
 
3.15  When the temperature in the fermenter reaches 105°C the Biocontroller is programmed to 
open valve VY-10.05 to allow steam into the inlet air filter. Listen for an audible click at 
which point open condensate drain valve V-10.06 below the inlet air filter. 
 
3.16  EMERGENCY SHUT DOWN:  at this stage and from now on when vessel is under 
pressure. Close main steam valve at services panel.  Close main condensate return 
valve at services panel.  Press Emergency Stop button on ADI 1065.  Using heat 
resistant gloves crack open one of the conical connections on the 3 way port, note: 
this may cause media to boil out. 
 
3.17  At 110°C open steam valve V-14.04 and condensate valve V-14.02. 
    
3.18  At 122°C slowly open valve V-11.01 to allow a small amount of steam to vent through 
the filter for the remainder of the sterilisation period. 
 
3.19  Close valve V-14.04.  Open side addition valve V-14.03.  
 
3.20  On the 3 way port turn each connector ring slightly counter clockwise and pull the 
blinded hose barb out in order to create a small bleed of steam. 
 
3.21  Close valve V-10.06.  Open valve V-10.08 to sparge line.  Open valve V-10.07 to 
headspace. 
 
3.22  To sterilise the sample assembly close sample valve V-17.01.   Open steam supply valve 
V-20.02.  Open condensate valve V-17.02. Crack open sample valve V-17.01 and allow 
steam to pass through the tubing into a suitable container. 
 
3.23  To sterilise the harvest port assembly close harvest valve V-12.01. Open steam supply 
valve   V-20.03. Open condensate valve V-12.02. Crack open harvest valve V-12.01 and 
allow steam to pass through the tubing into a suitable container. 
 
3.24  Maintain sterilisation temperature in the vessel for the desired time (usually 20 minutes). 
                                        
 
4.0  Cooling Down After Sterilisation 
 
4.1  Close valves V-17.01, V-17.02 and V-20.02 on sample assembly.  
 
4.2  Close valves V-12.01, V-12.02 and V 20.03 on harvest port. 
 
4.3  Close conical connectors on the 3 way port. 
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4.4  Close valves V-14.02 and V14.03.   
 
4.5  Close valve V-11.01 on exit air line.  
 
4.6  On BioXpert go to Control Laws and select Manual Setpoint ! sGas.  Check the box 
next to Manual and enter a value of 10 L/m.  Check for positive air pressure and 
connect air line to inlet Air filter. 
 
4.7  Close valves V10.08 and V10.07.   
 
4.8  Set Ferm/Off/Ster tumbler switch to Off. 
 
4.9  Close blue handled condensate valve at wall. This is to prevent the Kill Tanks filling 
up with cooling water returning from the condenser. 
 
4.10  Open Cooling Water Return valve at wall.  Open Cooling Water Supply valve at wall. 
 
4.11  Open valve V-10.09 to inlet air filter. 
 
4.12  On the ADI 1030 change the temperature setpoint to the desired process temperature. 
 
4.13  Set ‘ferm/off/ster’ tumbler switch to ‘ferm’(entation). 
  Water will now begin to enter the jacket and the fermenter will begin to cool down. 
 
4.14  At 0.1Bar open valve V-10.07 allowing air into the headspace.  
  The fermenter will now pressurise to 10psi. and cool safely to the new temperature 
setpoint. 
 
 
5.0  Set-Up for Fermentation Running 
 
5.1  The fermenter should now be sterile, pressurised to 10psi., agitator running and 
temperature at setpoint.  The fermenter ancillaries should be sterilised and ready for 
insertion. 
 
5.2  Connect condenser line labelled ‘water from condenser’ to Bio bench. 
  Connect condenser line labelled ‘water to condenser’ to Bio Bench. 
 
5.3  Open blue handled cooling water return ball valve at wall.  Check that the condenser gets 
cold otherwise adjust the condenser tuning valve inside Biobench. 
 
5.3  Slowly release the pressure in the fermenter by gradually opening valve V-11.01 on the 
exit air line. 
 
5.4  Open valve V-10.08 to sparge line.  Close valve V-10.07 to headspace. Check that air is 
sparging and there is no head pressure in the vessel 
 
5.5  Change setpoint of sGas to running value. 
 
5.6  Take a sample and use it to recheck pH.  Refer to SOP No. 6 for adjustment of the pH 
probe at this stage.  A sample can be taken to check sterility. 
 
5.7  With stirrer and air flow at desired settings, check DOT probe is reading 100.0%.  Refer 
to SOP No. 7 for adjustment of DOT probe at this stage.  Ensure mass spec. pump is 
connected and switched on.  Sparge nitrogen through air inlet filter to check DOT probe 
response and to check readings on mass spec.  Once the probe response has been   265 
checked, reconnect fermenter air supply to air inlet filter and ensure air flow is at the 
correct setting. 
 
5.8  For acid, alkali and PPG additions run the tubing through the appropriate pumphead on 
the ADI 1035.  Using aseptic technique remove the blinded conical connectors from the 3 
way inlet and replace with connectors from the addition bottles.  Check and adjust the pH 
setpoint if necessary.  Prime the lines up to the addition inlets.  Switch the acid and 
alkali control switches to the remote position to achieve pH control. 
 
5.9  If using foam control, set the probe height to the working height in the fermenter. Note: 
The probe should not be moved outwards during the fermentation (post inoculation) to 
prevent bacteriophage release. 
 
5.10   Once any other remaining media additions have been added, the fermenter can now be 
inoculated.  Connect the inoculum valve tree to the side addition port. Sterilise side 
addition port by opening steam valve V-14.04 and condensate valve V-14.02 for 20 
minutes. Close valves V-14.04 and V-14.02 once sterilised. Ensure logging has started on 
BioXpert computer before inoculating.  It may be necessary to stop or reduce the air flow, 
to allow the inoculum to run into the fermenter by gravity, or it can pumped in with a 
peristaltic pump. Sterilise the side addition port following inoculation, and disconnect 
inoculum valve tree once cool. 
 
5.11  Connect the valve tree attached to the 1L Nalgene with Tee’d connector to the side 
addition port. Sterilise side addition port by opening steam valve V-14.04 and condensate 
valve V-14.02 for 20 minutes. Close valves V-14.04 and V-14.02 once sterilised. 
 
5.12  Refer to SOP 45/P3 regarding the sampling procedure once inoculation has occurred. 
 
 
6.0  Closing Down The Fermenter 
 
6.1  Switch off automatic control of temperature, pH, etc.  Stop logging on BioXpert. 
 
6.2  Harvest cells if required through harvest port as outlined in SOP 45/P4, leaving stirrer 
running during harvesting.  Turn off stirrer when vessel is almost drained.  Ensure good 
containment practices are adhered to. 
 
6.3  Turn off the stirrer by turning control fully counter-clockwise then set tumbler switch to 
Off 
 
6.4  Close the acid, alkali and antifoam connectors on the 3-way port. 
 
6.5  If the cells are not to be harvested, then they should be killed off by sterilisation, 
following the same procedure as for sterilising the media, but exercising more care due to 
the increased danger of flash boiling.  Additional antifoam can be added to counteract any 
cell lysis which may cause foaming.  Do not attempt to vent steam out through air outlet 
filter if foaming occurs.  
In the event of having to carry out an emergency shut down when the vessel is at 
pressure carry out Step 6.6, below: 
 
6.6  EMERGENCY SHUT DOWN: when vessel is under pressure and contains live culture.  
Close main steam valve at services panel.  Close main condensate return valve at 
services panel.  Press Emergency Stop button on ADI 1065.  Crack open the side-
addition port valve leading to the 1L Nalgene. If this does cause release of any live 
culture, ensure that the collection vessel is autoclaved once the valve tree is re-sterilised 
as in step 5.10 before disconnection. 
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6.7  If cells are harvested, attach the sterile end of the harvest line to the second 20L Nalgene 
container. Remove the harvest line clamp. To sterilise the whole harvest line, ensure the 
harvest port is closed. Open steam supply valve V-20.03 and carefully open the harvest 
valve V-12.01. Ensure steam is passing through into the 20L Nalgene container. Leave 
for 20 minutes to sterilise the line, then close valves V-20.03 and V-12.01. The harvest 
line can now be disconnected.  
 
6.8  Similarly, to sterilise the sample line, attach the sterile end of the line to the second 1L 
Nalgene container. Remove the sample line clamp. To sterilise the whole sample line, 
ensure the sample port is closed. Open steam supply valve V-20.02 and carefully open 
the sample valve V-17.01. Ensure steam is passing through into the 1L Nalgene 
container. Leave for 20 minutes to sterilise the line, then close valves V-20.02 and V-
17.01. The sample line can now be disconnected.  
 
6.9   Refill the vessel with RO water to the working volume via the side addition port, and 
carry out a Sterilisation Kill Cycle using the same procedure as for sterilising the media. 
 
6.10  After killing the cells, clean the fermenter referring to SOP 32D. Ensure that both the 
DOT and pH probes are removed and properly stored before carrying out the cleaning 
procedure. Disconnect and drain the acid, alkali and antifoam vessels. 
  Disconnect the side addition valve-tree. 
Remove air inlet and exit filters. 
 
6.11  Ensure that all valves are closed, all control switches are in the off position and no steam 
or water is left on. 
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Standard Operating Procedure 
 
SOP No. 45/P2 
______________________________________________________________________ 
Title: 
Bacteriophage Fermentation: Inoculation of the Applikon 20L Fermenter to Minimise 
Bacteriophage Release 
______________________________________________________________________ 
 
WRITTEN BY DATE    OPERATING HEAD  DATE    DOC.REF. 
S. BRANSTON 16/08/07            SOP. 45/P2 
Signature        Signature 
 
 
 
 
1.0  Introduction 
 
1.1  This document describes the inoculation of the 20 L Applikon fermenter from a shake 
flask culture so as to minimise the release of bacteriophage into the facility. 
 
1.2  All culture transfers must be conducted away from the ACBE with thorough cleaning 
with 1 % Virkon solution after use. 
 
1.3  All fermentations must be carried out in the Advanced Centre fermentation suite where 
all drains are fed to kill tanks and negative air pressure is maintained so as to contain any 
release. 
 
1.4  Gloves must be worn during all culture transfer operations.  
 
 
 
 
2.0  Preparation for inoculation 
 
2.1  Take both sterilised inoculum flasks (joined by a T joint to a single addition line) to the 
biochemistry department laboratory G09 in a suitable sealed container. Ensure that the 
flasks, tubing and fittings are sound. Ensure gate clamps leading from each inoculum 
flask are closed. 
 
2.2  Aseptically transfer bacteriophage and E. coli inocula from their respective shake flasks 
into the inoculum flasks. 
 
2.3  Should any spillage occur refer to cleanup SOP 45/P5. 
 
2.4  Transfer inoculum flasks to the ACBE fermenter in a suitable sealed container. 
 
 
 
 
3.0  Inoculation 
 
3.1  Turn off the air supply to the fermenter to reduce pressure inside the vessel. Wind the 
silicone tubing through the appropriate pumphead on the ADI 1035 if adding inocula by 
peristaltic pump.  
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3.2  Connect the inoculum valve tree to the side addition port. Sterilise side addition port by 
opening steam valve V-14.04 and condensate valve V-14.02 for 20 minutes. Close valves 
V-14.04 and V-14.02 once sterilised. Remove clamps and allow the inocula to siphon into 
fermenter by gravity, or by peristaltic pump. Close clamps once inoculation is complete. 
Sterilise the side addition port and disconnect inoculum valve tree once cool. 
 
3.4  Treat disconnected inocula flasks with 1% Virkon solution for a minimum of 10 minutes, 
or autoclave to sterilise. 
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Standard Operating Procedure 
 
SOP No. 45/P3 
______________________________________________________________________ 
Title: 
Bacteriophage Fermentation: Sampling from the Applikon 20L Fermenter, minimising 
bacteriophage release. 
______________________________________________________________________ 
WRITTEN BY DATE    OPERATING HEAD  DATE    DOC.REF. 
S.BRANSTON 16/08/07            SOP. 45/P3 
Signature        Signature 
 
 
 
1.0   Introduction 
 
1.1    This document describes a sampling procedure from the 20 L Applikon fermenter during 
normal operation into 5 ml syringes. The procedure is designed to minimise the 
likelihood of bacteriophage release. 
 
 
 
2.0  Preparation of sampling equipment 
 
2.1  Following sterilisation and cooling of the fermenter, aseptically attach the Robersite 
needle-less valve to the sterilised sample port silicone tubing. Ensure that the sample 
tubing is sound. 
 
 
 
3.0   Sampling 
 
3.1  Swab the needle-less valve with towel dampened with 1% Virkon. Insert a sterile 5 ml 
syringe into the needle-less valve, and hold the assembly within paper towel dampened 
with 1 % Virkon solution. Carefully open the sample valve and draw 5 ml into the 
syringe. Close the sample valve. 
 
3.2  Hold the syringe vertically and disconnect from the needle-less valve within the Virkon-
soaked towel. Immediately cap the syringe and discard. Swab the needle-less valve with 
towel dampened with 1% Virkon. 
 
3.3  Insert a fresh 5 ml syringe and repeat the procedure to take the actual sample. Remove the 
capped syringe from the fermentation suite in a suitable container. In case of spillage, 
refer to SOP 45/P5 
 
 
 
4.0  Closing down after sampling 
 
4.1   Once the last sample has been taken, immerse the needle-less valve in a container 
containing 1 % Virkon solution. Clamp the line and detach the needle-valve from the end. 
Ensure Virkon solution  enters the line right up to the clamp seal. Leave in the solution 
for at least 10 minutes. Then follow the closing down section of SOP 45/P1. 
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Standard Operating Procedure 
 
SOP No. 45/P4 
______________________________________________________________________ 
Title: 
Bacteriophage Fermentation: Harvesting from the Applikon 20L Fermenter, minimising 
bacteriophage release. 
______________________________________________________________________ 
 
WRITTEN BY DATE    OPERATING HEAD  DATE    DOC.REF. 
S. BRANSTON               SOP. 45/P4 
Signature        Signature 
 
 
 
1.0  Introduction 
 
1.1    This document describes the harvesting procedure of the 20 L Applikon fermenter into 
sterile 20 L Nalgene containers in a manner minimizing the risk of bacteriophage 
release. 
 
 
 
2.0  Preparation of harvesting equipment 
 
2.1  Attach silicone lines with connectors at both ends to entry and exit ports on a 20 L 
Nalgene container. Ensure the lines are sound. Attach a 0.2 !m filter. Cover exposed 
line connectors with foil. Autoclave. Post-autoclaving, inspect the container and all 
lines for sign of damamge. If identified, renew where necessary. 
 
 
 
3.0  Harvesting 
 
3.1  Using aseptic technique, attach the harvest line from the 20 L Nalgene to the fermenter 
harvest port.  
 
2.2  Open the harvest port valve and drain cells and bacteriophages into the Nalgene. Turn 
off the stirrer when vessel is almost drained. 
 
2.3  Once drained, close the harvest port and valve V-12.01. Clamp the silicone harvest 
line in two places near the Nalgene. Immerse the line and both gate clamps under 1% 
Virkon solution and cut the line between the clamps. Ensure Virkon solution  enters the 
line right up to the clamp seal. Leave for 10 minutes. In case of spillage, refer to SOP 
45/P5. 
 
2.4  Continue to close down the fermenter as outlined in SOP 45/P1. 
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SOP No. 45/P5 
______________________________________________________________________ 
Title: 
Procedure for Decontamination following Bacteriophage Spillage 
______________________________________________________________________ 
WRITTEN BY DATE    OPERATING HEAD  DATE    DOC.REF. 
S. BRANSTON               SOP. 45/P5 
Signature        Signature 
 
 
 
 
1.0  Introduction 
 
1.1  This document describes the procedure to be followed following accidental release of 
bacteriophage in the ACBE fermentation suite. 
 
1.2  This SOP is based upon experimental data to show the effectiveness of the disinfectant 
chosen in achieving sterility; in particular the length of time required for contact of the 
sterilising agent with the spillage. 
 
 
 
2.0  Small spills (a few mls) 
 
2.2  In the event of a spillage, the operator should wear latex or nitrile gloves in addition to 
the usual lab coat and glasses. Small spills of the order of a few millilitres should be 
treated with 1 % Virkon solution. Liberally spray the Virkon solution around the 
spillage area and leave for 10 minutes. 
 
2.3  Wearing gloves, after 10 minutes any broken glassware can be collected and carefully 
disposed. 
 
2.4  The spillage can then be safely mopped up and dried with paper towels. All paper 
towels should be discarded in the contaminated waste bin. 
 
2.5   The building manager or person responsible for safety should be informed of the 
spillage and the   measures taken to deal with it. 
 
 
 
3.0   Large spills (tens of mls) 
 
3.1   In the event of a large spillage, again the operator should wear latex or nitrile gloves in 
addition to the usual lab coat and glasses. Treat the spill by the addition of Virkon 
powder directly, until all liquid is absorbed. Take care not to inhale the dry powder. 
Scrape or sweep the damp powder into a container for disposal. Subsequently apply 1 % 
Virkon solution to the affected area. After 10 minutes contact time, wipe dry with paper 
towels. 
 
3.2  The building manager or person responsible for safety should be informed of the 
spillage and the   measures taken to deal with it. 
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4.0   Wholesale release (litres) 
 
4.1  In the unlikely event of extremely large spillages (such as fermenter or harvest vessel 
failure) the operator should follow the procedure for large spills. 
 
4.2   The building manager or person responsible for safety should be informed of the 
spillage and the measures taken to deal with it.  
 
4.3  The area should be monitored in the weeks afters the spillage: take swabs at regular 
intervals for viable bacteriophage around the hall and keep a record of future culture 
infections. 
 
4.4  If persistent infection of cultures by the released bacteriophage occurs in the following 
months, then hydrogen peroxide or formaldehyde fumigation of the facility may need to 
be considered. 
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Appendix D 
20 Litre Applikon Fermentation Risk Assessment 
Growth of E. coli infected with the filamentous bacteriophage M13 
 
Evaluation of risk concerning bacteriophage containment 
  
Project:  
An investigation of the properties of bacteriophage M13 and the implications for its large-scale 
bioprocessing. 
Locations:    
The Department of Biochemical Engineering, ACBE fermentation hall and downstream 
processing areas. 
Description of work:   
The work will involve fermentation of E. coli infected with bacteriophage M13 in the 20L 
Applikon fermenter. The objective is to investigate the yield of bacteriophage on this scale, as 
well as to gain bacteriophage stocks for further experimentation.  
Persons involved:  
Steven Branston and Emma Stanley are the investigators. Involved academic staff are Eli 
Keshavarz-Moore and John Ward. Clive Orsborn and Gareth Mannall are involved with 
ensuring containment of bacteriophage. 
Hazard Identification (i.e. potential release points): 
o  Introduction of bacteria and phage inoculum flasks into fermentation hall 
o  Normal operation and sampling 
o  Harvesting into sealed containers 
o  Operation problems 
 
Risk Assessment:  
Assessment of the risks involved concerning bacteriophage release. 
 
Inoculation 
Risk of bacteriophage release is low but contamination could arise from: 
o  Bacteriophage contaminated inoculum flask outer surface- surface contamination risk. 
o  Breakage of the bacteriophage inoculum flask- aerosol and surface contamination risk. 
o  Inoculum line leak- aerosol and surface contamination risk 
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Normal operation and sampling 
Risk of bacteriophage release should also be low, but during normal operation unexpected 
bacteriophage release could arise from: 
o  Sample line leak- aerosol and surface contamination risk 
 
Harvesting into sealed containers 
Risk of bacteriophage release should be low if proper procedures are followed, but could 
unexpectedly arise from: 
o  Harvest line leak- aerosol and surface contamination risk 
 
Operation problems 
Risk of bacteriophage release should be low in the event of a fermenter electrical or mechanical 
fault, since manual shutdown is always available. Blockage of the exit gas filter may pose a 
release risk if pressure within the fermenter is allowed to build up to a point such that air pushes 
back into the acid, base and PPG containers. 
 
Control Measures:   
The control measures to minimize the probability of bacteriophage release apply to those in 
charge of the fermentation. 
 
Inoculation 
o  Good laboratory practice ensures flask outer surfaces are not contaminated. 
o  Inoculum flasks are transported in a secure manner (i.e. not by the flask necks). 
Consider the use of plastic, not glass inoculum flasks. Spillage from the bacteriophage 
inoculum flask presents one of the contamination risks most likely to occur. 
o  Applikon fermenter SOP 45/P2 is followed regarding inoculation procedure. 
 
Normal operation and sampling 
o  As part of the sampling SOP 45/P3, the sample line must be inspected prior to the 
fermentation and be renewed if necessary. 
o  providing that the SOP specifically concerning sampling are adhered to, there should be 
a low risk of bacteriophage release. The frequency of sampling means the risk of release 
may be higher than that of inoculation. 
o  The fitting and checking of exit and inlet air filters prior to fermenter sterilisation 
should prevent bacteriophage release from the fermenter off-gas. 
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Harvesting into sealed containers 
o  All harvest lines must be inspected prior to the fermentation and be renewed if 
necessary. This procedure is outlined in SOP 45/P4. 
o  Adherence to the devised harvesting SOP 45/P4 should minimise the risk of 
bacteriophage release. Spillage from the post-fermentation liquor presents the greatest 
consequences of bacteriophage release, due to the high phage concentration and largest 
volumes being handled. 
 
Operation problems 
A known potential issue is the blockage of the exit gas filter. A heated jacket is available, which 
will minimize the likelihood of blockage. Exit air filters on acid, base and PPG containers will 
prevent phage release in the event of fermenter pressure build up and flow back. The fermenter 
will be run in the daytime, and therefore not left unmanned for long periods. 
 
In the event of spillage, the operator should turn to SOP 45/P5, detailing how to deal with 
bacteriophage-contaminated spills. Briefly, small areas can be treated with a 1 % solution of 
Virkon, whilst larger areas can be treated with Virkon powder directly. 
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